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ABSTRACT
Introduction: Articular cartilage comprises a dense extracellular matrix (ECM) of 
primarily collagen, proteoglycans and water interspersed with the cartilage cell- the 
chondrocyte. Osteoarthritis (OA) is a disease characterised by articular cartilage 
degradation and a change in chondrocyte phenotype. Increased or abnormal joint loading 
is a risk factor for OA and can regulate chondrocyte phenotype. The chondrocyte 
cytoskeleton comprises actin microfilaments, tubulin microtubules and vimentin 
intermediate filaments and has been implicated in the propagation of physical signals to 
the chondrocyte nucleus, termed ‘mechanotransduction’. In addition, the organisation of 
chondrocyte cytoskeletal networks has been observed to differ in both human OA and in 
a rat model of OA when compared with normal chondrocytes. We hypothesise that 
dysregulation of cytoskeletal networks prevents normal ECM-chondrocyte signalling 
and promotes a catabolic phenotype as in OA.
Results: When compared with normal human chondrocytes, OA chondrocytes exhibited 
differences in the gene expression of components o f the cytoskeleton and in the spatial 
organisation and architecture of the cytoskeleton, both in situ and in vitro. In normal and 
OA human chondrocytes cultured in agarose hydrogels, disruption of each of the three 
main cytoskeletal elements resulted in gene expression changes in both normal and OA 
cells. A number of gene responses to cytoskeletal disruption were similar in normal and 
OA cells, such as SOX9, MMP14, TGFB1, CASP3 and PTGS2 (COX-2). Other genes 
responded differently to the same treatment in normal versus OA cells, including 
ADAMTS5, COMP, FGFR3 and NOS2A (iNOS). Cyclic compression (15% strain, 0.5 
Hz) for up to 40 minutes induced cytoskeletal reorganisation in normal and OA human 
chondrocytes and up-regulation of p-tubulin and destrin mRNA expression. Recovery in 
free swelling conditions for five hours post-load showed the chondrocyte phenotype was 
enhanced in OA chondrocytes. Cyclic compression in the presence of cytoskeletal 
disruption altered the transcriptional response of the actin depolymerising proteins 
cofilin and destrin in normal and OA chondrocytes, and the transcriptional response of 
SOX9 and the actin sequestering protein thymosin p4 in OA chondrocytes.
Conclusions: Changes in the cytoskeleton of OA chondrocytes are not simply a result of 
the altered mechanical environment in OA articular cartilage. Changes in the 
cytoskeleton can affect chondrocyte phenotype and the response of chondrocytes to 
cyclic compression, therefore the observed differences in organisation and expression 
could result in the altered phenotype of OA chondrocytes. Differences between the 
effect of cyclic compression on normal and OA human chondrocytes support the 
existence of different or divergent mechanotransduction pathways that are mediated in 
part by elements of the chondrocyte cytoskeleton.
ABBREVIATIONS
Human gene names are denoted using capitals in italics and human proteins (where the 
name is the same as that of the gene) are in capitals.
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1. GENERAL INTRODUCTION
1.1 Articular Cartilage
Articular cartilage is an avascular and aneural tissue, located at the ends of the long 
bones in articulating joints. It functions to protect the ends of the bones during joint 
movement and does this by providing an almost ffictionless surface to allow smooth 
articulation of the joint. Articular cartilage also protects the ends of the bones by 
dissipating any load experienced by the joint during movement.
1.1.1 Organisation of Articular Cartilage
The organisation of articular cartilage is not uniform throughout. The shape and spacing 
of chondrocytes and the orientation of collagen fibrils allows the cartilage to be split into 
zones, with the superficial zone beneath the articular surface, transitional (mid) zone, 
and radial (deep) zone above the calcified cartilage and subchondral bone (Fig 1.1). The 
superficial zone contains flattened chondrocytes orientated parallel to the articular 
surface. Collagen fibrils also run parallel to the surface and provide the superficial zone 
with high tensile strength, allowing it to resist and dissipate load applied to the tissue. 
The chondrocytes of the transitional zone possess a more rounded shape and collagen 
fibrils have an orientation intermediate to that of the superficial and deep zones, more 
randomly distributed but well-defined around chondrocytes (Pelletier et al., 1983b). In 
the radial (deep) zone, chondrocytes are spherical and arranged in columns with collagen 
fibres orientated perpendicular to the articular surface. The differences in the 
extracellular matrix (ECM) in these zones and the orientation of collagen fibrils lead to a 
difference in the mechanical properties of each zone.
In addition to the zonal variations within cartilage, the extracellular matrix can be 
divided into territories based on the matrix composition and its location with respect to 
the chondrocyte. Immediately surrounding a single chondrocyte is the pericellular matrix 
and together these make up the chondron [reviewed in (Poole, 1997)]. Surrounding 
chondrons are the ‘territorial’ matrices and these are separated from each other by the 
‘interterritorial’ matrix, which makes up the largest portion of the ECM of cartilage.
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> Calcified Cartilage
Figure 1.1:- Histologic micrograph and schematic diagram of the zonal 
organisation of human articular cartilage. Collagen fibrils are arranged 
parallel to the articular surface in the superficial zone and they become 
perpendicular to the surface in the deep zone; in the transitional zone fibrils 
have an intermediate orientation. Adapted from Griffin and Guilak (2005).
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1.1.2 Composition of Articular Cartilage
The characteristic functions of articular cartilage can be related to its structure and 
composition. The four main components of articular cartilage are collagen, 
proteoglycan, water, and the cartilage cell- the chondrocyte.
1.1.2.1 Collagen
Articular cartilage contains a heterogeneous network of collagen, consisting 
predominantly of type II collagen (80-90% of the total collagen), with small amounts of 
types VI, IX and XI collagen. Type II collagen forms fibrils along with types IX and XI 
collagen. These vary in diameter, with thicker fibrils located in the interterritorial matrix 
and thinner fibrils in the pericellular matrix. Type IX collagen is associated 
predominantly with thin collagen fibrils (Fig 1.2) and displays a largely pericellular 
localisation in mature mammalian articular cartilage (Hagg et al., 1998). Type VI 
collagen is also localised to the pericellular matrix and is used as a marker of chondron 
microanatomy (Poole, 1997).
The collagen matrix provides the tissue with its mechanical strength, resisting 
mechanical stress and reducing the deformation of the tissue in response to these 
stresses. The tensile strength of the collagen matrix also functions to resist the swelling 
pressure of the proteoglycans (Maroudas, 1976), and thus provides cartilage with 
elasticity, allowing recovery after deformation in response to applied load.
1.1.2.2 Proteoglycan
Large aggregating proteoglycans (‘aggrecan’) represent the largest proportion of the 
proteoglycans present in articular cartilage. An aggrecan monomer consists of a 
multidomain protein core containing two globular domains towards the N-terminus (G1 
and G2) and one at the C-terminus (G3) (Hardingham and Fosang, 1992). These are 
separated by chondroitin sulphate (CS) and keratan sulphate (KS) domains, to which the 
glycosaminoglycans CS or KS are attached. These glycosaminoglycans (GAGs) are 
highly negatively charged. Aggrecan monomers bind non-covalently, through their G1 
domain and link protein, to hyaluronic acid, resulting in the formation of large anionic 
complexes which sequester water molecules (Fig 1.2).
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Figure 1.2:- A schematic diagram illustrating the interaction between the major 
components of articular cartilage. Type II collagen forms fibrils along with types 
IX and XI collagen. Aggrecan interacts with hyaluronan through link protein to 
form large aggregating proteoglycans which bind water molecules. Extracellular 
matrix receptors expressed by the chondrocytes, including integnns and CD44, 
bind to matrix molecules. COMP- cartilage oligomeric protein, GAG- 
gly co saminogly can.
Adapted from (Silver and Glasgold, 1995)
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Other proteoglycans present in articular cartilage include the small leucine-rich 
proteoglycans (SLRPs) decorin, biglycan and fibromodulin. These molecules bind to 
other matrix molecules and help stabilise the matrix. Biglycan has a pericellular 
distribution whilst fibromodulin is interterritorial and decorin is found associated with 
thick collagen fibrils in the interterritorial matrix of the superficial and deep zones (Hagg 
et al., 1998).
Proteoglycans provide the articular cartilage with its elastic properties. As the tissue is 
deformed under mechanical compression, water is forced out of the region under stress. 
Following removal of the stress, the hydrophilic proteoglycans attract water in to the 
deformed region and cause it to return to its original state.
1.1.2.3 Water
Water constitutes between 65-80% of the wet weight of healthy human articular 
cartilage and varies with age; from newborn to age 2 0 , water content decreases from 
around 80% to 65-70% (Amado et al., 1976, Maroudas et al., 1973). Water is held in the 
articular cartilage tissue by proteoglycans and is an important component of articular 
cartilage. The movement of water molecules helps to dissipate any load applied to the 
cartilage and also enables the tissue to return to its original state following the removal 
of load; water is therefore essential to the mechanical properties and function of articular 
cartilage. Changes in water content, whether with age, loss of proteoglycans or 
disruption of collagen fibrils, would therefore affect the mechanical properties and 
function of cartilage. Increases in water content correlate with increases in tissue 
permeability and decreases in the equilibrium modulus (i.e. decreases in tissue matrix 
stiffness) in human articular cartilage (Armstrong and Mow, 1982). This is observed in 
osteoarthritic (OA) cartilage, which contains 6-9% more water than normal cartilage 
(Mankin and Thrasher, 1975, Maroudas et al., 1973).
1.1.2.4 Other Extracellular Components o f Articular Cartilage
The remaining macromolecules of the articular cartilage ECM are the non-collagenous 
proteins and glycoproteins, including cartilage oligomeric protein (COMP), fibronectin, 
and tenascin C (Buckwalter and Mankin, 1998). COMP is a pentameric glycoprotein 
used as a systemic marker of OA, whilst tenascin C is an oligomeric glycoprotein, 
shown to be mechanically regulated in fibroblasts (Chiquet, 1999) and capable of 
interfering with the adhesion of cells to fibronectin. Fibronectin is localised to the
- 5 -
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pericellular matrices of articular cartilage, interacting with type IX collagen and the cell 
surface of chondrocytes through the integrin cell surface receptors.
1.1.2,5 Extracellular Proteinoses
The predominant proteinases present in articular cartilage are the matrixin sub-family of 
metalloproteinases known as the matrix metalloproteinases (MMPs). There are 23 
different MMPs in humans (Table 1.1) and all are multidomain zinc metalloproteinases 
that exhibit sequence homology with the catalytic domain of MMP-1 (Murphy and 
Nagase, 2008). MMPs have historically been grouped based on their domain 
organisation and substrate preferences (Table 1.1); the gelatinases have three repeats of a 
fibronectin type II repeat inserted into their catalytic domain whilst the matrilysins lack a 
hemopexin domain (Figure 1.3). MMPs exhibit a zinc-dependant catalytic mechanism at 
the active site and are synthesised as pre-proenzymes. The signal peptide is removed 
during translation to generate proMMPs which are secreted in zymogen form. Activation 
of the latent forms of MMPs is proteolytic and can be performed by other MMPs or 
proteinases of the extracellular matrix, or by autocatalytic cleavage [reviewed in 
(Woessner, 1991)]. For example, all membrane-type MMPs (MT-MMPs) except MT4- 
MMP can activate proMMP-2 (Murphy and Nagase, 2008) and MT1-MMP (MMP-14) 
can also activate proMMP-13 (Knauper et al., 1996). MMPs have a role in ECM 
remodelling in both biological (e.g. wound healing) and pathological (e.g. cancer cell 
metastasis and arthritis) processes. The MMPs expressed in articular cartilage 
chondrocytes are indicated in table 1 .1, as are any changes with osteoarthritis, which are 
discussed in more detail in section 1.3.1.1.2.
The natural inhibitors of MMPs, called tissue inhibitors of metalloproteinases (TIMPs), 
bind reversibly in a 1:1 complex to the MMPs [reviewed in (Nagase et al., 2006)]. There 
are four TIMPs that have currently been characterised and they each show a different 
specificity for the different MMPs. Expression of all four TIMPs has been detected in 
human articular cartilage (Kevorkian et al., 2004). In normal cartilage there is a balance 
between the levels of TIMPs and MMPs, with a small excess of inhibitor (Dean et al., 
1989). The importance of this balance is indicated by the imbalance present in OA 
cartilage; an increase in MMPs is observed that is not sufficiently matched by an 
increase in TIMPs which ultimately results in ECM degradation and progression of OA. 
In human OA cartilage, levels of TIMP3 mRNA are elevated whilst TIMP1 and TIMP4
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mRNA levels are decreased when compared with normal tissue; TIMP2 mRNA levels 
are unchanged (Kevorkian et al., 2004).
Sub-group MMP Articular Cartilage Substrates In
Cartilage
Change 
with OA
Collagenases MMP-1 types I, II, III & X collagen, FN Yes111 ▼ '■'no'21
MMP-8 types I, II & III collagen No' 11
MMP-13 types I, II & III collagen, perlecan Yes" '31 ^ [ 1 - 3 ]
Gelatinases MMP-2 types I, II, III, V, X & XI collagen, 
aggrecan, decorin, laminin
Yes' 11 A '11
MMP-9 types V & XI collagen, denatured 
fibrillar collagens, aggrecan, FN
Yes' 11 A '11
Stromelysins MMP-3 decorin, perlecan, FN, laminin, types 
III, IX & X collagen
Yes' 11 y [ 1 . 2 ]
MMP-10 FN, weakly types III & V collagen Yes'11 T '11
Matrilysins MMP-7 decorin, FN
MMP-26 FN Yes'11
MMP-11 No' 11
MT-MMPs
1) TM-type
2) GPI- 
anchored
MMP-14 types I, II & III collagen141, aggrecan, 
CD44, proMMP-2 & proMMP-13
Yes'11 nc'11
MMP-15 laminin, FN, aggrecan, perlecan151
MMP-16 type III collagen, FN Yes'11 A '11
MMP-24 Yes'11
MMP-17
MMP-2 5
Other MMP-12 Yes'61
MMP-19 aggrecan, COMP, laminin, FN Yes'11
MMP-20 aggrecan, COMP No'11
MMP-21 Yes'11
MMP-23 Yes'11
MMP-27 Yes' 11
MMP-28 Yes' 11 A '11
Table 1.1:- Human matrix metalloproteinases (MMPs) and their substrates. Only 
substrates relevant to articular cartilage are included. MMPs whose expression has 
been detected in articular cartilage are indicated along with up- (A ) or down- (T ) 
regulation in osteoarthritic (OA) cartilage. COMP- cartilage oligomeric protein, FN- 
fibronectin, GPI- glycosylphosphatidylinositol, TM- transmembrane. [1](Kevorkian et 
al., 2004), pl(Bau et al., 2002), |31(Brew et al., 2010b), [41(Ohuchi et al., 1997), 
[5,(d'Ortho et al., 1997), [61(Kerkela et al., 2001).
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A- Matrix Metalloproteinases
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Figure 1.3:- A schematic representation of the primary domain structure of matrix 
metalloproteinases (A) and ADAMTSs (B), adapted from Nagase et al, (2006) 
and Porter et al, (2005), respectively. Cy- cytoplasmic domain, Cys-rich- 
cysteine-rich domain, DID- disintegnn domain, FNB- fibronectin type II repeal, 
GPI- glycosylphosphatidylinositol anchor, Ll/2- linker 1/2, SP- signal peptide, Sp 
R- spacer region, TM- transmembrane domain, TS- thrombospondin type I motif.
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Other enzymes involved in matrix turnover have been characterised as belonging to the 
ADAMTS (A Disintegrin and Metalloproteinase with ThromboSpondin motifs) gene 
family. There are 19 ADAMTS genes in humans (Table 1.2) and all are expressed in 
human articular cartilage, with the exception of ADAMTS-7 and -8  (Kevorkian et al., 
2004, Porter et al., 2005). As for MMPs, ADAMTSs are synthesised as inactive pre­
proenzymes and the signal peptide removed during translation (Porter et al., 2005). The 
pro-domain is proteolytically cleaved from ADAMTSs by furin before secretion (Figure 
1.3), although in the case of ADAMTS5, pro-domain processing occurs extracellularly 
(Longpre et al., 2009). The domain structure of ADAMTSs varies most at the C- 
terminus due to variations in the number of C-terminal thrombospondin type I motif 
(TS) repeats (Porter et al., 2005). The C-terminal TS repeats and spacer region are 
involved in ECM binding (Figure 1.3); for example, ADAMTS-7 and -12 bind COMP 
through their four C-terminal TS repeats (Liu et al., 2006a, Liu et al., 2006b) whilst 
ADAMTS4 binds to sulphated GAGs on aggrecan through its only TS motif and sites in 
the cysteine-rich and/or spacer region (Flannery et al., 2002). C-terminal processing of 
ADAMTSs can therefore alter ECM substrate binding and enzymatic activity. The 75 
kD full-length active form of ADAMTS4 undergoes C-terminal processing to produce 
isoforms of 60 and 50 kD (Gao et al., 2002). This releases ADAMTS4 from the ECM, 
increases the number of substrates cleaved and changes the site in aggrecan cleaved by 
the protease (Kashiwagi et al., 2004). C-terminally truncated ADAMTS5 retains 
aggrecanase activity and the ability to bind to sulphated GAGs, but aggrecanase activity 
is significantly decreased with truncation before the first TS motif (Zeng et al., 2006). 
Enzyme activity can also be regulated by binding to other ECM molecules; for example 
fibronectin binds to the spacer region of ADAMTS4 and inhibits its aggrecanase activity 
(Hashimoto et al., 2004).
ADAMTS-4 and -5 are referred to as aggrecanase-1 and -2 respectively [reviewed in 
(Caterson et al., 2000)], but ADAMTS-1, -9 and -15 also exhibit aggrecanase activity 
(Porter et al., 2005). A number of the ADAMTSs are dysregulated in human OA 
cartilage (Table 1.2). However knockout or knockdown studies have shown that 
ADAMTS5 is the aggrecanase involved in OA and inflammatory arthritis progression in 
mice (Glasson et al., 2004, Glasson et al., 2005, Stanton et al., 2005, Majumdar et al., 
2007) whereas both ADAMTS-4 and -5 mediate aggrecan degradation in human 
articular cartilage and human OA (Song et al., 2007); therefore only ADAMTS-4 and -5
- 9 -
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are discussed further. In addition to C-terminal processing discussed above, the activity 
of ADAMTS-4 and -5 can be regulated by TIMP3, which binds to and inhibits the 
aggrecanases (Kashiwagi et al., 2001). At the transcriptional level, ADAMTS4 
expression is induced by pro-inflammatory cytokines in human chondrocytes, whilst 
ADAMTS5 is constitutively expressed and is either modestly or unaffected by cytokines 
(Bau et al., 2002, Song et al., 2007, Fosang et al., 2008); work in our laboratory has 
demonstrated that ADAMTS5 expression is up-regulated in response to IL-1 in 
combination with oncostatin M.
Also present in the ECM are the serine proteinases which function in the turnover of 
matrix molecules. In addition to extracellular proteinases, the aspartate and cysteine 
proteinases are involved in the turnover of the ECM, but function predominantly 
intracellularly. These proteinases are not covered by the present study but have been 
reviewed recently (Cawston and Wilson, 2006, Cawston and Young, 2010).
LI.2.6 Chondrocyte
Chondrocytes are the cells embedded within the articular cartilage. In an aneural and 
avascular environment, they are responsible for the maintenance of the articular 
cartilage, synthesising and secreting collagen, proteoglycans and other ECM molecules. 
They also regulate the turnover of the matrix as they synthesise the proteinases which 
degrade the ECM components. The balance of synthesis and degradation of the matrix, 
as controlled by the chondrocyte, is essential in maintaining the function of articular 
cartilage. An imbalance and shift towards a catabolic phenotype, as occurs in OA 
[reviewed in (Goldring, 2000)], ultimately results in degradation of the articular cartilage 
and failure of the joint.
1.1.2.7 Extracellular Matrix Receptors
As discussed above, cartilage is an avascular and aneural tissue. This lack of ‘input’ 
from the outside environment means that the chondrocytes are responsible for tissue 
homeostasis. In normal cartilage each chondrocyte is surrounded by its pericellular 
matrix so there is no cell-cell contact. Cell-matrix interactions therefore provide the 
means of regulating chondrocyte metabolism and cartilage homeostasis. These 
interactions are through the cell adhesion receptors expressed by the articular cartilage 
chondrocytes, including both integrin and non-integrin transmembrane ECM receptors.
- 10-
Chapter 1: General Introduction
ADAMTS Articular Cartilage Substrates In
Cartilage11]
Change 
with OA[1]
ADAMTS-1 aggrecan Yes T
ADAMTS-2 procollagen I, II & III N-propeptides Yes ▲
ADAMTS-3 procollagen II N-propeptide Yes
ADAMTS-4 aggrecan, decorin, biglycan, fibromodulin Yes
ADAMTS-5 aggrecan, biglycan Yes T
ADAMTS-6 Yes
ADAMTS-7 COMPw No
ADAMTS-8 No
ADAMTS-9 aggrecan Yes ▼
ADAMTS-10 Yes
ADAMTS-12 COMP|JJ Yes A
ADAMTS-13 Yes
ADAMTS-14 procollagen I N-propeptide Yes A
ADAMTS-15 aggrecan Yes T
ADAMTS-16 Yes A
ADAMTS-17 Yes
ADAMTS-18 Yes
ADAMTS-19 Yes
ADAMTS-20 Yes
Table 1.2:- Human ADAMTSs (A Disintegrin and Metalloproteinase with 
ThromboSpondin motifs) and their substrates, adapted from Porter et al, (2005). Only 
substrates relevant to articular cartilage are included. ADAMTSs expressed in human 
articular cartilage are indicated along with up- (A ) or down- (T )  regulation in 
osteoarthritic (OA) cartilage. COMP- cartilage oligomeric protein. ll](Kevorkian et 
al., 2004), pl(Liu et al., 2006a), (3,(Liu et al., 2006b).
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1.1.2.7.1 Integrins
The integrins are a large family of cell adhesion molecules that are expressed on most 
cell types, including chondrocytes. They are heterodimeric transmembrane glycoproteins 
consisting of one a and one p subunit. There are eight genes encoding p integrin subunits 
and 18 encoding a  integrin subunits in mammals, with 24 different ap combinations 
identified at the protein level (Humphries et al., 2006).
Non-osteoarthritic human adult articular chondrocytes have been shown, by 
immunohistochemistry, to strongly express pi and a5 integrin subunits and to weakly 
and occasionally express a l and a3 integrins in situ (Salter et al., 1992). These results 
were supported by another group who also reported expression of the aVp5 and aVp3 
heterodimers (Woods et al., 1994). Another study demonstrated expression of a l, a5, 
aV, p i, p5 and occasionally P4 integrin subunits by both normal and osteoarthritic 
articular chondrocytes in situ (Ostergaard et al., 1998). The aV integrin subunit was 
observed to vary between the different cartilage zones and was more highly expressed in 
the surface zone when compared with the deep zone (Woods et al., 1994, Ostergaard et 
al., 1998). Chondrocyte integrin expression may be altered by enzymatic isolation of 
cells from tissue and changes in the ECM, with the expression levels of integrins shown 
to increase with culture period (Woods et al., 1994, Knudson and Loeser, 2002). Foetal 
chondrocytes express a 6 pi integrin (Salter et al., 1995) and chondrosarcoma and 
immortalised chondrocytes express higher levels of a 2 pl integrin compared to adult 
chondrocytes (Holmvall et al., 1995, Loeser et al., 2000), indicating that integrin 
expression also alters with chondrocyte differentiation (Knudson and Loeser, 2002).
Integrin expression can also change with osteoarthritis. Osteoarthritic cartilage stained 
for a2 and occasionally a4 and P2 integrins and these were not detected in normal 
samples (Ostergaard et al., 1998), which suggests that the expression of certain integrins 
by chondrocytes may be altered by damage or loss of the ECM as occurs in OA. 
Expression levels of a lp l  and a5pl integrins are elevated in OA cartilage when 
compared with normal tissue (Loeser, 2000). Furthermore, chondrocytes enzymatically 
isolated from human OA cartilage expressed a l, a2, a3, a4, a5, a 6 , aV and pi integrin 
subunits, with the most frequently expressed of the a subunits being a l ,  followed by a3, 
a5 then a2 (Lapadula et al., 1997).
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A common integrin-binding motif present in integrin ligands is the peptide sequence 
Arg-Gly-Asp (RGD). The extracellular domain of both a and p subunits are at the In­
ternum and both determine the specificity of the integrin. The ECM of articular cartilage 
contains a number of known integrin ligands (Table 1.3). Type VI collagen and 
fibronectin are bound by a lp  1 and a5pl integrins respectively- the primary chondrocyte 
receptors for these molecules (Loeser et al., 1995). Type II collagen is also a ligand of 
al pi integrin, as is matrilin-1 (Loeser et al., 1995, Knudson and Loeser, 2002). Another 
integrin receptor for type II collagen was identified as alOpl integrin. Originally isolated 
from bovine chondrocytes, it has been shown to be expressed by human articular 
chondrocytes in situ by immunohistochemistry and to bind both type I and type II 
collagen, but not fibronectin (Camper et al., 1998).
Integrin Ligand
a lp l Collagen, Laminin
a5pl {RGD) Fibronectin, COMP, Osteopontin
alOpi Collagen, Laminin
aVpl {RGD) Fibronectin, Vitronectin, Osteopontin, BSP, LAP-TGFp
aVp3 {RGD) Fibronectin, COMP, Vitronectin, Tenascin, Osteopontin, BSP, 
MMP-2, LAP-TGFp
aVp5 {RGD) Vitronectin, Osteopontin, BSP
a3pl Collagen, Fibronectin
a 6 pl Laminin
a2 pi Collagen, Laminin
a4pi Fibronectin, Osteopontin
Table 1.3:- Integrin heterodimers detected in articular chondrocytes and their 
extracellular ligands. Information is adapted from Loeser (2000) and Humphries et al, 
(2006) and only ligands relevant to cartilage and bone are included. Integrins that 
recognise the Arg-Gly-Asp (RGD) peptide sequence are indicated. BSP- bone 
sialoprotein, LAP-TGFp- latency-associated peptide transforming growth factor p.
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At the C-termini of a and p integrin subunits are the cytoplasmic domains. These 
cytoplasmic tails bind to signalling proteins and adaptor proteins. The ‘adaptor proteins’ 
are actin-binding proteins, making integrins a physical link between the ECM and the 
cytoskeleton. These cytoplasmic signalling complexes can be disrupted by catabolic 
mediators such as nitric oxide, which prevented the intracellular assembly of F-actin but 
did not affect clustering of a5pl integrin in the presence of its ligand fibronectin 
(Clancy, 1999). The proteins associated with the cytoplasmic tails and actin-binding 
proteins provide integrins with ‘bidirectional’ signalling properties. Binding of ligand to 
the integrin extracellular domains signals to the cytoplasmic tails, likely through a 
conformational change, resulting in phosphorylation of proteins in the cytoplasmic 
integrin-associated protein complex and subsequent signalling events. This is termed 
‘outside-in’ signalling, with extracellular changes transmitted to the cell. For example, 
chondrocyte binding of fibronectin by a5pl integrin is required to support constitutive 
proteoglycan synthesis (Clancy, 1999). It is through ‘outside-in’ signalling that integrins 
function as mechanoreceptors, sensing mechanical forces applied to the ECM and 
transducing the signal to effector proteins inside the cell; the role of integrins in 
mechanotransduction is discussed in more detail in section 1.4.2.1.2.
Integrins are also capable of signalling in the other direction, transmitting changes 
within the cell to the extracellular matrix. ‘Inside-out’ signalling occurs through 
modulation of integrin-ligand binding by proteins in the cytoplasmic complex. This 
‘integrin activation’ is mediated by the cytoplasmic domains and is required to increase 
the integrin affinity for a specific ligand (Longhurst and Jennings, 1998).
1.1.2.7.1.1 Cytoplasmic Integrin Complexes
Integrins do not have enzymatic or actin-binding properties themselves, therefore 
structural and signalling events are mediated by proteins associated with their 
cytoplasmic tails. Over 50 proteins have been identified in cytoplasmic focal adhesion 
complexes (Lo, 2006). Several are illustrated in figure 1.4, but only paxillin, talin, 
vinculin and focal adhesion kinase (FAK) are discussed here. One study of focal 
adhesion development in migrating endothelial cells demonstrated that newly formed 
focal complexes contained tyrosine phosphorylated (33 integrin at the leading edge 
(Zaidel-Bar et al., 2003). Talin and paxillin were incorporated next, followed by vinculin 
and FAK; all co-localised with phospho-tyrosine labelling. The application of
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mechanical stress to integins, either externally through the ECM or internally through 
actin contractility, increases the recruitment of talin and vinculin to focal adhesions and 
results in FAK-dependent adhesion strengthening (Ziegler et al., 2006, Dumbauld et al., 
2010).
Talin functions as an adaptor protein, binding to the cytoplasmic tails of p integrin 
subunits, actin microfilaments and other proteins such as vinculin and FAK (Critchley, 
2009). The N-terminal head of talin contains one integrin binding site, one actin binding 
site and also binds FAK, whilst the rod domain contains a second integrin binding site 
and two more actin binding sites (Figure 1.4). Talin can exist in an auto-inhibited 
conformation in which regions in the N-terminal head domain interact with a region in 
the rod domain. Phosphoinositide 4,5-bisphosphate (PIP2), the kinase Src and the 
integrin-activating small GTPase Rap-1 A have been implicated in the activation of talin. 
Talin is unique amongst the adaptor proteins in that it can alter the affinity of the integrin 
extracellular domain for its ligand, thereby mediating ‘inside-out’ signalling; talin 
promotes the separation of the a and P cytoplasmic tails thought to be required for 
integrin activation (Critchley, 2009).
Paxillin is also classified as a molecular adaptor and contains discrete structural domains 
which mediate protein-protein interactions (Deakin and Turner, 2008). At the C- 
terminus there are four LIM domains, with LIM2 and LIM3 required for the targeting of 
paxillin to focal adhesions. Paxillin interacts with numerous proteins including pi 
integrin, talin, FAK (Brown and Turner, 2004), vinculin (Turner et al., 1990) and tubulin 
(Deakin and Turner, 2008). Paxillin can be phosphorylated by kinases including p21- 
associated kinase (PAK), JNK, ERK and p38 MAPK, and phosphorylation of paxillin 
regulates its interaction with binding partners. Paxillin forms a scaffold for ERK 
activation as it binds the ERK kinase MEK and recruits inactive ERK, which associates 
with paxillin phosphorylated on Tyrl 18 (Ishibe et al., 2003). Although it does not bind 
F-actin directly, paxillin can regulate actin dynamics through the Rho GTPases (see 
section 1.2.1.1.6 ). Regulation of Rho GTPases is indirect, through recruitment of 
GTPase activating proteins (GAPs) and guanidine nucleotide exchange factors (GEFs); 
for example, tyrosine phosphorylation of paxillin at Tyr31 and Tyrl 18 indirectly 
activates Racl and inhibits RhoA (Deakin and Turner, 2008).
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Vinculin is also present in focal adhesions (Geiger et al., 1980) and as discussed above, 
binds to both talin and paxillin (Figure 1.4). As an adaptor protein, vinculin binds to a 
number of other intracellular proteins including the actin-bundling protein a-actinin, the 
actin nucleating protein Arp2/3 (see section 1.2.1.1.2) and PKCa (Ziegler et al., 2006). 
Vinculin also binds F-actin through a region in its C-terminus and actin-binding 
promotes vinculin dimerisation, which in turn promotes actin cross-linking. As for talin, 
vinculin can exist in an auto-inhibited conformation as a result of interaction between its 
N- and C-termini. Vinculin is activated by binding of two or more of its binding 
partners.
A number of enzymatic proteins have been detected in focal adhesions (Lo, 2006) and 
one of these is FAK. FAK is phosphorylated by Src, which can be activated through a 
direct interaction with the cytoplasmic tail of p integrin (Arias-Salgado et al., 2003). The 
C-terminus of FAK targets it to focal adhesions, where it interacts indirectly with 
integrins through talin and paxillin (Figure 1.4)(Mitra et al., 2005). A number of tyrosine 
residues in FAK are subject to phosphorylation which regulates both its catalytic activity 
and interaction with other proteins. Tyrosine-phosphorylated FAK is present in focal 
adhesions and levels increase with increasing rigidity of the ECM (Wozniak et al., 
2003). FAK and its phosphorylation is not required for focal adhesion formation but for 
their disassembly and turnover (Mitra et al., 2005). FAK also mediates cell signalling 
through binding or phosphorylation of downstream targets. The binding of a-actinin to 
actin is reduced following its phosphorylation by FAK, which therefore reduces actin 
bundling. FAK can also regulate actin microfilament dynamics through its association 
with GAPs and GEFs, which regulate the Rho GTPases. Phosphorylation of paxillin by 
the FAK-Src complex promotes binding of ERK and, through its role in enhancing the 
activation of ERK and JNK, FAK can promote MMP-9 secretion and cell migration 
(Hauck et al., 2001, Mitra et al., 2005).
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ECM
FAK
Figure 1.4:- A schematic o f select proteins in focal contact links between 
the extracellular matrix (ECM) and actin cytoskeleton (red). The 
extracellular domains o f integrin op heterodimers (blue) bind to ECM 
molecules. Intracellular proteins bind to the cytoplasmic tails o f integrin 
subunits and associate with each other and with actin micro fi laments. 
FAK- focal adhesion kinase. Adapted from Lo, 2006.
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1.1.2.7.2 CD44
CD44 is a single-pass transmembrane glycoprotein expressed by many cell types, 
including chondrocytes, where it is the primary hyaluronan (HA)-binding receptor 
(Knudson et al., 1996). As discussed above, in articular cartilage hyaluronan is bound to 
aggrecan monomers through link protein, forming large proteoglycan aggregates. 
Therefore, through its binding of HA, CD44 binds and retains the large proteoglycan 
aggregates that are important to the hydration and mechanical properties of articular 
cartilage tissue. The binding of HA molecules to the chondrocyte surface through CD44 
is independent of collagen and fibronectin molecules and matrices (Knudson and Loeser,
2002). CD44 is also involved in the assembly as well as the retention of the pericellular 
matrix (Knudson et al., 1996, Nofal and Knudson, 2002); antisense-mediated 
knockdown of CD44 in cartilage slices resulted in a distinct loss of the proteoglycan-rich 
matrix (Chow et al., 1998). An increase in the ‘NITEGE’ neoepitope, which is exposed 
in aggrecan molecules following cleavage by aggrecanases, was also noted, indicating 
that the loss of proteoglycan was catabolic as well as passive. In addition to its role in 
retaining HA and assembling the pericellular matrix, CD44 is also responsible for the 
internalisation of HA molecules, which are then subsequently degraded. Treatment with 
IL-la, a cytokine often used to induce a catabolic phenotype in chondrocytes, increases 
CD44 expression along with internalisation and catabolism of HA in human articular 
chondrocytes and cartilage slices (Chow et al., 1995, Nishida et al., 2000).
The cytoplasmic domain of CD44 has the potential for signal transduction, with serine 
residues (Ser336 and Ser337) that are subject to differential phosphorylation (Knudson 
and Loeser, 2002), and interactions between the cytoplasmic domain and actin-binding 
proteins including ankyrin and ezrin (Ponta et al., 2003, Legg et al., 2002). Changes in 
the interaction of CD44 with the actin cytoskeleton can modulate HA binding 
(Lokeshwar et al., 1994, Knudson and Loeser, 2002).
In cultured cartilage slices, both actin cytoskeletal disruption and CD44 knockdown 
cause similar changes in cultured cartilage slices; treatments resulted in a loss of 
proteoglycan and an increase in the appearance of the NITEGE aggrecan neoepitope 
(Chow et al., 1998, Nofal and Knudson, 2002). This demonstrates a clear link between 
CD44 and the cytoskeleton. Changes in the cytoskeleton, or removal of the ankyrin-
- 18-
Chapter 1: General Introduction
binding domain modulates CD44-HA binding, demonstrating an ‘inside-out’ signalling 
mechanism through CD44.
J.J.2.7.3 Syndecan Proteoglycans
Syndecans are type I transmembrane heparan sulphate proteoglycans (Okina et al., 
2009). There are four syndecans in mammals and they exhibit different tissue 
distribution. Syndecan-1 is expressed primarily in epithelial cells, syndecan-2 in 
mesenchymal cells including endothelia, syndecan-3 in neuronal cells whilst syndecan-4  
is detected in most tissues (Kim et al., 1994); expression of syndecan-1, -2 and -4 has 
been detected in cultured rat condyle chondrocytes (Molteni et al., 1999). All syndecans 
have an N-terminal extracellular domain, a transmembrane domain through which they 
form homodimers, and a short cytoplasmic domain at their C-terminus (Okina et al., 
2009). Heparan sulphate glycosaminoglycans are covalently linked to conserved Ser- 
Gly motifs surrounded by acidic residues in syndecan extracellular domains (Zhang and 
Esko, 1994). Through these heparan sulphate chains, syndecans can interact with ECM 
molecules, growth factors and cytokines (Okina et al., 2009). Intact syndecan 
extracellular domains are shed from the cell surface by MMPs including MMP-2, MMP- 
9 (Brule et al., 2006, Fears et al., 2006), MMP-7 (Li et al., 2002) and MMP-14 (Endo et 
al., 2003). Shedding of syndecan ectodomains can be inhibited by TIMP-2 (Endo et al.,
2003) and TIMP-3 (Fitzgerald et al., 2000). This is relevant to the function of syndecans, 
as soluble ectodomains can compete for cell surface binding and therefore inhibit 
downstream intracellular signalling.
The cytoplasmic domain of syndecans interacts with the actin cytoskeleton through 
binding to actin-associated proteins. The cytoplasmic domain of syndecan-2 interacts 
with ezrin (Granes et al., 2003), a protein that cross-links the actin cytoskeleton to the 
plasma membrane and binds regulators of actin microfilament assembly (Niggli and 
Rossy, 2008). The actin-bundling protein a-actinin binds to the cytoplasmic domain of 
syndecan-4 (Greene et al., 2003). Furthermore, syndecan-4 is enriched in focal 
adhesions and its overexpression increases focal adhesion formation (Woods and 
Couchman, 1994, Longley et al., 1999); this is suggested to be mediated by the 
extracellular domain and ligation of heparan sulphate chains (Okina et al., 2009). 
Syndecan-4 activates RhoA via PKCa and this is required for focal adhesion formation 
and maintenance of actin stress fibres in fibroblasts (Dovas et al., 2006).
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Of particular relevance to this project, recent research has begun to identify roles for 
syndecan-4 in both mechanotransduction and osteoarthritis. Mechanical stretching of 
fibroblasts through syndecan-4-specific cellular attachments activates ERK through a 
mechanism dependent upon an intact actin cytoskeleton (Beilin et al., 2009), indicating 
mechanotransduction pathways similar to those of integrins (see section 1.4.2.1.2). 
Syndecan-4 expression is elevated in human OA cartilage when compared with normal 
tissue and syndecan-4-knockout mice were protected against surgically-induced OA 
(Echtermeyer et al., 2009). In wild-type mice, intra-articular injection of syndecan-4 
blocking antibodies prevented surgically-induced OA-like changes in the cartilage. Loss 
of syndecan-4 reduced ERK 1/2 phosphorylation, MMP-3 release and aggrecanase 
(ADAMTS5) activity, suggesting that activation of syndecan-4 promotes MMP-3- 
mediated activation of ADAMTS5. Furthermore, a recent study has demonstrated that 
syndecan-4 interacts with the C-terminal domain of MMP-13 (Zhang et al., 2010).
The importance of the ECM receptors in cartilage is highlighted by the studies described 
above, all showing that uncoupling the chondrocyte cytoskeleton from the matrix, either 
through modulation of the cytoskeleton, the receptor-cytoskeleton interaction, receptor 
expression or receptor-ligand binding results in detrimental changes in the 
cartilage/chondrocyte matrix in a manner similar to that which occurs in OA.
1.2 The Cytoskeleton
All cells possess a three-dimensional (3D) cytoskeleton consisting of networks of actin 
microfilaments, tubulin microtubules and intermediate filaments. These networks are 
highly organised and function in diverse cellular processes.
1.2.1 Actin Micro filaments
Actin proteins are highly conserved and ubiquitously expressed in all eukaryotic cells. 
There are six actin genes in humans (Vandekerckhove and Weber, 1978a, Miwa et al., 
1991). p- and y-actin are known as cytoplasmic actins; their sequence is least similar to 
muscle (a-)actins and they lack the N-terminal cysteine residue found in a-actins 
(Vandekerckhove and Weber, 1978b, Gunning et al., 1983). a-actins are expressed in 
muscle cells, with isoforms specific for skeletal muscle, cardiac muscle, aortic smooth
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muscle and enteric smooth muscle (Vandekerckhove and Weber, 1978a, Miwa et al., 
1991). Monomeric actin has two major domains or lobes that can each be further divided 
into two subdomains (domains I to IV; Fig 1.5A) (Kabsch et al., 1990, Schutt et al., 
1993). Between the lobes lies a cleft that binds ATP/ADP and a magnesium ion (Fig 
1.5A). The globular actin monomers (G-actin) associate and form filaments (F-actin) 
with a diameter of 7-9 nm; each monomer can associate with four others and they 
polymerise to produce filaments forming a two-stranded helix (Holmes et al., 1990, 
Schmid et al., 1994). All monomers face the same direction in actin filaments providing 
polarity, with a barbed (or plus) end and a pointed (or minus) end at which the ATP- 
binding cleft of monomers is exposed (Fig 1.5B). Actin monomers can be added and lost 
at both ends of actin filaments in a process termed ‘treadmilling’, although the rate of 
polymerisation and depolymerisation is greater at the barbed end (Woodrum et al., 1975, 
Cooper and Schafer, 2000). Following the incorporation of ATP-bound actin monomers 
into filament ends, ATP is hydrolysed to ADP as the filament develops (Cooper and 
Schafer, 2000, Blain, 2009).
Regulation of actin filament polymerisation is complex and cyclical, involving a large 
number of proteins, only some of which are discussed below (Table 1.4). Filament 
disassembly is required to increase the availability of free actin monomers for 
polymerisation whilst capping proteins, nucleating proteins, sequestering proteins and 
their upstream regulators spatially and temporally control polymerisation. Cross-linking 
proteins then determine the 3D organisation and mechanical properties of filament 
networks. The complex interactions, along with suggested feedback and feed-forward 
loops, mean that the application of simple linear signalling pathways may be 
inappropriate or misleading when studying actin cytoskeletal dynamics (Insall and 
Machesky, 2009).
1.2.1.1 Actin Binding Proteins
Numerous actin binding proteins have been detected in vivo and co-ordinate to control 
actin filament polymerisation, depolymerisation and 3D organisation. Whilst filaments 
can elongate without assistance, actin-binding proteins assist and regulate 
polymerisation by promoting nucleation of filaments, binding and ‘capping’ filament 
ends, or sequestering monomers (Fig 1.5C). In general, capping proteins bind to the ends 
of filaments and therefore direct G-actin monomers and filament polymerisation to the
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free filament ends (Cooper and Schafer, 2000). The kinetic barrier to nucleation, or 
initiation, of new filaments observed in vitro is overcome in vivo by actin-binding 
proteins that promote nucleation of actin filaments, or proteins which generate free 
barbed ends by severing existing actin filaments. Using purified proteins in vitro to 
reconstitute sustained movement of Listeria, which utilise actin filament dynamics to 
move around the cytoplasm of living cells, Loisel et al demonstrated that, in addition to 
G-actin monomers, the inclusion of activated actin related protein 2/3 complex (Arp2/3), 
capping protein and actin depolymerising factor (ADF) was sufficient for actin 
polymerisation and bacterial motility; removal of any of these proteins abrogated 
motility (Loisel et al., 1999).
Actin Binding Protein Function
Capping protein Capping (+)
Gelsolin Filament severing, capping (+)
Arp2/3 complex Nucleation, filament branching, capping (-)
Formins Nucleation, processive capping (+)
Cofllin/Destrin Filament depolymerising, filament severing
Thymosin p4 Actin sequestering, inhibits growth at (+) and (-) ends
Profilin Actin sequestering, promotes growth at (+) end in the presence 
of thymosin p4 or FH1-containing formins
Filamin Actin cross-linking, 3D network, scaffold for signalling 
proteins
a-actinin Actin bundling
Table 1.4:- Table summarising the actin binding proteins discussed and their functions. 
(+)/(-) indicate whether the protein performs the function at the barbed/pointed end of 
the actin microfilament. FH1- formin homology 1 domain.
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Figure 1.5:- A schematic of actin monomer and microfilament structure and 
assembly dynamics. A- The 3-dimensional structure of an actin monomer 
indicating the subdomains in roman numerals and the nucleotide (ATP) binding 
site. B- The orientation of actin monomers within actin microfilaments produces a 
polarised filament with the ATP binding cleft exposed in subunits at the pointed 
end and subdomains 1 and 3 exposed at the barbed end. C- Actin binding proteins 
regulate filament assembly and disassembly. See text for details.
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1.2.1.1.1 Capping Proteins
Capping protein is a heterodimer of a and p subunits that binds to and caps the barbed 
ends of actin filaments (Cooper and Sept, 2008, Isenberg et al., 1980). Binding of 
capping protein prevents both the addition and loss of actin subunits from barbed ends 
and thus prevents both filament growth and depolymerisation. Capping protein is 
required for actin polymerisation in vitro (Loisel et al., 1999) and is suggested to 
‘funnel’ actin polymerisation to required regions in cells by preventing polymerisation at 
all filament ends. In support of this, knockdown of capping protein by RNA interference 
resulted in loss of lamellipodia from motile murine melanoma cells and the induction of 
vasodilator-stimulated phosphoprotein (VASP)-dependent filopodia formation 
(Mejillano et al., 2004). The capping protein subunit p2 isoform predominates in non­
muscle tissue and is a component of cell-cell contacts, whilst the pi isoform is the 
predominant form in muscle. The capping activity of capping protein is inhibited by 
phosphoinositide 4,5-bisphosphate (PIP2) (Heiss and Cooper, 1991) which binds directly 
to capping protein near the actin-binding site (Kim et al., 2007). PIP2 can also remove 
capping protein that is bound to actin filament barbed ends; this uncapping converts 
actin filaments from a non-growing to a growing state. Capping protein activity is also 
regulated by proteins including CARMIL, CKIP-1 and casein kinase 2, and CD2- 
associated protein (Cooper and Sept, 2008). Microfilament elongation factors including 
formins and VASP proteins can indirectly regulate capping protein by preventing its 
binding at barbed ends.
Gelsolin protein structure consists of two homologous halves connected by a long linker 
(Sun et al., 1999). Gelsolin binds to the side of an actin filament, bridging two 
longitudinally associated actin subunits, to induce a large conformational change and 
kink in the filament to sever it (McGough et al., 1998). After severing, gelsolin remains 
bound to the newly formed barbed end of one of the new shorter filaments, acting as a 
cap to prevent filaments re-annealing and inhibit growth at the barbed end (Sun et al., 
1999). Uncapping of gelsolin could therefore promote actin polymerisation as it 
increases the number of filaments and free barbed ends. Full-length gelsolin is activated 
by calcium, which induces a conformational change in the protein. In the inactive form 
the C-terminal tail inhibits actin binding by the N-terminal domain whilst calcium 
binding exposes the actin binding site; deletion of the C-terminal tail results in loss of 
the calcium requirement for gelsolin severing activity and actin-binding (Kwiatkowski et
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al., 1989). The C-terminal domain binds actin in a calcium-dependent manner whilst the 
N-terminal domain binds, severs and caps actin filaments independently of calcium 
(Kothakota et al., 1997, Sun et al., 1999). Caspase-3 cleaves gelsolin in the linker region 
and therefore generates a calcium-independent form of gelsolin (Kothakota et al., 1997, 
Kamada et al., 1998). A decrease in pH (i.e. increase in hydrogen ion concentration) 
reduces the calcium requirement for gelsolin severing activity (Lamb et al., 1993, Lin et 
al., 1997). In addition to calcium and hydrogen ions, gelsolin activity is regulated by 
PIP2 (Janmey and Stossel, 1987). PIP2 binds to the N-terminal domain of gelsolin and, as 
for F-actin subunits, binding is enhanced by calcium (Lin et al., 1997). 
Phosphotidylinositol monophosphate and PIP2 bind to gelsolin and inhibit its filament 
severing activity (Janmey and Stossel, 1987, Janmey et al., 1987). 
Polyphosphoinositides also dissociate gelsolin-actin complexes and can therefore uncap 
gelsolin from filament ends to promote filament growth.
In addition to its role in regulation of actin dynamics and therefore the associated 
processes (section 1.2.1.2), gelsolin also functions in apoptosis (Silacci et al., 2004). 
Gelsolin acts as a mediator of actin remodelling following cleavage by caspase-3, but is 
also suggested to act as an inhibitor of apoptosis; over-expression of gelsolin reduces 
caspase-3 activation and increases resistance to apoptosis (Ohtsu et al., 1997). In 
addition to the cytoplasmic isoform, a secreted plasma isoform of gelsolin is also 
expressed which is generated by alternative splicing (Silacci et al., 2004). Plasma 
gelsolin is suggested to have a prognostic and therapeutic use in a number of medical 
conditions including sepsis and major trauma (Bucki et al., 2008). Structural similarities 
and functions of other members of the gelsolin superfamily, including villin, advillin, 
supervillin, capG and adserervin are reviewed by Silacci et al, 2004.
Tropomodulins cap the pointed (slow-growing) end of actin filaments and are regulated 
by their interaction with tropomyosins, which bind along the side of the actin filament 
(Kostyukova, 2008). These proteins are not discussed here but have been reviewed by 
Kostyukova, 2008.
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1.2.1.1.2 Arp2/3 Complex Promotes Filament Nucleation
The Arp2/3 complex consists of seven subunits; Arp2 and Arp3 are similar to actin in 
structure and sequence and the other five subunits (ARPC1-5) are unique and highly 
conserved throughout evolution (Machesky et al., 1997, Welch et al., 1997). As 
mentioned above, Arp2/3 is required for actin polymerisation in vitro (Loisel et al., 
1999). Arp2/3 nucleates and therefore promotes the formation of actin filaments that 
elongate from their barbed ends (Mullins et al., 1998). The complex binds to and caps 
the pointed ends of preformed actin filaments but also binds to the sides of actin 
filaments. Through binding to the sides of filaments, Arp2/3 nucleates the formation of 
side branches at an angle of 70° from the mother filament, producing a network of 
branching actin filaments that elongate at their barbed ends (Mullins et al., 1998). As 
Arp2/3 binds with a higher affinity to ATP- than to ADP-actin filaments, phosphate 
dissociation in actin filament subunits leads to loss of Arp2/3 binding, debranching and 
depolymerisation of actin filament networks (Blanchoin et al., 2000). Arp2/3 is activated 
following interaction with an actin filament and the C-terminus of WASP family 
proteins (Rohatgi et al., 1999, Insall and Machesky, 2009); PIP2 activates WASP and 
actin nucleation by Arp2/3 (Higgs and Pollard, 2000). In humans, the WASP family 
includes WASP (Wiskott-Aldrich syndrome protein), which is restricted to 
haematopoietic cells, N-WASP, which is ubiquitously expressed, and four 
SCAR/WAVE isoforms (Wear et al., 2000). WASP proteins have no effect on actin 
polymerisation alone, but bind to and activate Arp2/3 to promote nucleation (Machesky 
et al., 1999).
Formins nucleate actin filaments from free actin monomers; the formin homology 2 
(FH2) domains of formins form dimers and stabilise an actin dimer, which then acts as a 
nucleus for elongation (Insall and Machesky, 2009, Paul and Pollard, 2009, Xu et al.,
2004). Dimers form a doughnut-like structure encircling the barbed ends of actin 
filaments and binding to F-actin subunits. The association of formins with barbed ends 
protects them from capping proteins, whilst allowing elongation (Zigmond et al., 2003), 
termed ‘processive capping’. FH1-containing formins bind to profilin and concentrate 
profilin-actin at the barbed ends to accelerate filament growth (Insall and Machesky, 
2009, Paul and Pollard, 2009).
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Other less-widely studied actin filament nucleation factors, such as Spire, Cobl and 
VopL/VopF, are not discussed but have been reviewed recently (Dominguez, 2009).
1.2.1.1.3 ADF/Cofilin family
Proteins of the ADF/cofilin family include ADF (known as destrin in mammals and 
referred to as this from here on), cofilin and actophorin and these mediate actin filament 
disassembly. As discussed above, destrin was required for reconstitution of actin 
filament dynamics in vitro; disassembly of older filaments is required to generate G- 
actin for the assembly of new filaments and prevent exhaustion of the free actin 
monomer pool (Loisel et al., 1999). Destrin/cofilin family proteins bind cooperatively to 
the side of actin filaments, bridging two longitudinally associated actin subunits 
(McGough et al., 1997). Binding of destrin/cofilin changes the orientation of actin 
subunits within the filament and changes the filament twist; this reduces the interactions 
between actin subunits within filaments, which is suggested to increase the chance that 
the filament will break and that subunits will dissociate (McGough and Chiu, 1999, 
Galkin et al., 2001). Destrin/cofilin proteins promote filament assembly both through 
increasing the rate of subunit dissociation from pointed ends (Carrier et al., 1997) and 
through filament severing (Maciver et al., 1998). Nucleotide exchange in actin subunits 
is inhibited by binding of destrin/cofilin proteins, which induce a conformational change 
in actin so that the ATP-binding cleft is in a ‘closed’ state (Paavilainen et al., 2008). In 
direct contrast to the Arp2/3 complex, the affinity of destrin/cofilin for ADP-bound G- 
and F-actin is higher than its affinity for ATP-bound forms (Carrier et al., 1997). 
Phosphate dissociation in actin filament subunits therefore leads to increased 
destrin/cofilin binding and enhanced disassembly of older filament networks (Insall and 
Machesky, 2009).
The F-actin binding and depolymerising activities of destrin and cofilin are inhibited by 
the phosphoinositides phosphatidylinositol, PIP and PIP2 which bind directly to the 
proteins (Yonezawa et al., 1990). Destrin/cofilin proteins are also negatively regulated 
by phosphorylation; phosphorylation of serine-3 inhibits the actin-binding and F-actin- 
depolymerising activities of destrin/cofilin (Morgan et al., 1993, Agnew et al., 1995, 
Moriyama et al., 1996).
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1.2.1.1.4 Actin Sequestering Proteins
Actin sequestering proteins bind to G-actin to decrease the pool of free actin and 
regulate actin filament polymerisation. Thymosin p4 binds to and sequesters monomeric 
actin to inhibit polymerisation at the barbed and pointed ends of filaments (Weber et al.,
1992, Yu et al., 1993). It does not suppress actin nucleation and does not bind to the 
ends or sides of actin filaments (Weber et al., 1992). Thymosin 04 forms a 1:1 complex 
with G-actin and the binding affinity for ATP-actin is 50-fold higher than for ADP-actin 
(Carlier et al., 1993). Furthermore, thymosin P4 binding inhibits nucleotide exchange in 
actin monomers (Goldschmidt-Clermont et al., 1992). Thymosin p4 is a small protein of 
43 amino acids and, when in aqueous solution is predominantly unstructured (Czisch et 
al., 1993, Domanski et al., 2004). Folding of thymosin p4 is coupled to its binding to G- 
actin; upon binding an N-terminal helix contacts actin subdomain 2 and is stabilised, a 
C-terminal helix is formed and binds to actin subdomain 1, and the thymosin p4 central 
segment forms an extended interface with actin (Domanski et al., 2004, Dedova et al., 
2006); thymosin p4 therefore binds to both the pointed and barbed ends of an actin 
monomer which explains why polymerisation is inhibited at both ends of actin filaments. 
No post-translational regulatory mechanism has been identified for thymosin P4 and 
desequestration of actin from the thymosin p4-actin complex occurs in response to 
changes in the free G-actin pool, i.e. thymosin P4 functions as a ‘G-actin buffer’ 
(Mannherz and Hannappel, 2009). Actin is released from the thymosin p4-actin 
complex in response to an increase in the number of filament barbed ends, which 
reduces the critical concentration of actin polymerisation (Nachmias et al., 1993). 
Desequestration of actin from thymosin P4 can therefore be triggered by uncapping of 
barbed ends, filament severing or filament nucleation by proteins such as Arp2/3, all of 
which increase the number of free barbed ends (Mannherz and Hannappel, 2009).
Another G-actin sequestering protein, profilin, competes with thymosin P4 for actin 
binding (Goldschmidt-Clermont et al., 1992). In contrast to thymosin P4, profilin 
promotes nucleotide exchange in actin monomers (Mockrin and Korn, 1980), with low 
concentrations of profilin able to overcome the inhibitory effects of high thymosin p4 
concentrations (Goldschmidt-Clermont et al., 1992). Profilin forms a 1:1 complex with 
G-actin and binding results in moderate opening of the nucleotide cleft (Schutt et al.,
1993, Baek et al., 2008). Profilin inhibits actin nucleation and filament growth at pointed
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ends but, in the presence of thymosin p4, promotes elongation at barbed ends (Pantaloni 
and Carlier, 1993, Kang et al., 1999, Dominguez, 2009). As mentioned above, profilin 
cooperates with formins to enhance filament growth at barbed ends. This is due to the 
fact that profilin can simultaneously bind to actin and proline-rich sequences (Ferron et 
al., 2007). Through this binding, processive barbed end elongation factors such as FH1- 
containing formins and VASP recruit the profilin-actin complex to enhance monomer 
addition and filament growth. Disruption of the phosphoinositide cycle inhibits actin 
polymerisation (Lassing and Lindberg, 1988) as PIP2 and PIP3 bind to profilin and can 
dissociate the profilin-actin complex to inhibit the effect of profilin (Lassing and 
Lindberg, 1985, Goldschmidt-Clermont et al., 1991, Lu et al., 1996).
1.2.1.1.5 Actin Cross-linking Proteins
Actin cross-linking proteins determine the 3D organisation of actin filaments and can 
contribute to the mechanical properties of the networks. One family of actin cross- 
linking proteins are filamins. Humans express three filamins, filamin-A, -B and -C 
(Chakarova et al., 2000); filamin C is specific to skeletal muscle (Thompson et al., 2000) 
whilst filamin A and B are ubiquitously expressed. Filamin A consists of an N-terminal 
actin-binding domain followed by 24 tandem immunoglobulin (Ig) repeats with two 
hinge regions and a C-terminus (Gorlin et al., 1990). Ig repeats 9-15 can bind F-actin 
(Nakamura et al., 2007) and the actin-binding domain binds F-actin at a ratio of 1:13.5 
actin monomers (Gorlin et al., 1990). Filamin A is dissociated from F-actin by the 
calcium-calmodulin complex (Nakamura et al., 2005). Filamin A monomers dimerise 
through their C-terminus and Ig repeat 24 to form a homodimer with a V-like shape 
(Gorlin et al., 1990). Dimerisation provides filamin A with the ability to form cross-links 
between actin filaments. Filamin A organises actin filaments into flexible 3D orthogonal 
networks and localises to filament intersections, which form X-, T- or Y-shaped 
junctions in the actin network (Hartwig et al., 1980, Hartwig and Shevlin, 1986); the first 
hinge region in filamin A, between Ig repeats 15 and 16, is required to maintain the 
viscoelastic properties of actin networks (Gardel et al., 2006). Ig repeats 16-24 in 
filamin A do not bind F-actin but are involved in protein-protein interactions with 
filamin A binding partners (Nakamura et al., 2007). Filamin A binds numerous cellular 
components including membrane receptors such as P integrins, ion channels, signalling 
intermediates such as TRAF2 and Smads, and transcription factors (Stossel et al., 2001, 
Feng and Walsh, 2004, Popowicz et al., 2006). Filamin A can therefore act as a scaffold
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for membrane-receptor-associated signalling proteins. A mechanoprotective role for 
filamin A was also identified when it was shown that filamin A prevented membrane 
depolarisation and apoptosis in fibroblasts subjected to integrin-mediated tensile force 
(Kainulainen et al., 2002). This was later shown to be due to the interaction between 
filamin A and a GTPase-activating protein (GAP) termed FilGAP; deletion of the 
filamin A binding site in FilGAP increased force-induced apoptosis in cells (Shifrin et 
al., 2009). FilGAP is phosphorylated by the Rho effector ROCK which stimulates its 
Rac-specific GAP activity and inhibits Rac-mediated lamella formation (Ohta et al., 
2006).
Other actin cross-linking proteins such as a-actinin and fascin are not discussed. Both a- 
actinin and fascin are actin-bundling proteins but they produce actin networks with 
different mechanical properties (Tseng et al., 2001).
1.2.1.1.6 Upstream Regulation o f Actin Dynamics: Rho GTPases
The mammalian family of Rho GTPases consists of 20 proteins which function as 
upstream regulators of the actin cytoskeleton (Heasman and Ridley, 2008). Rho 
GTPases cycle between an active GTP-bound form and an inactive GDP-bound form 
and are themselves regulated by factors which affect guanine nucleotide cycling termed 
guanine exchange factors (GEFs) and GTPase activating proteins (GAPs).
Rho stimulates actin stress fibre formation and assembly of focal adhesions, Racl 
stimulates lamellipodia formation and membrane ruffling, whilst Cdc42 induces 
filopodia formation at the leading edge of migrating cells. Cdc42 stimulates the 
formation of unbranched filaments and networks through activation of the formin mDia2 
(Peng et al., 2003). Cdc42 can also enhance the activity of N-WASP and WASP which 
activate Arp2/3 nucleation of actin filaments and formation of branched networks 
(Rohatgi et al., 1999, Tomasevic et al., 2007). Racl activates N-WASP or WAVE to 
promote Arp2/3-mediated actin nucleation, but has no effect on WASP (Heasman and 
Ridley, 2008, Tomasevic et al., 2007). Furthermore, Rac activation induces the 
dissociation of gelsolin-actin complexes and therefore uncaps filaments (Arcaro, 1998) 
which could promote polymerisation.
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The small GTPases Rho, Rac and Cdc42 can also regulate actin cytoskeletal dynamics 
through destrin/cofilin proteins (Cooper and Schafer, 2000). LIM kinase (LIMK) 
phosphorylates cofilin at serine-3 and therefore inhibits its activity and hence actin 
depolymerisation (Moriyama et al., 1996, Yang et al., 1998). The Rho effector ROCK 
phosphorylates and activates LIMK and increases cofilin phosphorylation (Maekawa et 
al., 1999). LIMK is also activated downstream of Rac or Cdc42 via the serine/threonine 
kinase PAK1, which directly phosphorylates LIMK and increases cofilin 
phosphorylation (Edwards et al., 1999).
Rac, Rho and Cdc42 also bind to filamin A independently of their GTP-binding (Ohta et 
al., 1999) and the filamin A-FilGAP interaction mediates RhoA antagonism of Rac to 
suppress leading edge protrusion (Ohta et al., 2006).
1.2.1.2 Functions o f Microfilaments
Microfilaments are involved in many diverse cellular processes including cell migration 
(Insall and Machesky, 2009), changes in cell shape (Sims et al., 1992), cytokinesis and 
therefore proliferation (Glotzer, 2005, Piekny et al., 2005), endocytosis and vesicle 
translocation (Girao et al., 2008), and extracellular matrix assembly (Hayes et al., 1999). 
The actin cytoskeleton is also involved in cell adhesion to ECM components through 
focal adhesions (Lo, 2006). As they are connected to the ECM through transmembrane 
receptors, actin microfilaments are ideally situated to transduce signals from the ECM to 
the cell nucleus. Their role in mechanotransduction in chondrocytes is discussed in 
section 1.4.3.3.
1.2.2 Microtubules
Tubulin proteins are ubiquitously expressed in eukaryotes and monomers consist of 
approximately 450 amino acids. Tubulins are divided into three main types termed a-, p- 
and y-tubulin, with a number of isoforms identified for each, a-, p- and y-tubulin have 
almost identical structures; each has an N-terminal domain containing a nucleotide- 
binding site, an intermediate domain containing the taxol-binding site and a C-terminal 
domain (Nogales et al., 1998, Aldaz et al., 2005). a- and p-tubulin monomers associate 
to form a stable heterodimer in which the N-terminal domain of a-tubulin is at the 
intradimer interface (Fig 1.6A), explaining why the GTP bound to a-tubulin is non­
exchangeable (Nogales et al., 1998). The GTP-binding site in P-tubulin is exchangeable
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Figure 1.6:- A schematic of the tubulin heterodimer and microtubule structure and 
assembly. A- a-tubulin and P-tubulin associate to form the tubulin heterodimer. B- 
Heterodimers associate longitudinally to form protofilaments, 13 of which associate 
laterally to form a 2-dimensional sheet which then forms the hollow cylindrical 
microtubule. C- The axoneme of motile cilia consist of nine microtubule doublets and 
a central pair of microtubules (9 +2); non-motile cilia lack the central pair (9 + 0). 
Adapted from Lodish et al, Molecular Cell Biology. 4th Ed.
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and partially exposed in the heterodimer, but buried and non-exchangeable in the 
microtubule. The p-tubulin-bound GTP is required for microtubule assembly and is 
hydrolysed to GDP following addition of the dimer to the microtubule end, therefore p- 
tubulin within microtubules is GDP-bound (Valiron et al., 2001). ap dimers associate 
head-to-tail to form protofilaments (Fig 1.6B). Protofilaments associate laterally to form 
a sheet which closes to form a 24 nm diameter hollow cylindrical microtubule consisting 
of 13 protofilaments. Subsequently, aP dimers are added to and lost from microtubule 
ends; during growth, dimers add to the ends of two-dimensional sheets which close 
continuously to form the cylinder (Chretien et al., 1995), whilst during 
shrinkage/disassembly protofilaments lose lateral associations and curl into rings (Wade 
and Hyman, 1997). Microtubules do not reach equilibrium in vivo. They undergo both 
‘treadmilling’, where aP dimers are added to the plus end and lost from the minus end 
with no change in microtubule length, and ‘dynamic instability’, where microtubules 
convert between phases of assembly and rapid disassembly with no maintenance of 
length (Valiron et al., 2001).
In a similar manner to actin in microfilaments, ap tubulin dimers have a uniform 
orientation within microtubules which provides them with polarity; p-tubulin is at the 
fast-growing plus end and a-tubulin at the slower-growing minus end (Figure 1.6B). The 
minus end is predominantly associated with the centrosome (microtubule organising 
centre (MTOC)) in vivo. The MTOC organises microtubule nucleation and contains the 
y-tubulin ring complex, which consists of 13 molecules of y-tubulin (Zheng et al., 1991, 
Wiese and Zheng, 2006). Lateral associations formed by GTP-bound y-tubulin are 
stronger than those formed by GDP-bound ap tubulin dimers in microtubules, perhaps 
explaining how y-tubulin helps to nucleate and promote microtubule formation (Aldaz et 
al., 2005).
As discussed for actin microfilaments, microtubule dynamics can be regulated by 
microtubule-associated proteins (MAPs) in vivo, a number of which are themselves 
regulated by phosphorylation or calcium (for example through interactions with 
calmodulin) (Valiron et al., 2001). Microtubule-stabilising proteins include the neuron- 
specific tau and MAP IB, along with the more widely expressed MAP6 and MAP4, the 
latter of which also promotes tubulin polymerisation (Katsuki et al., 1999, Valiron et al.,
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2001). Other proteins such as stathmin (Steinmetz et al., 2000) and the neuron-specific 
stathmin-2 destabilise microtubules (Valiron et al., 2001).
Other key proteins associated with microtubules are kinesin and dynein families of 
motor proteins. These use the energy from ATP to move cargo along microtubules in a 
direction determined by the microtubule polarity and motor protein; most kinesin family 
proteins move towards the plus end and therefore transport cargo towards the cell 
periphery, whilst dynein family proteins move towards the minus end and therefore the 
centre of the cell (Mallik and Gross, 2004).
1.2.2.1 Functions o f Microtubules
Microtubules are involved in many cellular processes including protein trafficking and 
vesicular transport during endo- and exocytosis (Hehnly and Stamnes, 2007). They form 
the mitotic spindle and are therefore required for cell division and proliferation 
(Mitchison et al., 1986). Microtubules also form the specialised cell structures cilia and 
flagella and therefore function in cell motility (Mitchell, 2007). Motile cilia and flagella 
contain a central bundle of microtubules, called the axoneme, which consists of a central 
pair of single microtubules surrounded by nine microtubule doublets (‘9 + 2’; Figure 
1.6C).
1.2.2.1.1 Primary Cilia
Distinct from the motile cilia on mammalian multiciliated epithelial cells, single non- 
motile primary cilia are present on both epithelial and non-epithelial cell types; these 
primary cilia lack the central pair of microtubules in their axoneme (‘9 + O’; Figure 
1.6C). The primary cilia on renal epithelial cells function as flow sensors; cilia bend 
passively with fluid flow and cause an increase in intracellular calcium concentration 
(Praetorius and Spring, 2001, Praetorius and Spring, 2003). Flow-induced calcium 
transients are reduced in ORPK (Oak Ridge Polycystic Kidney) mice, which lack the 
polaris protein required for cilia assembly (Liu et al., 2005). Endothelial cells lacking 
polycystin-2 in their primary cilium are unable to respond to increases in fluid shear 
stress (AbouAlaiwi et al., 2009), as are wild-type endothelial cells treated with 
colchicine to disrupt the connection of the cilium to the cytoplasm (Hierck et al., 2008). 
In bone cells, primary cilia were required for dynamic flow-induced increases in the 
osteogenic response of osteoblasts and decreases in the bone resorptive response of 
osteoclasts (Malone et al., 2007). Primary cilia are therefore suggested to function as
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mechanosensory organelles in a number of different tissues. In connective tissues, 
primary cilia have been observed projecting into the ECM in growth plate cartilage, 
tendon, ligament, meniscus and annulus flbrosus of the intervertebral disc (Donnelly et 
al., 2008). Primary cilia are also observed on hyaline cartilage chondrocytes (Kouri et 
al., 1996, Jensen et al., 2004, Poole et al., 2001). The evidence for a role of the 
chondrocyte primary cilium in mechanotransduction in cartilage is discussed later (see 
section 1.4.2.1.5).
1.2.3 Intermediate Filaments
Intermediate filaments are so named because, with a diameter of 10 nm, they are 
intermediate in diameter between actin microfilaments and tubulin microtubules. Unlike 
the globular and nucleotide-binding actin and tubulin monomers, intermediate filament 
monomers are filamentous proteins that do not bind or hydrolyse nucleotides (Chang and 
Goldman, 2004). Over 70 genes encoding intermediate filament proteins have been 
identified in humans and these are divided into five classes based on amino acid 
sequence homology, assembly properties and tissue expression. The acidic and basic 
keratins, which form heteropolymer filaments in epithelial cells, are the type I and II 
intermediate filament proteins respectively. Type III intermediate filaments form 
homopolymer filaments and include vimentin, desmin and glial fibrillary acid protein 
(GFAP), whilst neurofilament proteins including NF-L, NF-M and NF-H are type IV 
intermediate filament proteins. Type V intermediate filament proteins are the nuclear 
lamins, lamin A/C, lamin B1 and lamin B2.
Cytoplasmic intermediate filament proteins have similar secondary structures, with a 
conserved, largely a-helical central rod domain flanked by non-a-helical N- (head) and 
C-terminal (tail) domains (Parry et al., 2007); the N- and C-terminal domains exhibit 
little homology and differ in size between intermediate filaments (Chang and Goldman, 
2004). The characteristics of intermediate filament assembly are also conserved for the 
cytoplasmic intermediate filaments (Parry et al., 2007). The fibrillar monomers assemble 
in parallel to form a dimer with a ‘coiled-coif rod domain (Fig 1.7); dimers can be 
homo- or heterodimers depending on the intermediate filament type. Tetramers are 
formed from half-staggered, anti-parallel dimers and these associate laterally to form 
‘unit-length’ filaments (ULF) with a length of approximately 55 nm. The number of 
polypeptides/monomers in the ULF varies with intermediate filament type. ULFs anneal
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longitudinally in the elongation step to form immature intermediate filaments, which 
then undergo radial compaction to form mature intermediate filaments.
In contrast to microfilaments and microtubules, which exchange subunits at their ends 
only, intermediate filaments can exchange subunits or oligomers all along their length, 
making them highly dynamic in nature. Intermediate filament assembly and disassembly 
are regulated by phosphorylation and dephosphorylation events. Phosphorylation 
promotes disassembly of vimentin intermediate filaments into soluble tetramers, but also 
slows the rate of filament assembly; phosphorylation therefore affects the balance 
between filaments and disassembled subunits, along with the turnover of subunit 
exchange (Eriksson et al., 2004). Vimentin is phosphorylated on serine and threonine 
residues within the N- and C-terminal domains by kinases including PKA, PKC, ROCK 
(Eriksson et al., 2004) and PAK (Goto et al., 2002). As the N-terminal domain of 
vimentin intermediate filaments is involved in the interaction of filaments with the 
plasma membrane (Georgatos et al., 1985) in addition to intermediate filament formation 
(Beuttenmuller et al., 1994), phosphorylation of the head domain can also affect 
intermediate filament organisation.
Turnover and cytoplasmic organisation of vimentin filaments is partially dependant on 
microtubules and, to a lesser extent, actin microfilaments (reviewed by Chang and 
Goldman, 2004). In fibroblasts, microtubules recruit and co-localise with vimentin 
intermediate filaments (Gurland and Gundersen, 1995, Liao and Gundersen, 1998, 
Kreitzer et al., 1999) and expression of constitutively active Cdc42 or Racl causes 
vimentin intermediate filament reorganisation and perinuclear collapse (Meriane et al., 
2000). In HeLa cells, Cdc42 induced vimentin filament collapse was associated with 
increased phosphorylation of vimentin at serine-72 by PAK and p70 S6 kinase (Chan et 
al., 2002). The association of intermediate filaments with both microfilaments and 
microtubules places them well to mediate cytoskeletal crosstalk (Chang and Goldman,
2004). For example, the collapse of vimentin intermediate filaments in HeLa cells, 
induced by microtubule disruption or RhoA/ROCK activation (which results in vimentin 
phosphorylation), results in the translocation of ROCK to the cell periphery and actin 
stress fibre formation (Sin et al., 1998).
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Monomer Dimer
intermediate filament bundle
Figure 1.7:- A schematic o f intermediate filament structure and assembly. 
Intermediate filament monomers associate in parallel to form a dimer with a 
‘coiled-coiT rod domain Dimers then associate in parallel to form tetramers 
which associate laterally then longitudinally to form intermediate filaments. 
ULF- unit length filament Adapted from Blain, 2009.
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1.2.3.1 Functions o f Intermediate Filaments
The principal role of intermediate filaments has long been thought to be structural in 
maintaining the mechanical integrity of cells and tissues (Eckes et al., 1998, Blain, 
2009). They have been shown to be particularly important for the mechanical properties 
of cells under large deformation, increasing in stiffness with increasing strain applied 
(Wang and Stamenovic, 2000). However, in addition to mediating cytoskeletal crosstalk, 
intermediate filaments are believed to be important in signal transduction (Perlson et al., 
2006). Vimentin is one of the predominant phosphoproteins in vivo (Blain, 2009) and 
intermediate filaments are suggested to function as a phosphate ‘sink’ or ‘sponge’ during 
cell signalling (Kim and Coulombe, 2007). In neurons, soluble vimentin associates with 
phosphorylated ERK1/2, preventing dephosphorylation i.e. deactivation and enabling 
translocation towards the nucleus (Perlson et al., 2005, Perlson et al., 2006). In synovial 
fibroblasts from rheumatoid arthritis patients, vimentin binds directly to p53 (Yang et 
al., 2005). Caspase-4 mediated cleavage of vimentin released p53 for translocation to the 
nucleus, where it promoted apoptosis in the fibroblasts.
1.2.4 The Chondrocyte Cytoskeleton
The chondrocyte cytoskeleton consists mainly of actin microfilaments, tubulin 
microtubules and vimentin intermediate filaments (Benjamin et al., 1994). In addition, 
some cytokeratins are present along with nuclear lamins.
1.2.4.1 Functions o f the Cytoskeleton in Chondrocytes
Mature chondrocytes do not proliferate frequently under physiological conditions and 
they are trapped within their ECM and cannot migrate. The chondrocyte cytoskeleton 
therefore functions predominantly in maintaining cell phenotype and mechanical 
properties, aiding secretion of synthesised matrix molecules, forming cell-matrix 
interactions and in cell signalling (Blain, 2009). Changes in cytoskeletal organisation 
and cell shape result in changes in chondrocyte gene expression and the association 
between the cytoskeleton and phenotype is discussed further in sections 4.1 and 5.1. The 
Golgi complex interacts with the vimentin (Gao and Sztul, 2001) and tubulin (Vaughan,
2005) networks therefore synthesis and secretion of ECM molecules requires an intact 
chondrocyte cytoskeleton; disruption of microtubules (Lohmander et al., 1976, 
Takigawa et al., 1984) or vimentin intermediate filaments (Blain et al., 2006) inhibits the
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synthesis and secretion of proteoglycans and collagen in chondrocytes. The cytoskeletal 
networks also regulate the compressibility and mechanical properties of chondrocytes 
and this is discussed in section 1.4.3.1. Through their role in cell-matrix interactions, the 
cytoskeletal elements can regulate the retention of the ECM by regulating the affinity of 
receptors, such as integrins (Critchley, 2009) and CD44 (Nofal and Knudson, 2002), for 
their ligands (see section 1.1.2.7). Cytoskeletal elements are also well placed to 
transduce mechanical signals from the ECM to the chondrocyte nucleus; see section
1.4.2.1.5 and 1.4.3.3 for evidence of a role of the chondrocyte tubulin and actin 
cytoskeletal networks in mechanotransduction.
1.2.4.2 Structural organisation of the chondrocyte cytoskeleton
Knowledge of the structural organisation of the chondrocyte cytoskeleton has advanced 
in recent years due to improvements in confocal microscopy and immunofluorescence 
techniques. The chondrocyte cytoskeleton has been characterised in situ in mature 
bovine articular cartilage, showing actin microfilaments to be predominantly cortical, 
with dense, punctate staining beneath the plasma membrane (Langelier et al., 2000). 
Tubulin microtubules and vimentin intermediate filaments have a filamentous structure, 
with dense networks extending throughout the cytoplasm. As would be expected, tubulin 
filament bundles appeared thicker than the vimentin filament bundles and exhibited a 
looser organisation than the tighter vimentin network (Langelier et al., 2000). 
Organisation of actin and vimentin networks in rat articular cartilage chondrocytes has 
also been observed in situ, with actin again predominantly located at the cell periphery 
and vimentin exhibiting a complex network throughout the cytoplasm (Durrant et al.,
1999). In addition, actin staining at the cell surface was shown to co-localise with 
vinculin, a protein located in focal adhesions connecting the cells with the matrix. 
Visualisation of the cytoskeleton of human articular chondrocytes embedded in alginate 
hydrogel demonstrated a similar actin, tubulin and vimentin organisation to that 
described above (Trickey et al., 2004).
- 3 9 -
Chapter 1: General Introduction
1.3 Osteoarthritis
Osteoarthritis (OA) is a condition which affects the articular cartilage of the synovial 
joints, often causing stiffness of the joints and pain. It represents an increasingly large 
problem to society, with more than one million GP consultations for OA every year 
(Arthritis Research UK. 2008). More than six million adults in the UK have painful OA 
in one or both knees and over 650,000 have painful OA in one or both hips. 
Musculoskeletal conditions including arthritis cost the UK around £5.7 billion per year, 
with 10 million working days lost in 2006/7 because of the conditions. (Arthritis 
Research UK. 2008).
1.3.1 Pathophysiology of Osteoarthritis
OA predominantly affects the hip and knee joints, although it is most prevalent in the 
joints of the hand. Clinically, OA initially presents as joint pain and stiffness, affecting 
joint mobility. As the disease progresses, symptoms worsen, ultimately resulting in 
disability, thus requiring the affected joint to be surgically replaced. Over 55,000 hip 
replacements and 65,000 knee replacements were performed in England and Wales in 
2006/7, with a total hip replacement costing on average £7,350 (Arthritis Research UK,
2008). Physiologically, OA is characterised by degradation of the articular cartilage, 
causing fibrillation of the surface and cartilage thinning. However, OA does not only 
affect the articular cartilage, it affects the joint as a whole (Fig. 1.8). Inflammation of the 
synovium and the joint capsule is the cause of joint swelling and stiffness, and 
osteophytes form on the subchondral bone.
1.3.1.1 Osteoarthritic Changes in Articular Cartilage
The changes that occur in osteoarthritic (OA) cartilage have been extensively 
characterised in the hope that a better understanding of the pathology would lead to 
identification of targets for therapy. Articular cartilage from human OA and animal 
models of OA (section 1.3.4) has been thoroughly investigated, from the structural and 
organisational level, through the biochemical, to the gene expression level.
1.3.1.1.1 Organisational and Extracellular Matrix Changes
Macroscopically, osteoarthritic lesions are evident as interruptions to the smooth, shiny 
appearance of normal articular cartilage. Lesions occurring at the early stages of the 
disease are small, increasing in size and depth with disease severity until exposure of the
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Figure 1.8:- A schematic representation of the main structures of a healthy knee 
joint and the changes observed in an osteoarthritic joint Adapted from Aigner et 
a l  (2006).
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underlying subchondral bone. Systems have long been applied to attempt to quantify or 
‘grade’ the changes occurring in articular cartilage with development of OA, indicating 
the stage and severity of the disease. In 1971, Mankin et al published a grading system 
of histological changes which correlated with the established biochemical changes; a 
histologic-histochemical grading system (Mankin et al., 1971). Using human femoral 
head articular cartilage and histological analysis, they scored regions using four 
categories and totalled the scores from each. Structure was assessed, ranging from 
normal (grade 0), through surface irregularities and clefts (also referred to as fissures) 
extending into the transitional then radial zone, to complete disorganisation (grade 6). 
The appearance of cells was scored as normal, diffuse hypercellularity, cloning, or 
hypocellularity. Staining of mucopolysaccarides (proteoglycans) was also scored, 
ranging from normal, through ‘slight’, ‘moderate’ and ‘severe reduction’, to ‘no dye 
noted’. Finally, the integrity of the tidemark was assessed as either intact or crossed by 
blood vessels. An increasing severity of OA lesions scored in this way correlated with 
decreasing proteoglycan content and with increasing rate of proteoglycan and DNA 
synthesis, as assessed biochemically. The increase in proteoglycan synthesis but 
reduction in proteoglycan content supports the previously mentioned imbalance between 
anabolism and catabolism, which is characteristic of osteoarthritis. Mankin et al also 
noted a point in OA progression at which the articular cartilage ‘fails’; around grade 10 
the rates of proteoglycan and DNA synthesis plateau and begin to decrease, the cartilage 
no longer showing a ‘repair response’.
The heterogeneous nature of OA means that differences in organisation and matrix 
composition also occur over the surface of a single joint. Comparison of visually intact 
regions with disrupted regions of OA articular cartilage showed increased fibrillation 
and decreased glycosaminoglycan content. Chondrocyte ‘cloning’ (scored using the 
number of clusters containing more than four cells and their location) was increased in 
disrupted regions when compared with visually intact regions, although no increase in 
total cell number was observed (Yagi et al., 2005, Kouri et al., 1996). The concept of 
increased chondrocyte cloning with OA progression has been questioned recently. As 
there is no increase in total cell number and many chondrocytes with cilia or filipodia 
have been observed, it has been proposed that the increase in chondrocyte clusters is due 
to chondrocyte migration in OA (Kouri et al., 1996, Kouri et al., 1998).
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The synthesis, composition, size, and degradation of proteoglycan are altered in 
osteoarthritis. In the early stages of OA (Mankin grades 2-6) there is a general 
degradation of proteoglycans combined with replacement with new molecules of altered 
composition. Molecule size decreases, as does the hyaluronan content of cartilage, and 
there is an increase in chondroitin-4-sulphate glycosaminoglycan chains and foetal- 
common epitopes (Rizkalla et al., 1992). There is then extensive replacement of 
degraded molecules with larger, compositionally different proteoglycans in the later 
stages of OA (Mankin grades 7-13), as indicated by increased rates of synthesis (Mankin 
et al., 1971). Hyaluronan content decreases along with chondroitin-6-sulphate and 
keratan sulphate glycoaminoglycans, whilst chondroitin-4-sulphate and foetal-common 
epitopes continue to increase (Rizkalla et al., 1992).
Changes in the extracellular matrix with disease progression result in the organisational 
changes described which contribute to the mechanical failure of the articular cartilage. 
The orientation and integrity of collagen fibres have been shown to alter in an in vivo 
model of OA (Pond-Nuki dog model of OA- see section 1.3.4), initiating in the 
pericellular matrix. A decrease in the amount and diameter of collagen fibres was 
apparent two weeks after induction of OA, along with a change in orientation (Pelletier 
et al., 1983a). Small angle X-ray scattering showed differences in collagen fibre 
orientation between normal and OA articular cartilage in naturally occurring equine 
osteoarthritis. The degree to which normal organisation was disrupted increased with 
severity of OA lesions (Moger et al., 2007). The same was true of human articular 
cartilage when analysed using small-angle X-ray diffraction. Collagen fibres of the 
deeper layers of osteoarthritic tissue were reoriented in regions of cartilage damage, no 
longer showing the vertical orientation seen in normal cartilage (Mollenhauer et al., 
2003). Cleavage of type II collagen is increased in human OA. The pericellular cleavage 
in the deep zone of normal cartilage is increased in OA cartilage, along with the 
appearance of both territorial and interteritorial type II collagen cleavage in superficial 
and mid-zones (Dodge and Poole, 1989). Disruption of the collagen matrix is 
characteristic of OA and leads to further degeneration of the cartilage and mechanical 
failure of the tissue, with a reduction in compressive stiffness correlated with 
extracellular matrix integrity (i.e. a disruption of the collagen network) (Franz et al., 
2001).
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1.3.1.1.2 Changes in the Chondrocyte Phenotype
Once it was realised that the organisational and biochemical changes described above 
were predominantly a result of proteins secreted by the chondrocyte rather than proteins 
from other sources such as the synovial fluid or synovium, investigation of the 
chondrocyte phenotype became more extensive. The balance of synthesis and 
degradation of the matrix is controlled by the chondrocyte. This balance is essential in 
maintaining the function of articular cartilage. An imbalance and shift towards a 
catabolic phenotype, as occurs in OA (reviewed by (Goldring, 2000)), ultimately results 
in degradation of the articular cartilage and failure of the joint.
Knowledge of the proteins expressed by normal and osteoarthritic chondrocytes has 
increased recently with the use of proteomics and mass spectrometry. Osteoarthritic 
cartilage explants in culture secreted proteins including collagens II, VI and XI, COMP, 
fibronectin, cartilage glycoprotein 39, MMPs-1, -2, and -3, TIMPs-1 and -2, and CTGF 
(connective tissue growth factor) (Hermansson et al., 2004, Garcia et al., 2006). 
Comparison of proteins secreted by normal and osteoarthritic cartilage revealed 
increased synthesis of type II collagen in OA cartilage. A proteomic profile of 
osteoarthritic articular cartilage has identified over 100 proteins involved in extracellular 
matrix organisation, signal transduction and cell communication, immune response and 
metabolism, although no comparisons were made with normal cartilage (Garcia et al., 
2006). Comparisons have been made between proteins expressed by normal and 
osteoarthritic chondrocytes following isolation from articular cartilage and culture in 
either monolayer (Ruiz-Romero et al., 2008) or in alginate (Lambrecht et al., 2008). In 
monolayer cultured primary human chondrocytes, 28 proteins were identified as being 
differentially regulated in OA; 19 were increased and nine were decreased in OA 
compared to normal. Proteins involved in the cellular response to stress were increased 
in OA whilst those involved in glycolysis were decreased (Ruiz-Romero et al., 2008). In 
alginate, proteins in chondrocytes from visually intact and damaged OA cartilage were 
compared to each other and to normal chondrocytes, using 2D-electrophoresis and mass 
spectrometry (Lambrecht et al., 2008). 16 proteins were identified as being increased in 
OA chondrocytes compared to normal and seven of these were also increased in 
chondrocytes from visually intact OA cartilage. Eight proteins were identified as being 
decreased in OA chondrocytes compared to normal and seven of these were also
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decreased in chondrocytes from visually intact OA cartilage. In this case, differentially 
expressed intracellular proteins were involved in metabolic and apoptotic pathways and 
in the oxidative stress response (Lambrecht et al., 2008).
Gene expression analysis of normal and osteoarthritic chondrocytes has also been 
extensive, predominantly focusing on expression of genes for extracellular matrix 
molecules. Type II collagen mRNA expression is often increased in OA cartilage 
compared to normal (Martin et al., 2001, Gebhard et al., 2003, Aigner et al., 2006a). 
Other studies have found no significant difference in expression or no correlation with 
histological or clinical OA grade, due to the large variability associated with human 
samples (Yagi et al., 2005, Eid et al., 2006). Expression of types V, VI, IX, XI and XV 
collagen is also increased in OA cartilage compared to normal (Aigner et al., 2006a). 
The increased expression of types I and III collagen and type X collagen in OA cartilage 
has been attributed to dedifferentiation and hypertrophy, respectively. This concept has 
recently been challenged; as ratios of collagens I, III and X expression to that of collagen 
II showed no difference between normal and OA cartilage, it is argued that the increased 
expression is due to a general increase in anabolism rather than a shift in chondrocyte 
phenotype (Gebhard et al., 2003). In contrast, a comparison of normal and OA cartilage, 
showing increased expression of collagen I and significantly increased expression of 
collagen II in OA, found that the ratio of collagen II expression to that of collagen I was 
significantly decreased in OA (Martin et al., 2001).
The expression of non-collagenous matrix molecules has also been shown to change in 
osteoarthritis. Fibronectin, fibromodulin, tenasin C, CILP and osteonectin expression are 
increased in OA (Aigner et al., 2006a), as is osteopontin mRNA expression (Yagi et al., 
2005, Martin et al., 2001). Results regarding aggrecan expression in OA vary. Intra-joint 
comparisons have shown decreased expression of aggrecan in advanced OA regions 
compared to early OA regions of cartilage (Yagi et al., 2005) and an inverse correlation 
of aggrecan expression with increasing OA severity (Eid et al., 2006). In support of this, 
another study has shown decreased aggrecan expression in OA cartilage, but with no 
difference between advanced and minimal OA regions (Brew et al., 2010b). Other 
comparisons of normal and OA cartilage have shown no difference in aggrecan 
expression (Aigner et al., 2006a, Martin et al., 2001).
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Expression of the transcription factor SOX9, a marker of the chondrocyte phenotype, is 
decreased in OA cartilage compared to normal (Brew et al., 2010b, Aigner et al., 2003, 
Aigner et al., 2006a). In support of proteomic studies, discussed above, a comparison of 
gene expression in normal and OA cartilage using cDNA arrays revealed decreased 
expression of genes involved in the response to oxidative stress, including superoxide 
dismutase 2 and thioredoxin-interacting protein (Aigner et al., 2006a).
The importance of the balance between matrix synthesis and degradation is indicated by 
the imbalance present in OA cartilage. An increase in MMP is observed that is not 
sufficiently matched by the increase in TIMPs, ultimately resulting in degradation and 
progression of OA (Dean et al., 1989). In human late stage OA cartilage, expression of 
the aggrecanases ADAMTS-4 and -5 is increased compared to normal and early stage 
OA, whilst expression of MMP-3, which also degrades aggrecan, is decreased (Bau et 
al., 2002). MMP-3 mRNA expression was again shown to be decreased in OA cartilage 
when compared with normal, and in contrast to the above study, ADAMTS-5 expression 
was also reduced in OA (Kevorkian et al., 2004). The same study showed decreased 
expression of MMP-1, TIMP-1 and TIMP-4, but increased expression of MMP-2, -9 and 
-13 and TIMP-3. Another study has shown no difference in MMP-1 and MMP-14 
expression between normal and OA cartilage, but MMP-13 (collagenase 3) expression 
has been shown to be increased in OA cartilage (Bau et al., 2002, Brew et al., 2010b). 
Intra-joint comparisons showed no difference in expression of MMP-3, -9, or -13 (Yagi 
et al., 2005).
1.3.2 Pathogenesis of Osteoarthritis
Degradation and thinning of the articular cartilage observed in OA is brought about by 
an imbalance in homeostasis, with breakdown of articular cartilage components 
ultimately exceeding their synthesis. OA is a multi-factorial disorder but can generally 
be split into two broad classes, primar y OA and secondary OA, depending on the 
apparent causes.
1.3.2.1 Risk Factors fo r  development o f Osteoarthritis
The occurrence of OA increases with age and this late-onset form of the disease is 
known as primary OA. Age and gender contribute to its development, with knee and 
hand OA more prevalent in females (Blagojevic et al., 2010). However, OA should not 
be considered simply a disease of old-age, as not everyone will develop OA as they age.
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and function of the articular cartilage. Hyaluronic acid can be administered by intra- 
articular injection to help restore some of the fluid properties of the cartilage ECM, 
acting through its role in forming large, hydrophilic aggregates in the cartilage. Intra- 
articular injections of sodium hyaluronate improve the clinical symptoms of pain and 
inflammation but have also been shown to reduce levels of MMP-9 in the synovial fluid 
(Shimizu et al., 2010). The low incidence of adverse side effects is also an advantage 
over NSAIDs (Brzusek and Petron, 2008). Glucosamine and chondroitin sulphate are 
used as dietary supplements for some OA sufferers, with glucosamine suggested to 
stimulate chondrocytes to synthesise proteoglycans and collagen, and chondroitin 
sulphate able to competitively inhibit degradative enzymes. These have the potential to 
both increase synthesis of the ECM and reduce its degradation, both of which are key 
characteristics of OA pathogenesis. Administered in combination, these supplements 
have been shown to produce a greater improvement in knee pain in sufferers of OA than 
when used individually (Clegg et al., 2006). Other studies have demonstrated some 
clinical effectiveness of glucosamine sulphate in the treatment of OA (Black et al.,
2009). There is however, controversy over the effectiveness of this ‘matrix enhancement 
therapy’; hence they require further unbiased, large-scale clinical trials of commercially 
available formulations (Hochberg, 2006). For example, one study has shown that intra- 
articular injection of sodium hyaluronate demonstrated no advantage over physical 
exercise in reducing the clinical symptoms of knee OA (Kawasaki et al., 2009).
Non-pharmaceutical interventions include regular exercise and weight loss. As 
overweight sufferers are continuously subjecting weight-bearing joints such as the hip 
and the knee to higher mechanical loads than normal, weight loss can reduce the 
mechanical insult to joints during regular activities, such as walking, and help to 
improve mobility. Exercise will aid weight loss where it is required, although it has other 
advantages to OA sufferers; it can develop muscle tone which helps to support the joint, 
improving joint mobility and controlling the load received by a joint more effectively. 
One study has shown improvement in pain and physical function in hip or knee OA 
sufferers following six weeks of treatment with glucosamine sulphate and a further 
improvement with the introduction of a walking regime (Ng et al., 2010). Regular 
moderate exercise alone has been shown to improve the glycosaminoglycan (GAG) 
content of knee articular cartilage in middle-aged people at high risk of developing OA 
(Roos and Dahlberg, 2005). However, the long-term effects were not studied, nor can
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A number of genetic linkage analyses and genome-wide association studies have 
searched for a genetic susceptibility to OA (Loughlin, 2003, Valdes and Spector, 2010); 
genes associated with OA include factors involved in the bone morphogenic protein 
(BMP) or Wnt signalling pathways, apoptotic pathways and inflammation. In addition to 
age and genetics, there are four main non-heritable risk factors for developing OA; 
congenital abnormalities, trauma, obesity, and occupation, all four of which are risk 
factors for development of the other class of OA: secondary OA. Population-based 
studies have confirmed that the risk of developing knee OA is strongly associated with 
body mass index (i.e. obesity), previous knee injury or heavy physical stress at work 
(Blagojevic et al., 2010, Toivanen et al., 2010). Secondary OA tends to develop at a 
relatively young age, and causes relate to loading of the joint. Increased loading of a 
joint, whether due to obesity, environmental factors such as an occupation involving a 
large amount of bending, or impact trauma direct to the cartilage (e.g. sports injuries), 
can result in the development of OA. Abnormal loading of a joint can also contribute to 
OA; for example, that caused by congenital defects allowing dislocation, or by impact 
trauma which disrupts supporting ligaments and results in joint misalignment.
The number of people suffering from OA has increased in the last ten years and will 
likely continue to do so. This is due to two of its main risk factors- age and obesity. As 
the population is ageing, more people living over the age of 65 will mean that the 
occurrence of OA will increase. In addition to this, the prevalence of obesity is 
increasing in the UK. Besides the other health problems associated with obesity, it is a 
primary risk factor for development of knee OA. This increase in the number of 
overweight individuals is likely to result in an increase in the number of young and 
middle-aged adults suffering from OA. For these reasons, it is becoming increasingly 
important to find effective treatments for the disease.
1.3.3 Therapeutic Strategies for Osteoarthritis
Currently there is no ‘cure’ for OA and no disease-modifying drug; current 
pharmaceutical treatments focus on relieving symptoms such as pain and inflammation. 
Non-steroidal anti-inflammatory drugs (NSAIDs) can be used to treat the pain and 
inflammation that often occurs in osteoarthritic joints, but these have no effect on the 
progression of cartilage degradation. The use of ‘chondroprotective’ agents has recently 
emerged and rapidly gained ground due to their potential to improve the composition
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the improvements observed be applied to other groups, such as those with early- or late- 
stage OA (Roos and Dahlberg, 2005).
The treatment of OA symptoms gives some comfort to the sufferer and can moderately 
and temporarily improve joint function. Nevertheless, as there are no treatments which 
have been shown to sufficiently repair cartilage defects or alter chondrocyte phenotype, 
degradation of the cartilage continues, leading to severe disability which can only be 
treated through surgical replacement of the joint.
Radiography is the technique currently used to determine the presence of OA in a joint 
(Fig 1.9). The extent of OA in a joint is graded, taking into account the degree of 
osteophyte formation and joint space narrowing, an indication of thinning of the articular 
cartilage. The sensitivity of radiography means it is not capable of detecting early OA 
changes, only detecting changes after the cartilage has thinned and/or osteophytes have 
formed. The use of magnetic resonance imaging (MRI) is increasing due to its ability to 
provide clear and detailed imaging of intra-articular structures, including articular 
cartilage, menisci, and ligaments (Fig 1.10). The more water present in a tissue, the 
whiter it appears on MRI images. The greater detail of MRI images indicates its 
potential to detect early-stage OA, thus providing an earlier diagnosis and an opportunity 
for pharmacological intervention before degradation progresses.
1.3.4 Experimental Models of Osteoarthritis
In vivo studies have shown abnormal loading results in changes to the cartilage similar to 
those seen in OA. The Pond-Nuki dog model induces OA by producing joint laxity 
through transection of the anterior cruciate ligament in the knee (Pond and Nuki, 1973) 
which leads to abnormal loading of the knee as the dog exercises post-surgery. Changes 
in the joint are indistinguishable from naturally occurring secondary OA (McDevitt et 
al., 1977), with osteophyte formation just two weeks after the operation and thickening 
of the joint capsule after three weeks (Pelletier et al., 1983a, McDevitt et al., 1977). 
Increased thickness and vascularity of the synovial membrane was observed after two 
weeks and damage to the meniscus, initially surface splitting which progressed to 
tearing, was also observed, most often on the medial meniscus. Changes in articular 
cartilage included increased water content accompanied by increased cartilage thickness,
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Figure 1.9:- Radiographic images of a normal (A) and an osteoarthhtic knee 
joint requiring total knee replacement surgery (B). Joint space narrowing (white 
arrow head) indicates a severe loss of articular cartilage. Images are from 
meded.ucsd.edu/clinicalmed/joints.htm
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B
Figure 1.10:- Images of the knee joint, taken using Magnetic Resonance Imaging 
(MRI). A- A healthy knee joint The articular cartilage can be seen clearly, protecting 
the ends of the long bones (image from www.kneeclinic.info/knee imaging.php) B- 
A knee joint requiring total knee replacement due to the severe degradation of the 
articular cartilage, symptomatic of end-stage osteoarthritis (image used with kind 
permission of Dr. Hechmi Toumi, Department of Orthopedics, Llandough Hospital, 
Penlan Road, Llandough. CF64 2XX.).
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except in regions of fibrillation (McDevitt and Muir, 1976), and loss of proteoglycans in 
the superficial zone. Lesions on the cartilage progressed in severity and size with time 
after surgery, although this was notably more progressive and severe in the region of the 
medial tibial condyle not covered by the medial meniscus (McDevitt et al., 1977). The 
same is true for naturally occurring OA, indicating that regions experiencing higher 
mechanical loads become more severely damaged (Thambyah et al., 2006). Microscopic 
examination revealed an increase in cell density and number of clones (i.e. lacunae 
containing two or more nuclei) progressively with time after surgery, again with 
differences most pronounced in the region experiencing higher mechanical loads 
(McDevitt et al., 1977, Pelletier et al., 1983a). After 16 weeks, the tissue was 
microscopically indistinguishable from naturally occurring OA. Collagenolytic activity 
in articular cartilage also increased in this model, detectable after two weeks and peaking 
at four weeks post-surgery due to an increase in latent enzyme (Pelletier et al., 1983a). 
The structure of the collagen network altered after two weeks, with an initial decrease in 
the number, diameter, and orientation of the fibres which were parallel to the articular 
surface and no longer to the cell membrane. After eight weeks, fibres were of smaller 
diameter, fragmented, and orientated parallel to clefts and tears in the cartilage (Pelletier 
et al., 1983a). Therefore the increased water content observed is likely due to disruption 
of the collagen network, which becomes less effective in opposing the swelling pressure 
produced by the proteoglycans (Maroudas, 1976).
Following this early model (Pond and Nuki, 1973), surgical induction of OA through 
establishment of joint instability has been used in a number of mammalian species to 
provide models of the disease; joint instability is induced either through transection of 
the anterior cruciate ligament, as in the Pond-Nuki dog model, or through partial or 
complete meniscectomy (removal of the meniscus) (van den Berg, 2001, Capin- 
Gutierrez et al., 2004). Other models include animals that spontaneously develop OA- 
like cartilage degeneration with ageing, such as the STR/ort mouse (Walton, 1977, 
Mason et al., 2001), or transgenic models in which expression of cartilage matrix 
proteins or degrading enzymes are manipulated (van den Berg, 2001). Examples of the 
latter include mice lacking al(IX) collagen (Fassler et al., 1994) or a l integrin (Zemmyo 
et al., 2003), and mice with hyaline cartilage-specific postnatal expression of 
constitutively active MMP-13 (Neuhold et al., 2001), all of which develop degenerative 
joint disease resembling human OA.
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1.4 Mechanical Load
Load has long been hypothesised as a key mediator in the development of OA. It is a 
major element in all of the risk factors associated with the development of secondary OA 
(section 1.3.2.1). This is supported by observations that regions of fibrillation, known as 
OA lesions, most often occur at weight-bearing regions of the articular cartilage. In 
addition to clinical and surgical observations, a number of studies have implicated load 
as a mediator of cartilage turnover. Changes in joint loading patterns have been induced 
experimentally, both in vivo and in vitro, and the results demonstrate a clear role of load 
in the regulation of chondrocyte phenotype.
1.4.1 Load and Chondrocyte Phenotype
1.4.1.1 In vivo Studies
Previous studies have shown that physiological loading of a joint is required for the 
maintenance of healthy cartilage, as demonstrated by in vivo immobilisation studies. 
Immobilisation of the right hind limb of mature canines (at 90° flexion of hip and knee 
joints) using a cast resulted in a decrease in proteoglycan synthesis, initially apparent 
after just six days of joint immobilisation (Palmoski et al., 1979). This was accompanied 
by an increase in cartilage water content and a decrease in cartilage thickness after three 
weeks of joint immobilisation. However, the changes were reversible, with proteoglycan 
synthesis comparable to control levels one week after removal of the cast, water content 
after two weeks, and cartilage thickness four weeks following removal of the cast 
(Palmoski et al., 1979). The changes observed were subsequently proven to be due to the 
absence of normal loading rather than the absence of joint motion (Palmoski et al., 
1980). Transection of the ipsilateral paw, preventing loading of a canine knee whilst still 
allowing for its normal motion, showed changes in cartilage morphology after six weeks 
without load that were identical to the effects observed after immobilisation: increased 
water content, decreased cartilage thickness, and decreased proteoglycan synthesis and 
content (Palmoski et al., 1980). These studies show clearly that load is required to 
maintain a normal cartilage organisation and therefore function.
However, this applies only to physiological loading of a joint, as other in vivo studies 
have shown abnormal loading results in changes to the cartilage similar to those 
observed in OA (for changes in the cartilage with OA, see section 1.3.1.1). A number of 
the animal models of OA described in section 1.3.4 induce abnormal loading of a joint to
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promote OA-like phenotypic changes in the cartilage and chondrocytes. The Pond-Nuki 
dog model induces OA by producing joint laxity through severing of the anterior 
cruciate ligament (Pond and Nuki, 1973) which leads to abnormal loading of the knee as 
the dog exercises post-surgery. The subsequent changes in the joint are indistinguishable 
from naturally occurring secondary OA (McDevitt et al., 1977). Cartilage lesions were 
notably more progressive and severe in the region of the medial tibial condyle not 
covered by the medial meniscus. The same is true for naturally occurring OA, indicating 
that regions experiencing higher mechanical loads become more severely damaged 
(Thambyah et al., 2006). With regards to a more direct effect of load on chondrocyte 
phenotype, collagenolytic activity increases in the Pond-Nuki model of OA, detectable 
after two weeks and peaking at four weeks post-surgery due to an increase in latent 
enzyme (Pelletier et al., 1983a).
Of note here is a more recent trial investigating the effects of exercise on human knee 
cartilage, using subjects at risk of OA due to previous meniscectomy (Roos and 
Dahlberg, 2005). Using delayed gadolinium-enhanced magnetic resonance imaging of 
cartilage (dGEMRIC) to assess the GAG content of cartilage in vivo, the study found 
that an increase in moderate exercise led to a dose-dependent increase in GAG content 
as there was a correlation with the self-reported physical activity level. A reduction in 
pain and improved joint function were also reported.
The complexity of the role of load in articular cartilage turnover is evident. 
Physiological loading of the joint is required to maintain healthy cartilage, abnormal or 
over-loading results in cartilage damage and an OA phenotype, whilst moderate 
exercising of joints at risk of OA prove potentially beneficial. In vitro studies have 
attempted to better characterise the effects of load on articular cartilage.
1.4.1.2 Ex vivo Cartilage Explants
Numerous in vitro models have been used to monitor the effects of mechanical load on 
articular cartilage. The different conditions used can make it difficult to directly compare 
results, as there are variations in the magnitude and frequency of loads applied, 
including a single impact load (Jeffrey et al., 1997) or compressive loads which are 
either static (Palmoski and Brandt, 1984) or cyclic (Palmoski and Brandt, 1984, 
Steinmeyer and Knue, 1997, Blain et al., 2001), each with varying peak loads and
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duration. In general, static loads induce catabolic changes whilst cyclic loading is 
anabolic. As might be expected, increased damage to cartilage correlates with higher 
peak stress and strain rates, and increasing duration of loading (Kurz et al., 2005); these 
studies do confirm the ability of load to alter articular cartilage properties and 
chondrocyte gene expression (reviewed by Kurz et al. 2005).
The mechanical integrity of articular cartilage is disrupted by impact load, as indicated 
by the significant loss of matrix protein observed over a two week period after a single 
impact load to articular cartilage (Jeffrey et al., 1997). This was accompanied by a loss 
of GAG which increased with the severity of impact. Regulation of GAG synthesis and 
release are also observed following both static and cyclic compressive loading. In adult 
canine articular cartilage, static compressive loading for two hours suppressed GAG 
synthesis, as did prolonged cyclic compressive loading (one minute on /one minute off) 
showing a linear decrease with duration (Palmoski and Brandt, 1984). An increase in the 
frequency of cyclic loading (four seconds on/11 seconds off) decreased the inhibitory 
effects of a given load and, at the lower stresses, became stimulatory to increase GAG 
synthesis (Palmoski and Brandt, 1984). Mature bovine articular cartilage also showed a 
decrease in proteoglycan synthesis in response to cyclic compressive load (0.1-5.0 MPa) 
at 1 Hz, with a decrease in frequency of loading inhibiting the decrease in synthesis 
observed at a given load (Steinmeyer and Knue, 1997). Proteoglycan biosynthesis 
decreased with increasing load magnitude and duration (one to six days), whilst 
proteoglycan release increased with load magnitude but decreased with increasing 
duration. Loss of GAGs from articular cartilage will reduce the mechanical integrity of 
the tissue and an initial release is suggested to be due to direct mechanical damage rather 
than an increase in proteolysis (Kurz et al., 2005). This GAG loss could also be due to 
damage to the collagen network, allowing tissue swelling and diffuse GAG loss (Kurz et 
al., 2005). The observation that injurious compression of young bovine articular 
cartilage causes mechanical failure of the tissue, accompanied by an abrupt decrease in 
the tensile load-carrying capacity of the collagen matrix implies that certain loads can 
directly damage collagen networks (Quinn et al., 1998).
The modulation of GAG biosynthesis by load indicates that mechanical stress has an 
effect on chondrocytes as well as on the matrix. There is much evidence supporting this, 
with load shown to alter chondrocyte gene expression and morphology. A physiological
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level of cyclic compressive load has been shown to increase COL2A1 and aggrecan 
mRNA levels (Blain, 2002), along with increasing matrix metalloproteinase expression 
and activation in bovine articular cartilage explants (Blain et al., 2001). Increases in both 
latent and active forms of MMP-2 and -9 were detectable after three hours of loading. 
No change in response to load was detectable in the levels of TIMPs, inferring that load 
can alter cartilage homeostasis, increasing matrix turnover and possibly shifting it 
towards a catabolic phenotype.
In addition to phenotypic changes, the ultrastructure of chondrocytes can be altered by 
mechanical load. In response to continuous high hydrostatic pressure applied for three 
hours in vitro, normal human chondrocyte ultrastructure becomes similar to the 
morphology of unloaded OA chondrocytes, with a significant reduction in the number of 
mitochondria and Golgi bodies (Fioravanti et al., 2005). Lower, cyclical hydrostatic 
pressure applied to the same model failed to alter normal chondrocyte morphology in 
three hours (Fioravanti et al., 2003). However this loading regime significantly increased 
the number of mitochondria and Golgi bodies present in OA chondrocytes resulting in a 
morphology comparable to normal. The effects of load on chondrocyte ultrastructure 
thus parallel the effects on chondrocyte phenotype and matrix metabolism, with cyclic 
loads of lower magnitude inducing anabolic changes and high magnitude, static loads 
inducing catabolic changes.
Of note here is that the age and maturation of cartilage appears to affect the response of 
the tissue to load. Compared to immature bovine tissue, mature cartilage shows less 
apoptosis and GAG loss in response to mechanical injury (Kurz et al., 2005). 
Mechanical injury also has less effect on biosynthetic activity in mature cartilage, 
although mature cartilage exhibits a stronger response to peak stress. Peak stresses in 
cartilage during compression increase with tissue maturation (Kurz et al., 2005), 
therefore the different mechanical properties of young and old cartilage could contribute 
to the different responses to mechanical load.
1.4.2 Mechanotransduction in Chondrocytes
It is clear from the studies mentioned above, that load can alter gene expression in the 
chondrocyte. The mechanism(s) by which load is sensed and the signal(s) propagated to
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the nucleus, termed “mechanotransduction”, has not been fully characterised in 
chondrocytes but current knowledge is summarised below.
1.4.2.1 Cell Surface Mechanosensors
1.4.2.1.1 Mechanosensitive Ion Channels
Cyclic pressure-induced strain causes membrane hyperpolarisation in human 
chondrocytes in monolayer (Wright et al., 1996). This strain-induced hyperpolarisation 
is inhibited by the stretch activated ion channel blockers gadolinium and amiloride, the 
small conductance calcium-activated potassium channel blocker apamin, or the L-type 
calcium channel blocker nifedipine. In addition, depletion of extracellular calcium by 
chelation reduced the hyperpolarisation response to pressure-induced strain (Wright et 
al., 1996). The potassium channel blocker 4-aminopyridine inhibits dynamic 
compression-induced increases in sGAG synthesis (Mouw et al., 2007) and apamin 
inhibits membrane hyperpolarisation in normal human chondrocytes induced by 
exogenous ATP (Millward-Sadler et al., 2004). Cyclic mechanical stretch-induced 
increases in chondrocyte proliferation were abrogated by the L-type calcium channel 
blocker nifedipine, which also prevented stretch-induced up-regulation of cartilage 
matrix protein expression (Lee et al., 2000). Nifedipine treatment also prevented 
increased sGAG synthesis induced by dynamic compression of bovine chondrocytes in 
agarose (Mouw et al., 2007). Tyrosine phosphorylation of FAK, p-catenin and paxillin, 
up-regulation of aggrecan and down-regulation of MMP-3 expression in response to 
cyclic pressure-induced strain were inhibited by blocking stretch activated ion channels 
with gadolinium (Lee et al., 2000, Millward-Sadler et al., 2000a). In addition, 
gadolinium abolished increases in proliferation in response to cyclic mechanical 
stretching of chondrocytes in 3D collagen scaffolds (Wu and Chen, 2000). Stretch 
activated ion channels are also suggested to maintain chondrocyte phenotype 
independently of mechanical stimulation (Perkins et al., 2005). Gadolinium treatment 
induced dedifferentiation of rat chondrosarcoma cells and primary human chondrocytes 
in monolayer, as indicated by increased actin stress fibre formation and type I collagen 
and fibronectin expression; concomitant decreases in aggrecan and type II collagen 
expression were also observed. Removal of gadolinium from the culture media reversed 
the dedifferentiation.
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1.4.2.1.2 lntegrins
As chondrocytes are surrounded by a pericellular matrix and lack cell-cell contacts in an 
avascular and aneural tissue, integrins are important for the transduction of signals from 
the extracellular matrix to effect intracellular changes. As discussed in section 1.1.2.7.1 
chondrocytes express a number of different combinations of integrin ap heterodimers 
and their expression can alter with development or OA progression. In human articular 
chondrocytes cultured in monolayer, the extent of membrane hyperpolarisation induced 
by cyclic pressure-induced strain was reduced by inhibition of a5pl integrins (Wright et 
al., 1997). In addition to reducing the electrophysiological response to strain, blocking 
integrins with RGD-containing peptides inhibited downstream signalling, including 
strain-induced up-regulation of aggrecan, down-regulation of MMP3 expression 
(Millward-Sadler et al., 2000a) and tyrosine phosphorylation of FAK, P-catenin and 
paxillin (Lee et al., 2000). The integrin associated protein CD47 is expressed by normal 
and OA chondrocytes and directly binds to a5 integrin (Orazizadeh et al., 2008). 
Antibodies blocking CD47 function prevented changes in membrane potential, tyrosine 
phosphorylation and aggrecan expression induced by cyclic mechanical stimulation of 
chondrocytes (Orazizadeh et al., 2008). Using this model, IL-4 was identified as a 
soluble mediator released into culture media that signalled through IL-4 receptor-a and 
was required for strain-induced membrane hyperpolarisation and differential aggrecan 
and MMP3 expression (Millward-Sadler et al., 2000a, Millward-Sadler et al., 1999). 
Blocking of integrins also alters the response of chondrocytes in anchorage-independent 
culture conditions. The inhibition of nitric oxide release and increase in cell proliferation 
and sGAG synthesis induced by dynamic compression of bovine chondrocytes in 
agarose was abolished by blocking integrins with RGD-containing peptides (Chowdhury 
et al., 2006). In the presence of RGD-containing peptides the up-regulation of aggrecan, 
COL2A1 and MMP3 expression induced by dynamic compression of porcine 
chondrocytes in agarose was inhibited (Kock et al., 2009). Interestingly, the effects of 
integrin blocking on long-term sGAG biosynthesis were dependent upon the loading 
frequency; RGD peptides had no effect on the reduction of sGAG content induced by 
compression at 0.33 Hz, whilst they inhibited the increase in sGAG content induced by 
compression at 1 Hz (Kock et al., 2009). This could provide a mechanism underlying the 
differential effects of different loading frequencies on articular cartilage metabolism, pi 
integrin blocking antibodies prevented the dynamic compression-induced up-regulation 
of COMP expression in bovine chondrocytes in agarose and in cartilage explants
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(Giannoni et al., 2003). In bovine chondrocytes cultured in agarose, blocking either 
aVp3 or pi integrins prevented dynamic compression-induced increases in sGAG 
synthesis (Chai et al., 2010). As blocking aVp3 integrin decreased, but blocking pi 
integrin increased sGAG synthesis in unloaded controls, Chai et al. suggest these 
integrins regulate the stimulation of proteoglycan synthesis via separate mechanisms, 
perhaps sensing different mechanical signals.
1.4.2.1.3 Purinergic Mechanotransduction Pathway: Connexin and P2 Receptors
Extracellular ATP signals to cell through the transmembrane P2 receptors, which are 
subdivided into the P2X and P2Y families; P2X receptors are ligand-gated ion channels 
whilst P2Y receptors are G-protein-coupled receptors. P2 receptors expressed by human 
articular chondrocytes include P2Y1, P2Y2, P2X2, P2X4 and P2X7 (Knight et al.,
2009). In addition, P2X1 and P2X3 are expressed by bovine chondrocytes, with 
extracellular ATP inducing the release of nitric oxide and prostaglandin E2 (Varani et 
al., 2008).
A purinergic mechanotransduction pathway regulating the response to dynamic 
compression has been identified in chondrocytes embedded in agarose (Pingguan- 
Murphy et al., 2006, Chowdhury and Knight, 2006). The increases in proteoglycan 
synthesis and cell proliferation induced by dynamic compression for 48 hours (15%, 1 
Hz) were inhibited by the P2 receptor antagonist suramin or by hydrolysis of 
extracellular ATP (Chowdhury and Knight, 2006). P2 receptor signalling was also 
required for the suppression of nitric oxide release by dynamic compression; in the 
presence of suramin, dynamic compression enhanced nitric oxide release. ATP release 
was induced by cyclic compression of porcine chondrons in pellet culture (Graff et al.,
2000) and dynamic compression of bovine chondrocytes in agarose (Garcia and Knight,
2010). Dynamic compression (10-15%, 1 Hz) increased hemichannel opening in bovine 
chondrocytes. Load-induced ATP release was inhibited by blocking these hemichannels 
(Garcia and Knight, 2010), suggesting that load activates ATP release through 
hemichannels, with the extracellular ATP then activating P2 receptors on the 
chondrocyte (Pingguan-Murphy et al., 2006). Interestingly, the P2 receptor antagonist 
suramin reduced basal and load-induced ATP release from chondrocytes (Millward- 
Sadler et al., 2004, Garcia and Knight, 2010), suggesting the presence of an autocrine 
positive feedback loop in the purinergic mechanotransduction pathway (Garcia and
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Knight, 2010). Human articular chondrocytes in situ express the mechanosensitive ATP- 
release channel connexin 43 as an uncoupled hemichannel, therefore connexin 43 is 
suggested to be involved in load-induced ATP release (Knight et al., 2009).
1.4.2.1.4 FGF Receptor and Pericellular FGF-2
Basic fibroblast growth factor (FGF-2) is bound to perlecan in the pericellular matrix in 
articular cartilage (Vincent et al., 2007). Cyclic compression of cartilage explants causes 
release of FGF-2 which signals through FGF receptor 1 (FGFR1) to activate 
extracellular signal-regulated kinase (ERK) and induce synthesis of MMP-1, -3 and 
TIMP-1 (Vincent et al., 2002, Vincent et al., 2004). ERK activation, induced by cyclic 
compression or FGF-2 treatment of porcine cartilage explants and chondrocytes in 
alginate, was suppressed by inhibition of FGFR1 tyrosine kinase (Vincent et al., 2004, 
Vincent et al., 2007). Subsequent studies have shown that FGF-2 inhibits IL-la-induced 
ADAMTS4 and ADAMTS5 expression in normal human chondrocytes, IL-la-induced 
aggrecanase activity in normal human cartilage, and protects against the development of 
OA in mice (Sawaji et al., 2008, Chia et al., 2009), suggesting a role for FGF-2/FGFR1- 
mediated mechanotransduction in the maintenance of cartilage integrity.
1.4.2.1.5 Primary Cilia on Chondrocytes
As discussed in section 1.2.2.1.1, primary cilia are suggested to function as 
mechanosensors in a number of different cell types and have been observed to project 
into the ECM of various connective tissues (Donnelly et al., 2008). Hyaline cartilage 
chondrocytes possess primary cilia (Kouri et al., 1996, Jensen et al., 2004) and these are 
one of the most stable features of the chondrocyte microtubule cytoskeleton, as indicated 
by the presence of acetylated a-tubulin (Poole et al., 2001). In chick embryonic sternal 
cartilage one primary cilia per chondrocyte was observed and the cilia length varied 
between 1^4|im. Chondrocyte cilia are suggested to be required for chondrocyte 
differentiation and cartilage development as ORPK mice, which lack the polaris protein 
required for ciliary assembly, exhibit abnormal distribution of type II collagen, 
proteoglycan and type X collagen in their growth plate and impaired growth of the major 
long bones (McGlashan et al., 2007). In addition, growth plate chondrocytes exhibited 
altered cytoskeletal organisation; a-tubulin staining was increased, microtubules 
appeared as thick bundles and cortical F-actin appeared thicker and denser. Furthermore, 
as mice lacking one of the ciliary proteins Bbsl, Bbs2 and Bbs6 exhibit OA-like changes 
in their cartilage, primary cilia are also suggested to be required for the maintenance of
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cartilage integrity (Kaushik et al., 2009). In a naturally occurring bovine model of OA, 
the incidence and length of primary cilia is increased in OA articular cartilage 
chondrocytes when compared with normal (McGlashan et al., 2008).
Ultrastructural studies of chick embryonic sternal chondrocytes in situ showed direct 
connections between the cilia and ECM collagen fibres and, in support of this, pi 
integrin is expressed on chondrocyte primary cilia (Poole et al., 2001, McGlashan et al.,
2006). Cilia observed in situ were usually bent, whilst they were predominantly straight 
in chondrocytes isolated from their matrix (Poole et al., 2001, Jensen et al., 2004). As a 
result of these observations, it is suggested that the observed bending of chondrocyte 
cilia is a result of passive bending in response to forces exerted by the ECM; via this 
mechanism, mechanical force applied to collagen is transmitted to the axoneme and the 
inside of the chondrocyte. Furthermore, connexin 43, which is proposed to mediate the 
release of ATP in the purinergic mechanotransduction pathway (section 1.4.2.1.3), is 
expressed on 50% of cilia on bovine articular chondrocytes cultured in agarose 
hydrogels; a primary cilium was detected on approximately 30% of chondrocytes 
(Knight et al., 2009).
1.4.2.2 Intracellular Signal Transducers
1.4.2.2.1 Calcium
Both static and dynamic compression induces intracellular calcium signalling in bovine 
chondrocytes in agarose, as indicated by transient increases in intracellular calcium 
concentration (Pingguan-Murphy et al., 2005, Roberts et al., 2001). The effect of 
dynamic compression depends on the frequency; increases in calcium transients were 
maintained for up to five minutes under compression at 1 Hz, whilst increases were not 
maintained when compression was at 0.33 Hz (Pingguan-Murphy et al., 2006). By 
contrast, the duration of loading had no effect on intracellular calcium signalling 
(Pingguan-Murphy et al., 2005). Inhibition of ATP-dependent calcium pumps with 
thapsigargin, which increases the intracellular calcium concentration, reduced protein 
and sGAG synthesis in bovine cartilage explants and prevented the dynamic 
compression-induced increase in sGAG synthesis in bovine chondrocytes in agarose 
(Mouw et al., 2007). In support of this, inhibition of P2 receptors or removal of 
extracellular ATP, which abolished dynamic compression-induced increases in 
proteoglycan synthesis and cell proliferation (Chowdhury and Knight, 2006), prevented
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load-induced increases in intracellular signalling (Pingguan-Murphy et al., 2006). These 
results suggest a role for intracellular calcium signalling in both purinergic and other 
mechanotransduction pathways which mediate load-induced anabolic effects in 
chondrocytes.
Calcium signalling is also an intracellular mediator of other mechanotransduction 
pathways. Increased intracellular calcium concentration, in response to thapsigargin 
treatment, resulted in membrane hyperpolarisation in human chondrocytes in monolayer, 
with further hyperpolarisation in response to pressure-induced strain (Wright et al., 
1996). Cyclic pressure-induced membrane depolarisation in human monolayer 
chondrocytes was abolished by inhibitors of phospholipase C, inositol trisphosphate- 
mediated release of calcium from endoplasmic reticulum stores, or calmodulin (Wright 
et al., 1997). Furthermore, inhibition of calcium/calmodulin-dependent protein kinase II 
abolished membrane hyperpolarisation and prevented increases in aggrecan expression 
induced by mechanical stimulation of normal human chondrocytes (Shimazaki et al.,
2006). Changes in intracellular calcium concentration in response to mechanical 
stimulation could alter actin cytoskeletal organisation through regulation of gelsolin 
activity and other actin binding proteins (section 1.2.1.1).
1.4.2.2.2 Mitogen Activated Protein Kinases
A number of studies have demonstrated activation of mitogen activated protein kinases 
(MAPKs) in response to mechanical stimulation of chondrocytes and their requirement 
for downstream effects. ERK was activated by single impact load in rat cartilage, with 
phosphorylation of ERK 1/2 evident immediately after loading and maintained for up to 
one hour (Henson and Vincent, 2008). Static and dynamic loading of cartilage explants 
also activates ERK in chondrocytes (Fanning et al., 2003, Li et al., 2003, Vincent et al., 
2004, Fitzgerald et al., 2008, Ryan et al., 2009), as does dynamic loading of 
chondrocytes seeded in agarose (Bougault et al., 2008) or calcium polyphosphate 
scaffolds (De Croos et al., 2006). In bovine cartilage explants, inhibition of ERK 
phosphorylation prevented the increase in cell proliferation and decrease in proteoglycan 
synthesis induced by static compression (Ryan et al., 2009). ERK inhibition also 
partially reversed the down-regulation of COL2A1 and fibronectin expression caused by 
static compression of bovine cartilage explants for 24 hours (Fitzgerald et al., 2008). 
ERK signalling was also required for the anabolic changes induced by dynamic
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compression, as ERK inhibition prevented the up-regulation of aggrecan, COL2A1 and 
TIMP-1 expression in dynamically compressed cartilage explants (Vincent et al., 2004, 
Fitzgerald et al., 2008).
Phosphorylation and activation of p38 MAPK is also induced by static and dynamic 
compression of cartilage explants (Fanning et al., 2003, Fitzgerald et al., 2008) and 
dynamic compression of chondrocytes in agarose (Bougault et al., 2008). In a similar 
manner to ERK inhibition, inhibition of p38 MAPK partially reversed static 
compression-induced down-regulation of COL2A1 and fibronectin expression and 
abolished the dynamic compression-induced up-regulation of aggrecan expression 
(Fitzgerald et al., 2008). In contrast to ERK however, p38 MAPK inhibition had no 
effect on the up-regulation of COL2A1 in response to dynamic compression, but did 
suppress the up-regulation of the mechano-sensitive transcription factors c-fos and c-jun 
(Fitzgerald et al., 2008). Furthermore, p38 MAPK inhibition prevented the up-regulation 
of COL2AJ, SOX9 and aggrecan expression in response to dynamic compression of rat 
bone marrow-derived mesenchymal stem cells in alginate, indicating a role for p38 
MAPK in mechanically-enhanced chondrogenesis (Li et al., 2009a). In human articular 
chondrocytes in monolayer, p38 MAPK and c-jun N-terminal kinase (JNK) were 
activated by pressure-induced strain, with p38 MAPK inhibition abrogating strain- 
induced JNK1 and JNK2 phosphorylation and proteoglycan synthesis (Zhou et al.,
2007). In this model, ERK was not activated by mechanical stimulation and ERK 
inhibition had no effect on strain-induced proteoglycan synthesis.
The JNK pathway is activated by static compression in cartilage explants (Fanning et al., 
2003) and cyclic compression of chondrocytes seeded in calcium polyphosphate 
scaffolds (De Croos et al., 2006). Inhibition of JNK signalling blocked AP-1 binding and 
prevented the increased expression of MMPJ, MMP13, COL2A1 and aggrecan induced 
by cyclic compression of bovine chondrocytes in 3D scaffolds. Cyclic compression- 
induced increases in synthesis and accumulation of type II collagen and aggrecan were 
also abrogated by JNK inhibition.
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1.4.3 The Chondrocyte Cytoskeleton and Load
1.4.3.1 The Cytoskeleton Controls the Mechanical Properties o f the Chondrocyte
The cytoskeleton is important for maintaining the mechanical integrity of cells and this 
is also the case in chondrocytes. Disruption of actin and vimentin filaments with 
cytochalasin D and acrylamide respectively reduced the viscoelasticity of human 
chondrocytes in vitro in a dose dependant manner, whereas disruption of microtubules 
with colchicine had little effect (Trickey et al., 2004). The compressive properties and 
recovery behaviour of chondrocytes is also regulated by the cytoskeleton (Ofek et al., 
2009). Disruption of the actin cytoskeleton with cytochalasin D reduced cell stiffness. 
Vimentin intermediate filament disruption with acrylamide reduced chondrocyte 
compressibility, whilst tubulin disruption with colchicine increased cell compressibility. 
The recovery of chondrocytes following compression was delayed by disruption of each 
of the cytoskeletal elements. In addition, colchicine treatment reduced the strain 
threshold of chondrocytes, which is the point after which the biomechanical behaviour 
of cells is irreversibly altered (Ofek et al., 2009). As altering the biomechanical 
properties of the chondrocyte influences cell-matrix interactions (Guilak and Mow, 
2000), the evidence supports the role of the cytoskeleton in mechanical signal 
transduction. Further support for this comes from evidence that pre-stress in the 
cytoskeleton is required for physiological load to affect the nucleolus, with this effect on 
intra-nuclear structures showing its potential to propagate external signals to the nucleus, 
potentially altering gene expression (Hu et al., 2005).
1.4.3.2 Effects o f Load on the Chondrocyte Cytoskeleton
The distribution of the cytoskeletal elements in the different articular cartilage zones has 
been studied and suggests load can alter the chondrocyte cytoskeleton. Whilst the 
distribution of actin was constant throughout the zones of mature bovine cartilage, 
Western blots showed higher levels of actin present in the superficial zone; this could 
possibly be due to higher levels of G-actin available for microfilament remodelling in 
chondrocytes of the superficial zone (Langelier et al., 2000). p-tubulin and vimentin 
staining were more intense in the superficial zone and decreased through to the deep 
zone, although there was little difference between zones in cartilage from load-bearing 
regions of the joint. Differences in staining intensity between cartilage zones, most 
significantly in vimentin distribution, were suggested by the authors to be due to the 
different mechanical conditions experienced by the chondrocytes at different depths
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(Langelier et al., 2000), highlighting the connection between the cytoskeleton and 
mechanical load.
The response of the cytoskeleton to load has also been studied, both in vitro and ex vivo. 
In rat articular cartilage explants, actin distribution and organisation showed no change 
in response to static loads of 0.5-4 MPa, whilst changes were noted in vimentin 
distribution and organisation (Durrant et al., 1999). Tissue statically loaded (2—4 MPa) 
for one hour showed more widespread labelling of vimentin through the depth of the 
tissue with increasing load. However, a load of 1 MPa only showed vimentin staining in 
cells of the deep zone. A load of 0.5 MPa appeared to allow the tissue to act as if in free 
swelling culture with loss of vimentin organisation which, after one hour, was re­
established (Durrant et al., 1999). Disassembly of the vimentin cytoskeleton is induced 
by a single impact load (0.16 J) in rat articular cartilage, as indicated by increased 
vimentin immunofluorescence around the chondrocyte nucleus (Henson and Vincent,
2008). Disassembly peaked two hours after impact loading and then decreased, which 
the authors suggested was indicative of reassembly. An in vitro study using human 
chondrocytes encapsulated in alginate hydrogel demonstrated that there was no change 
in either actin or tubulin cytoskeletal organisation in response to physiological cyclic 
hydrostatic pressure (5 MPa, 0.25 Hz, 3 hours) (Fioravanti et al., 2003). However, 
continuous high hydrostatic pressure (non-physiological loads; 24 MPa, 3 hours) applied 
to the same system induced changes in both actin and tubulin organisation (Fioravanti et 
al., 2005). In contrast to the findings of Durrant et al. (1999) and Fioravanti et al. (2003), 
the actin cytoskeleton has been shown to reversibly remodel in response to load (Knight 
et al., 2006). Hydrostatic pressure (5 MPa) or compressive load (15%) applied either 
statically or cyclically (1 Hz) for two hours induced remodelling of actin microfilaments, 
with staining becoming significantly more punctate. This remodelling was reversible 
within one hour of removal of load, with the exception of cyclic hydrostatic pressure 
(Knight et al., 2006). Increases in punctate F-actin structures and actin remodelling have 
also been observed in agarose embedded normal human articular chondrocytes subjected 
to 20 minutes of dynamic compression (15%, 0.5 Hz) (Haudenschild et al., 2008a). 
Cyclic compression (15%, 1 Hz) for 10 seconds delayed fluorescence recovery after 
photo bleaching of cortical actin in bovine chondrocytes in agarose (Campbell et al.,
2007). As cortical actin intensity decreased 10 minutes post-compression, the authors 
suggest a net depolymerisation in response to cyclic compression.
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The above studies clearly show a link between mechanical conditions and the 
chondrocyte cytoskeleton. Changes observed in the cytoskeleton in response to load 
correlate with the altered mechanical properties of the chondrocyte (Trickey et al., 2004, 
Ofek et al., 2009) and therefore its mechanosensitivity in response to load, as suggested 
by Knight et al. (2006).
In addition to direct regulation of cytoskeletal organisation, mechanical load has been 
shown to modulate expression of cytoskeletal-associated and -regulatory proteins. 
Phosphorylation and activation of Rho kinase (ROCK), which promotes actin 
polymerisation, was increased by dynamic compression of human chondrocytes in 
agarose (Haudenschild et al., 2008a). In this study, inhibition of ROCK activity 
prevented the load-induced remodelling of the actin cytoskeleton and suppressed load- 
induced up-regulation of genes encoding the chemokine CCL20 and inducible nitric 
oxide synthase (iNOS). Expression of the actin-sequestering protein thymosin(34 was up- 
regulated in bovine articular cartilage explants subjected to cyclic compression (0.5 
MPa, 1 Hz) for 10 minutes (Blain et al., 2003). However, in bovine chondrocytes 
encapsulated in agarose thymosin P4 expression was unaffected by cyclic compression 
(15% strain, 1 Hz) for 10 minutes or six hours (Campbell et al., 2007). In the same 
model, expression of the actin depolymerising proteins cofilin and destrin were 
transiently increased in response to 10 minutes of cyclic compression. Both these studies 
demonstrate that load-induced actin reorganisation is orchestrated by increased 
expression of actin-depolymerising proteins.
1.4.3.3 The Role o f Rho GTPases and the Actin Cytoskeleton in Mechanotransduction 
in Chondrocytes
As integrins connect the cytoskeleton to extracellular matrix molecules, the actin 
cytoskeleton has unsurprisingly been shown to mediate some of the downstream effects 
of mechanical stimulation on integrins. Disruption of the actin cytoskeleton in human 
chondrocytes in monolayer by cytochalasin D treatment inhibited the integrin- and 
stretch activated ion channel-dependent membrane hyperpolarisation induced by cyclic 
pressure-induced strain (Wright et al., 1997). RhoA, ROCK and actin cytoskeletal 
remodelling was induced by dynamic compression of agarose embedded normal human 
chondrocytes (Haudenschild et al., 2008a). Dynamic compression-induced actin
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reorganisation and up-regulation of CCL20 and NOS2A expression was dependent upon 
ROCK. ROCK activity was also required for the increase in SOX9 phosphorylation and 
nuclear localisation in response to dynamic compression of human chondrocytes in 
agarose (Haudenschild et al., 2010). In addition to Rho, the small GTPases Rac and 
Cdc42 have been suggested to be involved in the mechanoregulation of chondrocyte 
gene expression. Shear stress-induced c-Jun activity and MMP9 expression was 
abolished by expression of dominant-negative forms of Rac or Cdc42 in rabbit 
chondrocytes cultured as a monolayer (Jin et al., 2000). Rac, and to a lesser extent 
Cdc42, are required for the shear stress-induced phosphorylation of c-Jun and COX-2 
mRNA expression in human chondrocytic cells (Healy et al., 2008).
1.5 Cytoskeletal Changes in Osteoarthritis
Differences between the cytoskeleton in normal and OA chondrocytes have recently 
been observed and have begun to be characterised. Human chondrocytes isolated from 
normal and end-stage osteoarthritic articular cartilage were found to have different 
viscoelastic properties. OA chondrocytes showed significantly increased elastic and 
viscous properties compared to normal chondrocytes (Trickey et al., 2000). It was 
subsequently shown that the chondrocyte actin and vimentin cytoskeleton was 
responsible for these viscoelastic properties (Trickey et al., 2004), indirectly supporting 
the hypothesis that differences exist between the cytoskeleton of normal and OA 
chondrocytes.
The first report of cytoskeletal element disorder in human OA was made by Kouri et al. 
(1998). Microscopic techniques were used to investigate the morphology of 
chondrocytes in situ from fibrillated and adjacent non-fibrillated regions of knee 
articular cartilage. Differences in labelling for all three cytoskeletal elements were 
observed between non-clonal and clonal chondrocytes (Kouri et al., 1998). Notable 
differences in the cytoskeletal organisation and morphology of normal and OA 
chondrocytes have also been observed in human chondrocytes in vitro (Fioravanti et al., 
2003) and in situ in a dog model of OA (Pelletier et al., 1983a). Normal chondrocytes 
contained abundant endoplasmic reticulum, Golgi bodies and secretory vesicles, with 
numerous mitochondria and euchromatic nuclei. Cell membranes were intact and had 
few cytoplasmic processes. In contrast, human OA chondrocytes contained significantly
- 6 7 -
Chapter 1: General Introduction
less endoplasmic reticulum, Golgi bodies and mitochondria compared to normal 
chondrocytes, while nuclei appeared partially heterochromatic (Fioravanti et al., 2005). 
In support of this is the observation that chondrocytes in the Pond-Nuki dog model of 
OA (see section 1.3.4) contained an extensive rough endoplasmic reticulum, large Golgi 
apparatus and an increased number of lysosomes, although this was just four weeks after 
induction of OA and possibly represents an initial repair response (Pelletier et al., 
1983a).
In addition to differences in morphology, the distribution of actin and tubulin was 
observed to differ significantly between normal and OA human chondrocytes in alginate 
culture. In normal chondrocytes, actin was found to be polarised on the apical sides of 
the cell, while tubulin was localised at the periphery of the cell (Fioravanti et al., 2003). 
In OA chondrocytes, the actin signal was diffuse or peripheral, with significantly fewer 
cells showing the apical localisation of normal chondrocytes. Tubulin staining was 
absent in 65% of OA chondrocytes and diffuse when detected, with a significant 
decrease in the number of cells showing the intense peripheral staining observed in 
normal chondrocytes (Fioravanti et al., 2003). It should be noted here that, whilst the 
organisation of actin and tubulin in normal chondrocytes is unlike that observed by 
others (Benjamin et al., 1994, Durrant et al., 1999, Langelier et al., 2000), possibly due 
to in vitro conditions and/or fixatives and buffers used (Blanc et al., 2005), normal and 
OA chondrocytes in this study were treated identically therefore differences observed 
represent real differences in the cytoskeletal organisation of normal and OA 
chondrocytes. Another study comparing normal and OA human chondrocytes in alginate 
culture found differences in the cytoskeleton (Lambrecht et al., 2008). Proteomics 
revealed increased vimentin in chondrocytes originally isolated from visually damaged 
regions of OA cartilage when compared with chondrocytes isolated from normal 
cartilage. Increased vimentin N-terminal cleavage was also observed in OA; the N- 
terminal of vimentin is involved in intermediate filament formation (Beuttenmuller et 
al., 1994) and the interaction of filaments with the plasma membrane (Georgatos et al., 
1985). Confocal microscopy revealed a disordered vimentin intermediate filament 
organisation in OA chondrocytes from both visually intact and damaged OA cartilage, 
no longer showing the narrow intense zone of fluorescence at the periphery of the 
cytoplasm observed in normal chondrocytes (Lambrecht et al., 2008). In addition to the 
differences in the vimentin cytoskeleton, protein levels of the other intermediate filament
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present in chondrocytes, lamin A/C, is increased in OA chondrocytes (Ruiz-Romero et 
al., 2008, Lambrecht et al., 2008). Although no differences in actin organisation were 
observed, comparison of OA chondrocytes from visually intact and damaged regions of 
cartilage showed increased cofilin protein levels in OA damaged regions (Lambrecht et 
al., 2008). Gelsolin, an actin depolymeriser, and vinculin, an actin binding protein in 
focal adhesions have been reported as being over-expressed in OA chondrocytes, whilst 
p-actin was decreased when compared with normal chondrocytes (Ruiz-Romero et al.,
2008).
In addition to the above reports of altered cytoskeletal organisation in human OA, 
differences have been reported in a rat model of OA (Capin-Gutierrez et al., 2004). 
Osteoarthritis was induced by partial menisectomy, and loading of the joint was 
increased by exercising control and OA-induced animals for 20 minutes a day for 20 
days after surgery. Electron microscopy revealed differences in the intermediate filament 
cytoskeleton of normal and OA chondrocytes in situ. In normal chondrocytes, 
intermediate filaments were uniformly distributed as perinuclear bundles with clear 
integrity, while in OA chondrocytes, intermediate filaments appeared fragmented and 
disordered. Differences in the organisation of all three cytoskeletal elements were also 
observed by immunohistochemistry and fluorescence microscopy. Normal chondrocytes 
in situ displayed the typical labelling patterns, as described previously for actin, tubulin 
and vimentin (Benjamin et al., 1994, Durrant et al., 1999, Langelier et al., 2000), whilst 
OA chondrocytes had disordered cytoskeletons. Vimentin labelling was dense and 
punctate in some OA chondrocytes, whilst actin labelling was absent in some cells and 
organised normally in others. Tubulin labelling also appeared fragmented in OA 
chondrocytes. Differences in fluorescent labelling of normal and OA chondrocytes (as 
quantified by using the pixel intensity of cytoskeletal and nuclear labelling) showed both 
vimentin and tubulin to be significantly decreased (by 37% and 20% respectively) in OA 
chondrocytes compared to normal. However, no decrease in actin labelling was 
observed. In addition to the structural and organisational observations, Western blot 
analysis also revealed differences in tubulin and vimentin expression between normal 
and OA cartilage (Capin-Gutierrez et al., 2004).
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1.6 Hypothesis
Although differences between the cytoskeletal architecture of normal and OA
chondrocytes are becoming more evident, it has not yet been determined whether or not
the altered cytoskeleton in OA is:
i. a cause of the disease,
ii. a result of the altered chondrocyte phenotype seen in OA, or
iii. a result of the altered mechanical environment of the chondrocyte, due to 
degradation of the surrounding matrix.
The clear link between cytoskeletal organisation, load, and chondrocyte phenotype, 
along with the altered cytoskeleton observed in OA has led us to hypothesise that an 
intact cytoskeleton is essential for transducing mechanical signals within articular 
cartilage chondrocytes, and that dysregulation o f cytoskeletal networks will prevent 
normal ECM-chondrocyte signalling, promoting an imbalance in cartilage 
homeostasis and a catabolic phenotype -  the hallmark o f OA.
1.7 Aims of PhD
The overall aim of this PhD is to determine the effects of disrupting cytoskeletal 
components on the overall phenotype of human chondrocytes, with more specific aims 
including:
1. To characterise the cytoskeletal architecture of human OA chondrocytes and its 
response to mechanical load.
2. To determine the effect of disrupting the three cytoskeletal elements on 
chondrocyte matrix biosynthesis.
3. To determine the effect of cytoskeletal disruption on the response of cartilage 
chondrocytes to mechanical load.
Chapter 2: Materials and
Methods
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2. MATERIALS AND METHODS
Reagents used were purchased from Sigma-Aldrich, UK, unless otherwise stated and 
were of analytical grade or above.
2.1 Source of Tissue
Human articular cartilage was obtained, with ethical consent through AstraZeneca 
(Alderley Edge, Cheshire), from the lateral and medial tibial plateau or femoral condyle. 
Macroscopically normal samples were obtained post-mortem from donors that had never 
presented with knee pain, and osteoarthritic samples were obtained from patients 
undergoing knee-replacement surgery. Articular cartilage was harvested from joints 
approximately 48 hours after removal from the donors. All cartilage samples were 
immediately snap frozen in liquid nitrogen and stored at -80°C until required.
2.2 In situ Determination of Articular Cartilage Composition
2.2.1 Preparation of Tissue for Histology and Immunohistochemistry
Cartilage was removed from storage at -80°C, mounted unfixed in Tissue-Tek mounting 
medium, and full-depth sections cut at 10pm and 20pm thickness using a cryostat 
(Bright, UK). Sections were adhered to Histobond® microscope slides (R.A.Lamb) and 
stored at -20°C. All frozen sections were equilibriated to room temperature before 
staining.
2.2.2 Histology
For histology, 10pm frozen sections were brought to room temperature, washed twice in 
phosphate buffered saline (PBS- 0.14M NaCl, pH 7.4, 2.7mM KC1, 1.8mM KH2P04, 
lOmM Na2H P04), fixed for 15 minutes in 4% paraformaldehyde in PBS and washed a 
further three times with PBS.
2.2.2.1 Haematoxylin and Eos in
Tissue integrity was visualised using haematoxylin and eosin staining. Sections were 
removed from PBS (pH 7.4) and washed in water for 10 seconds. Sections were 
incubated in 70% alcohol for 2 minutes, washed in running water for 2 minutes then 
stained in Mayer’s haematoxylin (0.1% (w/v) haematoxylin, 5% (w/v) aluminium 
ammonium sulphate, 0.1% (w/v) citric acid, 5% (w/v) chloral hydrate, 0.02% (w/v)
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sodium iodate) for 10 minutes. Sections were then washed for 5 minutes in running 
water, stained in 1% aqueous eosin for 5 minutes and washed in running water for 20 
seconds. Sections were then dehydrated by washing in 70% alcohol for 20 seconds, 95% 
alcohol for 30 seconds and 100% alcohol for 3 minutes. Sections were washed in xylene 
for 4 minutes and mounted under a coverslip in DPX mountant.
2.2.2.2 Alcian Blue
Glycosaminoglycans were visualised using alcian blue staining. Sections were removed 
from PBS, washed in water for 10 seconds and incubated in 70% alcohol for 2 minutes. 
Sections were washed in running water for 2 minutes, stained in Alcian blue (pH 2.5; 
1% (w/v) alcian blue, 3% (v/v) acetic acid) for 20 minutes and washed in running water 
for 1 minute. Sections were stained in Mayer’s haematoxylin (section 2.2.2.1) for 10 
minutes, washed for 5 minutes in running water and stained in 1% aqueous eosin for 5 
minutes. Following a 20 second wash in running water, sections were dehydrated and 
mounted as described in section 2.2.2.1.
2.2.2.3 Visualisation o f Staining
Tissue staining was visualised using a Leica DMRB light microscope, using 1.6x up to 
20x objectives. Scale bars were added (using calibration images) in Adobe Photoshop 6.
2.2.3 Optimisation of Fixation Protocols for Preservation of the Chondrocyte 
Cytoskeleton
For immunohistochemical localisation and visualisation of cytoskeletal networks in 
chondrocytes, preservation of the organisation was required. Various fixatives and 
buffers were tested on frozen sections of seven day old bovine articular cartilage 
removed from the carpo-metacarpal joint.
2.2.3.1 Paraformaldehyde
For immunohistochemistry, 20pm frozen sections were brought to room temperature, 
fixed with 4% paraformaldehyde in PBS pH 8 for 15 minutes, washed three times with 
PBST (PBS with 0.5% Tween-20), then permeabilised with cold 100% methanol for 30 
minutes.
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2.2.3.2 Fixation Methodfrom Zwicky and BaicL 2000
Sections were fixed according to the method published by Zwicky and Baici (2000). 
Frozen sections (20pm) were brought to room temperature, and sections to be stained for 
actin and vimentin were wet in buffer 1 (PBS containing 5.5mM sucrose, 4mM 
NaHCC>3, 2mM MgCl2, 2mM EGTA, lOmM 2-(N-morpholino)ethanesulfonic acid 
(MES), pH 6.1) and fixed with 4% paraformaldehyde in PBS for 15 minutes. Following 
washes in buffer 1, sections were permeabilised with 0.2% (v/v) Triton-X 100 in buffer
1. Sections to be stained for tubulin were wet in buffer 2 (60mM PIPES, 25mM HEPES, 
lOmM EDTA, 2mM MgCl2, pH 6.9) and simultaneously fixed and permeabilised with 
0.25% (v/v) glutaraldehyde and 0.5% (v/v) Triton X-100 in buffer 2 for 15 minutes. 
Following two washes in buffer 2, sections were post-fixed for 20 minutes with 1% (v/v) 
glutaraldehyde in buffer 2, washed three times, incubated in 0.5 mg/ml NaBHLj in buffer 
2 with three replacements of buffer at five minute durations to remove autofluorescence, 
then washed a further three times with buffer 2.
2.2.3.3 Fixation Methodfrom Blanc et aL 2005
Sections were fixed according to a method adapted from that published by Blanc et al. 
(2005). The buffer used in all steps was a modified Hank’s balanced salt solution 
(mHBSS) consisting of: 136.9mM NaCl, 5.36mM KC1, 2mM MgCl2, 0.336mM 
Na2HP04, 0.44mM KH2P 04, 4mM NaHC03, 2mM EGTA, 5.55mM D-glucose, 0.11% 
(w/v) MES, pH 6.5. Frozen sections (20pm) were brought to room temperature, washed 
twice with mHBSS, then simultaneously fixed and permeabilised in 0.6% (v/v) 
glutaraldehyde and 5% (v/v) Triton X-100 in mHBSS for 45 minutes. Sections were 
washed three times, incubated in 5 mg/ml NaBH4 in mHBSS twice for 5 minutes to 
block autofluorescence, then washed a further three times.
Following the results of the optimisation (see section 3.2.4), the cytoskeleton of human 
articular chondrocytes and cartilage sections were fixed using the Blanc et al. (2005) 
method.
2.2.4 Staining of Cytoskeletal Elements
Sections were blocked for 30 minutes with 5% goat serum in fixation buffer (section 
2.2.3.3), washed with buffer then incubated in primary antibody for 2 hours at room 
temperature. Actin microfilaments were detected using either Alexa Fluor® 488
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phalloidin (Molecular Probes, Invitrogen) at 5 units/ml or FITC-conjugated phalloidin at 
50|ig/ml in buffer, microtubules with mouse monoclonal anti-P-tubulin (TUB 2.1 clone, 
Sigma) at a dilution of 1:15, and vimentin intermediate filaments with mouse 
monoclonal anti-vimentin (V9 clone, Sigma) at a dilution of 1:20 in buffer. Sections 
were washed three times with buffer and those stained with phalloidin were mounted in 
Vectorshield containing DAPI (Vector Laboratories) to counter-stain nuclei. Sections 
incubated with primary antibodies were incubated with TRITC-conjugated goat anti­
mouse IgG (1:64 in buffer) for one hour. Following a further three washes with buffer, 
sections were mounted as above. To assess non-specific binding of the secondary 
antibody, primary antibody was replaced with buffer (appendix 1).
2.2.4.1 Visualisation o f Cytoskeletal Organisation
Fluorescence was viewed on a Leica DM6000 Confocal microscope using a 63x oil 
immersion objective. DAPI fluorescence was excited using a 405nm laser line and 
detection was between 430-500nm. Phalloidin fluorescence was excited at 488nm (argon 
laser) and detection was between 510-600nm. Finally, TRITC fluorescence was excited 
at 543nm using a helium/neon laser, with detection between 580-650nm. A series of 
scans were taken through the z-plane of the chondrocytes at 0.4pm increments, and these 
were used to produce three dimensional (3D) reconstructions using LCS lite (Leica 
Confocal software). In some cases, the DAPI signal was omitted from the 3D 
reconstruction to aid visualisation of the cytoskeletal organisation. For chondrocytes in 
situ or in agarose, approximately 25 scans covered the depth of the cells.
2.3 Biochemical Composition of Articular Cartilage
2.3.1 Water Content
Whole tissue was weighed, freeze-dried for 48 hours, re-weighed and wet and dry 
weights used to determine the approximate water content.
2.3.2 Sulphated Glycosaminoglycan Content
Pre-weighed tissue was incubated at 60°C in 20mM sodium phosphate buffer (20mM 
NaH2PC>4, ImM EDTA, 2mM DTT, pH6.8) containing 300pg/ml papain until all tissue 
had been digested. Iodoacetamide was added to a final concentration of lOmM to stop 
the reaction. The sulphated glycosaminoglycan (sGAG) content was determined using 
the dimethylmethylene blue (DMMB) assay (Famdale et al., 1986). Standards (10-
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50pg/ml) were prepared using shark chondroitin-4-sulphate and 40pl applied, along with 
digested samples, in duplicate on a 96 well microtitre plate. 200pl of DMMB solution 
(16pg/ml 1,9-dimethylmethylene blue, 1% (v/v) ethanol, 29.5mM NaOH, 0.34% (v/v) 
formic acid) was added to each well and absorbances read immediately at a wavelength 
of 525 nm. sGAG concentration in each sample was determined as described below.
2.3.2.1 Determination o f Sample Concentrations
Standards prepared for the specific assay were used to produce a calibration curve in 
Minitab 14. The function of the straight line was used to determine the concentration of 
the molecule being assayed in all samples. Samples which produced an absorbance 
outside the range of standards were diluted. Dilutions were then assayed and the results 
scaled up accordingly.
2.3.3 Collagen Content
As hydroxyproline is mainly found in collagen it can be used as a measure of collagen 
content. The hydroxyproline content of the tissue was determined following published 
methodology (Woessner, 1976). Pre-weighed tissue was hydrolysed in 6N hydrochloric 
acid for 24 hours at 110°C, freeze-dried for 16 hours to remove the acid, and 
resuspended in 200pl distilled water. 30pl hydroxyproline standards (0.5-10pg/ml) and 
samples were applied in duplicate to a 96 well microtitre plate. To each well, 70pl of 
diluent (66.6% (v/v) propan-2-ol) and 50pl oxidant (50mM chloramine T, 83.3% (v/v) 
stock buffer) (stock buffer- 0.42M sodium acetate trihydrate, 0.13M tri-sodium citrate 
dihydrate, 26mM citric acid, 4% (v/v) propan-2-ol) was added and incubated on a plate 
shaker for five minutes at room temperature. 125pl colour reagent (0.68M 
dimethylamino benzaldehyde, 9.15% (v/v) perchloric acid, 84.7% (v/v) propan-2-ol) 
was added to each well and plates incubated at 70°C for 10-20 minutes to obtain a 
colour change. Absorbances were read at a wavelength of 540nm and the 
hydroxyproline content of samples determined as in section 2.3.2.1. The collagen 
concentration was determined as seven times that of hydroxyproline (based on 14% 
hydroxylproline content of collagen (Leach, I960)).
2.3.4 Protein Extraction from Articular Cartilage
Pre-weighed whole tissue was powdered in chambers cooled in liquid nitrogen, using a 
Mikro-Dismembrator U (B.Braun Biotech International) at 2,000 rpm for 2 minutes.
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Protein was extracted overnight at 4°C in 2x Sample Buffer (0.06M Tris-HCl pH 6.8, 
2% (w/v) SDS, 10% (v/v) glycerol) containing phosphatase and protease inhibitors 
(Table 2.1), in a volume of 1ml per 50mg wet weight tissue. Samples were pelleted by 
centrifugation for 15 minutes at 4°C and 13,000 rpm to remove insoluble matter and 
supernatants stored at -20°C.
Name o f inhibitor cocktail 
and supplier
Name o f inhibitor Target of inhibitor lx  cone
Phosphatase Inhibitor 
cocktail, Set I 
(Sigma)
Cantharidin Protein Phosphatase 2A 5pM
Bromotetramisole Alkaline Phosphatase 25 pM
Microcystin Protein Phosphatase type 
1 and 2A
5nM
Phosphatase Inhibitor 
cocktail, Set II 
(Calbiochem)
Imidazole Cation Chelator 2mM
Sodium fluoride Serine/Threonine
Phosphatase
ImM
Sodium molybdate Acid and Phosphoprotein 
Phosphatases
1.15mM
Sodium orthovanadate Tyrosine Phosphatases ImM
Sodium tartrate dihydrate Acid Phosphatases 4mM
Protease Inhibitor cocktail, 
Set I
(Calbiochem)
AEBSF Serine Protease 500pM
Aprotinin Serine Protease 150nM
E-64 protease inhibitor Cysteine Protease 1 (iM
EDTA Cation Chelator 500pM
Leupeptin Serine and Cysteine 
Proteases
lpM
Table 2.1:- Components of the inhibitor cocktails included in protein extractions, the protease 
inhibited and their final concentration in extracts.
2.3.4.1 BCA Protein Assay
The protein concentration of each sample was determined using the BCA™ protein 
assay kit (Pierce). Bovine serum albumin was used to prepare standards (250-2,000 
pg/ml) which were assayed in duplicate alongside tissue extracts on 96 well microtitre 
plates. Standards and samples (25pi) were incubated with BCA™ working reagent 
(200pl) for 30 minutes at 37°C. Protein concentration was detected by colorimetric 
change by measuring the absorbance at a wavelength of 575 nm and determined as 
described in section 2.3.2.1.
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2.3.4.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
resolve protein extracts based on molecular size (Laemmli, 1970). The size of the 
protein(s) of interest determined the concentration of acrylamide used to prepare the 
resolving gel (Table 2.2). A 4% stacking gel was used in all instances. Gels were 
polymerised using 10% (w/v) ammonium persulphate and N,N,N',N'-tetramethylethyl- 
enediamine (TEMED). Aliquots of protein extracts were heat denatured at 60°C for 30 
minutes in lx sample buffer (30mM Tris-HCl, pH 6.8, 1% (w/v) SDS, 5% (v/v) 
glycerol, 1 mg/ml bromophenol blue), with (2.5% (v/v) p-mercaptoethanol) or without 
reduction. Equivalent amounts of protein samples were resolved on gels in Laemmli 
electrophoresis buffer (0.025M Tris, 0.19M glycine, 0.1% (w/v) SDS), at 100-MOV for 
between 1-2 hours, until the dye front had reached the bottom of the gel. BenchMark™ 
pre-stained protein ladder (Invitrogen) was resolved on gels alongside samples to 
provide molecular weight standards.
Reagents Resolving Gel Stacking Gel
7.5% 10% 12.5% 15% 4%
40% acrylamide/ 
bisacrylamide
2.72 ml 3.83 ml 4.53 ml 5.51 ml 575 pi
1M Tris HC1, pH 8.8 3.63 ml 3.63 ml 3.63 ml 3.63 ml -
1M Tris HC1, pH 6.8 - - - - 1.3 ml
10% SDS 100 pi 100 pi 100 pi 100 pi 50 pi
10% APS 75 pi 75 pi 75 pi 75 pi 37.5 pi
dH20 8.16 ml 7.05 ml 6.35 ml 5.37 ml 4.075 ml
TEMED 15 pi 15 pi 15 pi 15 pi 7.5 pi
Table 2.2:- Volumes and stock solutions used in the preparation of gels for sodium dodecyl 
polyacrylamide electrophoresis (SDS-PAGE). The percentage of acrylamide used in the 
resolving gel is dependent on the molecular weights of the proteins of interest.
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2.3.4.2.1 Visualisation o f  Protein Bands
Gels were stained for 1 hour in Coomassie blue (45% (v/v) methanol, 10% (v/v) glacial 
acetic acid, 0.25% (w/v) Coomassie Brilliant Blue R250) with agitation and then 
destained (10% (v/v) methanol, 7.5% (v/v) glacial acetic acid) with agitation to reveal 
protein bands.
2.3.4.3 Gelatin Zymography
The MMP-2 and MMP-9 content of the tissue samples was determined using gelatin 
zymography (Blain et al., 2001). Equivalent amounts of non-reduced samples were 
resolved on 7.5% SDS polyacrylamide gels containing 1 mg/ml gelatin (1ml of 15 mg/ml 
gelatin replaces 1ml of dfEO in the resolving gel; Table 2.2), using Laemmli 
electrophoresis buffer; running conditions were as described in section 2.3.4.2. Gels 
were washed three times, 10 minutes each, in 2.5% (v/v) Triton® X-100 to remove the 
SDS present in the gel, allowing proteins to refold. Gels were then incubated overnight 
at 37°C in MMP Proteolysis buffer (50mM Tris-HCl, pH 7.8, 50mM CaCL, 0.5M NaCl) 
to activate the MMPs. Gels were stained and destained as described in section 2.3.4.2.1, 
with destaining revealing clear bands on a blue background corresponding to zones of 
gelatinolytic activity.
2.3.4.3.1 Densitometric Analysis
Gels were scanned using UMAX software, and bands of interest quantified by 
densitometry using NIH Image 6.2. Where comparison across different gels was 
required, a standard was included on all gels for normalisation
2.3.4.4 Reverse Gelatin Zymography
The TIMP content of samples was determined using reverse gelatin zymography (Blain 
et al., 2001). Equivalent amounts of non-reduced samples were resolved on 12.5% SDS 
polyacrylamide gels containing 2mg/ml gelatin and conditioned media (1ml of 32.5 
mg/ml gelatin and 2ml of conditioned media replaced 3ml of dH20 in the resolving gel; 
Table.2.2) using Laemmli electrophoresis buffer; running conditions were as described 
in section 2.3.4.2. The conditioned media (a source of MMPs) was derived from serum 
starving bovine foreskin fibroblasts (BOVS-1 cell line, courtesy of Dr. Emma Blain). 
Gels were washed, incubated (section 2.3.4.3) and stained as described (section
2.3.4.2.1), with destaining revealing dark bands where inhibition of gelatinolytic activity
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has occurred. Densitometric quantification was performed as described in section 
2.3.4.3.1.
2.3.4.5 Western Blotting
Equivalent amounts of protein samples (± reduction) were resolved on SDS 
polyacrylamide gels (Table.2.2) in Laemmli electrophoresis buffer (Laemmli, 1970). 
Proteins were transferred to PVDF membrane (Millipore) in transfer buffer (80% 
Laemmli buffer, 20% methanol) at 20V for 16 hours (Towbin et al., 1979). 
BenchMark™ pre-stained protein ladder was used as a molecular weight marker and as 
an indicator of complete transfer of proteins onto the membrane. Protein extract (3pg) 
from human immortalised chondrocytes (TC28a2 cell line (Goldring et al., 1994)) was 
loaded as a positive control. Membranes were blocked for one hour in Tris-buffered 
saline with Tween-20 (TBST; 20mM Tris-HCl, pH 7.4, 0.9% (w/v) NaCl, 0.3% (v/v) 
Tween-20) containing 4% (w/v) skimmed milk powder. Membranes were incubated at 
room temperature for two hours in primary antibody in TBST at the dilutions indicated 
(Table 2.3). Following three washes in TBST, membranes were incubated, with 
agitation, in horseradish peroxidase (HRP)-conjugated secondary antibody (Table 2.3) in 
TBST for one hour at room temperature. Following a further six washes with TBST, 
protein bands were detected by chemiluminescence using ECL™ Western blotting 
detection reagents (GE Healthcare) and exposed to Hyperfilm™ (GE Healthcare). Films 
were developed using an AGFA Curix 60 automatic developer and bands quantified by 
densitometry as described above (section 2.3.4.3.1.).
Primary Antibody Primary Antibody 
dilution
Secondary Antibody Secondary 
Antibody dilution
Anti-actin - polyclonal 
(Cytoskeleton Inc. USA)
1:100 Anti-Rabbit IgG 
(-HRP; Sigma)
1:20,000
Anti-P-Tubulin -  IgGl 
(clone TUB 2.1; Sigma)
1:200 Anti-Mouse IgG 
(-HRP; Sigma)
1:10,000
Anti-Vimentin - IgGl 
(clone V9; Sigma)
1:200- 1:400 Anti-Mouse IgG 
(-HRP; Sigma)
1:10,000
Table 2.3:- Details of the primary and secondary antibodies used in Western blotting to 
detect cytoskeletal proteins in articular cartilage extracts.
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23.4.6 Collagen Protein Extraction
Pre-weighed whole tissue was powdered in chambers cooled in liquid nitrogen, using a 
Mikro-Dismembrator U (B.Braun Biotech International) at 2,000 rpm for two minutes. 
Protein was extracted using an adapted method (Vincourt et al., 2006). Powdered 
cartilage was agitated in cartilage extraction buffer (500mM NaCl, 50mM HEPES, pH
7.2 including protease and phosphatase inhibitors (Table 2.1) for two hours at room 
temperature, in a volume of 1ml per lOOmg wet weight tissue. Samples were then 
centrifuged for five minutes at 6,000g to separate insoluble matter from the supernatants. 
Supernatants were incubated with 1% (w/v) cetylpyridinium chloride (CPC) at room 
temperature for one hour with agitation, allowing CPC and proteoglycans to aggregate, 
then centrifuged at 6,000g for five minutes. The resulting supernatants were dialysed 
against distilled water for 20 hours at 4°C using dialysis tubing with a molecular weight 
cut off of 12-14,000 daltons. Dialysed supernatants were freeze-dried, resuspended in 
sample buffer and stored at -20°C. Pellets containing matter insoluble in cartilage 
extraction buffer were subjected to guanidium hydrochloride extraction in order to 
remove proteoglycans and other non-collagenous proteins. The guanidine-insoluble 
pellets were digested with pepsin to solubilise the collagen.
2.3.4.6.1 Guanidine-HCl Extraction
Pellets were weighed to determine their approximate wet weight prior to extraction in 
lml 4M guanidium hydrochloride (4M guanidium HC1, pH 6.8, 0.05M sodium acetate, 
0.01 M Na2EDTA, 0.1M 6-amino hexanoic acid) per lOOmg wet weight of tissue. 
Extractions were performed at 4°C for 48 hours with agitation. Samples were 
centrifuged at 14,000rpm and 4°C for 15 minutes and the supernatants dialysed, freeze- 
dried and resuspended as described in section 2.3.4.6, then stored at -20°C.
2.3.4.6.2 Pepsin Digestion
Guanidine-insoluble pellets were re-weighed, washed twice with 0.5M acetic acid and 
then resuspended in lmg/ml pepsin in 0.5M acetic acid (100:1 wet weight to pepsin). 
Digests were incubated, with agitation, at 4°C for 16 hours and then centrifuged at 
13,000rpm and 4°C for 15 minutes. Supernatants were freeze-dried and resuspended in 
lx sample buffer. Collagen content of samples was determined using the hydroxyproline 
assay (section 2.3.3) and protein content determined using the BCA assay (section
2.3.4.1). In order to visualise differences in the collagen types present in normal and OA
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tissue, samples with equivalent hydroxyproline amounts were resolved by SDS-PAGE 
(section 2.3.4.2) and analysed by Western Blotting (section 2.3.4.5), using antibodies 
raised in-house against specific collagen types (Table 2.4).
Primary Antibody Primary Antibody 
dilution
Secondary Antibody Secondary Antibody 
dilution
AVT6E3
(anti-type II collagen)
1:5 Anti-Mouse IgG 
(-HRP; Sigma)
1:10,000
Anti-human type I 
collagen
1:500 Anti-Goat IgG 
(-HRP; Sigma)
1:80,000
Table.2.4:- The names and dilutions of the primary and corresponding secondary 
antibodies used in Western blotting to detect collagen in articular cartilage 
extracts.
2.4 Analysis of Gene Expression in Articular Cartilage
RNA was extracted from frozen human articular cartilage using RNase (ribonuclease) 
and DNase (deoxyribonuclease) free plasticware only and molecular biology grade 
reagents.
2.4.1 Extraction of RNA from Cartilage
Frozen cartilage tissue was powdered in a liquid nitrogen freezer mill (Certi Prep Spex 
6850) using a pulverisation protocol of five minutes pre-cool, followed by three cycles 
of one minute grinding with one minute cooling. Powdered tissue was emptied into 8ml 
of ice-cold Trizol® reagent (Invitrogen, approx lOml/g tissue) in Oakridge centrifuge 
tubes (40 ml capacity) and inverted to create a suspension. Samples were kept on ice for 
as much of the procedural duration as possible.
2.4.1.1 RNA Isolation and Precipitation
Aqueous and organic phases were separated by adding 0.2 volumes of chloroform to the 
tissue-Trizol® mixture, incubating at room temperature for five minutes with occasional 
inversion, followed by centrifugation at 10,000 rpm for 30 minutes at 4°C (Beckman 
centrifuge, rotor SS-34). The aqueous phase containing the RNA was removed into clean 
tubes, with care taken to transfer as little of the interphase as possible and an equal
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volume of isopropanol added. RNA was precipitated at -20°C for 16 hours and 
subsequently pelleted by centrifugation at 10,000 rpm for 15 minutes at 4°C (SS-34 
Beckman rotor). Pellets were washed with 75% ethanol, centrifuged for seven minutes at
9,000 rpm at 4°C, air dried for 10 minutes at room temperature and resuspended in 500pl 
RNase free water.
2.4.1.2 Removal o f Contaminating Genomic DNA and Salts
Samples were applied to RNeasy® Mini columns (Qiagen), to increase the purity and 
concentration of the RNA, following the supplied protocol, splitting one sample between 
two Mini columns. RNA was bound to the silica-gel membrane and an on-column 
DNase I digestion performed for 15 minutes at room temperature, using 27.3 Kunitz 
units of DNase I per column. Following ethanol washes, RNA was eluted in 30pl (per 
Mini column) of RNase-free water.
2.4.1.3 Determination o f RNA Quantity and Quality
The concentration of RNA in samples from individual columns was determined using 
the NanoDrop® ND-1000 Spectrophotometer (with NanoDrop 3.0.1 software). Where 
samples had previously been split into sub-samples for RNA clean-up, the sub-samples 
were pooled after each was determined to be of acceptable quality, and the new 
concentration determined. The RNA concentration was determined by absorbance at 
260nm on a spectrophotometer (1 absorbance unit = 40pg/ml RNA). The A260/A280 
ratio should be approximately 2.0 with the acceptable range being between 1.8-2.1.
2.4.2 Real Time-PCR
2.4.2.1 Confirmation o f Primer Binding and Expected Product Size
2.4.2.1.1 RNA Extraction from Immortalised Human Chondrocytes
RNA was extracted from human chondrocytes for use in optimisation of primers 
designed for amplification of genes expressed in human articular cartilage. Immortalised 
human chondrocytes (TC28a2 cell line) derived from primary culture of costal 
chondrocytes (Goldring et al., 1994), were harvested at passage 16, with lx l0 6 cells, in 
duplicate, resuspended in 1ml Trizol® reagent and stored at -80°C until RNA extractions 
were performed. RNA was isolated as described above (section 2.4.1.1) but RNA pellets 
were resuspended in 89pl RNase free water. Genomic DNA present in RNA extracts
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was removed by digestion with 1 unit RNase-free DNase (deoxyribonuclease) in lx 
reaction buffer (40mM Tris-HCl, pH 8.0, lOmM MgSCU, ImM CaCl2) (Promega). 
Samples were mixed and the reaction incubated at 37°C for 30 minutes. 0.1 volumes of 
DNase Inactivation Reagent (DNA-^ree™, Ambion) was immediately added, incubated 
with agitation at room temperature for two minutes, then DNase enzyme and divalent 
cations removed by centrifugation at 10,000 rpm for two minutes. RNA (lOOpl) was 
removed into clean tubes and stored at -80°C until required.
2.4.2.1.2 cDNA Synthesis
Total RNA was reverse transcribed to produce cDNA for subsequent use in PCR. The 
mRNA population was enriched by incubating lOpl of total RNA for five minutes at 
65°C with 250ng random primers (Promega) and 0.5mM dNTPs (Promega) in a final 
reaction volume of 20pl. 40 units of recombinant RNasin® RNase inhibitor (Promega) 
was added in the presence of lx first-strand buffer (50mM Tris-HCl, pH 8.3, 75mM 
KC1, 5mM MgCb) and lOmM DTT, both supplied with Superscript™ III reverse 
transcriptase (Invitrogen), of which 200 units was added. Reactions were incubated at 
25°C for five minutes, followed by 50°C for 50 minutes, then the reaction inactivated by 
heating to 70°C for 15 minutes. Samples were held at 4°C before storage at -20°C, until 
cDNA was required.
2.4.2.1.3 PCR
Genes of interest were amplified from cDNA using primers designed against the known 
gene sequences (http://www.ncbi.nlm.nih.gov/nucleotide). PCR was performed in total 
reaction volumes of 10pl containing lpl of cDNA (or RNase-free water as a control), in 
a lx reaction containing 0.55 units of Taq DNA polymerase in lx PCR buffer (lOmM 
Tris-HCl, pH 9.0, 50mM KC1, 0.1% Triton® X-100), 2.5mM MgCl2 (Promega), and 
0.2mM of each dNTP (Promega). Forward and reverse primers (Table 2.5) were added 
to a final concentration of 0.3 pM.
Samples were initially denatured at 95°C for five minutes, followed by 40 cycles of: 
95°C denaturation for 30 seconds, primer annealing at 60°C (standard Taqman annealing 
temperature) for 30 seconds, and 72°C extension for 30 seconds. A final extension at 
72°C for 10 minutes was performed and samples held at 4°C before analysis of products 
by agarose gel electrophoresis.
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2.4.2.1.4 Agarose Gel Electrophoresis
PCR products were separated by electrophoresis on 2% agarose gels containing lng/ml 
ethidium bromide. Samples, combined with 6x gel loading dye, were loaded alongside a 
BenchTop lOObp DNA ladder (Promega) and separated with 60V. RNA or DNA bands 
were visualised under ultra-violet light and images taken through a Gel Doc 2000 (Bio- 
Rad). Where products were expected to be more than 500bp, a 1 or 1.5% agarose gel 
was used rather than a 2% gel.
Gene of 
Interest
Forward (F) and Reverse (R) primer 
sequence
Annealing 
Temp (°C)
Product size 
(bp)
p-actin F: 5 ’-TTCGAGACCTTCAACACCCC-3 ’ 
R: 5’ -GGCCAGAGGCATACAGGGA-3 ’
60 70
Cofilin F: 5 ’ - A ATG ATTTATGCC AGCTCC A AGG-3 ’ 
R: 5’-CAGGGTGCAGCGGTCCTTGACC-3’
60 106
Destrin F: 5 ’-GCATCATTGTAGAAGAAGGCAA-3’ 
R: 5’-CAGGAAGCATTCCCACAAA-3’
58 93
Filamin A F: 5’-CTTACGGAGCAGGTCTGGA-3’ 
R: 5 ’ -GTGTTCACGACGAACTCAGC-3 ’
58 61
Gelsolin F: 5’-TGTGATCGAAGAGGTTCCTG-3’ 
R: 5’-CAGGTGTCCAGAAGCATGAC-3’
60 75
Paxillin F: 5’-GTGGCATCCTGAGTGCTTT-3’ 
R: 5’-AAGCTGCCGTTCACGAAT-3’
55 60
Thymosin p4 F: 5 ’-TGCAAAGAGGTTGGATCAAG-3’ 
R: 5 ’ -CC AG AC AG AC AG ATGGG A AA-3 ’
58 103
Vimentin F: 5 ’-AAGAGGAAATCCAGGAGCTG-3 ’ 
R: 5’-AGGTCAGGCTTGGAAACATC-3 ’
58 79
Tubulin (p-2a) F: 5’-GGATGTGGTGAGGAAGGAGT-3’ 
R: 5’-TACTCTTCCCGGATCTTGCT-3’
60 126
Table 2.5:- Primer sequences used in PCRs, shown along with their expected molecular size.
2.4.2.2 Taqman* Q-PCR
Known RNA concentrations were used to dilute an aliquot of the RNA samples to 
10ng/p.l in RNase-free water. Reactions were performed in a final volume of 25pl, each 
containing 25ng RNA, 400nM forward and reverse primers, 200nM probe, 12.5pl 2x 
QuantiTect Probe RT-PCR Master Mix and 0.25pl QuantiTect RT Mix (Qiagen
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QuantiTect Probe RT-PCR Master Mix and 0.25pl QuantiTect RT Mix (Qiagen 
QuantiTect Probe RT-PCR Kit). Fluorescently labelled probes and primers designed to 
GAPDH, SOX9, COL2A1, VEGF, ADAMTS5, cofilin (CFL1), destrin (DSTN), filaminA 
(FLNA), gelsolin (GSN), paxillin (PXN), thymosin 04 (TMSB4X), (3-tubulin (TUBB2A) 
and vimentin (VIM) were used (see Table 2.6). Plates were covered with ABI Prism™ 
optical adhesive covers (Applied Biosystems) and centrifuged to collect the reactions at 
the bottom of the wells. Real-time PCR was carried out on an ABI PRISM™ 7700 
Sequence Detection System using SDS. 1.9.1 software, with reaction conditions as 
follows: reverse transcription at 50°C for 30 minutes, reverse transcriptase inactivation 
and DNA polymerase activation at 95°C for 15 minutes, followed by 40 cycles of 95°C 
denaturation for 15 seconds and 60°C annealing and extension for one minute.
2.4.2.2.1 Analysis o f Differential Gene Expression
The threshold was set manually so that it was in the centre o f the logarithmic growth 
phase of the amplification curve for each gene (Fig 2.1). To allow comparison of 
samples and genes across plates, GAPDH for all samples was included on each plate and 
used as the endogenous control (Ct values normalised to the GAPDH Ct value for each 
sample, giving a ACt value per sample per gene). Relative expression units (REU) were 
calculated using the following formulae:
R.E.U. = 2(a*ACt) where a = the highest ACt value of all samples and
genes to be compared.
Cog
scale)
ARn
 ►
Cycle no./time
Figure.2.1:- Diagrammatic 
representation of a Taqman™ 
amplification curve. The threshold 
(blue) is set in the logarithmic phase 
o f all curves (green, one per sample). 
The Ct value is the cycle number at 
which the curve crosses the 
threshold.Ct Ct Ct
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Gene of 
Interest
Forward (F) and Reverse (R) primer sequences and probe sequences 
with modifications as indicated
Cofilin
F: 5 ’-AATGATTTATGCCAGCTCCAAGG-3 ’
R: 5 ’-CAGGGTGCAGCGGTCCTTGACC-3 ’
Probe: Fam 5 ’-TGCAATTCATGCTTGATCCCTGTCA-3 ’ Tamra
Destrin
F: 5 ’-GCATCATTGTAGAAGAAGGCAA-3 ’
R: 5 ’-CAGGAAGCATTCCCACAAA-3 ’
Probe: Fam 5 ’-TGGTTACACCAACATCTCCAACCAA-3 ’ Tamra
Filamin A
F: 5’-CTTACGGAGCAGGTCTGGA-3’
R: 5 ’ -GTGTTC ACG ACG AACTC AGC-3 ’
Probe: Fam 5’-TGGGTTCCCTGTGACACCGC-3’ Tamra
Gelsolin
F: 5’-TGTGATCGAAGAGGTTCCTG-3’
R: 5 ’ -CAGGTGTCCAGAAGCATGAC-3 ’
Probe: Fam 5’-TCCGTTGCCAGGTCTTCCTGC-3’ Tamra
Paxillin
F: 5 ’-GTGGCATCCTGAGTGCTTT-3 ’
R: 5 ’ - AAGCTGCCGTTCACG A AT-3 ’
Probe: Fam 5’-CGTGAAGCATTCCCGGCACA-3’ Tamra
Thymosin p4
F: 5’-TGCAAAGAGGTTGGATCAAG-3’
R: 5 ’ -CCAGACAGACAGATGGGAAA-3 ’
Probe: Fam 5’-CTGACAACGAAGGCCGCGC-3’ Tamra
Vimentin
F: 5 ’ - A AG AGG A AATCC AGG AGCTG-3 ’
R: 5 ’ -AGGTCAGGCTTGGAAACATC-3 ’
Probe: Fam 5’-TCAGGAACAGCATGTCCAAATCGA-3’ Tamra
Tubulin (P-2a)
F: 5 ’-GGATGTGGTGAGGAAGGAGT-3 ’
R: 5’-TACTCTTCCCGGATCTTGCT-3’
Probe: Fam 5’-ATGAGCAGGGTGCCCATCCC-3’ Tamra
Sox-9
F: 5 ’-GCCCCAACAGATCGCCTACAG-3 ’
R: 5 ’ -GAGTTCTGGTGGTCGGTGTAGTC-3 ’
Probe: Fam 5’-CAGCCCCTCCTACCCGCCCA-3’ Methyl Red
ADAMTS5
F: 5’-CAGCCACCATCACAGAATTCC-3 ’
R: 5’-TCGTAGGTCTGTCCTGGGAGTT-3’
Probe: Fam 5’-CATGGTAACTGTTTGCTGGACCTACCACGA-3’ Methyl Red
VEGF
F: 5 ’-CGAGGGCCTGGAGTGTGT-3 ’
R: 5 ’-CGCATAATCTGCATGGTGATG-3 ’
Probe: Fam 5’-CCCACTGAGGAGTCC-3’ Methyl Red
Table 2.6:- Primer and probe sequences used in quantitative Taqman™ PCR. 5’ and 3’ 
modifications to probes are shown in italics.
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2.5 Disruption of Cytoskeletal Elements in 3D-Cultured Human 
Articular Chondrocytes
2.5.1 Three-Dimensional Culture of Human Articular Chondrocytes
In order to retain the rounded morphology and phenotype characteristic of chondrocytes 
in cartilage, isolated chondrocytes were encapsulated and cultured in agarose hydrogels. 
Basal media used for all cell culture was Dulbecco’s Modified Eagle’s Medium 
(DMEM) / F-12 +Glutamax® supplemented with 100 units/ml penicillin, lOOpg/ml 
streptomycin, 292pg/ml L-glutamine, 2.5 jig/ml amphotericin B and 50 pg/ml ascorbate- 
2-phosphate. All tissue culture reagents were purchased from Invitrogen unless 
otherwise stated.
2.5.1.1 Monolayer Expansion of Human Articular Chondrocytes
Human chondrocytes were previously isolated by collagenase digestion of articular 
cartilage removed from the tibial plateau or femoral condyle of donor knees and stored 
in liquid nitrogen (courtesy of Dr. John Wardale, AstraZeneca). Vials of cells were 
thawed and seeded into 225cm2 cell culture flasks in serum-containing media (basal 
media supplemented with 10% foetal calf serum (FCS)). At confluency, cells were 
passaged and split in a 1:3 ratio. In order to remove cells that had adhered to the base, 
flasks were washed twice in 37°C PBS, twice in 37°C 0.05% trypsin-EDTA, then 
incubated at 37°C for approximately five minutes or until, with a tap, cells no longer 
adhered to the flask. Cells were rinsed from the base of the flask with media and 
resuspended in a volume of 15ml media before seeding into clean flasks in a split ratio 
of 1:3.
2.5.1.1.1 Chondrocyte Culture in Monolayer
Chondrocytes at passage 2 were removed from flasks as described above and counted 
using a haemocytometer. The cell suspension was then diluted to approximately 5xl04 
cells per ml and plated at a density of 5x104 cells per well of a 24-well plate. For 
immunohistochemistry, cells were plated at 2.5x104 cells per well of 8-well chamber 
slides (Nalge-Nunc International). Following plating out, cells (now at passage 3) were 
left for four days to adhere before analysis.
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2.5.1.1.2 Analysis o f Chondrocyte Gene Expression in Monolayer
RNA was extracted from chondrocytes, adding 500pl Trizol® reagent per well of a 24- 
well plate (5xl04 cells per well) following removal of media, and plates stored at -80°C 
until required. Plates were thawed at room temperature and lysates removed into labelled 
tubes, ensuring samples were kept on ice as often as possible. In order to ensure cells 
were sufficiently lysed and resuspended in Trizol®, pipette tips were thoroughly run over 
the base area of each well before removal of the reagent. Aqueous and organic phases 
were separated by adding 0.2 volumes of chloroform to the Trizol®, incubating at room 
temperature for five minutes with occasional inversion, followed by centrifugation at
12,000 rpm for 15 minutes at 4°C. The aqueous phase was removed into a clean tube and 
an equal volume of isopropanol added. RNA was precipitated at -20°C for 16 hours and 
subsequently pelleted by centrifugation at 12,000 rpm for 15 minutes at 4°C. Pellets 
were washed with 75% ethanol, centrifuged for five minutes at 12,000 rpm at 4°C, air 
dried for 15 minutes at room temperature, and resuspended in 100pl RNase free water. 
Resuspended RNA was applied to RNeasy® Micro columns (Qiagen) for purification 
and concentration, following the manufacturers’ protocol. The theory and practise is as 
described in section 2.4.1.2, although RNA was eluted in 14pl RNase-free water. The 
concentration and quality of RNA extracts were determined as in section 2.4.1.3. Gene 
expression was analysed using custom-designed arrays (section 2.5.4.2).
2.5.1.1.3 Visualisation o f Cytoskeletal Organisation in Monolayer
Cells were washed once in mHBSS buffer then simultaneously fixed and permeabilised 
as described in section 2.2.3.3. After a 45 minute fixation, cells were washed twice in 
mHBSS then stored frozen at -20°C until required. Frozen chamber slides were thawed 
at room temperature and the cells washed once with mHBSS. An auto fluorescence block 
was performed as described in section 2.2.3.3. The cytoskeletal elements were stained 
and organisation visualised by confocal microscopy as described in section 2.2.4, with 
the following modifications: Alexa Fluor® 633 goat anti-mouse IgG (1:100) was used as 
the secondary antibody and fluorescence was excited at 633nm and detected between 
639-660nm. The series of scans taken across the chondrocytes were at 0.3pm 
increments.
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2.5.1.2 Seeding o f Human Articular Chondrocytes into Three-Dimensional Culture
Following expansion in monolayer (section 2.5.1.1), human articular chondrocytes at 
passage 2 were removed from flasks by trypsinisation, counted using a haemocytometer 
and resuspended to lxlO6 cells per ml in serum-containing media. The chondrocyte 
suspension was added to an equal volume of 6% agarose in Earle’s Balanced Salt 
Solution (EBSS, Sigma) to yield a final concentration of 5x105 cells per ml in 3% 
agarose. The cell/agarose suspension (12ml) was allowed to solidify in a 60mm diameter 
Petri dish for 15 minutes at room temperature. Constructs of cells in agarose were 
removed using a sterile sharp trephine (11mm diameter). Constructs were expelled into 
individual wells of a 12-well plate and incubated in 2ml serum-containing media for 
24hrs at 37°C.
2.5.2 Cytoskeletal Disruption
Serum-containing media was removed from wells and replaced with basal media 
supplemented with lx Insulin-Transferrin-Sodium selenite (ITS) media supplement. 
Cells were allowed to stabilise for 24 hours then ITS-supplemented media was replaced 
with media containing lpM cytochalasin D, lpM  colchicine (Tocris), or 2mM 
acrylamide; untreated cells served as controls. Cells were incubated at 37°C for 6, 12, 24 
and 48 hours, with no change of media. Cytochalasin D is a fungal metabolite that 
inhibits polymerisation of actin microfilaments, sometimes causing depolymerisation, 
and is used to disrupt structures such as stress fibres (Cooper, 1987). Colchicine is a 
plant alkaloid that interferes with and disrupts microtubule organisation through 
distortion of the protein-protein interactions required for polymerisation (Andreu and 
Timasheff, 1982). The neurotoxin acrylamide selectively disrupts intermediate filaments 
by an, as yet, unidentified mechanism (Eckert, 1985).
Figure 2.2:- Schematic diagram indicating 
the processing of cell/agarose constructs for 
analysis of gene expression (RNA), 
cytoskeletal organisation (IHC) and cell 
viability.
RNA
IHC
RNA
Cell viability
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At the required time point, a 2mm slice was removed from the centre of each construct 
and half was used to assay for cell viability (Fig 2.2). The other half was snap frozen for 
visualisation of cytoskeletal organisation. The remaining portions of the constructs were 
snap frozen in liquid nitrogen and stored at -80°C until RNA extraction. Media samples 
were stored at -20°C.
2.5.2.1 Cell Viability Assay
The effects of treatment and the duration of culture on cell viability were determined 
using the LIVE/DEAD® Viability/Cytotoxicity kit for mammalian cells (Molecular 
Probes). Cell/agarose plugs were incubated, in the dark, for 45 minutes at 37°C in ITS- 
supplemented media containing 0.5pM calcein AM and lpM ethidium homodimer, 
followed by three 15 minute washes with PBS at 37°C. Staining was viewed through 
FITC (calcein AM) and TRITC (ethidium homodimer) filters on an inverted 
fluorescence microscope (Olympus). Images were captured through a camera using 
SimplePCI software (C.Imaging Systems). Cell viability was calculated by counting the 
number of red (dead) and green (live) chondrocytes in focus on images, then using the 
following equation:
Cell viability (%) = number of live cells (green) x 100
Total number of cells (red + green)
2.5.3 Visualisation of Cytoskeletal Disruption in Agarose
A frozen slice from each plug was mounted and sectioned as described in section 2.2.1. 
Sections were fixed (section 2.2.3.3) and the cytoskeletal elements stained and visualised 
as described (section 2.2.4), with the following modifications: anti-tubulin and anti- 
vimentin primary antibodies were used at 1:50 and 1:80 dilutions respectively. At least 
five cells per test group were viewed and a representative cell scanned by confocal 
microscopy. Serial scans were taken across chondrocytes at 0.4pm increments and 3D 
reconstructions performed.
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2.5.4 Analysis of Chondrocyte Gene Expression Changes Following Cytoskeletal 
Disruption
2.5.4.1 Extraction o f RNA from Chondrocytes
The depth of agarose plugs was determined to the nearest 0.1mm using a micrometer 
and values used to calculate plug volumes. RNA was extracted directly from 
chondrocytes in agarose using RNeasy Mini kits (Qiagen) and following a published 
method (Mio et al., 2006). Buffer RLT was added to samples at a volume four times that 
of the agarose plug (4pl RLT per 1 pi plug volume) and plugs thawed on ice. Agarose 
samples were disrupted by drawing up and down through pipette tips and the pH of 
homogenised samples adjusted using 2M sodium acetate, pH 5.5 (5.05pl per 1ml total 
volume), then 0.71 volumes (of RLT volume) of 100% ethanol added and samples 
mixed by pipetting. Samples were loaded onto RNeasy mini columns in 700pl volumes 
and processed according to the manufacturer’s protocol. RNA was eluted in 45pi 
RNase-free water, then genomic DNA present in RNA extracts was removed by 
digestion with 2 units recombinant DNase I in lx DNase I Buffer (lOmM Tris-HCl, pH
7.5, 2.5mM MgSC>4, 0.5mM C aC y (DNA-free™, Ambion). Samples were mixed and 
the reaction incubated at 37°C for 30 minutes. 0.1 volumes of DNase Inactivation 
Reagent (DNA-^ree™, Ambion) was immediately added, incubated with agitation at 
room temperature for 2 minutes, then DNase enzyme and divalent cations removed by 
centrifugation at 10,000 rpm for 2 minutes. RNA (approximately 50pl) was removed 
into a clean tube and stored at -80°C until required. The concentration and quality of 
RNA extracts were determined as in section 2.4.1.3 and concentrations used to dilute 
samples to 5ng/pl. cDNA was synthesised as described in section 2.4.2.1.2, starting from 
50ng of RNA for each sample.
2.5.4.2 Real-Time PCR: Microfluidics TaqMan® Custom Arrays
Applied Biosystems TaqMan® Low Density Custom Array 384 well cards were used to 
investigate early gene expression changes in human chondrocytes in 3D-culture as a 
result of 6 hours of cytoskeletal disruption, and to compare gene expression of 
monolayer- and 3D-cultured human chondrocytes. Cards contained four repeats of 96 
gene targets selected by AstraZeneca as targets of interest in osteoarthritis. 200ng of 
RNA per sample (four samples per card) were loaded onto the 96 wells on cards, in the 
presence of 206pl QuantiTect Probe RT-PCR Master Mix and 2pl QuantiTect RT Mix
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(reagents from the Qiagen QuantiTect™ Probe RT-PCR kit). Plates were centrifuged in 
custom-made buckets at 1,200 rpm for one minute at room temperature, ensuring a low 
deceleration, and then sealed. Real-time PCR was carried out on an ABI PRISM™ 
7900HT Sequence Detection System using SDS.2.1 software, with reaction conditions 
as follows: reverse transcription at 50°C for 30 minutes, reverse transcriptase 
inactivation and DNA polymerase activation at 95°C for 15 minutes, followed by 40 
cycles of 95°C for 15 seconds and 60°C for one minutes. Samples from all four treatment 
groups, from both normal and osteoarthritic donors, from two repeats of the experiment 
were analysed on array cards (n=2). Results were analysed using a relative quantification 
study, and the threshold set automatically for each gene. GAPDH was set as the 
endogenous control and a control sample (i.e. untreated) as the exogenous control. 
Genes and samples with Ct>36 were removed from calculations and the Ct values 
(Fig.2.1) normalised to the GAPDH Ct value for each sample (giving a ACt value per 
sample per gene); amplification curves for housekeeping genes showed the least 
variability in GADPH expression across samples (appendix 2). For normalisation to an 
exogenous control, a A ACt value was calculated (being the difference between the ACt 
of the test sample and that of the control sample, for each gene of interest). Relative 
expression units and Relative quantification units were calculated using the following 
formula (Pfaffl, 2001):
R.E.U. = 2(a'ACt) where a = the highest ACt value of all samples and genes to be
compared.
RQ = 2‘(AACt) A value below 1 represents a negative fold change.
2.5.4.3 Real-Time PCR: SYBR Green
For a more in-depth analysis of gene expression changes over time with cytoskeletal 
disruption, expression of selected genes of interest was analysed by quantitative PCR in 
the presence of SYBR green, performed on a Mx3000P™ (Strategene) using MxPro 
software.
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2.5.4.3.1 Primer Design
Forward and reverse primers for use in quantitative PCR were designed for genes of 
interest. AC AN, SOX9 and COL1A1 were selected as these are commonly used as 
markers of chondrocyte phenotype, dedifferentiation or hypertrophy. MMP13, BMF and 
ADAMTS5 were selected from the results of the Taqman array and the cytoskeletal gene 
ACTB selected. Accession numbers for mRNA sequences were obtained from NCBI 
(www.ncbi.nlm.nih.gov/), and exon boundaries viewed in Ensembl (www.ensembl.org). 
If variants were found in either NCBI or Ensembl, sequences were aligned using EBI 
(www.ebi.ac.uk/Tools/clustalw/index.html) and primers designed to regions common to 
all variants. Primers were designed using Primer3 (http://frodo.wi.mit.edu/) and 
parameters set as follows; product size between 80 and 220bp, optimum primer melting 
temperature of 60°C, optimum primer length of 20bp. Primer sequences were then run 
through a nucleotide BLAST algorithm (www.ncbi.nlm.nih.gov/Blast.cgi) to ensure that 
they did not cross-react with other genes expressed by chondrocytes. Unmodified 
oligonucleotides were ordered from Eurofins-MWG and sequences, accession numbers 
and product sizes are shown in Table 2.7.
Primers shown in Table 2.5 were also used in SYBR green quantitative PCR.
2.5.4.3.2 Generation o f  Standard Curves
Standard curves were required for each gene in SYBR green quantitative PCR to allow 
for comparison across plates and experimental repeats and for determination of the 
reaction efficiency. PCR was performed as described in section 2.4.2.1, using cDNA 
from TC28a2 immortalised chondrocytes as the template. 5pi of each reaction was 
analysed by agarose gel electrophoresis (section 2.4.2.1.4) to ensure a single product was 
present (Fig 2.3 A).
2.5.4.3.2.1 Ligation into pGEM®-T
Following PCR, 1.5pl of the reaction was incubated overnight at 4°C with 25ng 
pGEM®-T vector (appendix 3) and 1.5 Weiss units T4 DNA Ligase in the presence of 
2.5pi 2x Rapid Ligation Buffer (pGEM®-T Vector System, Promega).
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Gene of 
Interest
Forward (F) and Reverse (R) primer 
sequence
Accession
No.
Annealing 
Temp (°C)
Product 
size (bp)
ACAN F: 5’-CCTCTGGACAACCAGGTGTT -3’ 
R: 5’-AAACCAGGTCAGGGACTCCT -3’
NM001135 58 174
SOX9 F: 5’-AATCTCCTGGACCCCTTCAT-3’ 
R: 5 ’-GTCCTCCTCGCTCTCCTTCT-3 ’
NM000346 56 198
COL1A1 F: 5’-GTGCTAAAGGTGCCAATGGT-3’ 
R: 5 ’-CTCCTCGCTTTCCTTCCTCT-3 ’
NM000088 58 228
MMP13 F: 5’-CCATTACCAGTCTCCGAGGA-3’ 
R: 5 ’ -GGAAGTTCTGGCC AAAATGA-3 ’
NM002427 58 118
BMF F: 5 ’-CAGGGGCTTTCCACTTGAG-3 ’
R: 5 ’ -CCAAGTGGGACCAAGTCAGT-3 ’
NM033503 58 236
ADAMTS5 F: 5’-GAGGCCAAAAATGGCTATCA -3’ 
R: 5 ATCGGTCACCTTTGGAGAAA-3’
NM007038 53 159
GAPDH F:5’GGTATCGTGGAAGGACTCATGA-3’ 
R: 5’-GGGCCATCCACAGTCTTCTG -3’
NM002046 60 68
Table 2.7:- Sequences of primers used in quantitative PCR with SYBR green. Annealing 
temperatures and product sizes are also shown.
2.5.4.3.2.2 Transformation into highly competent E. coli cells
Ligation reactions (2pl) were incubated on ice for 20 minutes with 25pi of JM109 high 
efficiency competent cells in 14ml culture tubes (BD Biosciences). Cells were heat- 
shocked at 42°C for 50 seconds and returned to ice for two minutes. Following the 
addition of 475pl S.O.C. media (Invitrogen), transformations were incubated, with 
agitation, at 37°C and 210 rpm for 90 minutes.
2.5.4.3.2.3 Blue/White Colony Selection
Transformations (lOOpl) were plated onto LB agar containing lOOpg/ml ampicillin 
(BioLine), 50pg/ml X-gal (5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside, 
Promega) and 0.5mM IPTG (isopropyl p-D-l-thiogalactopyranoside) and incubated for 
16 hours at 37°C. The pGEMT vector confers ampicillin-resistance therefore only 
transfected cells will grow on the selection media. The ligation site in the pGEMT vector 
is within the p-galactosidase gene, therefore vectors containing an insert (PCR product) 
will not produce functional P-galactosidase and colonies will appear white on the 
selection media. Vectors that have ligated with no insert synthesise p-galactosidase
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(gene transcription induced by IPTG) which acts upon the X-gal substrate in the 
selection media and appear blue (Biard et al., 1992, Horwitz et al., 1964). White colonies 
were picked from plates and cultured in 10ml LB broth containing lOOpg/ml ampicillin 
at 37°C for 18 hours, with agitation at 180 rpm.
2.5.4.3.2.4 Plasmid Purification
Cells were pelleted by centrifugation at 2,000g and plasmids extracted from cells using 
Wizard® Plus SV Miniprep DNA Purification System (Promega), according to the 
manufacturer’s instructions. Following DNA sequencing (Cardiff University DNA 
Sequencing Core: http://probe.biosi.cfac.uk/seq/) of plasmid inserts to confirm ligation 
and correct sequence of the required PCR product, plasmid DNA was quantified using a 
NanoDrop® ND-1000 Spectrophotometer (with NanoDrop 3.0.1 software). 
Concentrations were used to dilute plasmids to lng/pl and then a 1:10 dilution series 
produced standards ranging from lfg/pl to lng/pl.
C
«
£
Figure 2.3> Cloning of qPCR primer 
products and generation o f standard 
curves. A- Agarose gel electrophoresis 
confirming a single PCR product for 
ligation into pGEM®-T vector. B- 
Dissociation curves o f qPCR products 
confirming amplification o f a single 
product. C- Standard curve generated by 
qPCR o f a 1:10 dilution series o f cloned 
plasmid containing the PCR product 
insert (A).
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2.5.4.3.3 Quantitative PCR
Reactions were performed in 25 pi volumes, containing 2pl cDNA and 300nM forward 
and 300nM reverse primers in the presence of 12.5pl 2x SYBR® Green JumpStart™ 
Taq Ready Mix™, in 96-well polypropylene plates (Stratagene) and wells sealed with 
optical caps (Stratagene). Real-time PCR was carried out on a Mx3000P™ using MxPro 
software, with reaction conditions as follows; DNA polymerase activation and cDNA 
denaturation at 95°C for 10 minutes, followed by 40 cycles of 95°C for 30 seconds, 
primer annealing for one minute (for annealing temperatures see Table 2.7) and primer 
extension at 72°C for 30 seconds. Dissociation curves were generated by an additional 
cycle of 95°C for one minute, 55°C for 30 seconds and 95°C for 30 seconds Providing 
that dissociation curves showed a single product (Fig 2.3 B) and standard curves 
demonstrated reaction efficiency between 90-110% (Fig 2.3 C), the threshold was set 
automatically for each gene and results exported. The absolute value, generated using 
the standard curve, was normalised to that of the endogenous control GAPDH, for each 
sample.
2.6 Compressive Loading of Three Dimensional-Cultured Human 
Articular Chondrocytes
Human articular chondrocytes from normal and osteoarthritic donors were expanded in 
monolayer and cultured in agarose as described in section 2.5.1. Following culture for 24 
hours in serum-containing media, chondrocyte/agarose constructs were cultured for 24 
hours in ITS-supplemented, ‘serum-free’ media. Prior to loading, constructs were treated 
for a further 24 hours with cytoskeletal disrupting reagents, as described in section 2.5.2, 
or left untreated for 24 hours in fresh serum-free media, serving as undisrupted controls. 
Plugs were subjected to unconfined, uniaxial cyclic compression to a 15% strain at 
0.5Hz (one second on / one second off), for 10, 20 or 40 minutes. Samples were 
processed as described in section 2.5.2 -  2.5.4.
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2.6.1 Loading Machine
A custom-made mechanical loading apparatus (Advocet Engineering Services Ltd., UK) 
was used to load chondrocyte/agarose constructs over short periods of time. The loading 
apparatus, shown in Figure 2.4, consists of six 25mm diameter aluminium compression 
plates, controlled by a pneumatic compressor and UDT (universal digital timer), beneath 
which a 6-well plate can be placed. There is uniform, adjustable displacement across all 
six wells. Each well contains an individual load sensor with output through a digital 
transformer. Both compressive force and displacement were visualised and recorded 
using AcqKnowledge software (both supplied by Biopac, USA). The type of 
compression cycle and frequency are adjustable and controlled via the UDT on the 
control panel.
The smallest displacement achievable was 0.75 mm, which equates to a 15% strain as 
plugs had a depth of 5 mm. A frequency of 0.5 Hz was used for cyclical compressive 
loading to maintain the integrity of chondrocyte/agarose constructs.
Peak stress was determined for chondrocyte/agarose constructs under a 15% 
compressive strain; changes in voltage, recorded and visualised using AcqKnowledge 
software, were converted into force (Newtons) using a calibration curve (see Fig 6.26 A) 
and force then converted to stress using the equation below.
Force (N) = stress (Pa) x cross-sectional area (m )
2.6.2 Analysis of Chondrocyte Gene Expression Changes with Cyclic Compressive 
Load
RNA was extracted as described in section 2.5.4.1 and gene expression analysed by 
quantitative PCR with SYBR green (section 2.5.4.3.3).
- 9 7 -
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Figure 2.4:- The custom-made mechanical 
loading apparatus used for cyclic 
compressive loading of chondrocyte/agarose 
constructs. Six 25mm diameter aluminium 
compression plates (y) are controlled by a 
pneumatic compressor (w) and universal 
digital timer. A 6-well plate (x) containing 
chondrocyte/agarose plugs and culture media 
is placed beneath and compression plate 
height adjusted (y). Each well contains an 
individual load sensor (z) with output through 
a digital transformer.
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2.7 Statistical Analyses
All statistical comparisons were performed using Minitab 15 software.
For comparison of normal to osteoarthritic cartilage or chondrocytes, treated to untreated 
chondrocytes, and loaded to unloaded chondrocytes, the Anderson Darling test for 
normality was performed for each group of data and the variance ratio (F-test) used to 
determine the equality of variance. A two-sample t test was used to compare data where 
both groups were normally distributed and had an equal variance. In the case that a 
group of data was not normally distributed, data was transformed logarithmically and 
tests for normality and equal variance were performed as before. If, following 
transformation, data was not normally distributed, comparisons of the medians of the 
untransformed data were performed using the non-parametric Mann-Whitney test.
Results are presented graphically as mean ± SEM. The number of samples used to 
produce data is indicated in the relevant figure legend. Data are significantly different at 
p < 0.05. Due to the higher variability associated with human samples p values <0.10, 
although not significant, are included to show trends where an increase in n number 
could produce statistical significance.
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3. CHARACTERISATION OF NORMAL AND 
OSTEOARTHRITIC CARTILAGE: CYTOSKELETAL 
ELEMENT PROFILE AND EXTRACELLULAR MATRIX 
METABOLISM
3.1 INTRODUCTION
As described in section 1.3.1.1.1, cartilage organisation and extracellular matrix (ECM) 
composition is altered in osteoarthritis (OA). The smooth surface is disrupted and 
fibrillated, with collagen fibres in the superficial zone significantly less parallel to the 
surface (Saarakkala et al., 2010). Proteoglycan is lost from the ECM and enzymatic 
cleavage of both aggrecan and collagen is increased as a result of a shift in the 
chondrocyte phenotype towards catabolism (section 1.3.1.1.2).
In addition to changes in cartilage organisation, ECM composition and chondrocyte 
phenotype, differences between the cytoskeletal architecture of normal and OA 
chondrocytes are becoming more evident. Differences in the cytoskeletal architecture of 
normal and OA chondrocytes have been observed in human OA (Fioravanti et al., 2003, 
Lambrecht et al., 2008) and a rat model of OA (Capin-Gutierrez et al., 2004) and the 
changes are discussed in section 1.5.
Using human normal and OA articular cartilage I sought to:
• Compare the tissue organisation, extracellular matrix composition and gene 
expression of normal and OA articular cartilage.
• Characterise the cytoskeletal differences between normal and OA chondrocytes, 
comparing the gene expression, protein expression and organisation of 
cytoskeletal proteins in normal and OA cartilage.
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3.2 RESULTS
3.2.1 Articular Cartilage Organisation
3.2.1.1 Comparison of Normal and Osteoarthritic Cartilage
Normal healthy articular cartilage showed even alcian blue staining indicating that loss 
of glycosaminoglycan (GAGs) was minimal (Fig 3.1a). The articular surface appeared 
predominantly intact, although a small amount of disruption to the surface was observed. 
Chondrocytes were well separated with no signs of clustering. Osteoarthritic articular 
cartilage showed characteristic features of OA histopathology, with obvious disruption 
and fibrillation of the articular surface. Chondrocyte clusters were evident throughout 
the depth of the sample (Fig 3.1b). Loss of alcian blue staining occurred throughout the 
depth of the section but was most evident in the superficial zone, indicating the loss of 
GAG that is characteristic of OA. Remaining GAGs in the tissue were localised to the 
pericellular regions of the cartilage (Fig 3.1b). When examined histologically, normal 
samples, classed as such because post-mortem donors had no ‘overt’ symptoms of OA, 
showed a range of degradative changes (Fig 3.2). Only one sample of the eight normal 
samples examined histologically had no obvious loss of GAG (Fig 3.2a); two had a 
small loss in the superficial zone only (Fig 3.2b,c). These three samples had relatively 
intact surfaces with a small degree of surface disruption. Three samples showed clear 
loss of GAG from the superficial zone but little from the transitional and radial zones 
(Fig 3.2d-f). Fibrillation of the articular cartilage surface was also evident. Two samples 
had more extensive GAG loss, similar to that of the OA samples, with highly fibrillated 
surfaces, fissures and cell clusters (Fig 3.2g,h). Of note is that the normal and OA tissue 
sections (Fig 3.1) do not represent the full depth of the cartilage as samples were 
removed from the joints as shavings parallel to the articular surface. Most lack the 
calcified cartilage that lies above the subchondral bone and may therefore also lack some 
of the lower deep zone.
3.2.1.2 Comparison of Fibrillated and Non-fibrillated Regions within One Joint
Human articular cartilage was obtained post-mortem from the lateral tibial plateau of a 
donor with no ‘overt’ symptoms of osteoarthritis, i.e. had never presented to a GP with 
knee pain. However, macroscopically, regions of fibrillation were observed on the tibial 
plateaus. Therefore full-depth cartilage was sampled from both fibrillated and non-
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Figure 3.1:- Alcian blue staining o f normal and osteoarthritic (OA) human articular cartilage, 
with tissue samples sectioned perpendicular to the articular surface to allow visualisation o f 
zonal variations (Scale bars = 200pm). Differences in glycosaminoglycan (GAG) content and 
tissue organisation can be seen between normal and osteoarthritis tissue. A- Normal articular 
cartilage, showing even GAG content throughout and little disruption o f die articular surface. 
B- Osteoarthritic articular cartilage, showing loss o f GAG throughout, most apparent in the 
surface zone, with fibrillation o f die articular surface and chondrocyte clusters (arrows).
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Figure 3 3 :- Alcian blue staining o f human articular cartilage from a macroscopically non- 
fibrillated (A) and fibrillated (B) region o f a lateral tibial plateau obtained from an 
individual with no ‘overt’ symptoms o f OA. Tissue samples were sectioned perpendicular 
to the articular surface to allow visualisation o f  zonal variations (Scale bars = 200pm). 
Differences in glycosaminoglycan (GAG) content and tissue organisation can be seen 
within die same joint
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fibrillated regions of the same lateral tibial plateau. Macroscopically non-fibrillated 
sections showed a small degree of disruption and fibrillation of the articular surface 
accompanied by a clear loss of alcian blue staining (i.e. loss of GAG) in the surface zone 
(Fig 3.3a). There was no loss of staining in the transitional and radial zones, although a 
small number of chondrocyte clusters were detected in these zones. Sections of 
fibrillated regions showed complete loss of alcian blue staining of the superficial zone 
and part of the transitional zone, although loss of staining was evident throughout the 
tissue depth (Fig 3.3b). As with OA cartilage, GAGs were localised to the pericellular 
regions and chondrocyte clustering occurred throughout the transitional and radial zones.
3.2.2 Composition of the Extracellular Matrix of Articular Cartilage
3.2.2.1 Water Content
The percentage water content of articular cartilage samples was determined by 
comparing wet weights to dry weights obtained following freeze-drying of the tissue. 
Results for normal and OA samples (n=9) were significantly different at the 94% 
confidence level (p = 0.056), with OA tissue containing more water compared to normal 
(Fig 3.4a).
3.2.2.2 Sulphated-Glycosaminoglycan Content
The sulphated-glycosaminoglycan (sGAG) content of tissue samples was determined 
using the DMMB assay (Famdale et al., 1986) and results normalised to the dry weight 
rather than wet weight of the tissue to remove any effect of the difference in water 
content. OA articular cartilage contained significantly less sGAG (p = 0.013, n = 4) 
when compared with normal tissue (Fig 3.4b). As physiologically normal and OA 
cartilage contain different amounts of water, a comparison of the sGAG content of tissue 
samples normalised to wet weight was also performed and showed OA cartilage to 
contain significantly less sGAG compared to normal (p=0.036, n=9).
3.2.2.3 Collagen Content
Articular cartilage collagen content was determined using an assay of hydroxyproline 
content, as this rare amino acid is only found in the triple-helical domains of collagen. 
Amounts of hydroxyproline were multiplied by seven to convert to amounts of collagen, 
based on an estimation of 14% hydroxyproline content of type II collagen (Leach, 1960). 
OA cartilage contained significantly more collagen per mg dry weight tissue than normal
- 1 05 -
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Figure 3.4:- Comparison o f the biochemical composition o f normal and osteoarthritic 
(OA) human articular cartilage. A- The percentage water content o f  normal and 
osteoarthritic tissue, determined using wet and dry weights (n=9). OA tissue contained 
more water than normal (p = 0.056). B- The amount (mg) o f sulphated glycosaminoglycan 
per mg dry weight o f tissue, as quantified by the DMMB assay (n=4)_ OA tissue contained 
significantly less sGAG than normal (p = 0.013). Data are expressed as mean ± SJEJM, * 
p<0.05.
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cartilage (Fig 3.5a; p=0.030, Mann-Whitney test). However, a comparison of collagen 
content per mg wet weight tissue revealed no difference between normal and OA 
articular cartilage (p=0.518).
The levels of type II collagen present in the insoluble portion of normal and 
osteoarthritic cartilage extracts were detected by Western Blotting. Type I collagen 
levels were below the limit of detection in most samples, regardless of pathology. There 
was no difference between the levels of type II collagen detected in normal and OA 
articular cartilage (Fig 3.5b).
3.2.2.4 Matrix Metalloproteinases and Inhibitors
Articular cartilage protein extracts were assayed for MMPs-2 and -9 content using 
gelatin zymography. Clear zones of gelatinolytic activity corresponding to both latent 
and active forms of MMP-2 were observed on gels (Fig 3.6a) and quantified by 
densitometry using NIH image software. Possible variations due to potential differences 
in SDS removal and MMP activation between gels was removed by normalising to the 
pro-MMP-2 standard common to each. Results for normal and OA protein extracts were 
compared (Fig 3.6b), with no difference found between either pro- (p=0.936) or active- 
MMP-2 (p=0.395). MMP-9 was not detected in any of the samples, even with increased 
protein loading.
The levels of TIMPs in protein extracts, quantified using reverse gelatin zymography, 
also showed little difference between normal and OA samples (Fig 3.7), with no 
significant difference in levels of TIMP-1 (p=0.801), TIMP-2 (p=0.559) or TIMP-3 
(p=0.927).
3.2.3 Gene expression in Articular Cartilage
The expression profile of key genes involved in matrix turnover, previously shown to 
change in OA, was analysed in chondrocytes in normal and osteoarthritic articular 
cartilage by quantitative Taqman® PCR or quantitative PCR (qPCR) with SYBR green® 
{MMP 13). RNA extracted directly from articular cartilage was used in qPCR reactions 
with primers and probes designed against genes of interest (Table 2.6, MMP 13 in Table 
2.7). GAPDH expression showed little variation across samples and was used as an 
endogenous control. Relative expression units were calculated as described in section
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Figure 3.5:- Collagen content o f normal and osteoarthritic (OA) human articular cartilage. 
A- The amount o f collagen (mg) per mg dry weight o f tissue, as determined by assay o f 
hydroxyproline content (n=4), showed an increased collagen content in OA tissue 
compared to normal (p = 0.030, Mann-Whitney test). Data are expressed as mean ± 
S.E.M, * p< 0.05. B- Western blots o f guanidine-insoluble type II collagen present in 
normal (n=7) and OA (n=6) human articular cartilage extracts. Equivalent amounts o f 
collagen (2pg o f hydroxyproline) were loaded, along with a type II collagen standard (std) 
and detected using the mouse monoclonal antibody AVT6E3 and a sheep anti-mouse IgG 
secondary antibody.
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Figure 3.6:- Quantification of the MMP-2 content o f normal and osteoarthritic (OA) human 
articular cartilage (normal, n = 9. OA, n = 8). A- Gelatin substrate zymography was used to 
detect die latent (72kD) and active (62kD) forms of MMP-2 , with white bands representing 
zones o f gelatmolytic activity. Equivalent amounts o f protein (5 fig) were loaded. B- Bands 
from gelatin zymography (A) were quantified by densitometry using NIH image software and 
values normalised to the pro-MMP-2 standard loaded on the relevant geL There was no 
difference in pro- (p = 0.936) or active MMP-2 (p = 0395) between normal and OA articular 
cartilage. MMP-9 was not detected.
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Figure 3.7:- Quantification o f the TIMP content o f normal and osteoarthritic (OA) human 
articular cartilage (normal, n = 9. OA, n = 8). A- Gelatin reverse zymography was used to 
detect TTMPs -1,-2, and -3, with dark bands representing zones o f inhibition o f gelatinolytic 
activity. Equivalent amounts o f protein (5pg) were loaded. B- Bands from reverse 
zymography (A) were quantified by densitometry using NTH image software and values 
normalised to the TIMP-1 standard loaded on the relevant geL There was no difference in 
TEMP-1 (p = 0.801), TEMP-2 (p = 0.559) or TEMP-3 (p = 0.927) between normal and OA 
articular cartilage.
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2.4.2.2.I. Expression of COL2A1 and MMP 13 was significantly higher in OA cartilage 
compared to normal (Fig 3.8a; p<0.001 and p=0.016 respectively), while SOX9 
expression was significantly lower in OA cartilage compared to normal (p=0.001). The 
expression of vascular endothelial growth factor (VEGF) and the aggrecanase 
ADAMTS-5 were also significantly decreased in OA cartilage compared to normal 
(p=0.005 and p=0.037 respectively) (Fig 3.8b). There was no difference in aggrecan 
(ACAN) expression between normal and OA cartilage (p=0.293).
3.2.4 Optimisation of Fixation Protocols
In order to determine the optimal fixation protocol for preservation of all three 
cytoskeletal elements, four different protocols were tested using frozen immature bovine 
cartilage sections.
3.2.4.1 Distribution of Cytoskeletal Protein Labelling
Young bovine articular cartilage sections fixed with paraformaldehyde (PFA) and 
permeabilised with cold methanol, with PBS as the buffer, showed uniform phalloidin 
fluorescence throughout the tissue zones, whilst vimentin and tubulin staining was 
brightest around the edges of the sections (data not shown). This was not observed in 
sections fixed with PFA and permeabilised with Triton® X-100 in the presence of buffer 
1 (Zwicky and Baici, 2000) and could therefore simply represent a less effective mode 
of permeabilisation. Staining of all three cytoskeletal elements was throughout the tissue 
sections fixed in buffer 1, although tubulin staining was weak which may be due to a 
lack of microtubule preservation. Sections fixed with glutaraldehyde and permeabilised 
with Triton® X-100 in buffer 2 (Zwicky and Baici, 2000) or in mHBSS (Blanc et al., 
2005) also showed labelling of the cytoskeletal elements throughout the tissue depth, 
although in sections fixed in mHBSS, tubulin staining in the deep zone was brighter 
(data not shown).
3.2.4.2 Cytoskeletal Organisation
For determination of the effects of different fixation protocols on cytoskeletal 
organisation, four chondrocytes from the mid or deep zone were viewed using a confocal 
microscope and a representative cell scanned for presentation.
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Figure 3.8:- Gene expression in normal (green) and osteoarthritic (red) articular cartilage, 
determined using cpiantitative I aqman™ PCR with RNA extracted directly from cartilage 
tissue (graphs show mean ±  S.E.M, n=7, with the exception o f  n=6 for normal 
AD AM TS5). A- COL2A1 and M M P 13 expression are significantly increased in 
osteoarthritic articular cartilage compared to normal B Osteoarthritic articular cartilage 
expressed significantly less SO X 9, VEGF  and ADAM FS5 compared to normal There was 
no difference in aggrecan mRNA expression between normal and osteoarthritic articular 
cartilage. *p<0.05, **p<0.01, ***p<0.001.
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3.2.4.2.1 Actin
Young bovine articular cartilage sections fixed with paraformaldehyde and 
permeabilised with cold methanol (phosphate buffered saline (PBS) was used as the 
buffer) showed diffuse staining with some evidence of filament bundles at the periphery 
of the chondrocyte (Fig 3.9a). Staining appeared close to the nucleus (Fig 3.9b), 
although it was unclear whether this represented collapse of the microfilaments around 
the nucleus or diffuse staining extending from the nucleus to the plasma membrane. 
Chondrocytes in tissue fixed with paraformaldehyde but permeabilised with Triton® X- 
100 and washed in buffer 1 (Zwicky and Baici, 2000) showed a better preservation of 
the microfilament network, with staining less condensed around the nucleus and 
punctate at the cell periphery (Fig 3.9d). Diffuse staining was again observed throughout 
the cytoplasm, and fluorescence was also closely associated with the nucleus (Fig 3.9e). 
Preservation of actin microfilaments with glutaraldehyde in buffer 2 (Zwicky and Baici, 
2000) was poor, with weak fluorescence that was diffuse and close to the nucleus (Fig 
3.9h). However, the use of glutaraldehyde and Triton® X-100 in modified Hank’s 
balanced salt solution (mHBSS) (Blanc et al., 2005) appeared to more effectively 
preserve the microfilament organisation. Staining was bright and extended throughout 
the cytoplasm, with a fine punctate appearance at the periphery (Fig 3.9j), and the actin 
cytoskeleton no longer appeared condensed around the nucleus (Fig 3.9k,l).
3.2.4.2.2 p-tubulin
In young bovine articular cartilage sections fixed with paraformaldehyde and 
permeabilised with cold methanol in the presence of PBS, microtubules were located 
close to the nucleus (Fig 3.10b), with a punctate appearance both at the periphery (Fig 
3.10a) and throughout the cytoplasm that appeared loosely packed (Fig 3.10c). 
Microtubule organisation was most poorly preserved by fixation in paraformaldehyde 
(PFA) and permeabilisation with Triton® X-100 in buffer 1 (Zwicky and Baici, 2000), 
which resulted in very weak staining with a small number of dense, bright foci of 
fluorescence (Fig 3.1 Od-f). Cartilage chondrocytes fixed with glutaraldehyde and 
permeabilised with Triton® X-100 in the presence of buffer 2 (Zwicky and Baici, 2000) 
showed a better preservation of the microtubule network, with brighter staining 
throughout the cytoplasm. There was little evidence of filament bundles, and staining
still appeared condensed around the nucleus (Fig 3.1 Og-i). As with actin microfilaments,
  * ®simultaneous fixation and permeabilisation with glutaraldehyde and Triton X-100 but
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Figure 3 .9:- The effect o f  different fixation protocols on the preservation o f  the actin 
cytoskeleton in young bovine articular cartilage chondrocytes in situ . Actin microfilaments 
were visualised using FTTC-conjugated phalloidin (green) and nuclei counterstained with 
DAPI (blue). PBS- paraformaldehyde (PFA) fixed and permeabilised with cold methanol (a- 
c), Buffer 1- PFA fixed and permeabilised with Triton® X-100 (d-f), Buffer 2 (g-i) and 
mHBSS (j-l>- glutaraldehyde fixed and permeabilised with Triton® X-100. The mHBSS 
protocol best preserved actin micro filament organisation.
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Figure 3.10:- The effect o f  different fixation protocols on die preservation o f  the tubulin 
cytoskeleton in bovine articular cartilage chondrocytes in siiu . Tubulin microtubules were 
visualised using anti-p-tubulin primary antibody followed by 1’RITC-oonjugaled anti-mouse 
IgG secondary antibody (red), with nuclei counterstained with DAPI (blue). PBS- 
paraformaldehyde (PFA) fixed and permeabilised with cold methanol (a-c), Buffer 1- PFA 
fixed and permeabilised with Triton® X-100 (d-f), Buffer 2 (g-i) and mHBSS (j-1)- 
ghitaraldefayde fixed and permeabilised with Triton ® X-100. The mHBSS protocol best 
preserved tubulin microtubule organisation.
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in the presence of mHBSS as a buffer (Blanc et al., 2005) appeared to best preserve 
microtubule organisation. Staining was fine and punctate throughout the cytoplasm and, 
as with actin microfilaments (Fig 3.9j-l), microtubules no longer appeared condensed 
around the nucleus (Fig 3.1 Oj-1), although there were no obvious filament bundles.
3.2.4.2.3 Vimentin
In young bovine articular cartilage sections, vimentin staining was strong and 
fluorescence bright with all fixatives and buffers used. Sections fixed with PFA and 
permeabilised with Triton® X-100 in PBS showed dense staining around the nucleus 
(Fig 3.11b) with thick, loose filament bundles at the periphery (Fig 3.1 la). Chondrocytes 
in tissue fixed with PFA but permeabilised with Triton® X-100 and in buffer 1 (Zwicky 
and Baici, 2000) had preserved vimentin intermediate filament bundles that were less 
condensed around the nucleus than those in PBS (Fig 3.1 ld-f). Fixation using 
glutaraldehyde in buffer 2 (Zwicky and Baici, 2000) also preserved the filamentous 
organisation of the vimentin cytoskeleton, showing a network of filament bundles 
extending from the nucleus to the plasma membrane (Fig 3.1 lh). Sections fixed with 
glutaraldehyde but in mHBSS showed little difference to those fixed in the presence of 
buffer 2, with a meshwork of filament bundles extending throughout the cytoplasm of 
the chondrocyte (Fig 3.1 lj-1).
Collectively, the preservation of all three cytoskeletal elements was best following 
simultaneous permeabilisation with Triton® X-100 and fixation with glutaraldehyde in 
mHBSS (Blanc et al., 2005). This protocol was therefore used for subsequent studies.
3.2.5 Cytoskeletal Organisation of Human Chondrocytes in situ
3.2.5.1 Comparison of Normal and Osteoarthritic Chondrocytes
Full depth cartilage biopsies were collected from the same region of the tibial plateau of 
four normal and four osteoarthritic donors. Human articular cartilage sections were
(Sbsimultaneously fixed and permeabilised in glutaraldehyde and Triton X-100 in mHBSS 
buffer (Blanc et al., 2005). Three chondrocytes from the superficial, middle and deep 
zones were scanned from each of the donors. Images were ‘blind’ scored by two 
independent individuals. Scores between one and five were assigned to cell images 
according to the criteria in Figure 3.12. Images used to score each cell were single scans 
through the edge and centre of the cell, along with 3D reconstructions of the series of
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Figure 3.11:- The effect o f  different fixation protocols on the preservation o f the vimentin 
cytoskekton in bovine articular cartilage chondrocytes in situ. Vimentin intermediate filaments 
were visualised using anti-vimentin primary antibody followed by TRITC-conjugated anti-mouse 
IgG secondary antibody (red), with nuclei counterstained with DAPI (blue). PBS- 
paraformaldehyde (PFA) fixed and permeabilised with cold methanol (a-c), Buffer 1- PFA fixed 
and permeabilised with Triton® X-100 (d-l), Buffer 2 (g-i) and mHBSS (j-1)- glutaraldehyde 
fixed and permeabilised with Triton ® X-100. The mHBSS protocol best preserved vimentin 
intermediate filament organisation.
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Figure 3.12:- Images and criteria used to ‘blind’ score the organisation of the actin 
(A), tubulin (B) and vimentin (C) elements of the cytoskeleton of human articular 
chondrocytes in situ. A score was assigned to each chondrocyte by two 
independent individuals using single scans from the edge and centre of cells, along 
with 3D reconstructions of the series of scans across the depth of the cell.
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Score 3D reconstruction Centre o f  cell Descriptive Criteria
• sharp punctate spots
• cytoplasmic localisation
• no evidence of peripheral 
organisation
• punctate spots
• some cytoplasmic localisation
• some evidence of peripheral 
organisation but not continuous
• intense peripheral stain 
•punctate
• continuity of label al the 
periphery
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Tubulin
3D reconstruction Centre o f cell Descriptive Criteria
• no visible networks
• extensive punctate staining
• voids in cytoplasm
• some networks visible
• some punctate staining
• voids in cytoplasm
• networks visible and extend 
through the cytoplasm
• no voids
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3D reconstruction
Vimentin
Centre o f cell
1
f i l
Descriptive Criteria
no obvious filaments 
no visible netwoiks
• some filaments visible
• some netwoiks visible but not 
throughout the cytoplasm
• intact filaments extend 
throughout the cytoplasm
• netwoiks visible
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scans across the depth of the chondrocyte.
3.2.5.1.1 Distribution o f Labelling in Cartilage Zones
Low power images of normal and osteoarthritic human articular cartilage illustrated the 
distribution of the fluorescently labelled cytoskeletal elements. Cells throughout the 
depth of both normal and OA human articular cartilage labelled for actin microfilaments 
(Fig 3.13a-d). In OA cartilage, actin staining of clustered chondrocytes around surface 
fibrillations appeared brighter than other cells in OA and normal cartilage (Fig 3.13c). 
Tubulin staining was fainter but not absent in chondrocytes of the superficial and upper- 
mid zone of normal cartilage (Fig 3.13e) compared to lower-mid and deep zone 
chondrocytes (Fig 3.13f). This was not the case in OA cartilage, which showed brighter 
tubulin labelling in the chondrocytes surrounding surface fibrillations (Fig 3.13g). The 
superficial and upper-mid zone of normal cartilage also showed fainter vimentin 
staining, with brighter staining extending into the deep zone (Fig 3.13i). This was not 
observed in OA cartilage where vimentin labelling was evident throughout the depth of 
the tissue, although it did appear brighter in the deep zone (Fig 3.13k,l).
3.2.5.1.2 Actin Microfilament Organisation
In mature human normal articular cartilage chondrocytes the actin microfilaments were 
bright and punctate at the cell periphery (Fig 3.14 a and c). Punctate staining was often 
observed throughout the cytoplasm, extending from beneath the plasma membrane to the 
nucleus (Fig 3.14b). The typical organisation of actin microfilaments in osteoarthritic 
articular cartilage chondrocytes showed less defined punctate spots at the cell periphery 
(Fig 3.14 d and f) and, unlike that seen more typically in normal chondrocytes, 
fluorescence was predominantly localised cortically (Fig 3.14e). Scoring of 
chondrocytes in the superficial, middle and deep zones showed a significant difference 
in actin microfilament architecture between normal and OA deep zone chondrocytes 
(p=0.042) (Fig 3.14g).
3.2.5.1.3 Tubulin Microtubule Organisation
In normal human articular cartilage chondrocytes typical tubulin staining was visualised 
as a tightly packed, fine filamentous meshwork of microtubule bundles extending 
throughout the cytoplasm (Fig 3.15 a-c). In OA chondrocytes microtubule bundles were 
less clear. Microtubules were observed, but staining was more punctate than that 
typically observed in normal chondrocytes (Fig 3.15d) and was often more evident in the
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Figure3.13:- Comparison o f  the distribution o f  cytoskeletal elements through the depth o f  normal and osteoarthritic (OA) human articular cartilage. 
There was a difference in cytoskeletal labelling intensity in the surface and upper-mid zone chondrocytes (arrow heads) and in chondrocytes 
surrounding surface fibrillations in OA tissue (arrows). Actin (a-d) was detected with Alexa Fluor 488-phalloidin. Tubulin (e-h) and vimentin (l-l) 
were detected indirectly with primary antibodies and TRITC-conjugated secondary antibody.
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Figure 3.14:- Comparison of the organisation of the actin cytoskeleton in normal (a-c) and osteoarthritic (d-f) chondrocytes from human 
articular cartilage (20pm sections). Punctate spots (arrows) were less defined and predominantly cortical (arrow heads) in OA chondrocytes. 
The cells displayed are from the mid (a-c) and superficial (d-f) zone. Actin microfilaments were directly stained with Alexa Fluor 488- 
phalloidin (green) and nuclei were counterstained with DAPI (blue). Actin organisation was scored and superficial, middle and deep zone 
normal and OA chondrocyte scores compared to reveal a significant difference between normal and OA in deep zone chondrocytes (g): 3 
cells were scored for each zone, from each of the 4 normal and 4 OA donors (n=12). Graphs show mean ± S.E.M. * p< 0.05.
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Figure 3.15:- Comparison of the organisation of the tubulin cytoskeleton in normal (a-c) and osteoarthritic (d-f) chondrocytes from human 
articular cartilage (20pm sections). Microtubulc bundles (arrow heads) were less clear and staining was more punctate (arrows) in OA 
chondrocytes. The cells displayed are from the deep (a-c) and mid (d-f) zone. Tubulin microtubules were detected by indirect 
immunofluorescence using an anti-P-tubulin primary antibody and a TRITC-conjugated anti-mouse IgG secondary antibody (green). 
Nuclei were counterstained with DAPI (blue). Tubulin organisation was scored and superficial, middle and deep zone normal and OA 
chondrocyte scores compared to reveal a significant difference between normal and OA in superficial and mid zone chondrocytes (g): 3 
cells were scored for each zone, from each of the 4 normal and 4 OA donors (n=12). Graphs show mean ± S.E.M. ** p< 0.01.
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Figure 3.16:- Comparison of the organisation of the vimentin cytoskclcton in normal (a-c) and osteoarthritic (d-f) chondrocytes from 
human articular cartilage (20pm sections). Intermediate filament bundles (arrows) appeared thicker and more loosely packed in OA 
chondrocytes. The cells displayed arc from the deep (a-c) and mid (d-f) zone. Vimentin intermediate filaments were detected by indirect 
immunofluorescence using an anti-vimcntin primary antibody and a TRITC-conjugated anti-mouse IgCi secondary antibody (green). 
Nuclei were counterstained with DAP1 (blue). Vimentin organisation was scored and superficial, middle and deep zone normal and OA 
chondrocyte scores compared to reveal a significant difference between normal and OA in deep zone chondrocytes (g): 3 cells were scored 
for each zone, from each of the 4 normal and 4 OA donors (n=12). Graphs show mean ± S.E.M. *** p< 0.001.
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Figure 3.17:- Comparison of the organisation of the vimentin cytoskeleton in normal (a and 
b) and osteoarthritic (c and d) chondrocytes within human articular cartilage (20pm 
sections). Images shown are 3D reconstructions of a series of scans taken at 0.4pm 
increments across the chondrocyte. Vimentin intermediate filaments were detected by 
indirect immunofluorescence using anti-vimentin primary antibody and TRITC-conjugated 
anti-mouse IgG secondary antibody (red). Nuclei are counterstained with DAPI (blue). 
Vimentin intermediate filaments appear more loosely packed in osteoarthritic chondrocytes 
compared to normal chondrocytes.
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perinuclear region (Fig 3.15e). Scoring of chondrocytes showed a significant difference 
in tubulin microtubule architecture between normal and OA chondrocytes in the 
superficial (p=0.010) and mid (p=0.002) zones (Fig 3.15g).
S.2.5.1.4 Vimentin Intermediate Filament Organisation
Networks of vimentin filament bundles were observed in both normal and OA human 
articular cartilage chondrocytes. In normal chondrocytes vimentin filament networks 
were typically evident at the cell periphery (Fig 3.16a), extending throughout the cell 
and often appearing as a bright cortical ring (Fig 3.16b). Vimentin tended to appear as 
fine filamentous networks (Fig 3.17 a and b). In OA chondrocytes vimentin intermediate 
filament bundles extended from the nucleus to the cell periphery, although networks of 
intermediate filament bundles were typically more loosely packed and diffuse than those 
in normal chondrocytes (Fig 3.16 d-f and Fig 3.17 c and d). Scoring of chondrocytes in 
the superficial, middle and deep zones showed a significant difference in vimentin 
intermediate filament architecture between normal and OA deep zone chondrocytes 
(p<0.001) (Fig 3.16g).
3.2.5.2 Comparison of Cytoskeletal Organisation in Chondrocytes from Fibrillated 
and Non-fibrillated Regions within One Joint
The organisation of the chondrocyte cytoskeleton in fibrillated and macroscopically non- 
fibrillated regions of human articular cartilage taken from the lateral tibial plateau of a 
donor with no ‘overt’ symptoms of osteoarthritis was compared. Full-depth tissue 
sections were fixed and permeabilised according to the (Zwicky and Baici, 2000) 
method (section 2.23.2).
3.2.5.2.1 Actin Microfilaments
Actin staining was observed throughout most cells of the non-fibrillated sections, 
although fluorescence was not present in all cells. Organisation was punctate and 
extended throughout the cytoplasm of chondrocytes (Fig 3.18 a and b) and was 
comparable to the organisation observed in normal articular cartilage chondrocytes (Fig 
3.14 b and c). Chondrocytes in fibrillated regions of cartilage also showed punctate actin 
staining (Fig 3.18d), but in contrast to actin organisation in non-fibrillated regions, this 
was cortical and did not extend towards the nucleus (Fig 3.18c). This cortical 
localisation of microfilaments was comparable to that seen in OA articular cartilage
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Figure 3.18:- Comparison o f  the cytoskeletal organisation o f  human chondrocytes within articular cartilage tissue taken from either a fibrillated or 
macroscopically non-fibrillated region o f  Hie lateral tibial plateau o f  a post-mortem donor. Articular cartilage sections (20pin) were fixed with either 
paraformaldehyde (actin and vimentin) or ghitaraldchyde (tubulin) and pcrmeabilised with Triton® X-100, in the presence o f  either bufFer 1 (actin and 
vimentin) or buffer 2 (tubulin). Actin microfilaments were directly stained with Alexa Fluor 488-phalloidin (green), whilst tubulin and vimentin were 
detected with primary and TRITC-conjugated secondary antibodies (red). Nuclei were countcrstaincd with DAPI (blue).
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chondrocytes (Fig 3.14e). Fluorescence was not detected in all cells of the fibrillated 
tissue, but was most noticeably weak or absent in the superficial zone and adjacent to 
fibrillation and tears.
3.2.5.2.2 Tubulin Microtubules
In non-fibrillated cartilage chondrocytes, microtubule bundles appeared thick and were 
condensed around the nucleus, with no visible filamentous network (Fig 3.18 e and f). 
Microtubule organisation in chondrocytes in fibrillated sections was similar, with dense 
staining located around the nucleus, although the presence of a filamentous network was 
more apparent (Fig 3.18h). Whilst the microtubule organisation in chondrocytes was 
similar between fibrillated and non-fibrillated regions, the distribution of staining 
differed. Tubulin staining in non-fibrillated sections occurred throughout all cells and 
cartilage zones, whereas in fibrillated sections staining in the deep zone was poor and 
was very weak or absent in some cells of the heavily fibrillated superficial zone.
3.2.5.2.3 Vimentin Intermediate Filaments
Vimentin intermediate filament bundles in chondrocytes of non-fibrillated tissue 
appeared as a thick, filamentous network located close to the nucleus (Fig 3.18 i and j). 
In fibrillated areas, chondrocytes also contained a filamentous vimentin cytoskeleton. A 
network of filament bundles extended throughout the chondrocyte cytoplasm, forming a 
denser network at the cell periphery which extended throughout the cell to the nucleus 
(Fig 3.18 k and 1).
3.2.6 Cytoskeletal Proteins in Articular Cartilage
3.2.6.1 Cytoskeletal Element Protein Expression
Levels of the three main cytoskeletal proteins, actin, p-tubulin and vimentin, were 
detected by Western blotting and amounts present in normal and osteoarthritic cartilage 
compared by densitometry. Actin levels appeared to be increased in OA cartilage 
extracts compared to normal tissue, although this difference was not significant 
(p=0.306). This may be attributed to the fact that actin was not detected in all samples 
therefore only samples with visible bands at 42 kD were quantified and used in statistical 
analyses (n=6, Fig 3.19a), hence a greater variability. P-tubulin was detected in all 
samples and showed no difference between normal and OA articular cartilage extracts 
(Fig 3.19b). Vimentin was also detected in all protein extracts and although there
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Figure 3.19:- Quantification showed no difference in levels o f the cytoskeletal proteins A actin (42 kD), B ft tubulin (55 kD) and C- vimentin (58 
kD) between normal and osteoarthritic (OA) human articular cartilage (n=9 for normal, n 8 for OA, n=6 for actin). Cytoskeletal proteins were 
detected by western immunoblot, with equivalent loading o f  protein (50pg total protein). Bands on immunoblots were quantified by densitometry 
using NIH image software and normal and osteoarthritic tissue extracts were compared following normalisation to the positive control (+ve) on die 
relevant gel.
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Figure 3.20:- Western blot o f  sample buffer-soluble vimentin protein present in normal 
(n=9) and osteoarthntic (n=8) articular cartilage extracts, showing film with a longer 
exposure to that presented in Figure 3.19c. Following longer exposure, a doublet 
(arrowheads) around 40 45kD could be detected in most samples below die expected 
band at 58kD (arrows). Equivalent amounts o f protein (50pg) were loaded, and protein 
extracted from human immortalised chondrocytes (TC28a2 cell line) was loaded as a 
positive control (3pg, +ve).
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appeared to be a decrease in vimentin levels in OA (Fig 3.19c and Fig 3.20), this 
difference was not statistically significant (p=0.589). Following a longer period of 
exposure to film than that presented in Figure 3.19c, vimentin blots revealed a doublet 
around 40—45 kD beneath the expected vimentin protein band of 58 kD (Fig 3.20). This 
appeared in most of the cartilage extracts and, although these bands have not been 
characterised, they could represent vimentin degradation products as reported in protein 
extracts from isolated human normal and OA chondrocytes (Lambrecht et al., 2008). A 
similar banding pattern on vimentin Western blots was observed and the decreased 
molecular weight shown to be due to N-terminal vimentin cleavage (Lambrecht et al., 
2008).
3.2.6.2 Cytoskeletal Component Gene Expression
Gene expression of the cytoskeletal elements and other cytoskeletal associated proteins 
was determined using quantitative Taqman™ PCR or quantitative PCR with SYBR 
green (p-actin). RNA extracted directly from articular cartilage was used in PCR 
reactions with primers and probes designed against genes of interest (Table 2.6, P-actin 
in Table 2.5). GAPDH was used as an endogenous control and relative expression units 
calculated for each gene as described in section 2.4.2.2.I. In contrast to Western blotting 
results, p-tubulin mRNA expression was significantly increased in OA cartilage 
compared to normal (p=0.031, Fig 3.21). OA cartilage expressed significantly less 
vimentin when compared with normal cartilage (p=0.007, Fig 3.21). There was no 
difference in p-actin mRNA expression levels in normal and OA human cartilage 
(p=0.520). Differences in the mRNA expression of cytoskeletal associated proteins were 
also observed, with OA cartilage expressing significantly less paxillin mRNA (p=0.007) 
and significantly more thymosin-p4 mRNA (p=0.018) when compared with normal 
cartilage (Fig 3.21). There was no difference in mRNA expression levels of filamin A, 
cofilin, destrin and gelsolin between normal and osteoarthritic cartilage.
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destrin and n=5 for normal paxillin following removal o f  2 outliers). *p<0.05, **p<0.01.
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3.3 DISCUSSION
Osteoarthritis (OA) is a disease which affects synovial joints and is characterised by 
degeneration of the articular cartilage. Characterisation of differences that exist between 
normal and osteoarthritic articular cartilage has led to a better understanding of the 
disease process, determining how and why degeneration of the tissue progresses and 
potential targets for therapeutic intervention (Aigner et al., 2006b). However, very little 
is known about the underlying cellular/molecular mechanisms that propagate such a 
pathological condition.
3.3.1 Histology of Human Articular Cartilage Samples
Both macroscopic and microscopic differences are apparent between normal articular 
cartilage and that removed from OA joints. Normal, healthy articular cartilage appears 
white and shiny with a smooth surface, whilst OA cartilage is yellow with a more 
‘velvety’ appearance, due to disruption of the articular surface. Examination of alcian 
blue stained sections by light microscopy demonstrated histological differences between 
normal and OA cartilage. Healthy normal cartilage had a predominantly intact surface 
accompanied by an apparently intact matrix interspersed with isolated chondrocytes, 
with no evidence of glycosaminoglycan (GAG) loss. An increased cell density was 
observed in OA cartilage along with the formation of chondrocyte clusters. Disruption 
and fibrillation of the articular surface was apparent, and a loss of GAG was observed 
throughout the tissue. As fibrillation of the articular surface is characteristic of OA, it is 
not surprising that the morphology of cartilage removed from a fibrillated region of a 
lateral tibial plateau from an apparently ‘clinically normal’ joint is comparable to that of 
OA cartilage. The morphology of adjacent non-fibrillated regions of the same lateral 
tibial plateau was most comparable to that of normal cartilage, although OA changes 
could be observed in the form of GAG loss in the superficial zone along with the 
presence of chondrocyte clusters. These changes would alter the mechanical properties 
of the cartilage and therefore affect its normal function. A decrease in cartilage 
compressive stiffness has been shown to correlate with severity of structural alterations 
of the tissue, such as fibrillation of the articular surface and disruption of the collagen 
network (Franz et al., 2001). Loss of GAG would reduce the compressive stiffness of the 
cartilage and also reduce its ability to reform following removal of compressive loads. 
Disruption and fibrillation of the articular surface, as observed in OA cartilage, would 
result in altered load and deformation experienced by chondrocytes in the transitional
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and radial zones, as collagen networks in the superficial zone would no longer run 
parallel to the articular surface. In all, the morphological changes observed in OA 
cartilage will alter the loads experienced by the cartilage chondrocytes and also alter the 
tissue’s response to load.
The differences that are shown to exist between fibrillated and non-fibrillated regions of 
the same cartilage highlight the potential importance of sampling. Different regions of 
the lateral and medial tibial plateau experience different load magnitudes during joint 
articulation, as regions covered by the menisci are exposed to lower forces (Thambyah et 
al., 2006). Increased load can lead to the development of OA, as shown by in vivo 
models of the disease where induction of OA results from altered and increased loading 
of joint cartilage (Pond and Nuki, 1973). The severity of the lesions, cartilage damage 
and biochemical changes that occurred were most severe in regions experiencing higher 
loads due to lack of protection by the menisci (McDevitt et al., 1977). Important to this 
study is that the location of the fibrillations were indistinguishable from those observed 
in naturally occurring OA. Therefore, the regions of both a normal and OA joint from 
which tissue is removed may need to be taken into account, as different regions will 
have experienced different load magnitudes. Load has been shown to have different 
effects on chondrocyte phenotype and matrix turnover in vivo (Bayliss et al., 2001, 
Palmoski et al., 1980, Pelletier et al., 1983a). However, in the Pond-Nuki dog model of 
OA, the metabolism of articular cartilage chondrocytes as a whole appears to be 
affected, rather than localised effects in the regions of fibrillation (McDevitt and Muir, 
1976). This implies that knowledge of the exact topographical location sampled from 
within the joint may not be required as this would not affect the significance of any 
changes detected in the biochemical composition of cartilage, with ‘true’ OA 
biochemical and phenotypic changes represented throughout the tissue. Due to the 
importance of the sampling site and the different load magnitudes across a joint, biopsies 
from the same region of the tibial plateau were used for the comparison of the 
cytoskeletal organisation of normal and osteoarthritic chondrocytes in situ.
It should be noted that the tissue morphology of ‘normal’ post-mortem samples varied. 
This has been observed previously in normal human articular cartilage. When assessed 
histologically and scored according to the Mankin scale, grossly normal femoral head 
cartilage ranged from grade one to five (Mankin et al., 1971). Using the same scale,
- 135-
Chapter 3: Characterisation of Normal and Osteoarthritic Cartilage
another study demonstrated grossly normal femoral condyles ranging from grade zero to 
three (Rizkalla et al., 1992). Mankin grades also varied within donor specimens 
demonstrating the heterogeneity of osteoarthritis (Mankin et al., 1971, Rizkalla et al., 
1992). The comparison of fibrillated and non-fibrillated regions of the same joint in this 
study also demonstrates this. The range of morphologies of the normal samples could 
therefore be due to the random selection of a piece of cartilage that was originally 
located in a weight-bearing region of the joint, or it could be that the donors had early- 
stage OA. The advancing age of post-mortem donors increases the likeliness of early- 
OA characteristics appearing, even though donors had never presented to a GP with knee 
pain; this is possible as there is no correlation between radiographic disease severity 
scores and clinical pain and function scores (Link et al., 2003). The possibility that some 
‘normal’ samples may in fact be in the early stages of OA could mask the significance of 
some biochemical and cytoskeletal element differences observed.
3.3.2 Composition of Normal and Osteoarthritic Human Articular 
Cartilage
3.3.2.1 Biochemical Composition of Normal and Osteoarthritic Articular Cartilage
Analysis of the biochemical composition of normal and OA articular cartilage showed 
there to be an increased water and collagen content in OA tissue when compared to 
normal, accompanied by a decrease in the sGAG content. Increased water content in 
articular cartilage is a characteristic of OA (Martin et al., 2001), and is caused by tissue 
swelling as a result of disruption of the collagen matrix (Maroudas, 1976). The normal 
function of collagen is to provide tensile strength and stiffness to the articular cartilage. 
Where secondary OA arises from joint trauma or impact loading, it is likely that load can 
directly damage the collagen network, as indicated by the abrupt decrease in the tensile 
load-bearing capacity of the collagen network following injurious compression (Quinn et 
al., 1998). The disruption of the collagen network observed in osteoarthritis and models 
of the disease (Pelletier et al., 1983a, Pelletier et al., 1983b, Dodge and Poole, 1989) 
reduces the ability of the collagen matrix to resist the swelling pressure caused by the 
polyanionic proteoglycans, resulting in increased water content (Maroudas, 1976). In 
normal cartilage this swelling pressure provides the tissue with a compressive stiffness 
and an ability to reversibly deform in response to compressive loads. The loss of tensile 
strength caused by disruption of the collagen matrix reduces the compressive stiffness
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and therefore the ability of the tissue to recover following deformation. In addition, it 
reduces the ability of the tissue to resist mechanical compression during joint loading, 
and ultimately this causes mechanical failure of the cartilage by altering the 
responsiveness of the tissue to load.
The loss of GAG, indicated by the loss of alcian blue staining in the OA cartilage, was 
confirmed biochemically by the dimethylmethylene blue (DMMB) assay. The 
significant loss of GAG content per dry weight of OA cartilage is also characteristic of 
the pathology and contributes to the mechanical failure of articular cartilage in OA, 
along with the disruption of the collagen matrix. My results showed no difference in the 
expression of aggrecan mRNA in normal and OA cartilage, implying that reduced 
synthesis is not responsible for the loss of proteoglycan in OA. By contrast, a recent 
study has shown that aggrecan gene expression is reduced in OA cartilage (Brew et al., 
2010a). The progressive release of GAG observed in all forms of OA is due to 
proteoglycan catabolism by matrix metalloproteinases (MMPs) and the ‘aggrecanases’, 
ADAMTS-4 and -5 (Caterson et al., 2000). Here, comparison of ADAMTS5 expression 
in normal and OA cartilage revealed a significant decrease in mRNA levels in OA 
cartilage compared to normal, as previously demonstrated in human articular cartilage 
(Kevorkian et al., 2004). These data are in contrast to other studies showing increased 
expression of ADAMTS5 mRNA in human OA cartilage (Bau et al., 2002) and a rat 
model of OA (Appleton et al., 2007b). Of note though is that mRNA expression levels 
do not necessarily correlate with protein levels or enzyme activity. However, an 
immuno-histochemical study of the distribution of the aggrecanase cleavage (NITEGE) 
neoepitope in human cartilage showed a loss of immunoreactivity in OA cartilage, 
possibly indicating a decrease in aggrecanase (ADAMTS-4 and -5) activity in OA 
(Bayliss et al., 2001).
The significant increase in collagen content per dry weight tissue of OA cartilage 
compared to normal is in contrast to previous evidence of decreased levels of type II 
collagen protein in OA cartilage (Martin et al., 2001). As type II collagen content is 
highest in the deep zone of cartilage (Langelier et al., 2000), and OA cartilage often 
shows a loss in the superficial zone, this observed increase could be due to the increased 
proportion of deep zone in OA samples compared to normal. In addition, type II pro­
collagen synthesis is reported to increase in OA cartilage, particularly in the mid and
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deep zones (Nelson et al., 1998). The collagen content was determined using a 
hydroxyproline assay, which does not distinguish between intact collagen networks and 
degraded collagen fibrils, nor would it distinguish between cross-linked collagen fibrils 
and newly synthesised collagen fibrils, or specific collagen types. Therefore it is also 
possible that the increased collagen content of OA samples is due to a repair response of 
chondrocytes (Poole et al., 1993), synthesising type II pro-collagen (Nelson et al., 1998) 
in an attempt to replace damaged networks in the extracellular matrix (ECM). However, 
it could also simply represent an increased content of collagen that is partially degraded 
and no longer functional. The highly significant increase in COL2A1 expression in OA 
cartilage found here and previously reported in human articular cartilage (Aigner et al., 
2003, Martin et al., 2001) supports the former mechanism.
Matrix metalloproteinases (MMPs) are responsible for the progressive degradation of 
collagen matrices, and a minor proportion of the aggrecan degradation observed in all 
forms of OA. The balance between the levels o f MMPs and their natural inhibitors, the 
tissue inhibitors of metalloproteinases (TIMPs) is therefore important in articular 
cartilage, as a shift towards catabolism will ultimately reduce the mechanical integrity of 
the tissue. This occurs in and is characteristic of OA. In the Pond-Nuki dog model of OA 
an increase in collagenolytic activity was observed 2-8 weeks following induction of OA 
(Pelletier et al., 1983a). This collagenolytic activity was also observed in human OA 
(Pelletier et al., 1983b). Increased levels of a number of the MMPs have been reported in 
OA cartilage, such as MMP-2, -8, -9,-13 and -14 (membrane-type I MMP) (reviewed in 
Aigner et al, (2006)). In the present study there was no difference in the levels of latent 
or active forms of the gelatinase, MMP-2, present in protein extracts of normal and OA 
cartilage, although this is likely due to its constitutive expression. MMP-9 activity was 
not detected (even with increased protein loading) by gelatin substrate zymography. 
Comparison of gene expression in normal and OA articular cartilage showed a 
significant increase in MMP 13 expression in OA, supporting previous work 
demonstrating that the collagenase MMP-13 is elevated in OA cartilage (Billinghurst et 
al., 1997, Dean et al., 1989, Bau et al., 2002, Brew et al., 2010a, Kevorkian et al., 2004). 
As no difference in the levels of TIMPs-1, -2 or -3 was observed between normal and 
OA cartilage, any increase in MMP levels observed in OA relative to normal would 
indicate a characteristic shift towards a catabolic phenotype, as induced by load in vitro 
(Blain et al., 2001) and as occurs in OA (Dean et al., 1989).
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3.3.2.2 Gene Expression in Normal and Osteoarthritic Articular Cartilage
In addition to the significant differences in ADAMTS5, MMP 13 and COL2A1 expression 
between normal and osteoarthritic cartilage discussed above, significant differences in 
the expression of the transcription factor SOX9 and the angiogen vascular endothelial 
growth factor (VEGF) were also found. OA cartilage was found to express significantly 
less SOX9 mRNA compared to normal, in agreement with previous reports 
demonstrating a significant loss of SOX9 mRNA in late stage OA human cartilage 
(Aigner et al., 2003, Aigner et al., 2006a, Brew et al., 2010a). As SOX9 is known to be 
required for chondrogenesis and is used commonly as a marker of chondrocyte 
phenotype, the loss of SOX9 expression in OA supports the loss of the differentiated 
phenotype reported to occur in OA. The decrease in SOX9 mRNA and concomitant 
increase in COL2A1 mRNA expression supports previous evidence that there is no 
correlation in the expression of the two genes in adult human cartilage, suggesting that 
SOX9 is not the key regulator of COL2A1 expression in adult human cartilage (Aigner et 
al., 2003, Yagi et al., 2005). VEGF expression was significantly lower in OA cartilage 
when compared with normal, as demonstrated in a recent study (Brew et al., 2010a). 
These data however are in contrast to previous studies implying an increased VEGF 
expression in OA, either through an increase in the number of VEGF immunopositive 
chondrocytes in OA cartilage (Pfander et al., 2001) or a significant increase in VEGF 
protein extracted from OA cartilage (Enomoto et al., 2003). A positive correlation 
between VEGF immunoreactivity and OA severity has also been reported (Enomoto et 
al., 2003). In addition, OA cartilage loses the resistance to vascular invasion exhibited 
by normal cartilage, with exogenous VEGF enhancing vascular invasion in the same 
model (Smith et al., 2003), providing indirect evidence for increased VEGF in OA 
cartilage. Finally, synovial fluid from OA patients reportedly contains significantly 
higher levels of VEGF protein than that from normal patients (Fay et al., 2006).
3.3.3 Differences in the Profile of Cytoskeletal Elements
Analysis of the three main cytoskeletal proteins in articular cartilage chondrocytes by 
Western blotting revealed a large degree of variation between samples. An increase in 
actin protein expression in two of the six OA samples was apparent, but due to high 
variability in human samples this increase was not significant compared to normal. This 
is in contrast to a reported decrease in P-actin protein levels in OA chondrocytes,
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although in this study primary chondrocytes were isolated from cartilage and cultured in 
monolayer (Ruiz-Romero et al., 2008). There was no difference in p-actin mRNA levels 
between normal and OA cartilage. An increase in actin levels has been observed in the 
superficial zone of mature bovine articular cartilage (Langelier et al., 2000). In this 
study, Western blotting analysis showed increased levels in the superficial zone 
compared to the transitional and radial zones and, as this difference was not observed in 
the levels of F-actin detected by phalloidin, the authors proposed that this represented a 
higher content of soluble G-actin in the superficial zone, corresponding to an increased 
requirement for actin microfilament remodelling (Langelier et al., 2000). In agreement 
with findings using mature bovine articular cartilage, no increase in phalloidin staining 
was observed in the superficial zone of normal human articular cartilage in the present 
study. However, chondrocyte clusters surrounding surface fibrillations of OA cartilage 
sections showed brighter phalloidin staining. It is possible that the altered mechanical 
properties of OA cartilage (due to the biochemical changes discussed above) results in a 
greater requirement for remodelling of the chondrocyte actin cytoskeleton as they 
experience greater loads due to disruption of the articular surface and collagen matrix. 
The increase in actin observed in OA cartilage may also relate to the increased stiffness 
of OA chondrocytes (Trickey et al., 2000), as microfilaments have been shown, along 
with vimentin intermediate filaments, to determine the mechanical properties of 
chondrocytes (Trickey et al., 2004). To further clarify possible changes in the 
requirements for actin remodelling, differences in the gene expression of the actin 
binding proteins thymosin p4, paxillin, filamin, cofilin and gelsolin were determined.
Expression of thymosin p4, a 5 kD actin sequestering protein, has been shown to be 
mechanically regulated in bovine articular cartilage in vitro (Blain et al., 2003). The 
results presented here showed that, in human articular cartilage, thymosin p4 mRNA is 
expressed at significantly higher levels in OA cartilage compared to normal. This 
increase in expression may be due to the increased load experienced by OA cartilage 
chondrocytes as a result of the altered mechanical properties of the tissue. As thymosin 
P4 binds G-actin and therefore assists in the regulation of actin filament dynamics, the 
increased levels of expression observed support the hypothesis that increased actin 
remodelling is required in OA cartilage in response to the altered mechanical 
environment of chondrocytes. In addition, cofilin and destrin, both actin depolymerising 
proteins, have been shown to be mechanically regulated in chondrocytes in culture
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(Campbell et al., 2007). No difference in cofilin or gelsolin mRNA expression was 
observed between normal and OA cartilage in the present study, in contrast to reported 
increases in protein levels in OA chondrocytes (Ruiz-Romero et al., 2008, Lambrecht et 
al., 2008). OA cartilage expressed significantly less paxillin mRNA than normal 
cartilage. As paxillin is an actin-associated protein located in focal adhesions, it is 
present in the physical link between the actin cytoskeleton and the extracellular matrix. 
The role of integrin-containing focal adhesions and the actin cytoskeleton in 
mechanotransduction is emerging, with paxillin phosphorylation a downstream response 
to mechanical stimulation of a5pl integrins in human articular chondrocytes (Salter et 
al., 2001). Therefore the decrease in paxillin expression found here may indicate a 
decrease in, or a disruption of, one of the mechanical signalling pathways in OA 
cartilage chondrocytes. Vinculin, another actin-associated protein in focal adhesions, has 
been reported to be increased in OA chondrocytes (Ruiz-Romero et al., 2008).
Whilst there was no difference in the levels of p-tubulin protein between normal and OA 
cartilage, as detected by Western Blotting, quantitative PCR demonstrated that OA 
cartilage expressed significantly more P-tubulin mRNA. In support of this, tubulin 
staining intensity was decreased in the superficial zone of normal cartilage and increased 
in the chondrocytes surrounding the surface fibrillations in OA cartilage. These 
differences between normal and OA cartilage were not observed throughout the depth of 
the tissue and therefore this could mask differences observed by Western blotting. The 
lack of correlation of protein with gene expression and immunohistochemical data could 
be due to difficulties in extraction of intracellular proteins from human articular 
cartilage. Alternatively, as P-tubulin mRNA levels are auto-regulated, with decreases in 
the pool of p-tubulin monomers below a critical level releasing p-tubulin mRNA from 
degradation mechanisms (Cleveland and Havercroft, 1983, Cleveland et al., 1983, Yen 
et al., 1988), the increase in p-tubulin mRNA levels in human OA cartilage when 
compared with normal tissue could indicate that the ratio of monomeric to polymerised 
p-tubulin is decreased in OA cartilage chondrocytes, with total levels of P-tubulin 
unchanged.
Western blots showed no difference in vimentin levels present in OA cartilage compared 
to normal, although it should be noted that this only represents the sample buffer-soluble 
portion of vimentin. A study of cytoskeletal protein expression in mature bovine
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cartilage revealed a gradient of RIPA-insoluble vimentin that decreased with depth, 
which was extracted from insoluble pellets with guanidine-HCl (Langelier et al., 2000). 
Sample buffer-soluble vimentin blots revealed a doublet around 40-45 kD beneath the 
expected vimentin protein band of 58 kD. This appeared in most of the cartilage extracts 
and, although these bands have not been characterised, they could represent vimentin 
degradation products. Of interest is a change in the banding pattern of vimentin on 
Western blots that has also been reported in a rat model of OA and in human OA 
cartilage, with several bands appearing between 55-38 kD, along with the expected 58 
kD band for vimentin (Capin-Gutierrez et al., 2004). A recent comparison of vimentin in 
isolated human normal and OA chondrocytes demonstrated a similar banding pattern on 
Western blots (Lambrecht et al., 2008). They showed a series of bands migrating below 
that of the native 58 kD vimentin, with an increased abundance of a lower molecular 
weight form of vimentin (43 kD) in chondrocytes isolated from OA cartilage. The 
decreased molecular weight was shown to be due to N-terminal vimentin cleavage 
(Lambrecht et al., 2008). A single band for native vimentin was present in one normal 
sample but the other normal samples contained some lower molecular weight bands in 
addition to the native band (Lambrecht et al., 2008), as did the normal samples in the 
present study. This implies that N-terminal vimentin cleavage is a normal turnover event 
in adult human articular cartilage that becomes more pronounced with OA progression. 
The increased N-terminal vimentin cleavage in OA could reduce the association of 
vimentin with the plasma membrane (Georgatos et al., 1985) and alter vimentin 
intermediate filament organisation (Beuttenmuller et al., 1994), the mechanical 
properties of the chondrocyte (Trickey et al., 2004, Ofek et al., 2009) and chondrocyte 
mechanotransduction.
The organisation of actin microfilaments, tubulin microtubules and vimentin 
intermediate filaments in human chondrocytes in vitro have been characterised (Trickey 
et al., 2004), as has the cytoskeletal organisation of osteoarthritic human chondrocytes in 
situ (Kouri et al., 1998). Comparisons have not previously been made between the 
cytoskeletal organisation of normal and osteoarthritic human chondrocytes in situ. Of 
particular relevance to the aims of this project are that differences in the localisation and 
fluorescent labelling of the cytoskeleton have been shown to exist between normal and 
OA human chondrocytes in alginate gels in vitro (Lambrecht et al., 2008, Fioravanti et 
al., 2003) and between normal and OA chondrocytes in situ in a rat OA model (Capin-
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Gutierrez et al., 2004). In the present study, visualisation of in situ chondrocyte 
cytoskeletal organisation by immunofluorescence and scanning confocal microscopy 
showed clear differences between normal and osteoarthritic human cartilage 
chondrocytes. In chondrocytes from normal cartilage, staining of actin microfilaments 
appeared punctate, as previously described in mature bovine articular cartilage 
(Langelier et al., 2000), although staining was throughout the cytoplasm rather than 
localised cortically as previously reported. Microtubule bundles formed a fine 
filamentous network that extended throughout the cytoplasm, as did vimentin 
intermediate filament bundles. Chondrocytes in OA cartilage showed an altered 
cytoskeleton to that observed in normal chondrocytes; scoring of confocal images 
revealed significant differences in actin and vimentin organisation in deep zone 
chondrocytes and tubulin organisation in superficial and mid zone chondrocytes. Actin 
staining remained punctate but was localised to the cell periphery rather than distributed 
throughout the cytoplasm. A microtubule network was less evident, whilst vimentin 
filament bundles appeared more diffuse and loosely packed than those in normal 
chondrocytes. This ‘looser’ organisation of vimentin intermediate filaments has also 
been observed in chondrocytes isolated from human OA cartilage cultured in alginate 
and may be due to the increased N-terminal vimentin cleavage that the same group 
demonstrated in OA tissue (Lambrecht et al., 2008). The N-terminal of vimentin is 
involved in intermediate filament formation (Beuttenmuller et al., 1994) and the 
interaction of filaments with the plasma membrane (Georgatos et al., 1985). Therefore 
the increased cleavage of this domain is likely to result in a disordered vimentin 
intermediate filament organisation.
Zonal variations in vimentin have been observed in mature bovine articular cartilage 
(Langelier et al., 2000), as have changes in vimentin organisation and labelling in 
response to load (Durrant et al., 1999, Langelier et al., 2000). The observed decrease in 
vimentin mRNA expression levels in OA cartilage are not reflected in the 
immunostaining patterns, as vimentin labelling was less intense in the superficial and 
upper-mid zones of normal cartilage. The vimentin immunostaining results are also in 
contrast to the increased vimentin signal intensity reported in the superficial zones of 
mature bovine cartilage (Langelier et al., 2000). Langelier et al. showed increased 
vimentin labelling throughout the depth of the tissue from regions experiencing high 
loads. As the human cartilage tissues used in the present study were from highly loaded
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regions of tibial plateaus, vimentin labelling throughout the depth is as expected. The 
differences observed in vimentin expression levels may represent a response to the 
altered mechanical loads experienced by chondrocytes in these regions as a result of 
extracellular matrix disruption and loss from the tissue. As vimentin has been shown to 
influence the mechanical properties of the chondrocyte itself (Trickey et al., 2004), the 
difference in intensity of vimentin staining in some regions could represent a change in 
the mechanical properties of the chondrocyte. This could potentially result in an altered 
response to mechanical stimuli and therefore altered synthesis and maintenance of the 
surrounding matrix. This is supported by a recent study in vitro, showing that disruption 
of vimentin results in a significant decrease in type II collagen, and would therefore 
contribute to the observed OA phenotype (Blain et al., 2006). Finally, another possible 
explanation for the loss of staining of cytoskeletal proteins in localised regions of the 
cartilage zones is the existence of different chondrocyte cell types. Kouri et al. 
demonstrated that chondrocytes which they characterised as ‘clonal’ or ‘secretory’ 
displayed different labelling intensities for the three main cytoskeletal elements (Kouri 
et al., 1998) and different intermediate filament organisation (Kouri et al., 1996) when 
compared with other chondrocytes in human OA cartilage.
The ability of load to alter cytoskeletal element organisation (Durrant et al., 1999, 
Fioravanti et al., 2005, Knight et al., 2006) indicates that the original location of the 
cartilage specimens in the joint is likely to be important, as the differences in loads 
experienced by distinct regions of the joint could result in an altered cytoskeletal 
architecture. This is implied by the alterations in the organisation and distribution of 
cytoskeletal element labelling observed in the present study, where a comparison of 
cartilage from different regions of the same joint was performed. Furthermore, observed 
differences in the distribution of tubulin and vimentin labelling through the depth of 
mature bovine articular cartilage, existing between peripheral and central load-bearing 
regions of the same joint surface would support this conclusion (Langelier et al., 2000). 
For this reason, cartilage sampled from the same region in knee joints was used for the 
comparison of cytoskeletal organisation. Cartilage was sampled from the highly loaded 
region of the tibial plateau, unprotected by the meniscus, of normal and OA donors. 
Therefore the differences in cytoskeletal organisation observed here between normal and 
OA chondrocytes in situ are not due to loading differences over the joint, but are due to 
pathology or different loading histories of patients. Whether the differences are a result
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of the altered mechanical environment and matrix composition of OA or the cause of it 
remains to be determined.
As discussed above, the appearance of early-OA histological changes were observed in 
some of the specimens classed as ‘normal’. In addition, it has been observed in the 
Pond-Nuki dog model of OA that changes occur in chondrocyte morphology before any 
obvious disruption of the articular surface or changes in the cartilage ECM (McDevitt et 
al., 1977, McDevitt and Muir, 1976). It could therefore be argued that some apparently 
normal specimens could contain numerous chondrocytes undergoing changes that will 
ultimately lead to the development of OA. If cytoskeletal dysregulation or reorganisation 
is an early change in OA, or if indeed it is causal, as we hypothesise, is it possible to be 
confident that the ‘normal’ cytoskeletal organisation observed is truly normal? This is 
compounded by a recent comparison of vimentin protein expression and organisation in 
human OA chondrocytes (Lambrecht et al., 2008). The greatest difference in vimentin 
organisation was between chondrocytes isolated from normal cartilage and those isolated 
from OA cartilage regions with no signs of fibrillation, whilst the greatest difference in 
abundance of native and N-terminally cleaved vimentin protein was between normal 
chondrocytes and chondrocytes isolated from visually fibrillated regions of OA 
cartilage. There was little difference in vimentin content between normal chondrocytes 
and OA chondrocytes from visually intact regions (Lambrecht et al., 2008). Whilst this 
raises the problem of the disease state and cytoskeletal organisation of ‘normal’ samples, 
it does support our hypothesis that changes to the organisation of the cytoskeleton 
appear to be an early event in OA, whether causal or not remains to be proven.
3.3.3.1 The Effects of Fixation Protocol on Cytoskeletal Organisation
The fixative, permeabilising agent, and buffer used during fixation of chondrocytes has 
an effect on the preservation of cytoskeletal architecture, and therefore the structural 
organisation, shown in situ in the present study, and shown previously in vitro (Blanc et 
al., 2005). In addition, a decreased stability of microtubules has been noted in sections 
stored above -20°C and below room temperature, even following fixation; many reports 
characterise cytoskeletal organisation following incubation and/or storage of samples at 
4°C. These differences in protocol may explain the variations in the reported cytoskeletal 
organisation of chondrocytes (Benjamin et al., 1994, Capin-Gutierrez et al., 2004, 
Durrant et al., 1999, Fioravanti et al., 2003, Langelier et al., 2000, Trickey et al., 2004,
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Lambrecht et al., 2008). In cases where the cytoskeleton appeared close to the nucleus, it 
is not certain whether or not this is representative of an in vivo collapse of the 
cytoskeleton, the cytoskeleton extending throughout the cytoplasm which is largely 
occupied by the nucleus, or a manifestation of the fixation protocol. Blanc et al. (2005) 
reported that the use of paraformaldehyde in conjunction with Triton® X-100 resulted in 
shrinkage and distortion of the cytoskeleton (when compared with live chondrocytes) 
and therefore glutaraldehyde was used in the present study.
In comparing human normal and OA articular cartilage, I have observed that:
• Despite the early OA histological changes observed in the ‘normal’ articular 
cartilage samples, biochemical comparisons showed the expected increase in 
water and collagen content and decreased sGAG content in OA cartilage. In 
addition, the expected decrease in SOX9 and increase in MMP13 mRNA 
expression was observed. This indicates that significant pathological differences 
exist between the ‘normal’ and OA cartilage samples used in the present study.
• Differences exist between the cytoskeleton of normal and OA cartilage 
chondrocytes. These differences were in network organisation and mRNA 
expression.
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4. THE EFFECT OF A THREE-DIMENSIONAL 
ENVIRONMENT ON CHONDROCYTE PHENOTYPE IN 
CULTURE
4.1 INTRODUCTION
Chondrocytes are the cellular component of articular cartilage and are responsible for the 
synthesis and degradation of the extracellular matrix which gives the articular cartilage 
its functional properties. Physiological and pathological processes in chondrocytes are 
often studied using cells isolated from the extracellular matrix of articular cartilage and 
cultured in vitro, which allows the easy manipulation of the chondrocytes and detection 
of the effects. Isolation of chondrocytes from articular cartilage has been shown to affect 
chondrocyte gene expression (Benz et al., 2002, Eleswarapu et al., 2007, Hayman et al., 
2006). The presence of the pericellular matrix also has an effect on the gene expression 
of isolated chondrocytes (Zhang et al., 2006b). In addition, the type and concentration of 
enzymes, and the incubation periods used in the digestion of the cartilage extracellular 
matrix to release the chondrocytes can have differing effects on subsequent gene 
expression in vitro (Hayman et al., 2006). The in vitro system used for the subsequent 
culture of chondrocytes also affects chondrocyte gene expression and phenotype.
4.1.1 Monolayer Culture of Chondrocytes
When cultured on plastic following their isolation from cartilage, chondrocytes adhere 
and proliferate. However, this proliferation is accompanied by a steady loss of the 
differentiated chondrocyte phenotype over the culture period; a phenomenon termed 
‘dedifferentiation’ (Benya et al., 1978). A decrease in the expression and synthesis of 
type II collagen, the predominant collagen of articular cartilage, is accompanied by an 
increase in types I and III collagen, collagens which are more typical of fibroblasts 
(Benya et al., 1977, Benya et al., 1978, Mayne et al., 1976). In addition to changes in the 
collagen phenotype, proteoglycan synthesis also changes in monolayer culture. 
Sulphated glycosaminoglycan synthesis decreases with cell-flattening and versican 
synthesis increases to replace aggrecan (Glowacki et al., 1983). This altered synthesis is 
reflected in gene expression changes within the monolayer subculture; expression of 
COL2A1, COL11A1 and aggrecan decrease whilst COL1A1 and COL3A1 expression 
increases (Stokes et al., 2001). In addition to changes in matrix production and gene
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expression, cell morphology alters with culture of chondrocytes in monolayer. 
Chondrocytes lose the round, spherical morphology observed in situ, becoming 
polygonal, then flattened, elongated and fibroblast-like (Stokes et al., 2001). 
Concomitant with the changes in cell shape is the appearance of actin stress fibres in 
dedifferentiating chondrocytes (Mallein-Gerin et al., 1991). This actin cytoskeletal 
organisation is again more typical of fibroblasts. However, the fibroblastic changes in 
cell shape do not necessarily correlate with the altered matrix production by 
dedifferentiating chondrocytes in monolayer culture (Mallein-Gerin et al., 1990, von der 
Mark et al., 1977). Despite this, it has been established that the rounded morphology of 
chondrocytes plays a crucial role in the maintenance of their differentiated phenotype 
(Benya and Shaffer, 1982a, Glowacki et al., 1983).
4.1.2 Three-Dimensional Culture of Chondrocytes
The requirement of a rounded morphology for maintenance of the chondrocyte 
phenotype led to development of culture systems that supported this spherical shape and 
prevented cell flattening. Often collectively referred to as a ‘suspension culture’, culture 
systems used include three-dimensional (3D) encapsulation of the chondrocytes in 
‘hydrogels’ such as agarose (Benya and Shaffer, 1982a) or alginate (Guo et al., 1989), 
3D pellet culture (Abbott and Holtzer, 1966), alteration of the adhesiveness of the 
substratum by coating with poly(2-hydroxyethyl methacrylate) (polyHEMA) (Glowacki 
et al., 1983) or culture on the surface of a hydrogel (Watt and Dudhia, 1988). In these 
systems, the chondrocyte phenotype is better maintained; cells have a rounded 
morphology and synthesise a matrix containing type II collagen and sulphated 
glycosaminoglycan (Benya and Shaffer, 1982a, Glowacki et al., 1983). Stress fibres do 
not appear and the actin cytoskeleton maintains a punctate and peripheral localisation 
(Knight et al., 2006). In these culture conditions the rate of DNA synthesis and 
proliferation in chondrocytes is reduced when compared with that in monolayer culture 
(Glowacki et al., 1983, Guo et al., 1989). Therefore, whilst these culture systems prevent 
the loss of the rounded morphology and chondrocyte phenotype, the very slow 
proliferation means that cell numbers cannot readily be increased for experimentation.
A number of studies have shown that dedifferentiated chondrocytes cultured in 
monolayer retain the ability to re-express the differentiated chondrocyte phenotype. 
Transfer of subcultured chondrocytes from monolayer to suspension culture results in
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up-regulation of type II collagen and glycosaminoglycan synthesis, a reduction in cell 
proliferation and rounding of the chondrocytes; so called ‘redifferentiation’ (Benya and 
Shaffer, 1982a). Therefore chondrocyte numbers can be expanded in monolayer culture 
before being transferred to 3D culture for redifferentiation, a model with particular 
implications for cartilage tissue engineering. The concept of autologous chondrocyte 
transplantation (ACT) for treatment of cartilage lesions thus followed, whereby 
chondrocytes are harvested from small undamaged cartilage regions in the patient, 
expanded ex vivo to obtain sufficient number, then implanted into cartilage lesions 
where they synthesise a matrix and repair the defect (Grande et al., 1989, Solursh, 1991, 
Peterson et al., 2000).
The extent to which redifferentiation occurs reduces with increasing number of 
subcultures and cell divisions (Zaucke et al., 2001). Oxygen tension, cell density and 
concentration of alginate can influence the redifferentiation of chondrocytes (Domm et 
al., 2002, Wang et al., 2008a) and application of cyclic hydrostatic pressure to 3D 
cultures enhances redifferentiation of chondrocytes (Heyland et al., 2006, Kawanishi et 
al., 2007). The addition of specific growth factors or serum to culture medium during 
chondrocyte expansion in monolayer influences the extent of redifferentiation when 
placed in 3D culture, and also the potential for dedifferentiation and proliferation in 
monolayer (Jakob et al., 2001, Hsieh-Bonassera et al., 2009). For example, the 
redifferentiation potential of chondrocytes in monolayer is stabilised and extended by 
treatment with IGF-I, which increases levels of the chondrocyte transcription factor 
SOX9 and its interaction with phosphorylated ERK1/2 in chondrocyte nuclei (Shakibaei 
et al., 2006). Transduction of growth factors such as TGFpi or IGF-I into chondrocytes 
has also been shown to increase cartilage matrix synthesis in monolayer and enhance 
redifferentiation (Shuler et al., 2000, Smith et al., 2000, Sung et al., 2009). The 
redifferentiation of chondrocytes is also enhanced by transduction with SOX9 which 
sensitises the cells to growth factors (Li et al., 2004, Tew et al., 2005). Chondrocytes 
from osteoarthritic cartilage also dedifferentiate in monolayer and these too retain the 
ability to re-express the chondrocyte phenotype when placed in 3D culture, although 
redifferentiation of OA cells occurs to a lesser extent than normal chondrocytes (Yang et 
al., 2006, Tallheden et al., 2005). Transduction of OA chondrocytes with SOX9 
enhances redifferentiation, indicating that a pathological background does not 
permanently compromise the chondrocyte phenotype (Tew et al., 2005). In support of
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this, SOX9 transduction of normal and OA chondrocytes in alginate or in native 
cartilage increases cartilage matrix synthesis; matrix produced by transduced OA 
chondrocytes reaches levels equal to or above that of non-transduced normal 
chondrocytes (Cucchiarini et al., 2007).
Considering the aim of tissue engineering, it is unsurprising that the large number of 
studies on chondrocyte redifferentiation focus on the quantity and quality of matrix 
produced by chondrocytes. Long time points are studied, often weeks in culture, to allow 
for completion of redifferentiation and accumulation of matrix. Few studies have 
assessed the early changes in phenotype that occur during chondrocyte redifferentiation. 
Benya and Schaffer showed a transient decrease in the rates of collagen, proteoglycan, 
protein and DNA synthesis when rabbit articular chondrocytes were transferred from 
monolayer to 3D-agarose culture; the rates of synthesis by fourth passage chondrocytes 
began to increase after 24-48 hours in agarose culture (Benya and Shaffer, 1982a). More 
recently, Haudenschild et al. used cDNA libraries generated by subtractive hybridisation 
to analyse differentially regulated genes in chondrocytes, isolated from normal human 
articular cartilage, either cultured as a monolayer or embedded in an alginate suspension 
(Haudenschild et al., 2001). Following 48 hours in alginate culture, genes involved in 
cell growth, extracellular matrix deposition and remodelling, cell adherence and 
apoptosis were differentially regulated. Expression of genes encoding matrix proteins 
decreased whilst expression of MMP1, MMP3, IL6 and heat shock protein 90 increased. 
To the best of my knowledge, there has been no comparison of the early gene expression 
changes between redifferentiating normal and OA chondrocytes.
Custom-designed Taqman arrays (AstraZeneca) were used to compare the gene 
expression profile of passage three chondrocytes isolated from normal or osteoarthritic 
articular cartilage, cultured either as a monolayer or after 72 hours in a 3D-agarose 
environment.
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4.2 RESULTS
4.2.1 Changes in Cytoskeletal Organisation
The cytoskeletal organisation of human normal and osteoarthritic chondrocytes cultured 
either as a monolayer or embedded within a 3D-agarose hydrogel was visualised using 
immunohistochemistry in conjunction with confocal microscopy. In monolayer, both 
normal and OA passage three chondrocytes were flat and spread, with processes 
extending out from the cell (Fig 4.1a-f). Phalloidin staining revealed the presence of 
stress fibres in monolayer cultured chondrocytes, although OA cells appeared to contain 
more when compared to normal cells (Fig 4.1 a and d). Microtubule bundle networks 
were clear and extended throughout the cytoplasm to the cell periphery (Fig 4.1 b and e). 
Normal and OA monolayer cultured chondrocytes also contained clear networks of 
vimentin intermediate filament bundles. In normal chondrocytes, intermediate filament 
networks appeared to be orientated predominantly in a single direction (Fig 4.1c); this 
was not seen in OA chondrocytes (Fig 4.If). After 72 hours in agarose culture, passage 
three normal and OA chondrocytes had regained a rounded morphology (Fig 4.1g-l). 
Both normal and OA cells were devoid of stress fibres (Fig 4.1 g and j). In normal 
chondrocytes, actin microfilament staining appeared punctate and was predominantly 
cortical, with some staining throughout the cell (Fig 4.1g). In OA chondrocytes, staining 
was localised entirely at the cell periphery, punctate spots appeared larger when 
compared with normal cells, and networks were evident at the periphery (Fig 4.1j). 
Microtubule bundle networks were less evident in agarose cultured chondrocytes; 
tubulin staining was perinuclear in normal chondrocytes (Fig 4.1h) and distributed at the 
cell periphery in OA chondrocytes (Fig 4.1k). Vimentin intermediate filament bundle 
networks were apparent in both normal and OA chondrocytes cultured in agarose, 
extending from the nucleus into a cortical network (Fig 4.1i,l).
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4.2.2 Comparison of Gene Expression in Normal and Osteoarthritic 
Chondrocytes
Analysis of chondrocyte gene expression using custom-designed Taqman arrays 
revealed differences between normal and OA chondrocytes in both monolayer and 3D 
agarose culture.
4.2.2.1 Gene Expression Differences in Monolayer Culture
Of the genes detected on the array, three of the four genes involved in angiogenesis 
(including VEGF) and four of the six apoptosis genes (including GADD45B and CASP3) 
were expressed at higher levels in OA chondrocytes compared to normal (Fig 4.2). All 
genes involved in hypertrophy were expressed more highly in OA chondrocytes, as were 
all genes involved in osteogenesis, p-actin expression was almost three-fold higher in 
OA chondrocytes compared to normal chondrocytes in monolayer. Expression of the 
anabolic growth factor TGF-pi (TGFB1) and FGF2 (basic FGF) was increased and 
expression of TGF binding protein (LTBP1) and IGF1 decreased in OA chondrocytes. 
Differences in matrix and degradation gene expression varied. MMP3 expression was 
four-fold lower and MMP13, TIMP1 and FN1 (fibronectin) expression was two-fold 
lower in OA chondrocytes. TIMP3 expression was four-fold higher in OA chondrocytes 
in monolayer compared to normal. COL2A1 expression was only detected in OA and not 
in normal monolayer chondrocytes; therefore no fold difference could be calculated. 
Expression of the common markers of ‘dedifferentiation’, including COL1A1 and 
COL3A1, was higher in OA chondrocytes than in normal chondrocytes. However, 
expression of SOX9, a chondrocyte phenotype marker, was also higher in OA 
chondrocytes. Expression of ‘S I’, used by AstraZeneca as a marker of non-pathological 
cartilage, was decreased in OA chondrocytes when compared with normal.
4.2.2.2 Gene Expression Differences in 3D agarose culture
As observed with cells cultured in monolayer, three of the four genes involved in 
angiogenesis were more highly expressed in OA chondrocytes, although, unlike the 
monolayer, VEGF expression was decreased in OA (Fig 4.3). Expression of ‘S I’ was 
decreased in OA chondrocytes when compared with normal. In contrast to the 
monolayer cells, COL2A1 expression was detected in normal chondrocytes cultured in 
3D agarose hydrogels. In OA chondrocytes, COL2A1 expression was increased and
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Figure 42,:- The Ibid difference in expression o f selected genes between chondrocytes isolated from normal and OA cartilage and cultured in monolayer 
(normalised to the housekeeping gene GAPDH). Differences were determined following quantitative PCR using a Taqman custom-designed array (AZ). 
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Figure 4 3 :- The fold difference in expression o f  selected genes between chondrocytes isolated from normal and OA cartilage in 3D agarose culture 
(normalised to the housekeeping gene GAPDH). Differences were determined follow ing quantitative PCR using a Taqman custom-designed array (AZ). 
G ene names are shown, except where confidentiality is required by AZ, in which case a code o f  one letter and number have been used. Letters (and 
colours) indicate a process/category which the gene product is involved/belongs; A- adhesion, C- angiogen, D- apoptosis, E - carbohydrate, F- 
dcgradation, H- growth factor, I- hypertrophy, J- hypoxia/pH, K- inflammation, L- matrix, M- metabolism, N - neurogen, P- osteogen, Q- proliferation, 
R-transporter, S-housekeeper. n=2
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SOX9 expression decreased compared to normal. Expression of COL1A1 and COL3A1 
was also higher in OA chondrocytes. As with the cells cultured in monolayer, all genes 
involved in hypertrophy and osteogenesis were expressed more highly in OA 
chondrocytes. In contrast to the differences observed in monolayer, expression of FGF2 
(basic FGF) was decreased and expression of IGF1 increased in OA chondrocytes 
cultured in 3D agarose hydrogels. Differences in matrix and degradation gene expression 
varied. MMP3, TIMP3 and FN1 (fibronectin) expression was over two-fold lower in OA 
chondrocytes. COL11A1 and MMP1 expression was higher in OA chondrocytes 
embedded in 3D agarose hydrogels when compared with normal chondrocytes. In 
contrast to the increase observed in OA monolayer chondrocytes (Fig 4.2), ADAMTS5 
expression was decreased in 3D-cultured OA chondrocytes compared to normal (Fig 
4.3). A large difference in the gene expression of the pro-inflammatory mediators 
NOS2A, PTGS2 (encoding COX-2), IL6 and IL8 was observed in 3D-cultured OA 
chondrocytes. It should be noted that expression of these genes in one normal sample 
(n=2) was much higher than in the other samples and may therefore be skewing the 
results.
4.2.3 Early Gene Expression Changes with Redifferentiation
Analysis of chondrocyte gene expression using custom-designed Taqman® arrays 
revealed gene expression changes in monolayer-expanded normal and osteoarthritic 
chondrocytes following 72 hours culture in a 3D environment.
4.2.3.1 Gene Expression Changes in Normal Chondrocytes
Of the genes detected on the array, four of the five genes involved in adhesion were 
down-regulated in 3D culture (Fig 4.4). Four of the six apoptosis genes (including 
GADD45B and HSPBI, encoding hsp27) were also down-regulated in 3D culture. Of the 
genes encoding growth factors, five were down-regulated in 3D culture whereas TGF-pl 
(TGFB1) and TGF binding protein (LTBPJ) were up-regulated. All genes involved in 
hypertrophy were down-regulated in 3D culture, as were three of the four detected genes 
involved in osteogenesis. The genes encoding matrix molecules were down-regulated in 
3D culture. COL2A1 expression was only detected in 3D-cultured normal chondrocytes 
but not in monolayer-cultured normal chondrocytes, therefore no fold change could be 
calculated. However, SOX9 expression increased and COL1A1 and COL3A1 expression 
decreased in 3D culture, indicating the expected shift back towards the chondrocyte
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Figure 4.4:- The fold change in expression of selected genes between chondrocytes isolated from normal cartilage and cultured in monolayer or a 3D 
agarose hydrogel (normalised to flic housekeeping gene GAPDH). Differences were determined following quantitative PCR using a Taqrnan custom- 
designed array (AZ). Gene names are shown, except where confidentiality is required by AZ, in which case a code o f one letter and number have been 
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phenotype. Changes in the expression of degradation genes varied. MMP1 and MMP14 
expression was increased in 3D culture, whereas ADAMTS5 expression decreased by 
over 55-fold. Expression of P-actin mRNA increased 5.6-fold in 3D culture.
4.2.3.2 Gene Expression Changes in Osteoarthritic Chondrocytes
As observed in normal chondrocytes (Fig 4.4), four of the five genes involved in 
adhesion and four of the six apoptosis genes were down-regulated in OA chondrocytes 
in 3D culture (Fig 4.5). Four of the seven growth factor genes were up-regulated in 3D 
culture including TGFB1 and IGF1. All of the genes involved in hypertrophy were 
down-regulated in OA chondrocytes in 3D culture, as were three of the five detected 
genes involved in osteogenesis. As for normal chondrocytes, all genes encoding matrix 
molecules were down-regulated in 3D culture, including a large decrease in COL2A1 
expression (371 fold decrease in 3D). The expected decrease in COL1A1 and COL3A1 
expression was observed in OA chondrocytes, but, unlike in normal chondrocytes, SOX9 
expression was also decreased in 3D culture. Changes in the expression of degradation 
genes varied, but ADAMTS5 mRNA expression was again decreased by over 55-fold. 
Again, as observed in normal chondrocytes, P-actin mRNA expression increased in the 
3D culture of OA chondrocytes (1.6 fold increase).
4.2.3.3 Comparison of the Changes in Normal and Osteoarthritic Chondrocytes
Changes in the expression of many of the genes on the array were similar in the early 
redifferentiation of both normal and osteoarthritic chondrocytes (Table 4.1). Genes 
expressing matrix molecules were down-regulated after 72 hours redifferentiation, 
although the magnitude of ACAN and COL15A1 down-regulation was greater in OA 
chondrocytes (Fig 4.6A); ACAN and COL15A1 expression was decreased 5.4- and 3.7- 
fold in 3D normal chondrocytes and 37- and 23-fold in 3D OA chondrocytes. Expression 
of all of the genes on the array involved in hypertrophy was decreased in 
^differentiating normal and OA chondrocytes (Fig 4.6B). Changes in the expression of 
genes involved in osteogenesis remained the same in both normal and OA chondrocytes 
(Fig 4.6C). The largest fold change induced by redifferentiation in both normal and OA 
chondrocytes was seen in the decreased expression of ‘P3\ The expected decrease in the 
expression of the typical ‘ dedifferentiation’ markers COL1A1 and COL3A1 was 
observed, irrespective of pathology (Fig 4.7A). Transcription of MMP14 increased and 
ADAMTS5 decreased in redifferentiating normal and OA chondrocytes (Fig 4.7B). An
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Figure 4.5:- The fold change in expression of selected genes between chondrocytes isolated from OA cartilage cultured in monolayer or a 3D agarose 
hydrogel (normalised to the housekeeping gene GAPDII). Differences were determined following quantitative PCR using a Taqman custom-designed 
array (AZ). Gene names are shown, except where confidentiality is required by AZ, in which case a code of one letter and number have been used. 
Letters (and colours) indicate a process/category which the gene product is involved/belongs; A- adhesion, C- angiogen, D- apoptosis, B- carbohydrate, 
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Figure 4.6:- Fold changes in gene expression of normal (green) and osteoarthritic (red) 
chondrocytes cultured in a 3D agarose hydrogel compared to monolayer culture (n=l). A- 
Genes encoding extracellular matrix proteins. B- Genes linked with chondrocyte hypertrophy. 
TGM2 encodes transglutaminases2 and PTCH encodes patched. C- Genes involved in 
osteogenesis. SPP1 encodes osteopontm.
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A  - Differentiation
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COL1A1 COL3A1 SOX9
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Figure 4.7:- Gene expression in normal and osteoarthritic (OA) chondrocytes cultured in a 
monolayer or a 3D agarose hydrogel (n=l). A- Typical markers o f chondrocyte phenotype 
(SOX9) and dedifferentiation (COLIA1 and COL3A1). B- Genes encoding matrix degrading 
enzymes MMP-2, MMP-13, MMP-14, and ADAMTS-5. Normal samples are in green, OA in 
red. Filled columns are samples cultured in a monolayer and hatched columns are those 
cultured in a 3D agarose hydrogeL
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increase in TGFB1 mRNA levels and decrease in FGF2 mRNA expression were also 
observed in early redifferentiation (Fig 4.8A).
However, differences were observed in gene expression profiles between normal and 
osteoarthritic chondrocytes during early redifferentiation (Table 4.2). Normal 
chondrocytes showed the expected increase in SOX9 expression after 72 hours in 3D 
agarose culture whilst in OA chondrocytes SOX9 expression decreased (Fig 4.7A). 
MMP13 expression decreased in normal chondrocytes but increased in OA chondrocytes 
(Fig 4.7B), and the same was true for IGF1 expression (Fig 4.8A). The change in CASP3 
expression from monolayer to 3D also differed, increasing in normal chondrocytes and 
decreasing in OA chondrocytes (Fig 4.8B). In addition, although expression of the 
apoptotic genes HSPBI and GADD45B decreased in both normal and OA chondrocytes, 
the decrease was bigger in OA chondrocytes (Fig 4.4 and 4.5).
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Figure 4.8:- Gene expression in normal and osteoarthritic (OA) chondrocytes cultured in a 
monolayer or a 3D agarose hydrogel (n l) . A- Genes encoding growth factors TGFpi, IGF-1 
and FGF-2 (hFGF). B- Genes involved in apoptosis (HSPBI encodes Hsp27). Normal 
samples are in green, OA in red. Filled columns are samples cultured in a monolayer and 
hatched columns are those cultured in a 3D agarose hydrogel
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Genes Change from monolayer to 3D
COL1A1 and COL3A1
Matrix
Hypertrophy
‘P3’ (in osteogenesis)
ADAMTS5
MMP14 t
TGFB1 t
Table 4.1:- Gene expression changes in chondrocytes cultured in a 3D agarose hydrogel 
when compared with monolayer culture. Changes were the same in both normal and OA 
chondrocytes.
Genes Change in normal Change in OA
chondrocytes chondrocytes
SOX9 t I
MMP13 \ t
IGF1 I t
CASP3 t I
Table 4.2:- Gene expression changes in chondrocytes cultured in a 3D agarose hydrogel 
when compared with monolayer culture. Changes differed between normal and OA 
chondrocytes.
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4.3 DISCUSSION
4.3.1 Differences between Normal and Osteoarthritic Chondrocytes
As in articular cartilage tissue (chapter 3) differences in the cytoskeletal organisation of 
chondrocytes isolated from human normal and osteoarthritic cartilage were apparent 
when cultured as either a monolayer or embedded in a 3D agarose hydrogel. In 
monolayer culture, OA chondrocytes contained more actin stress fibres than normal 
chondrocytes whereas vimentin intermediate filament bundles had a more clear 
orientation in normal chondrocytes. Differences in the actin cytoskeleton of normal and 
OA chondrocytes were still apparent in agarose culture; peripheral spots of actin staining 
were larger in OA chondrocytes.
In the case of many of the detected genes on the custom array, the difference in 
expression between normal and osteoarthritic chondrocytes was similar in both culture 
conditions. The gene ‘S I’ is used by AstraZeneca as a marker of non-pathological 
cartilage and has previously been shown to be down-regulated in moderate/severe late- 
stage OA cartilage (Aigner et al., 2006a). In both monolayer and 3D agarose culture, 
expression of ‘S I’ was decreased in OA chondrocytes compared to normal. Genes 
classed as involved in hypertrophy were expressed more highly in OA chondrocytes in 
both culture conditions, including COMP, TGM2, FGF18 and FGFR3. Chondrocyte 
hypertrophy is characteristic of late-stage OA and genes associated with chondrocyte 
terminal differentiation have been associated with early focal degeneration in cartilage 
(Pullig et al., 2000, Tchetina et al., 2005, von der Mark et al., 1992). Cartilage 
oligomeric protein (COMP) is elevated in OA cartilage and serum levels are associated 
with cartilage loss (Hunter et al., 2007, Koelling et al., 2006). TGM2 encodes 
transglutaminase-2, a protein required for and up-regulated with chondrocyte 
hypertrophy (Johnson et al., 2003, Johnson and Terkeltaub, 2005). In the Hartley guinea 
pig model of spontaneous OA, TGM2 expression increases with OA and serum levels 
correlate with disease severity (Huebner et al., 2009). FGF18 signals through FGFR3 to 
regulate chondrocyte proliferation and differentiation and is required for chondrocyte 
hypertrophy (Davidson et al., 2005, Liu et al., 2007).
In OA chondrocytes in monolayer and agarose culture, expression of CASP3, encoding 
the pro-apoptotic caspase-3, and HSPBI, encoding the anti-apoptotic heat shock protein
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27 (Hsp27), was higher when compared with normal chondrocytes. HSPBI expression 
has been shown to be up-regulated in human OA articular cartilage, as has expression of 
caspase-3 (Sharif et al., 2004, Lambrecht et al., 2009, Ijiri et al., 2008). Growth arrest 
and DNA damage-inducible protein 450 (GADD450) is also involved in apoptosis. Up- 
regulation of GADD45B by NFkB leads to inhibition of TNFa-induced apoptosis (De 
Smaele et al., 2001). GADD450 binds to JNK kinase 2 (MAPK kinase 7), inhibiting its 
catalytic activity and subsequent activation of JNK signalling, thus protecting the cells 
against apoptosis (Papa et al., 2004). In contrast to this anti-apoptotic role, GADD450 
can also be pro-apoptotic; it activates p38 MAPK and promotes TGF-0-induced 
apoptosis (Yoo et al., 2003). In cartilage chondrocytes, GADD450 has previously been 
shown to play a cytoprotective role (Ijiri et al., 2008). GADD45B expression decreases 
in both OA bone and articular cartilage (Hopwood et al., 2007, Ijiri et al., 2008). In 
chondrocyte cultures, GADD45B expression was lower in OA chondrocytes cultured in a 
3D environment, but higher in OA chondrocytes cultured as a monolayer when 
compared with the respective normal cells.
In monolayer, expression of the angiogen VEGF was higher in OA chondrocytes 
compared to normal chondrocytes. This supports work by others indicating an increase 
in VEGF protein levels in OA cartilage (Pfander et al., 2001, Enomoto et al., 2003). 
However, comparison of normal and OA cartilage (chapter 3) showed VEGF mRNA 
expression was decreased in OA. This was also the case in the 3D agarose culture, where 
VEGF expression was lower in OA chondrocytes compared to normal. As chondrocytes 
are reported to be dedifferentiated in OA, the elevated COL1A1 and COL3A1 expression 
in OA chondrocytes in both monolayer and 3D agarose culture is as predicted, and 
correlates with the observation in OA cartilage (Adam et al., 1984). The expected 
reduction in SOX9 expression in OA compared to normal chondrocytes, another 
indication of loss of the chondrocyte phenotype, was observed in 3D agarose culture but 
not in monolayer. The proteases MMP-13 and ADAMTS-5, analysed in normal and OA 
cartilage (chapter 3) also showed different effects of pathology depending on the culture 
conditions. MMP13 expression is elevated in OA cartilage (chapter 3; (Bau et al., 2002)) 
and in OA chondrocytes in 3D culture; however in monolayer culture MMP13 
expression was higher in normal chondrocytes than in OA chondrocytes. ADAMTS5 
expression was higher in OA chondrocytes cultured as a monolayer when compared with 
normal and this is in support of previous reports indicating elevated ADAMTS5
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expression in OA (Bau et al., 2002). However, comparison of normal and OA cartilage 
(chapter 3) revealed decreased ADAMTS5 expression in OA and this was also observed 
in 3D agarose culture.
Collectively, these data indicate that the differences in gene expression between 
chondrocytes in normal and OA cartilage are more accurately reflected when isolated 
chondrocytes are cultured in a 3D environment i.e. agarose, specifically in the case of 
VEGF, SOX9, MMP13 and ADAMTS5 expression.
4.3.2 Changes with ‘Redifferentiation’ in 3D Culture
When cultured in 3D agarose hydrogels, both normal and osteoarthritic chondrocytes 
regained a morphology and cytoskeletal architecture that is characteristic of a 
chondrocyte phenotype. Normal and OA chondrocytes became round and actin stress 
fibres disappeared, with actin staining becoming localised to the cell periphery, as is 
typical of chondrocytes in articular cartilage (Langelier et al., 2000). In addition, P-actin 
expression increased in early redifferentiation in both normal and OA chondrocytes, 
possibly as a result of the cytoskeletal remodelling occurring with the changes in cell 
shape and chondrocyte phenotype.
Following 72 hours redifferentiation, expression of adhesion genes decreased in both 
normal and OA chondrocytes. This is as expected as cells have transferred from an 
anchorage-dependant culture system to a non-adhesive 3D culture system. In support of 
this, a previous study has shown that VC AMI and ITGB1 (integrin pi) expression was 
down-regulated following seven and 14 days redifferentiation, respectively, of human 
articular chondrocytes isolated from non-OA patients undergoing autologous 
transplantation (ACT) therapy (Tallheden et al., 2004). Expression of the gene \42’ 
increased in 3D culture but, whilst classed by AstraZeneca as a gene encoding an 
adhesion protein, the ‘A2’ protein is localised to the plasma membrane rather than 
playing a more typical role in cell adhesion.
All hypertrophic genes were down-regulated following 72 hours redifferentiation of both 
normal and OA chondrocytes. COL10A1, a marker of chondrocyte hypertrophy, has 
been shown to be down-regulated in chondrocytes from ACT patients following seven 
and 14 days of redifferentiation (Tallheden et al., 2004). Although undetected in the
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cartilage cDNA samples used in the present study, the decreased COL10A1 expression 
shown previously supports the apparent decrease in chondrocyte hypertrophy with 
redifferentiation. Results from the study of redifferentiation of chondrocytes from ACT 
patients showed an increase in COMP expression at seven and 14 days (Tallheden et al., 
2004). In contrast, results presented here indicate in excess of a 50-fold down-regulation 
of COMP expression in both normal and OA chondrocytes. This could be explained by 
the shorter time point investigated here, where chondrocytes were subject to 
redifferentiation for three days only, compared to seven and 14 days in the published 
study.
Changes in the expression of apoptotic genes in early redifferentiation were variable in 
both normal and OA chondrocytes. HSPBI and ‘D2’ expression decreased in 3D culture 
in both normal and OA chondrocytes and these both encode anti-apoptotic proteins. 
GADD45B expression also decreased in 3D culture and, as discussed above, GADD45p 
can be both pro- and anti-apoptotic (De Smaele et al., 2001, Yoo et al., 2003) but has 
been shown to be cyto-protective in chondrocytes (Ijiri et al., 2008). In addition, 
expression of BMF, encoding a pro-apoptotic protein not previously described in 
chondrocytes, increased with redifferentiation. This suggests decreased resistance to 
apoptosis in early redifferentiation. Changes in expression of ‘D5’ and CASP3 differed 
between normal and OA chondrocytes. ‘D3’ encodes an anti-apoptotic protein and, from 
monolayer to 3D culture, expression decreased in normal chondrocytes but increased in 
OA chondrocytes. Caspase-3 is an executioner of apoptosis and, from monolayer to 3D 
culture, expression increased in normal chondrocytes but decreased in OA chondrocytes. 
This further suggests a decreased resistance to apoptosis in normal chondrocytes. 
However this is inconsistent with previous reports of redifferentiation in human normal 
articular chondrocytes which showed improved resistance to apoptosis and cell survival 
following 48 hours redifferentiation, and decreased CASP3 expression after seven days 
redifferentiation (Haudenschild et al., 2001, Tallheden et al., 2004). The changes in 
apoptotic gene expression in early redifferentiation of OA chondrocytes is varied, with 
some gene changes implying decreased resistance to apoptosis and others implying an 
increased resistance.
Genes encoding extracellular matrix components were down-regulated after 72 hours 
redifferentiation of normal and OA chondrocytes. This is consistent with previous
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reports of decreased matrix synthesis and matrix gene expression in early 
redifferentiation (Benya and Shaffer, 1982a, Haudenschild et al., 2001). The decrease in 
COL1A1 and COL3AJ expression supports the expected redifferentiation towards a 
chondrocytic phenotype (Benya and Shaffer, 1982a, Stokes et al., 2001). COL2A1 
expression was detected in normal chondrocytes in 3D agarose but undetected in normal 
monolayer chondrocytes, implying an up-regulation and redifferentiation of the cartilage 
collagen phenotype. However, in OA chondrocytes COL2A1 expression decreased 
following 72 hours in agarose culture. This could be due to a general decrease in 
anabolism early in redifferentiation which would be followed by increased matrix 
synthesis and deposition. Another study has shown that OA chondrocytes, like normal 
chondrocytes, are able to redifferentiate in 3D culture following monolayer expansion; 
extracellular type II collagen and glycosaminoglycans were detected at seven days and 
had increased by 14 days (Tallheden et al., 2005). It is also possible that the decrease in 
COL2A1 expression is due to a delayed or slower redifferentiation of OA chondrocytes 
compared to normal. This is supported by the differential expression of SOX9 which 
increased in normal chondrocytes cultured in a 3D agarose hydrogel but decreased in 
OA chondrocytes. A transient decrease in SOX9 expression in early redifferentiation has 
also been observed in ACT chondrocytes, and this was followed by the expected up- 
regulation with sustained redifferentiation (Tallheden et al., 2004). Previous work has 
shown that OA chondrocytes retain the ability to redifferentiate, but that their response 
differs to normal chondrocytes in that they synthesise less total collagen and continue to 
proliferate after 14 days in 3D pellet culture (Tallheden et al., 2005). The apparent 
slower redifferentiation of OA chondrocytes is rescued by SOX9 transduction into 
chondrocytes in vitro prior to 3D culture (Tew et al., 2005, Cucchiarini et al., 2007).
Gene expression changes showing the same response of normal and OA chondrocytes to 
72 hours culture in 3D agarose supports previous work indicating that a pathological 
background does not compromise the potential of chondrocytes for redifferentiation 
(Cucchiarini et al., 2007, Tallheden et al., 2005, Tew et al., 2005). Gene expression 
changes differing between normal and OA chondrocytes in early redifferentiation, 
including SOX9, CASP3, MMP13 and IGF1, suggest that there are inherent differences 
between normal and OA chondrocytes that are not lost with isolation of chondrocytes 
from their ECM, or with the transfer of chondrocytes to a culture system more 
supportive of the chondrocyte phenotype.
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• When cultured in 3D agarose hydrogels, chondrocyte phenotype and cytoskeletal 
organisation resembles that observed in articular cartilage in situ.
• The differences in cytoskeletal organisation and gene expression observed 
between normal and OA cartilage are better represented when chondrocytes are 
cultured in 3D agarose hydrogels rather than as a monolayer.
• Inherent differences between normal and OA chondrocytes are not lost with 
isolation from cartilage followed by monolayer culture and embedding in 3D 
agarose hydrogels.
• During early redifferentiation, genes involved in adhesion and hypertrophy are 
down-regulated in chondrocytes isolated ffom both normal and OA cartilage, 
whilst apoptosis gene regulation varies between normal and OA chondrocytes.
• OA chondrocytes are slower to redifferentiate when compared with normal 
chondrocytes.
The work discussed in the chapter is preliminary, with repeats of the comparisons using 
different donors required before firm conclusions can be drawn ffom the differences 
observed here.
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5. CYTOSKELETON AND CHONDROCYTE PHENOTYPE
5.1 INTRODUCTION
Alterations in cell phenotype are linked to changes in the cytoskeleton, whether through 
direct modification of the cytoskeletal networks or using treatments which alter 
cytoskeletal organisation.
5.1.1 Direct Modification of the Cytoskeleton Alters Cellular Phenotype
Links between the chondrocyte phenotype and cytoskeletal organisation were discovered 
following the establishment of the link between phenotype and cell shape (Benya and 
Shaffer, 1982a). Disruption of actin microfilaments with cytochalasin B/D or 
microtubules with colchicine inhibited the synthesis and secretion of proteoglycans and 
collagen in foetal guinea pig epiphyseal chondrocytes (Lohmander et al., 1976, 
Lohmander et al., 1979). In articular chondrocytes, increased proteoglycan synthesis and 
secretion was associated with cytochalasin D-induced disruption of the actin 
cytoskeleton and cell rounding (Newman and Watt, 1988). The recovery of chondrocyte 
phenotype upon cell rounding, as indicated by increased type II collagen production, was 
shown to be due to reorganisation of the actin cytoskeleton rather than cell rounding 
(Benya et al., 1988, Brown and Benya, 1988). Expression of COL2A1, aggrecan and 
SOX9 is increased in murine chondrocytes in monolayer following disruption of the 
actin microfilaments with cytochalasin D (Woods and Beier, 2006). Disruption of actin 
microfilaments in fibroblasts inhibited the synthesis and secretion of GAGs and proteins, 
and the endocytosis of hyaluronic acid in a dose-dependent manner (Evangelisti et al., 
1995). The synthesis and secretion of GAGs and protein synthesis were also inhibited in 
fibroblasts by disruption of tubulin microtubules, again in a dose-dependent manner 
(Evangelisti et al., 1995). In rabbit chondrocytes, GAG synthesis was inhibited and 
chondrocyte phenotype lost following microtubule disruption with colchicine (Takigawa 
et al., 1984). Collagen synthesis and degradation was decreased following disruption of 
vimentin intermediate filaments with acrylamide in bovine chondrocytes; mRNA 
expression of COL2A1 and aggrecan core protein was also down-regulated with 
vimentin disruption (Blain et al., 2006).
In addition to modulation of extracellular matrix molecule expression and synthesis, 
cytoskeletal disruption alters MMP expression. Disruption of actin stress fibres in
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cultured rabbit synovial fibroblasts using cytochalasin B caused cells to round, and 
induced the expression of pro-MMP-1 and pro-MMP-3 (Werb et al., 1986). The 
presence of actin stress fibres correlated negatively with expression of pro-MMP-1 and - 
3, indicating that reorganisation of the actin cytoskeleton can induce changes in MMP 
gene expression (Werb et al., 1986). A further study, using cultured human fibroblasts, 
showed that disruption of actin stress fibres, again using cytochalasin B, increased 
MMP-2 and MT1-MMP (MMP-14) mRNA levels (Tomasek et al., 1997). In addition, 
the disruption of actin stress fibres resulted in a significant increase in the activation of 
pro-MMP-2 enzyme. Disruption of microtubules with nocodazole demonstrated that the 
changes in gene expression were due to a specific reorganisation of the actin 
cytoskeleton and not due to changes in cell shape (Tomasek et al., 1997), as observed in 
chondrocytes (Brown and Benya, 1988). More recently it has been shown using human 
fibroblasts cultured in monolayer, that disruption of actin stress fibres also significantly 
increases the levels of MMP-3, -9, -13 and -14 mRNA (Lambert et al., 2001). This study 
also indicated that the observed activation of pro-MMP-2 was due to its activation by 
other MMPs, likely MMP-14. Pro-MMP-2 expression and activation is reduced in 
bovine chondrocytes following disruption of vimentin intermediate filaments with 
acrylamide (Blain et al., 2006).
In addition to altering the chondrocyte phenotype in differentiated cells, disruption of the 
actin, tubulin or vimentin cytoskeleton can also alter chondrogenesis in progenitor cells. 
Disruption of the actin cytoskeleton with cytochalasin D treatment up-regulates 
COL2A1, SOX9 and aggrecan expression and enhances chondrogenesis in murine 
embryonic stem cells cultured in chondrogenic medium (Zhang et al., 2006c). 
Chondrogenesis in murine mesenchymal limb bud cells is enhanced by cytochalasin D 
treatment but inhibited by disruption of microtubules with colchicine, as indicated by 
SOX9 expression and GAG accumulation (Woods et al., 2005). siRNA knockdown of 
vimentin reduced the expression of SOX5, SOX6 and SOX9 in human bone marrow- 
derived multipotent progenitor cells in pellet culture (Bobick et al., 2010). Expression 
and accumulation of aggrecan and type II collagen was also reduced by vimentin 
knockdown, which reduced cartilage formation in the model of adult progenitor cell 
chondrogenesis.
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5.1.2 Upstream Regulators of the Actin Cytoskeleton Modulate 
Chondrocyte Phenotype
The Rho family GTPases regulate actin cytoskeletal dynamics through multiple 
pathways; downstream kinases such as the LIM kinases and ROCK are activated and 
these regulate actin-modifying proteins including cofilin, profilin and the Arp2/3 
complex. RhoA/ROCK signalling promotes actin stress fibre formation and inhibits 
SOX9 expression preventing chondrogenesis (Woods et al., 2005). Conversely, 
inhibition of ROCK signalling reduces actin stress fibres, induces SOX9 and restores 
chondrogenesis (Woods et al., 2005, Tew and Hardingham, 2006). Hypertrophic 
differentiation of chondrocytes is also inhibited by RhoA/ROCK signalling, with 
downregulation of type X collagen and MMP 13 expression, whilst cyclin D1 expression 
and chondrocyte proliferation is enhanced (Wang et al., 2004). Overexpression of 
constitutively active Rho, in articular chondrocytes cultured as a monolayer, increases 
ROCK-dependent stress fibre formation and upregulates expression of MMP 13 and 
COL1A1, indicating a loss of chondrocyte phenotype (Novakofski et al., 2009). 
Inhibition of Rho activity with C3 transferase increases AC AN, COL2A1 and SOX9 
expression and reduces COL1A1, indicating promotion of the chondrocyte phenotype by 
Rho inhibition. Furthermore, Rho A protein expression increases with chondrocyte 
dedifferentiation in monolayer and decreases with redifferentiation in 3D alginate 
(Kumar and Lassar, 2009).
Activation of the Rho GTPases Rac-1 and Cdc42 is elevated in mature chick embryonic 
chondrocytes when compared with immature cells implying a role in chondrocyte 
differentiation (Kerr et al., 2008). Rac-1 increases cortical actin staining when 
overexpressed in a chondrocyte cell line, with Rac-1 and Cdc42 overexpression 
inhibiting chondrocyte proliferation whilst promoting COL10A1 expression and 
hypertrophic differentiation (Wang and Beier, 2005). In micromass culture both Rac-1 
and Cdc42 promote chondrogenesis, up-regulating expression of SOX9 and type II 
collagen, and in the case of Rac-1, increasing aggrecan mRNA and GAG synthesis 
(Woods et al., 2007). By contrast, in equine chondrocytes cultured as a monolayer 
inhibition of Cdc42 with a dominant-negative mutant increased type II collagen and 
decreased MMP3 expression, suggesting Cdc42 inhibits the chondrocyte phenotype in 
chondrocytes containing actin stress fibres (Fortier et al., 2004).
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The effects of the Rho GTPases on chondrocyte differentiation further demonstrate the 
close link between cytoskeletal organisation and chondrocyte phenotype.
5.1.3 Growth Factors and Cytokines Affect the Cytoskeleton
Cytoskeletal organisation can also be modulated by exogenous growth factors or 
cytokines. TGFpl treatment activates RhoA and Racl in retinal epithelial cells, inducing 
Rho-dependent phosphorylation of LIM kinase and cofilin and rearrangement of the 
actin cytoskeleton (Lee et al., 2008). In fibroblasts, TGFpl activates RhoA and RhoB to 
induce actin polymerisation and stress fibre formation through ROCK1 -mediated 
phosphorylation of LIM kinase 2 and cofilin (Vardouli et al., 2005). In chondrocytes in 
3D culture, TGFp treatment alters actin cytoskeletal organisation, inducing lamellar 
ruffling and actin extensions which is indicative of Rac/Cdc42 activation (Haudenschild 
et al., 2009). TGFpi and IGF-I maintain chondrocytes in a round morphology and 
increase F-actin labelling, resulting in increased cell stiffness (Leipzig et al., 2006). 
Chondrocyte rounding and cortical actin staining is increased by IGF-I treatment, which 
reduces Rho activity (Novakofski et al., 2009). IGF-I treatment also reduces Cdc42 
activation and decreases actin stress fibres in articular chondrocytes (Fortier et al.,
2004). By contrast, TGFa treatment increases actin stress fibre formation in rat 
chondrocytes (Appleton et al., 2007a).
The pro-inflammatory cytokine TNFa disrupts actin stress fibres in fibroblasts 
(Gronowicz et al., 1992) and another pro-inflammatory cytokine, IL-1, reorganises the 
actin cytoskeleton in osteoclasts (Nakamura et al., 2002). In astrocytes, IL-ip treatment 
results in disruption of actin filaments, aggregation of vimentin networks and down- 
regulates expression of vimentin and microtubule-associated protein 4 (Liu et al., 1994). 
In chondrocytes, IL-1 a increases Rho activity and stress fibre formation (Novakofski et 
al., 2009); IL-lp causes cellular contraction indicative of RhoA activation (Haudenschild 
et al., 2009). In addition, a whole genome array identified a number of cytoskeletal- 
associated genes regulated in chondrocytes treated with IL-1 P (Joos et al., 2008). IL-1 P 
treatment altered actin organisation and down-regulated expression of vimentin, P- 
tubulin and the actin-associated LIM protein FHL2. IL-1 treatment has also been shown 
to reduce expression of the cytoskeletal proteins tensin, talin, paxillin and focal adhesion 
kinase in articular chondrocytes (Vinall et al., 2002).
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5.1.4 Growth Factors and Cytokines Modulate Chondrocyte Phenotype
TNFa-induced increases in fibroblast collagenase expression and activity is associated 
with disruption of actin stress fibres (Gronowicz et al., 1992). In canine chondrocytes 
cultured in 3D agarose, TNFa reduces GAG content and increases production of nitric 
oxide and prostaglandin E2 (Kuroki et al., 2005), whilst it promotes MMP-mediated 
collagen breakdown in bovine cartilage explants (Hui et al., 2001). Loss of the 
chondrocyte phenotype is induced by IL-1 (Vinall et al., 2002), as IL-1 a reduces 
COL2A1 expression and up-regulates MMP 13 in articular chondrocytes (Novakofski et 
al., 2009). IL-lp also down-regulates expression of COL2A1 and aggrecan whilst up- 
regulating MMP 13, BMP2 and the pro-inflammatory cytokines IL-6 and IL-8 (Sandell et 
al., 2008). Along with MMP 13 expression, IL-1 p increases TIMP1 and TIMP2 
expression, enhances production of nitric oxide and prostaglandin E2 and decreases 
GAG content in chondrocytes cultured in 3D agarose hydrogels (Kuroki et al., 2005). 
Some of the phenotypic changes induced by IL-1 are antagonised by TGFpi (Sandell et 
al., 2008). Conversely, pre-treatment with IL-lp abrogates TGFp-induced up-regulation 
of COL2A1, aggrecan and SOX9 expression (Roman-Blas et al., 2007). TGFpi or IGF-I 
can reduce TNFa-induced collagenase expression in bovine cartilage explants (Hui et 
al., 2001).
TGFpl has been shown to both up-regulate and down-regulate type II collagen synthesis 
in chondrocytes (Galera et al., 1992b, Galera et al., 1992a). TGFpi effects are dependent 
on the differentiation state and cell morphology, inhibiting synthesis in differentiated 
chondrocytes and promoting synthesis in dedifferentiated cells (Galera et al., 1992a, 
Ballock et al., 1993). In addition, TGFpi increases GAG synthesis in immature, but not 
mature human articular cartilage where it alters GAG composition to that of more 
immature cartilage (Hickery et al., 2003). However, TGFP induces chondrogenic 
differentiation in bone-marrow derived mesenchymal stem cells encapsulated in alginate 
(Mehlhom et al., 2006). TGFa increases chondrocyte proliferation and clustering and 
up-regulates expression of MMP 13 and cathepsin C (Appleton et al., 2007a). In addition, 
the expression levels of aggrecan, cartilage link protein, type II collagen and SOX9 are 
reduced, indicating suppression of the chondrocyte phenotype by TGFa treatment. IGF-I 
treatment exerts anabolic effects on chondrocyte phenotype, promoting both GAG and 
type II collagen synthesis (Fortier et al., 2002, Jenniskens et al., 2006). IGF-I up- 
regulates type II collagen mRNA and protein expression through PI3K signalling, whilst
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down-regulating MMP 13 expression and activation via the ERK/MAPK pathway in rat 
chondrocytes (Zhang et al., 2009).
As growth factors and cytokines can modulate both cytoskeletal organisation and 
chondrocyte phenotype, it is possible that their effect on gene expression is mediated by 
the cytoskeleton. In support of this, TNFa-induced increases in fibroblast collagenase 
expression and activation are associated with disruption of actin stress fibres (Gronowicz 
et al., 1992), whereas TGFpl-induced increases in expression of plasminogen activator 
inhibitor requires an intact actin cytoskeleton (Yang et al., 2007). In addition, Racl 
inhibition or actin disruption prevents TGFpi-induced biglycan expression (Groth et al.,
2005), whilst TGFpi-stimulated type I collagen expression and accumulation requires 
Rho/ROCK signalling and an intact actin cytoskeleton in mesangial cells (Hubchak et 
al., 2003). It has also been suggested that tubulin microtubules act to negatively regulate 
TGFp signalling by sequestering Smads (Dong et al., 2000). However it is also possible 
that the effects on gene expression are mediated by cytoskeletal-independent pathways. 
Inhibition of Rho with C3 transferase or inhibition of ROCK block the IL-la-induced 
increase in actin stress fibre formation but, despite the effects of Rho activation 
mimicking those of IL-1 a, inhibition of Rho or ROCK does not block the effects of IL- 
la  on chondrocyte gene expression (Novakofski et al., 2009).
The cytoskeletal differences observed between normal and OA chondrocytes (chapter 3), 
along with the ability of cytoskeletal changes to alter cell phenotype, could suggest that 
the phenotypic change observed in OA chondrocytes is a result of an altered 
cytoskeleton. In order to determine whether the cytoskeletal changes are a cause or 
effect of the OA phenotype, the effects of cytoskeletal disruption on the phenotype of 
chondrocytes isolated ffom normal and OA cartilage and cultured in agarose hydrogels 
were further investigated.
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5.2 RESULTS
Normal and osteoarthritic human articular chondrocytes were initially expanded in 
monolayer. Chondrocytes were taken at passage three, encapsulated in 3% agarose and 
cultured for 48 hours. Chondrocytes were treated for 6, 12, 24 or 48 hours with either 
1 pM cytochalasin D to disrupt actin microfilaments, 1 pM colchicine to disrupt tubulin 
microtubules, or 2mM acrylamide to disrupt vimentin intermediate filaments.
5.2.1 The Effect of Cytoskeletal Element Disrupting Treatments on Cell 
Viability
The viability of normal and osteoarthritic human chondrocytes in agarose culture was 
determined using the LIVE/DEAD® Viability/Cytotoxicity kit for mammalian cells. In 
viable chondrocytes the fluorogenic esterase substrate calcein AM is hydrolysed and 
fluorescence is visible through a FITC (green) filter, whilst dead chondrocytes are 
visualised with the nucleic acid stain ethidium homodimer-1 and fluorescence detected 
through a TRITC (red) filter. Normal and OA chondrocytes survived the transition from 
monolayer to agarose culture and remained viable at 4 days, the latest timepoint assayed 
(Fig 5.1). Cell death did not increase from the 6 to the 48 hour untreated timepoints in 
normal chondrocytes in 3D agarose culture (Fig 5.1 A, a,b). However there was a 
decrease of 13% in the viability in OA chondrocytes (Fig 5.1 B, a,b). There appeared to 
be an increase in viability of untreated OA chondrocytes (Fig 5.1 B a,b) when compared 
with normal chondrocytes (Fig 5.1 A a,b). Cytochalasin D treatment did not affect 
chondrocyte viability after 6 hours (Fig 5.1 A and B, c). At 48 hours, a decrease in cell 
viability was observed in normal (15%, Fig 5.1 A d) and OA chondrocytes (17%, Fig 5.1 
B d) treated with cytochalasin D when compared with untreated controls (Fig 5.1 A and 
B, b). Colchicine treatment did not affect chondrocyte viability at either 6 or 48 hours 
and no increase in cell death was evident from 6 hours to 48 hours in colchicine-treated 
OA chondrocytes (Fig 5.1 B e,f). By contrast, an 11% decrease in cell viability was 
observed between 6 and 48 hours in colchicine-treated normal chondrocytes (Fig 5.1 A 
e,f). Acrylamide treatment had no effect on chondrocyte viability at either 6 or 48 hours 
(Fig 5.1 A and B, g,h).
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5.2.2 Visualisation and Confirmation of Cytoskeletal Disruption
The cytoskeletal architecture of chondrocytes in agarose culture was visualised by 
immunofluorescence in conjunction with confocal microscopy.
5.2.2.1 Untreated Chondrocytes
Following expansion in monolayer and transfer into a 3D agarose culture, both normal 
and OA chondrocytes regained a rounded morphology (section 4.2.1). Actin 
microfilament staining appeared punctate and was predominantly cortical in untreated 
normal chondrocytes (Fig 5.2 A and B, a). In untreated OA chondrocytes, actin staining 
was restricted to the cell periphery, punctuate spots appeared more elongated and 
networks were visible at the periphery (Fig 5.2 A and B, g). Tubulin microtubule 
staining appeared diffuse in untreated normal and OA chondrocytes although fine 
filamentous networks were apparent at the cell periphery (Fig 5.2 A and B, b and h). 
Untreated normal and OA chondrocytes contained clear vimentin intermediate filament 
bundle networks, extending throughout the cell ffom the nucleus to the plasma 
membrane (Fig 5.2 A and B, c and i).
5.2.2.2 Cytochalasin D-treated Chondrocytes
Treatment of chondrocytes with lpM  cytochalasin D for 24 hours altered the 
organisation of actin microfilaments. Punctate spots of actin staining appeared larger and 
less evenly distributed in both normal (Fig 5.2 A and B, d) and OA chondrocytes. Actin 
staining was also no longer restricted to the periphery of OA cells (Fig 5.2 A and B, j). 
The tubulin architecture was unaffected by actin microfilament disruption with 
cytochalasin D treatment (Fig 5.2 A and B, b,e,h and k). Vimentin intermediate filament 
bundle networks were also unaffected by microfilament disruption in both normal and 
OA chondrocytes (Fig 5.2 A and B, c,f,i and 1).
5.2.2.3 Colchicine-treated Chondrocytes
Treatment of chondrocytes with lpM colchicine for 24 hours altered the appearance of 
the tubulin network when compared with untreated controls (Fig 5.3 A and B, a and g). 
In colchicine-treated normal chondrocytes tubulin microtubule bundles appeared shorter 
and thicker, with staining less tightly packed around the nucleus (Fig 5.3 A and B, d). In 
OA chondrocytes microtubule bundles also appeared thicker and more clearly visible 
following colchicine treatment (Fig 5.3 A and B, j). Tubulin fluorescence was brightest 
at the cell
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Figure 5.2 A:- 3D reconstruction - Cytoskeletal organisation of normal (a-f) and 
osteoarthritic (g-1) human articular chondrocytes in 3D agarose culture following 
disruption of actin microfilaments by treatment with 1 pM cytochalasin D for 24 hours. 
Punctate spots (arrows) appeared larger and less evenly distributed following treatment 
Images shown are 3D-reconstmctions of a series of scans taken at 0.4pm increments 
across the chondrocyte. Actin was detected with Alexa fluor 488-phalloidin. Vimentin 
and tubulin were detected by indirect immunofluorescence using primary antibodies and 
TRITC-conjugated anti-mouse IgG. ‘Un’- untreated chondrocytes, ‘CD’- cytochalasin D 
treated chondrocytes.
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Figure 5.2 B> Single scan - Cytoskeletal organisation of normal (a-f) and osteoarthritic 
(g-1) human articular chondrocytes in 3D agarose culture following disruption of actin 
micro filaments by treatment with lpM cytochalasin D for 24 hours. Punctate spots 
appeared larger and less evenly distributed following treatment Images shown are a 
single scan through the centre of the chondrocyte. Actin was detected with Alexa fluor 
488-phalloidin. Vimentin and tubulin were detected by indirect immunofluorescence 
using primary antibodies and TRITC-conjugated anti-mouse IgG. ‘Un1- untreated 
chondrocytes, ‘CD’- cytochalasin D treated chondrocytes.
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Figure 5.3 A:- 3D reconstruction - Cytoskeletal organisation of normal (a-f) and 
osteoarthritic (g-1) human articular chondrocytes in 3D agarose culture following 
disruption of tubulin microtubules by treatment with lgM colchicine for 24 hours. 
Microtubule bundles (arrows) appeared thicker and were more clearly visible following 
treatment Images shown are 3D-reconstructions of a series of scans taken at 0.4pm 
increments across the chondrocyte. Vimentin and tubulin were detected by indirect 
immunofluorescence using primary antibodies and TRITC-conjugated anti-mouse IgG. 
Actin was detected with Alexa fluor 488-phalloidin. ‘Un’- untreated chondrocytes, ‘Ch’- 
colchicine treated chondrocytes.
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Figure 5.3 B > Single scan - Cytoskeletal organisation of normal (a-f) and osteoarthritic 
(g-1) human articular chondrocytes in 3D agarose culture following disruption of tubulin 
microtubules by treatment with lpM colchicine for 24 hours. Microtubule bundles 
(arrows) appeared thicker and were more clearly visible following treatment Images 
shown are a single scan through the centre of the chondrocyte. Vimentin and tubulin 
were detected by indirect immunofluorescence using primary antibodies and TRITC- 
conjugated anti-mouse IgG. Actin was detected with Alexa fluor 488-phalloidin. TJn’- 
untrealed chondrocytes, ‘Ch’- colchicine treated chondrocytes.
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periphery of both normal and OA colchicine-treated chondrocytes. With colchicine 
treatment the actin microfilaments of normal chondrocytes became more like those of 
untreated OA chondrocytes (Fig 5.3 A and B, e and h); punctate spots appeared larger 
when compared with untreated normal chondrocytes and networks were visible at the 
cell periphery. Actin staining remained restricted to the cortical region in colchicine- 
treated normal chondrocytes. Actin microfilaments in OA chondrocytes were unaffected 
by colchicine treatment (Fig 5.3 A and B, h and k). Vimentin intermediate filament 
bundle networks were apparent in both untreated and colchicine-treated normal and OA 
chondrocytes and were unaffected by colchicine treatment (Fig 5.3 A and B, c,f,i and 1).
5.2.2.4 Acrylamide-treated Chondrocytes
Treatment of chondrocytes with 2mM acrylamide for 24 hours altered the appearance of 
vimentin networks (Fig 5.4 A and B). In acrylamide-treated normal chondrocytes 
vimentin intermediate filaments formed thick bundles and appeared more loosely packed 
(Fig 5.4 A and B, d). Vimentin filament bundles appeared asymmetrically distributed in 
both normal and OA chondrocytes following acrylamide treatment, with diffuse or faint 
intermediate filament bundle networks around the nucleus on one side of the cell and 
loose networks on the opposing side (Fig 5.4 A and B, d and j). In acrylamide-treated 
OA chondrocytes vimentin staining was bright at one side of the cell and loosely packed 
faint intermediate filament bundles surrounded the nucleus (Fig 5.4 A and B, j). Actin 
microfilaments were unaffected by acrylamide treatment in both normal and OA 
chondrocytes. In normal chondrocytes, actin staining remained punctate and restricted 
predominantly to the cell periphery (Fig 5.4 A and B, b and e). In OA chondrocytes, 
punctate spots of actin staining remained slightly elongated as in untreated controls, but 
staining was less clearly restricted to the cell periphery (Fig 5.4 A and B, h and k). The 
appearance of tubulin microtubules in normal and OA chondrocytes was unaffected by 
acrylamide treatment, with microtubule bundle networks remaining fine and filamentous 
throughout the cell (Fig 5.4 A and B, c,f,i and 1).
Changes in the organisation of the actin (Fig 5.5), tubulin (Fig 5.6) and vimentin (Fig 
5.7) cytoskeletal elements are summarised below. In all instances, disruption of a 
specific cytoskeletal element did not significantly affect the spatial organisation of the 
other major elements in the chondrocyte after 24 hours of treatment.
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F igure 5.4 A :- 3D  reconstruction  -  C ytoskeleta l organisation o f  norm al (a-f) and  
osteoarthritic (g-1) human articular ch on d rocytes in 3 D  agarose culture fo llo w in g  
disruption o f  v im entin  interm ediate filam ents b y  treatm ent w ith  2m M  acrylam ide for 24  
hours. Intermediate filam ent b undles becam e asym m etrically  distributed fo llo w in g  
treatm ent Im ages show n are 3D -reconstructions o f  a series o f  scans taken at 0 .4 p m  
increm ents across the chondrocyte. V im entin  and tubulin w ere detected  b y  indirect 
im m unofluorescence u sing  primary an tib od ies and TRITC -conjugated anti-m ouse IgG. 
A ctin  w as detected  w ith  A lex a  fluor 488-p h allo id in . ‘U n ’- untreated chondrocytes, ‘A c ’-  
acrylam ide treated chondrocytes.
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Figure 5.4 B:- Single scan - Cytoskeletal organisation of normal (a-f) and osteoarthritic 
(g-1) human articular chondrocytes in 3D agarose culture following disruption of 
vimentin intermediate filaments by treatment with 2mM acrylamide for 24 hours. 
Intermediate filament bundles became asymmetrically distributed following treatment 
Images shown are a single scan through the centre of the chondrocyte. Vimentin and 
tubulin were detected by indirect immunofluorescence using primary antibodies and 
TRITC-conjugaled anti-mouse IgG. Actin was detected with Alexa fluor 488-phalloidin. 
‘Un’- untreated chondrocytes, ‘Ac’- acrylamide treated chondrocytes.
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5.2.3 Gene Expression Changes Following Cytoskeletal Element 
Disruption
The effect of cytoskeletal disruption on chondrocyte phenotype was analysed using 
quantitative PCR to determine gene expression changes.
5.2.3.1 Cytoskeletal Associated Genes
There was no difference in p-actin mRNA expression detected between normal and OA 
chondrocytes at all time points assayed (Fig 5.8). Disruption of actin microfilaments 
with 1 pM cytochalasin D treatment had a significant effect on P-actin mRNA expression 
in both normal and OA chondrocytes (Fig 5.8). In normal chondrocytes, P-actin 
expression was increased by cytochalasin D treatment at 12 and 24 hours (5.6 fold; 
p=0.019 and 4.3 fold; p=0.015 respectively) and remained elevated over controls at 48 
hours (4.2 fold; p=0.068). In OA chondrocytes, the increase in P-actin expression at 12 
hours (2.5 fold; p=0.037) remained significant at 24 and 48 hours (2.5 fold; p=0.023 and 
2.7 fold; p=0.046 respectively). Disruption of tubulin microtubules or vimentin 
intermediate filaments had no effect on p-actin expression, with the exception of 
increased expression in normal chondrocytes treated for 12 hours with colchicine (2.1 
fold; p=0.049).
Disruption of the actin, tubulin or vimentin cytoskeleton had no significant effect on P- 
tubulin mRNA expression in normal and OA chondrocytes (Fig 5.9). P-tubulin 
expression was highly variable, particularly in OA chondrocytes. Vimentin mRNA 
expression was unaffected by cytoskeletal disruption and no difference was observed 
between normal and OA chondrocytes (Fig 5.10).
The organisation of actin microfilaments can be regulated by a number of actin-binding 
proteins. Therefore the effect of cytoskeletal disruption on the expression of a number of 
actin-binding proteins was investigated. Expression of the actin-depolymerising protein 
cofilin in normal and OA chondrocytes increased with cytochalasin D treatment at 12 
hours and reached significance in normal chondrocytes treated for 24 hours (Fig 5.11; 
normal 1.9 fold; p=0.013 and OA 1.6 fold; p=0.153). Cofilin expression remained 
elevated at 48 hours but was no longer significant (1.7 fold; OA p=0.068, data not 
shown). Cytochalasin D treatment increased destrin expression in normal chondrocytes
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Figure 5.8:- P-actin gene expression changes with cytoskeletal disruption. Absolute 
mRNA levels were determined using SYBR Green quantitative PCR and normalised 
to the housekeeping gene GAPDH. Nucleic acids were isolated from chondrocytes 
from normal and osteoarthritic (OA) cartilage, encapsulated in 3D agarose and 
cultured without (untreated) or with treatment for 6,12,24 or 48 hours -  treatments 
included lpM cytochalasin D to disrupt actin micro filaments, lpM colchicine to 
disrupt tubulin microtubules, or 2 mM acrylamide treatment to disrupt vimentin 
intermediate filaments. Data are presented as mean ± S.E.M (n=5). * p < 0.05, 
treatment compared to untreated control.
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Figure 5.9:- jk-tubulin gene expression changes with cytoskeletal disruption. Absolute 
mRNA levels were determined using SYBR Green quantitative PCR and normalised 
to the housekeeping gene GAPDH. Nucleic acids were isolated from chondrocytes 
from normal and osteoarthritic (OA) cartilage, encapsulated in 3D agarose and 
cultured without (untreated) or with treatment for 6,12,24 or 48 hours -  treatments 
included lpM cytochalasin D to disrupt actin microfilaments, lpM colchicine to 
disrupt tubulin microtubules, or 2 mM acrylamide treatment to disrupt vimentin 
intermediate filaments. Data are presented as mean ± S.E.M (n=5).
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Figure 5.10:- Vimentin gene expression changes with cytoskeletal disruption. 
Absolute mRNA levels were determined using SYBR Green quantitative PCR and 
normalised to the housekeeping gene GAPDH. Nucleic acids were isolated from 
chondrocytes from normal and osteoarthntic (OA) cartilage, encapsulated in 3D 
agarose and cultured without (untreated) or with treatment for 6,12,24 or 48 hours -  
treatments included lpM cytochalasin D to disrupt actin microfilaments, lpM 
colchicine to disrupt tubulin microtubules, or 2 mM acrylamide treatment to disrupt 
vimentin intermediate filaments. Data are presented as mean ± S.E.M (n=5).
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Figure 5.11:- Actin binding protein gene expression changes with cytoskeletal 
disruption. Absolute mRNA levels were determined using SYBR Green quantitative 
PCR and normalised to the housekeeping gene GAPDH. Nucleic acids were isolated 
from chondrocytes from normal and osteoarthntic (OA) cartilage, encapsulated in 
3D agarose and cultured without (untreated) or with treatment for 6, 12, 24 or 48 
hours -  treatments included lpM cytochalasin D to disrupt actin microfilaments, 
lpM colchicine to disrupt tubulin microtubules, or 2mM acrylamide treatment to 
disrupt vimentin intermediate filaments. Data are presented as mean ± S.E.M (n=5). 
* p < 0.05, treatment compared to untreated control.
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at 12 and 24 hours (Fig 5.11: 1.8 fold; p=0.045 and 1.7 fold; p=0.033, respectively), with 
expression remaining elevated at 48 hours (1.7 fold; p=0.060, data not shown). Destrin 
expression in normal chondrocytes was also increased following 12 hours treatment with 
colchicine (Fig 5.11: 1.8 fold; p=0.046), coinciding with the significant increase in p- 
actin mRNA levels (Fig 5.8); destrin mRNA levels returned to those of untreated 
controls by 48 hours treatment (data not shown). Differential regulation of destrin 
mRNA followed the same trend in OA chondrocytes as normal chondrocytes, although 
none reached statistical significance. Other cytoskeletal associated genes investigated 
included thymosin p4, gelsolin and paxillin, none of which showed significant 
differences between normal and OA chondrocytes or between treated and untreated 
controls (data not shown).
5.2.3.2 Custom-designed Taqman Array
(R)Custom-designed Taqman arrays (Applied Biosystems, customised for AstraZeneca) 
were used to more widely analyse gene expression changes following cytoskeletal 
disruption in normal and OA cartilage chondrocytes. RNA extracted from chondrocytes 
treated for 6 hours with a cytoskeletal disrupting agent was used in order to determine 
early gene expression changes, following normalisation to the housekeeping gene 
GAPDH and then to untreated controls. Fold changes in the expression of selected genes 
are summarised in Table 5.1.
5.2.3.2.1 Actin Microfilament Disruption
Treatment with lpM  cytochalasin D for 6 hours resulted in up-regulation of p-actin 
mRNA expression in normal (3 fold) and OA chondrocytes (2.4 fold) (Fig 5.12; ACTB). 
With regards to the typical markers of chondrocyte phenotype, in normal chondrocytes, 
early actin microfilament disruption down-regulated COL1A1 (1.4 fold), up-regulated 
SOX9 (1.2 fold), and showed little effect on aggrecan; COL2A1 was not detected in 
normal untreated chondrocytes and therefore no fold change could be determined. 
COL1A1 and SOX9 expression was unaffected by 6 hours cytochalasin D treatment in 
OA chondrocytes, whilst both COL2A1 (1.9 fold) and ACAN  (1.2 fold) expression were 
down-regulated.
The affect of cytochalasin D on FGFR3 expression differed between normal and OA 
chondrocytes, with FGFR3 up-regulated 1.8-fold in normal chondrocytes and down- 
regulated 1.2-fold in OA chondrocytes. BMF mRNA expression was down-regulated in
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Figure 5.12:- The fold changes o f selected genes, expressed by normal and osteoarthntic 
chondrocytes cultured in 3D agarose, in response to treatment with lpM  cytochalasin D far 6 hours. 
Changes in response to microfilament disruption were determined relative to untreated controls 
following quantitative PGR using a Taqman9 custom-designed array (AZ) and normalisation to die 
housekeeping gene GAPDH. Gene names are shown, except where confidentiality is required by 
AZ, in which case a code o f one letter and number have been used. Letters (and colours) indicate a 
process in /  category which the gene product is mvolved/bekjngs; A- adhesion, C- angiogen, D- 
apoptosis, E- carbohydrate, F- degradation, H- growth factor, I- hypertrophy, J- hypoxia/pH, K- 
inflammation, L- matrix, M- metabolism, N- neurogen, P- osteogen, Q- proliferation, R- transporter, 
S- housekeeper, n = 2
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normal (1.3 fold) and OA chondrocytes (1.6 fold). By contrast, GADD45B was up- 
regulated in normal (1.5 fold) but down-regulated in OA chondrocytes (1.6 fold).
5.2.3.2.2 Tubulin Microtubule Disruption
Following 6 hours treatment with IjiM colchicine to disrupt tubulin microtubules, 
mRNA expression levels of the chondrocyte phenotype markers COL1A1 and SOX9 did 
not change in normal and OA chondrocytes, whilst COL2A1 and AGC were down- 
regulated in OA chondrocytes (1.2 fold) (Fig 5.13). BMF was down-regulated in normal 
(1.3 fold) and OA chondrocytes (2 fold). Colchicine treatment appeared to have a greater 
effect on inflammatory gene expression in OA chondrocytes than in normal 
chondrocytes; PTGS2 (encoding COX-2), IL6 and IL8 were up-regulated in normal (1.3- 
, 1.2- and 1.3-fold, respectively) but more extensively elevated in OA chondrocytes (1.7- 
,4.4- and 2.4-fold, respectively).
5.2.3.2.3 Vimentin Intermediate Filament Disruption
Treatment for 6 hours with 2mM acrylamide had no effect on the expression of 
chondrocyte phenotype markers COL1A1 and AC AN  in normal and OA chondrocytes 
(Fig 5.14). SOX9 expression was down-regulated in normal chondrocytes (1.2 fold) and 
COL2A1 expression was down-regulated in OA chondrocytes (1.2 fold). Acrylamide 
treatment affected growth factor gene expression differently in normal and OA 
chondrocytes: in OA chondrocytes six of the seven genes were up-regulated, whilst in 
normal chondrocytes only two of the genes were up-regulated (Fig 5.14). GADD45B 
was down-regulated in normal (1.2 fold) and OA chondrocytes (1.3 fold) whilst BMF 
was up-regulated in normal chondrocytes (1.5 fold) but remained unchanged in OA 
cells.
Inflammatory genes were altered by 6 hours of treatment with acrylamide. TNFST1J and 
NOS2A were differentially affected in normal and OA chondrocytes; TNFST1J, 
encoding RANK ligand, was up-regulated in normal (2.6 fold) but down-regulated in 
OA chondrocytes (1.3 fold), whilst NOS2A, encoding iNOS, was down-regulated in 
normal (3.3 fold) but up-regulated in OA chondrocytes (3.9 fold). In addition, although 
down-regulated in both, expression changes in IL6, IL8 and PTGS2 were greater in 
normal chondrocytes when compared with OA chondrocytes.
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Figure 5.13:- The fold changes o f selected genes, expressed by normal and osteoarthritic 
chondrocytes cultured in 3D agarose, in response to treatment with lpM  colchicine for 6 hours. 
Changes in response to microtubule disruption were determined relative to untreated controls 
following quantitative PCR using a Taqman® custom-designed array (AZ) and normalisation to die 
housekeeping gene GAPDH. Gene names are shown, except where confidentiality is required by 
AZ, in which case a code o f one letter and number have been used. Letters (and colours) indicate a 
process in /  category which die gene product is involved/belongs; A- adhesion, C- angiogen, D- 
apoptosis, E- carbohydrate, F- degradation, H- growth factor, I- hypertrophy, J- hypoxia/pH, K- 
infiammation, L- matrix, M- metabolism, N- neurogen, P- osteogen, Q- proliferation, R- transporter, 
S- housekeeper, n = 2
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Vimentin Disruption (2mM acrylamide)
Normal R1
P I
N 2 O t
M 2
CCL11A1
X I
COL1A1
F I
0 3
kogRQ(GAPOI) ,
2
a m
1.2 logHQ(GAPOH) 2
Figure 5.14:- The fold changes o f selected genes, expressed by normal and osteo arthritic 
chondrocytes cultured in 3D agarose, in response to treatment with 2mM acrylamide for 6 hours. 
Changes in response to vimentin intermediate filament disruption were determined relative to 
untreated controls following quantitative PCR using a Taqman9 custom-designed array (AZ) and 
normalisation to foe housekeeping gene GAPDH. Gene names are shown, except where 
confidentiality is required by AZ, in which case a code of one letter and number have been used. 
Letters (and colours) indicate a process in / category which foe gene product is involved/belongs; A- 
adhesion, C- angiogen, D- apoptosis, E- carbohydrate, F- degradation, H- growth factor, I- 
hypertrophy, J- hypoxia/pH, K- inflammation, L- matrix, M- metabolism, N- neurogen, P- osteogen, 
Q- proliferation, R- transporter, S- housekeeper, n = 2
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Function Gene
Actin disruption 
Normal OA
Tubulin Disruption 
Normal OA
Vimentin Disruption 
Normal OA
P-actin ACTB + 3 + 2.4 + 1.3 + 1.4 - 1.2 - 1.2
Ph
en
ot
yp
e 
m
ar
ke
rs COL1A1 - 1.4 = = = = =
COL3A1 - 1.4 = = = - 1.2 + 1.2
SOX9 + 1.2 = = = - 1.2 =
ACAN = - 1.2 = - 1.2 = =
COL2A1 nd in Un - 1.9 nd in Un - 1.2 nd in Un - 1.2
D
eg
ra
d­
at
io
n
ADAMTS5 = - 1.2 = + 1.4 = =
MMP13 = + 2 - 1.2 = - 1.3 =
MMP14 + 1.2 + 1.3 = = = + 1.2
G
ro
w
th
fa
ct
or
s
FGF2 = - 1.3 = = = =
FGFR3 + 1.8 - 1.2 = -2.3 + 1.3 + 1.6
TGFB1 = - 1.2 - 1.2 = - 1.2 - 1.2
IGF1 - 1.4 - 1.4 - 1.8 - 1.2 + 1.2 =
A
dh
es
io
n
ITGA2 + 1.6 + 1.6 - 1.2 + 1.2 = + 1.3
ITGB5 = = = = + 1.2 + 1.3
DPT - 1.3 - 1.3 = = + 1.2 —
VCAM1 -2.6 - 1.4 - 1.2 + 1.7 - 1.7 - 1.4
A
po
pt
os
is
CASP3 + 1.4 + 1.2 + 1.2 = = + 1.3
BMF - 1.3 - 1.6 - 1.3 -2 + 1.5 =
HSPB1 + 1.4 = + 1.2 = = - 1.3
GADD45B + 1.5 - 1.6 = + 1.4 - 1.2 - 1.3
In
fla
m
m
at
io
n
PTGS2 + 2 + 1.5 + 1.3 + 1.7 - 1.9 - 1.2
NOS2A - 2 nd nd nd -3.3 + 3.9
IL6 = = + 1.2 + 4.4 - 1.9 - 1.2
IL8 + 1.4 + 1.3 + 1.3 + 2.4 - 1.4 =
TNFSF11 = = + 1.5 - 1.3 + 2.6 - 1.3
Table 5.1:- Summary of fold changes in expression of selected genes in normal and OA 
cartilage chondrocytes in response to cytoskeletal disrupting treatments, relative to 
untreated controls. Gene expression was determined using custom-designed Taqman® 
arrays. Chondrocytes were cultured in 3D agarose hydrogels and treated for 6 hours 
with lpM  cytochalasin D to disrupt actin microfilaments, lpM colchicine to disrupt 
tubulin microtubules or 2mM acrylamide to disrupt vimentin intermediate filaments, 
‘nd’ is not detected; ‘nd in Un’ indicates where expression was not detected in 
untreated controls; = refers to fold changes of magnitude < 1.2.
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S.2.3.2.4 Comparison of Gene Changes Across Treatments
Some of the detected fold changes in gene expression in response to cytoskeletal 
disruption were similar in both normal and osteoarthritic chondrocytes for all treatments 
(Table 5.2). As the response was consistent in all treatments for both normal and OA 
cells, these changes could relate to more general effects of cytoskeletal disruption rather 
than the disruption of specific signalling pathways.
Other genes were similarly regulated in normal and OA chondrocytes, but changes were 
different depending on the treatment and therefore the cytoskeletal element disrupted 
(Table 5.3). A difference in response dependent on the disrupted element implies that the 
change in expression of the gene is not due to general disruption. It could be that 
transcriptional regulation is a response to altered signalling via pathways involving one 
or more of the cytoskeletal elements.
A number of genes also demonstrated a differential response to cytoskeletal disruption in 
OA chondrocytes when compared with normal chondrocytes (Table 5.4). The difference 
in transcriptional response of diseased cells may be indicative of, or due to, existing 
alterations in the cytoskeletal elements and pathological changes in OA chondrocytes.
Gene Name Increased (+) / decreased (-) expression 
compared to untreated controls
TGFB1 -
VEGF +
TGM2 +
T1MP2 +
TIMP3 +
MMP14 +
CASP3 +
Table 5.2:- Genes showing similar responses to cytoskeletal disruption in normal and 
osteoarthritic chondrocytes. Chondrocytes were cultured in 3D agarose and gene 
changes, following 6 hours of treatment with reagents known to disrupt individual 
cytoskeletal elements of the cytoskeleton, were determined using a Taqman® custom 
designed array.
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Gene Name Cytoskeletal element disrupted 
resulting in increased expression
Cytoskeletal element disrupted 
resulting in decreased expression
ADAMTS4 Actin & Vimentin Tubulin
SOX9 Actin Vimentin
IGF1 Vimentin Actin & Tubulin
FGFR3 Vimentin Tubulin
IL8 Actin & Tubulin Vimentin
PTGS2 Actin & Tubulin Vimentin
RUNX2 Actin & Tubulin Vimentin
GADD45B Tubulin Vimentin
BMF Vimentin Actin & Tubulin
SLC2A3 Actin & Vimentin Tubulin
SDC2 Actin Tubulin
Table 5.3:- Genes showing similar responses in normal and osteoarthritic chondrocytes, 
but different responses depending on the cytoskeletal element disrupted. Chondrocytes 
were cultured in 3D agarose and gene changes, following 6 hours of treatment with 
reagents known to disrupt different cytoskeletal elements, were determined using a 
Taqman® custom designed array.
Gene Name
Increased(+) / decreased(-) 
expression 
Normal OA
Disrupted Cytoskeletal Element
ADAMTS5 - + Tubulin & Vimentin
COMP - + Actin
FGFR3 + - Actin
MMP13 - + Actin
PTCH - + Vimentin
TNFSF11 + - Actin, Tubulin & Vimentin
NOS2A - + Vimentin
VCAM1 - + Tubulin
GADD45B + - Actin
Table 5.4:- Genes showing a different response in osteoarthritic chondrocytes compared 
to normal following the same treatment and therefore disruption of the same 
cytoskeletal element. Chondrocytes were cultured in 3D agarose and gene changes, 
following 6 hours of treatment with reagents known to disrupt different cytoskeletal 
elements, were determined using a Taqman® custom designed array.
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5.2.3.3 Other Genes of Interest
From the Taqman® custom-designed array results, genes of interest were selected and 
the effect of cytoskeletal disruption on mRNA expression levels determined using 
quantitative PCR with SYBR green.
Unlike gene expression detected in articular cartilage (section 3.2.3), and as implied by 
differences observed by Taqman® custom designed arrays (section 4.2.2.2), aggrecan 
gene expression in chondrocytes in 3D agarose culture was significantly affected by 
pathology (Fig 5.15); expression was decreased in OA chondrocytes when compared 
with normal chondrocytes at all time points assayed, as determined using a general linear 
model (p < 0.0035 at 6, 12, 24 and 48 hours). In chondrocytes treated for 6 hours with 
colchicine, aggrecan expression was significantly lower in OA chondrocytes than in 
normal chondrocytes (p = 0.043). Aggrecan expression was also lower than normal in 
OA chondrocytes treated with cytochalasin D for 6 (p = 0.055), 12 (p = 0.058) and 24 
hours (p = 0.015). An effect of vimentin cytoskeletal disruption on aggrecan expression 
was evident in normal chondrocytes; treatment with acrylamide resulted in 
downregulation of aggrecan expression, with the decrease reaching significance at 48 
hours (Fig 5.15: 4.2 fold; p = 0.021).
COL1A1 expression was higher in OA chondrocytes when compared with normal 
chondrocytes at all time points and in all treatment groups, although a higher degree of 
variability meant that differences did not reach statistical significance (data not shown). 
There was no clear effect of cytoskeletal disruption on COLIA1 expression in normal 
and OA chondrocytes. As in articular cartilage (section 3.2.3), SOX9 expression was 
lower in OA chondrocytes when compared with normal chondrocytes, regardless of 
treatment or culture period (data not shown). SOX9 expression in normal and OA 
chondrocytes was unaffected by cytoskeletal disruption.
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Figure 5.15:- Aggrecan gene expression changes with cytoskeletal disruption. 
Absolute mRNA levels were determined using SYBR Green quantitative PCR and 
normalised to the housekeeping gene GAPDH. Nucleic acids were isolated from 
chondrocytes from normal and osteoarthritic (OA) cartilage, encapsulated in 3D 
agarose and cultured without (untreated) or with treatment for 6,12, 24 or 48 hours 
— treatments included 1 pM cytochalasin D to disrupt actin micro filaments, 1 pM 
colchicine to disrupt tubulin microtubules, or 2 mM acrylamide treatment to disrupt 
vimentin intermediate filaments. Data are presented as mean ± S.E.M. (n=5). * p < 
0.05, treatment compared to untreated control.
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As observed in cartilage (section 3.2.3), ADAMTS5 expression was significantly lower in 
untreated OA chondrocytes when compared with untreated normal chondrocytes at all 
time points assayed (Fig 5.16 A; p = 0.034 at 12 hours). In support of changes observed 
on Taqman® arrays (Fig 5.13), quantitative PCR using SYBR green indicated that 
colchicine treatment resulted in up-regulation of ADAMTS5 expression in OA 
chondrocytes at 6 hours (2.7 fold; p = 0.012, Mann Whitney) and 12 hours (2.4 fold; p = 
0.034); this effect of colchicine on ADAMTS5 expression was lost following 24 and 48 
hours treatment (data not shown). There was no clear effect of cytoskeletal disruption on 
ADAMTS5 expression in normal chondrocytes, which showed more varied levels of 
ADAMTS5 mRNA (Fig 5.16 A).
At 12 hours MMP13 mRNA expression was significantly higher in OA chondrocytes 
when compared with normal chondrocytes in all treatment groups. However, an effect of 
cytoskeletal disruption on MMP13 expression was not apparent until 24 hours, when 
expression in OA chondrocytes was reduced by colchicine (2.2 fold; p = 0.024) and 
acrylamide (2.8 fold; p = 0.014) treatment (Fig 5.16 B). At 48 hours the effect of 
acrylamide treatment on MMP13 expression in OA chondrocytes remained significant 
(5.4 fold; p = 0.015) whilst the effect of colchicine was no longer significant (2.3 fold; p 
= 0.127). MMP13 expression in normal chondrocytes followed the same trend as in OA 
cells, although the effects did not achieve significance.
BMF mRNA expression appeared higher in untreated OA chondrocytes when compared 
to normal chondrocytes, with the difference increasing over the culture period, but not 
reaching statistical significance (p = 0.092 at 48 hours; Fig 5.16 C). Treatment of OA 
chondrocytes with cytochalasin D (2.0 fold; p = 0.069), colchicine (2.6 fold; p = 0.022) 
or acrylamide (4 fold; p = 0.010) for 48 hours reduced BMF expression (Fig 5.16 C). 
There was no significant effect of cytoskeletal disruption on BMF mRNA levels in 
normal chondrocytes.
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5.2.4 Changes in MMP-2 Expression or Activation Following 
Cytoskeletal Disruption
Levels of pro-MMP2 released into the media increased over the 48 hour culture period, 
indicating that both untreated normal and OA chondrocytes were able to synthesise and 
secrete proteins (Fig 5.17). Active-MMP2 was barely detectable in untreated normal 
chondrocyte cultures but was evident in culture media from untreated OA chondrocytes, 
where levels were observed to increase over the culture period. Disruption of actin 
microfilaments by cytochalasin D treatment increased the activation of MMP-2 in both 
normal and OA chondrocytes, with active-MMP2 evident after 6 hours of treatment. 
Levels of active-MMP2 were higher in cytochalasin D-treated OA chondrocytes 
compared to untreated controls, and active-MMP2 levels increased over those of pro- 
MMP2 at 24 hours. Disruption of tubulin microtubules with colchicine or vimentin 
intermediate filaments with acrylamide appeared to have no effect on the levels of pro- 
and active-MMP2 in normal and OA chondrocyte culture media. MMP-9 was not 
detected in untreated chondrocyte culture media by gelatin zymography and treatments 
did not increase MMP-9 expression to the level of detection.
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F igure 5 .1 7 :- T he expression  and activation o f  M M P-2 in chondrocytes isolated  
from  normal and osteoarthritic (O A ) cartilage, encapsulated in 3 D  agarose and  
cultured w ith  or w ithout treatment for 6 , 12 , 2 4  or 48 hours. G elatin substrate 
zym ography w as used  to detect the latent (72kD ) and active (62k D ) form s o f  
M M P-2 w ith  w h ite  bands representing zon es o f  gelatinolytic activity. E quivalent 
v o lu m es o f  m edia w ere loaded. ‘U n ’- untreated chondrocytes, ‘C D ’-  1|±M  
cytochalasin  D , ‘C h 7-  lp M  co lch ic in e , ‘A c 7- 2  m M  acrylam ide treated  
chondrocytes.
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5.3 DISCUSSION
Osteoarthritis is characterised by a shift in the balance between anabolism and 
catabolism in the articular cartilage of synovial joints as a result of an altered 
chondrocyte phenotype. In addition to an altered phenotype, differences in the 
chondrocyte cytoskeleton have also been observed in OA chondrocytes (chapter 3). 
What remains to be determined is whether the changes in the cytoskeleton occur before, 
alongside or as a result of phenotypic changes in articular chondrocytes.
Numerous studies have highlighted a link between the cytoskeleton and cell phenotype, 
with changes in cytoskeletal organisation altering gene expression. In chondrocytes, 
phenotype and cell shape have long been known to be closely associated, with a round 
morphology associated with a chondrocytic type II collagen phenotype (Benya and 
Shaffer, 1982b). Alongside changes in chondrocyte phenotype, changes in actin 
cytoskeletal organisation were also observed (Brown and Benya, 1986), and 
subsequently shown to be the cause of the phenotypic changes, independent of cell shape 
perturbations (Benya et al., 1988). Disruption of actin microfilament dynamics promotes 
hypertrophic differentiation in mouse embryonic tibia chondrocytes (Woods et al., 2009) 
and increased expression of SOX9, a transcription factor required for chondrogenesis and 
maintenance of the chondrocyte phenotype (Woods et al., 2005). By contrast, SOX9 
expression and GAG synthesis are decreased following microtubule disruption (Woods 
et al., 2005, Takigawa et al., 1984). Finally, vimentin intermediate filament disruption in 
chondrocytes results in decreased expression of the chondrocyte phenotype markers 
COL2A1 and ,4 C4 A (type II collagen and aggrecan respectively) (Blain et al., 2006).
Changes in the cytoskeleton have been shown to affect chondrocyte gene expression, 
and differences in the organisation and expression of cytoskeletal elements are apparent 
between normal and osteoarthritic human chondrocytes (chapter 3). Therefore the 
response of human chondrocytes to cytoskeletal disruption has been investigated to 
determine whether or not the response of OA chondrocytes differs to that of normal 
chondrocytes. In 3D agarose culture the cytoskeletal organisation and phenotype of 
chondrocytes resembles that of cartilage chondrocytes in situ (chapter 3 and 4). In 
addition, the differences between normal and OA chondrocyte gene expression in 
cartilage are more accurately represented in 3D agarose culture (chapter 4);
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chondrocytes were therefore cultured and treated with cytoskeletal disrupting agents in a 
3D agarose construct.
The concentrations of cytoskeletal disrupting reagents used were based on previous 
studies on chondrocytes cultured as a monolayer. Treatment with lpM  colchicine 
effectively disrupts microtubules and reduces SOX9 expression in chondrocytes 
(Evangelisti et al., 1995, Woods et al., 2005). My preliminary work on human 
chondrocytes cultured as a monolayer confirmed disruption of microtubule bundles 
following 12 hours of treatment with lpM colchicine (appendix 4). Actin microtubules 
are disrupted by lpM  cytochalasin B (Evangelisti et al., 1995); cytochalasin D has also 
been used to disrupt microfilaments at concentrations ranging from 0.4pM (Castilla et 
al., 2000) to 8pM (Tomasek et al., 1997). In mouse chondrocytes, 3pM cytochalasin D 
induces up-regulation of SOX9 expression (Woods et al., 2005), whilst in human 
chondrocytes, cell rounding is induced in monolayer by lpM cytochalasin D (Tew and 
Hardingham, 2006) (appendix 4). In bovine chondrocytes treatment with 5mM 
acrylamide induces perinuclear collapse of vimentin intermediate filaments (Blain et al., 
2006). However vimentin disruption remains effective at 2mM acrylamide with the 
additional benefit of reduced cytotoxicity (Blain, unpublished observations). Treatment 
with 2mM acrylamide disrupts vimentin intermediate filament bundles in monolayer 
human chondrocytes (appendix 4). In all instances disruption of a specific cytoskeletal 
element was achieved in chondrocytes cultured in 3D agarose, with little or no effect on 
the organisation of the other major elements after 24 hours of treatment.
5.3.1 Cytoskeletal Elements and Cytoskeletal-associated Proteins
mRNA expression levels of P-actin and the actin-depolymerising proteins cofilin and 
destrin were increased in response to disruption of actin microfilaments. As cytochalasin 
D disrupts microfilament dynamics through actin filament capping and cleavage 
(Urbanik and Ware, 1989) and thus increases the G-actin pool, it is interesting that these 
F-actin severing proteins are up-regulated. In normal chondrocytes, treatment with 
colchicine up-regulated P-actin and destrin mRNA expression at 12 hours, perhaps 
providing an explanation for the small effect of microtubule disruption on actin 
microfilament organisation observed at 24 hours. Differential regulation of these genes 
in response to cytoskeletal disruption was primarily observed in chondrocytes isolated 
from normal cartilage, indicating that these cytoskeletal genes are more sensitive to
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cytoskeletal disruption in normal chondrocytes than in OA chondrocytes. Expression of 
the cytoskeletal and associated proteins that were observed to differ in expression 
between normal and OA cartilage (chapter 3), including vimentin, p-tubulin, thymosin 
P4 and paxillin, were unaffected by cytoskeletal disrupting reagents over the 48 hour 
period studied.
5.3.2 Chondrocyte Phenotype Markers and Matrix Metabolism Genes
With regards to the typical markers of the chondrocyte phenotype, COL2A1 and AC AN  
were down-regulated in OA chondrocytes with disruption of individual cytoskeletal 
elements. Reduced expression and synthesis of type II collagen and aggrecan has been 
demonstrated following vimentin intermediate filament disruption with acrylamide 
(Blain et al., 2006) and reduced GAG synthesis following microtubule disruption with 
colchicine suggests a decrease in aggrecan core protein (Takigawa et al., 1984). No 
significant changes in SOX9 expression were observed in chondrocyte-agarose 
constructs over the 48 hours of cytoskeletal disruption. Previous studies have 
demonstrated down-regulation of SOX9 with microtubule disruption (Woods et al., 
2005) and up-regulation with actin disruption (Woods et al., 2005, Tew and 
Hardingham, 2006, Zhang et al., 2006c), although these studies focused on the effects of 
cytoskeletal disruption on chondrogenesis or dedifferentiation/ redifferentiation. For 
example, Tew and Hardingham, 2006 showed an increase in SOX9 mRNA expression in 
mature human chondrocytes after 5 hours of treatment with lpM cytochalasin D. 
However, this was observed in monolayer conditions and was associated with a loss of 
actin stress fibres. Although they demonstrated an up-regulation of SOX9 expression 
when monolayer chondrocytes were transferred to alginate culture, the effect of 
cytochalasin D on SOX9 expression in chondrocytes cultured in 3D conditions was not 
investigated (Tew and Hardingham, 2006). The difference in cell morphology and lack 
of stress fibres could influence the observed effects of treatment, as demonstrated by 
recent studies in which p38 MAPK stabilised SOX9 mRNA in human chondrocytes only 
in the absence of actin stress fibres (Tew and Hardingham, 2006, Tew et al., 2009). 
Cytoskeletal disruption had little effect on the expression of COL1A1 and COL3A1 in 
3D agarose culture, with down-regulation observed only in the Taqman® array data and 
in normal chondrocytes treated with cytochalasin D. As type I and type III collagen are 
markers of a fibroblastic phenotype, these changes could be an indication of enhanced
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redifferentiation with actin disruption in normal chondrocytes; this effect, if any, is small 
as no significant changes were detected with SYBR® green.
Disruption of actin stress fibres in fibroblasts results in increased expression of pro- 
MMP1 and -3 (Werb et al., 1986), MMP-2 and MMP-14 (Tomasek et al., 1997), MMP- 
3, -9, -13 and -14 (Lambert et al., 2001), and increased activation of pro-MMP2 
(Lambert et al., 2001, Tomasek et al., 1997). In contrast to reports in fibroblasts, MMP3 
expression was down-regulated following six hours of microfilament disruption in 
normal and OA chondrocytes. MMP1 was also down-regulated in OA, but up-regulated 
in normal chondrocytes. Activation of pro-MMP2 was increased in both normal and OA 
chondrocytes with actin disruption, and expression of MMP-14 was increased in all 
treatment and pathology groups. In support of previous work in bovine chondrocytes 
(Blain et al., 2006), no induction of MMP-2 expression or activation was observed with 
vimentin disruption. On Taqman® arrays, MMP13 expression was up-regulated with
actin disruption in OA chondrocytes, but no significant differences were observed with
(£)SYBR green using an increased number of samples. By contrast, MMP13 was down- 
regulated with disruption of the tubulin or vimentin cytoskeleton in OA chondrocytes. 
Tubulin disruption also resulted in increased expression of ADAMTS5 in OA 
chondrocytes.
Disruption of any of the major cytoskeletal elements in chondrocytes therefore has the 
potential to affect extracellular matrix composition through the regulation of genes 
encoding both matrix proteins and matrix-degrading enzymes.
5.3.3 Growth Factor-related Genes
Changes in expression of the growth factor-related genes varied depending on the 
pathology and the cytoskeletal element disrupted. Expression of TGFB1 was down- 
regulated irrespective of the cytoskeletal element disrupted and of pathology. Disruption 
of microtubule dynamics in bovine chondrocytes with colchicine reduces TGFpl 
secretion but has no effect on TGFB1 transcription (E.J. Blain, unpublished results). By 
contrast, cytochalasin B, cytochalasin C and colchicine have been shown to induce 
increases in TGFpi mRNA and protein expression (Varedi et al., 1997, Nahm et al., 
2004). It should be noted however that this was observed using fibroblasts, which 
exhibit a morphology and cytoskeletal organisation closer to that of dedifferentiated
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chondrocytes, and distinct from that of differentiated chondrocytes. Whilst TGFpi 
induces chondrogenesis (Mehlhom et al., 2006) and is anabolic for dedifferentiated 
chondrocytes, it can also enhance dedifferentiation of mature, differentiated articular 
(Galera et al., 1992a) and epiphyseal chondrocytes (Ballock et al., 1993) cultured as a 
monolayer. Up-regulation of Rho GTPase activity and stress fibre formation in 
chondrocytes by TGFpl could also be detrimental to the chondrocyte phenotype 
(Haudenschild et al., 2009). Therefore down-regulation of TGFB1 with cytoskeletal 
disruption does not necessarily imply a reduction in anabolism.
In contrast to TGFB1, changes in IGF1 expression varied according to the cytoskeletal 
element disrupted; expression was up-regulated with vimentin disruption but down- 
regulated with actin or tubulin disruption. IGF-I induces anabolic changes in 
chondrocytes (Fortier et al., 2002, Jenniskens et al., 2006, Zhang et al., 2009) and also 
promotes a typical chondrocyte morphology and cytoskeletal organisation by reducing 
Rho and Cdc42 GTPase activity and actin stress fibres (Fortier et al., 2004, Novakofski 
et al., 2009). Down-regulation of IGF1 with actin disruption could therefore be a 
response to altered actin cytoskeletal dynamics and a requirement for Rho GTPase 
activity. Up-regulation of the anabolic growth factor by vimentin disruption is 
interesting considering the down-regulation of type II collagen and aggrecan expression 
observed in the present study and in bovine chondrocytes (Blain et al., 2006).
Changes in FGFR3 expression varied depending on pathology but were independent of 
the cytoskeletal element disrupted; expression was up-regulated in normal but down- 
regulated in OA chondrocytes. FGFR3 and its activation by FGF18 is associated with 
anabolic effects on articular cartilage and chondrocytes (Ellman et al., 2008). Gain-of- 
function mutations of FGFR3 are associated with chondrodysplasias and overexpression 
of constitutively active FGFR3 in foetal chondrocytes is associated with premature 
hypertrophic differentiation (Legeai-Mallet et al., 2004). FGF18 signals through FGFR3 
to suppress mesenchymal cell proliferation and promote chondrogenesis and cartilage 
matrix synthesis (Davidson et al., 2005). In adult human articular chondrocytes, loss of 
FGFR3 expression, along with COL2A1, is associated with a reduced capacity to form 
cartilage in vivo (Dell'Accio et al., 2001). In addition, FGFR3-knockout mice exhibit 
increased expression of MMP13 and type X collagen along with increased degradation 
of type II collagen and aggrecan, resulting in cartilage degradation similar to that
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observed in OA (Valverde-Franco et al., 2006). In support of this connection with OA, 
intra-articular injection of FGF18 promotes new cartilage formation and reduces 
cartilage degeneration in a rat model of OA (Moore et al., 2005). It is interesting 
therefore that FGFR3, which is more highly expressed in OA than in normal 
chondrocytes (chapter 4), should be down-regulated with cytoskeletal disruption in OA 
chondrocytes but up-regulated in normal chondrocytes. FGF18 expression was also 
down-regulated in OA chondrocytes with disrupted actin and vimentin networks. 
Differences in FGF18 expression between normal and OA human chondrocytes and 
changes in FGF18 expression with cytoskeletal disruption in normal chondrocytes could 
not be calculated due to undetected expression in untreated normal chondrocytes; 
however, detection of expression in treated normal chondrocytes could imply an up- 
regulation, with FGF18 changes therefore mirroring those of FGFR3. Up-regulation of 
FGFR3 and FGF18 in OA chondrocytes could be indicative of hypertrophy (Davidson et 
al., 2005, Liu et al., 2007) or of an anabolic repair response.
Disruption of any of the main elements of the chondrocyte cytoskeleton therefore has the 
potential to affect chondrocyte phenotype and extracellular matrix composition through 
the expression of genes encoding growth factors that regulate chondrocyte 
differentiation, matrix synthesis and matrix degradation.
5.3.4 Inflammation-related Genes
Changes in the expression of NOS2A, which encodes inducible nitric oxide synthase 
(iNOS), and TNFSF11, the gene encoding receptor activator of NFkB ligand (RANKL), 
varied depending on pathology. Vimentin disruption with acrylamide reduced NOS2A 
expression in normal chondrocytes but increased expression in OA chondrocytes. 
Previous work in neurons has shown increased iNOS expression in response to 
acrylamide treatment (Kim, 2005). Up-regulation of NOS2A was also observed in 
normal chondrocytes treated with cytochalasin D. In support of this, disruption of actin 
cytoskeletal dynamics, either by cytochalasin D or inhibition of Rho/ROCK signalling, 
enhances cytokine-induced iNOS mRNA expression in epithelial cells (Witteck et al., 
2003). NOS2A expression was undetected in colchicine-treated chondrocytes and 
therefore no fold-change could be determined. Colchicine decreases iNOS expression in 
smooth muscle cells (Marczin et al., 1996) and neurons (Gahm et al., 2005), therefore it 
is possible that down-regulation of NOS2A with tubulin disruption resulted in lack of
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detection in these samples. Disruption of the tubulin or vimentin cytoskeleton resulted in 
up-regulation of TNFSFJ1 expression in normal but down-regulation in OA 
chondrocytes. In prostate cancer cells, RANKL is up-regulated during the epithelial to 
mesenchymal transition and is therefore associated with up-regulation of vimentin 
(Odero-Marah et al., 2008). RANKL is expressed by osteoblasts and promotes 
osteoclastogenesis and bone resorption (Bezerra et al., 2005) and its expression is 
elevated in a subpopulation of OA subchondral bone osteoblasts (Kwan Tat et al., 2008) 
and late stage OA cartilage (Ijiri et al., 2008). However, whilst RANKL and its receptor, 
RANK, are expressed in normal and OA cartilage, exogenous RANKL does not activate 
human articular chondrocytes in culture (Komuro et al., 2001). Down-regulation of 
RANKL expression in OA chondrocytes could be indicative of the existing difference in 
expression between OA and normal chondrocytes (chapter 4 and Ijiri et al, 2008); up- 
regulation in normal chondrocytes would therefore indicate a detrimental response to 
cytoskeletal disruption.
In contrast to NOS2A and TNFSF11 expression changes, PTGS2 and IL8 expression 
changes were independent of pathology but dependent on the cytoskeletal element 
disrupted. PTGS2, encoding cyclooxygenase-2 (COX-2) was up-regulated with 
disruption of actin or tubulin but down-regulated with vimentin disruption. In support of 
this, colchicine or cytochalasin D treatment increases COX-2 protein expression and 
synthesis of prostaglandin E2 in human endothelial and epithelial cells (Sawyer et al., 
2001, Subbaramaiah et al., 2000). In chondrocytes however, disruption of the actin 
cytoskeleton by cytochalasin D inhibits COX-2 expression and prostaglandin E2 
production induced by nitric oxide (NO) (Kim et al., 2003). IL8 expression was also up- 
regulated in chondrocytes with actin and tubulin disruption but down-regulated with 
disruption of vimentin. The effects of cytoskeletal changes on IL8 expression have not 
previously been demonstrated in chondrocytes. However, microtubule disruption by 
colchicine induces IL8 expression in epithelial cells (Shibata et al., 1996) and 
cytochalasin D enhances IL8 expression in monocyte-like cells (Kustermans et al., 
2008). IL-8-induced cell migration and phosphorylation of focal adhesion kinase 
requires an intact actin and tubulin cytoskeleton (Cohen-Hillel et al., 2006), suggesting 
that cytoskeletal disruption can alter IL-8 signalling as well as expression.
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Prostaglandin E2 decreases aggrecan expression, proteoglycan synthesis and type II 
collagen in human articular chondrocytes (Li et al., 2009b); by contrast, very low 
concentrations of prostaglandin E2 suppress MMP13 expression and type II collagen 
cleavage in OA cartilage (Tchetina et al., 2007). Furthermore, NO suppresses 
proteoglycan and type II collagen synthesis whilst increasing MMP activity in articular 
cartilage chondrocytes (Taskiran et al., 1994, Cao et al., 1997, Murrell et al., 1995). 
Dysregulation of key inflammatory genes in response to disruption of any of the main 
elements of the chondrocyte cytoskeleton could therefore further affect chondrocyte 
phenotype and extracellular matrix composition.
5.3.5 Apoptosis-related Genes
Expression of CASP3, which encodes pro-apoptotic caspase-3, was up-regulated with 
cytoskeletal disruption, independently of treatment and pathology. CASP3 expression is 
elevated over normal levels in human OA chondrocytes cultured in 3D agarose (chapter 
4) and in human OA cartilage (Sharif et al., 2004). Acrylamide increases caspase-3 
activity in chondrocytes (Blain et al., 2006), lymphocytes (Blasiak et al., 2004) and 
neurons (Sumizawa and Igisu, 2007). In chondrocytes, NO-induced caspase-3 activation 
is suppressed by actin disruption with cytochalasin D (Kim et al., 2003). Actin 
cytoskeletal disruption with cytochalasin D also prevents caspase-3 activation in a 
number of other cell types including platelets (Ben Amor et al., 2006), B-cells (Melamed 
and Gelfand, 1999) and cardiomyocytes (Okada et al., 2005). As cell viability assays 
showed no significant increase in cell death over 48 hours with each treatment, the up- 
regulation of CASP3 expression could have apoptosis-independent consequences. For 
example, caspase-3 can cleave vimentin at asparagine 85, resulting in disruption of 
intermediate filament networks in cells (Byun et al., 2001). Modified isoforms of 
caspase-3-cleaved vimentin are detected in synovial tissue from patients with 
rheumatoid arthritis (Tilleman et al., 2008). In addition to cleavage of vimentin, caspase- 
3-mediated cleavage of gelsolin generates a product that severs actin filaments in vitro 
and induces cell rounding (Kothakota et al., 1997). Therefore up-regulation of CASP3 
expression by cytoskeletal disruption in agarose-embedded chondrocytes could result in 
further modification of cytoskeletal organisation.
GADD45B expression was up-regulated in chondrocytes following tubulin disruption 
but down-regulated after vimentin disruption. There is little clear evidence linking
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GADD45P with the cytoskeleton in any cell type. Differential GADD45B expression in 
actin disassembled chondrocytes was dependent upon pathology; GADD45B expression 
was up-regulated in normal but down-regulated in OA chondrocytes, corroborating the 
observation of decreased GADD45B expression in OA chondrocytes encapsulated in 
agarose (chapter 4). GADD45B expression is reduced in both bone and cartilage in late 
stage OA (Hopwood et al., 2007, Ijiri et al., 2008). GADD45p can be both pro-and anti- 
apoptotic, inhibiting TNFa-induced or promoting TGFP-induced apoptosis (De Smaele 
et al., 2001, Yoo et al., 2003). In human articular chondrocytes, GADD45P is 
cytoprotective whilst suppressing COL2AJ promoter activity and mRNA expression 
(Ijiri et al., 2008); in murine epiphyseal chondrocytes GADD45p promotes terminal 
differentiation and stimulates MMP13 promoter activity (Ijiri et al., 2005). Altered 
expression of GADD45B could therefore affect the chondrocyte phenotype and 
ultimately the matrix composition of the cartilage tissue.
Taqman® array data revealed down-regulation of BMF expression in normal and OA 
chondrocytes with disruption of actin and tubulin, whilst in acrylamide-treated cells, 
BMF expression was elevated in normal chondrocytes but was unchanged in OA. 
Further investigation by quantitative PCR demonstrated down-regulation of BMF 
expression after 48 hours of actin, tubulin or vimentin disruption in OA chondrocytes. 
My results indicated that BMF is expressed more highly in agarose-cultured OA 
chondrocytes when compared with normal cells. BMF encodes Bcl2-modifying factor, a 
Bcl2 family member that promotes apoptosis through binding of pro-survival Bcl2 
proteins (Puthalakath et al., 2001). Interestingly, Bcl2 expression is reduced in OA 
cartilage when compared with normal (Brew et al., 2010a). BMF binds to the dynein 
light chain 2 (DLC2) component of the myosin V motor complex, which sequesters it to 
actin microfilaments; cytochalasin D treatment releases BMF from F-actin (Puthalakath 
et al., 2001). The loss of cell attachment and hence integrin signalling, an apoptotic 
signal termed “anoikis”, releases BMF from DLC2, enabling its interaction with pro­
survival Bcl2 proteins (Puthalakath et al., 2001). In mammary epithelial cells, BMF 
expression is elevated following actin disruption or loss of matrix attachment (Schmelzle 
et al., 2007). This is in contrast with my results in human articular chondrocytes which 
indicate a down-regulation of BMF with disruption of the actin cytoskeleton, particularly 
in OA chondrocytes. Down-regulation of BMF in response to cytoskeletal disruption in
- 2 18 -
Chapter 5: Cytoskeleton and Chondrocyte Phenotype
chondrocytes suggests an anti-apoptotic response; this is in direct contrast to the 
observed up-regulation of pro-apoptotic CASP3.
Whilst the response of normal and osteoarthritic chondrocytes is not straightforward, it 
is clear that cytoskeletal dysregulation has the ability to alter expression of genes 
involved in diverse processes. Cytoskeletal disruption affects expression of genes with 
established roles in chondrocyte metabolism and extracellular matrix turnover (Goldring, 
2000), in addition to genes that can further alter cytoskeletal organisation and those not 
previously associated with chondrocytes or the cytoskeleton. The data demonstrating 
dysregulation of the cytoskeleton in OA chondrocytes infers that this could contribute to 
the altered chondrocyte phenotype that is a hallmark of OA.
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6. THE EFFECT OF LOAD AND CYTOSKELETAL 
ELEMENT DISRUPTION ON CHONDROCYTE 
PHENOTYPE
6.1 INTRODUCTION
6.1.1 Load and Chondrocyte Phenotype
Load has long been hypothesised as a key mediator in the development of OA. It is a 
major element in all of the risk factors associated with the development of secondary OA 
(section 1.3.2.1) and in OA joints regions of fibrillation most often occur at weight­
bearing regions of the articular cartilage. A number of studies have implicated load as a 
mediator of cartilage turnover. As discussed in section 1.4.1, experimental induction of 
changes in joint loading patterns in vivo and mechanical compression of ex vivo cartilage 
explants clearly demonstrates a role of load in the regulation of chondrocyte phenotype. 
The effect on chondrocyte phenotype depends on the loading regimen used, but in 
general, static loads induce catabolic changes whilst dynamic/cyclic loading is anabolic, 
and damage to the cartilage increases with increasing load magnitude and duration (Kurz 
et al., 2005).
In order to remove variables associated with differences in the mechanical integrity of 
the cartilage matrix, in addition to enabling easy manipulation of chondrocytes and 
culture conditions, the effects of load have been studied using chondrocytes isolated 
from cartilage. As chondrocyte phenotype is lost in monolayer but maintained in 3D 
agarose culture (section 4.1), chondrocytes embedded in hydrogels have been used to 
study the effects of mechanical loading regimes on chondrocyte phenotype.
6.1.1.1 Chondrocytes Embedded in Agarose
Chondrocytes embedded in agarose transcribe and synthesise chondrocyte matrix 
molecules (Buschmann et al., 1995, Knight et al., 1998). Bovine chondrocytes show 
increases in collagen and sGAG content from day one to day six of culture (Knight et al., 
1998). Matrix molecules, including proteoglycans and type VI collagen form a 
pericellular matrix surrounding the chondrocytes, visible after just 24 hours, that 
develops and increases over the duration of culture (Buschmann et al., 1995, Dimicco et
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al., 2007). Static compression reduces proteoglycan and protein synthesis in 
chondrocyte/agarose constructs, indicating that the biochemical response of in situ 
cartilage chondrocytes is preserved in agarose culture (Buschmann et al., 1995). Cell 
proliferation has also been shown to be reduced by static compression of bovine 
chondrocytes in agarose (Lee and Bader, 1997). By contrast, bovine chondrocytes in 
agarose subjected to four hours of a 5 MPa static hydrostatic pressure, which does not 
cause cell deformation, showed increased aggrecan expression and GAG synthesis 
(Toyoda et al., 2003). As in cartilage, cyclic or dynamic compression of chondrocytes in 
hydrogel produces anabolic changes including increased proteoglycan synthesis 
(Buschmann et al., 1995, Chowdhury et al., 2003, Mauck et al., 2003, Mio et al., 2005, 
Wang et al., 2008b), aggrecan gene transcription (Mio et al., 2005, Mauck et al., 2007) 
and cell proliferation (Lee and Bader, 1997). Protein synthesis or type II collagen 
content is increased with dynamic compressive loading after 10 hours (Buschmann et al., 
1995), 48 hours (Wang et al., 2008b), 21 and 28 days (Mauck et al., 2003, Chokalingam 
et al., 2009). COL2A1 promoter activity and mRNA expression has been shown to be 
increased by dynamic compression for 24 hours (Mio et al., 2005), seven days and 14 
days (Chokalingam et al., 2009), whilst loading for just 30 minutes reduced COL2A1 
promoter activity (Bougault et al., 2008).
The frequency of dynamic compressive loading regimes can influence the response of 
chondrocytes, as observed for proteoglycan synthesis and release in cartilage explants 
(section 1.4.2). Stimulation of protein synthesis in dynamically compressed bovine 
chondrocyte/agarose constructs were increased with increasing frequency, from 0.01 Hz 
to 1 Hz (Buschmann et al., 1995). Proteoglycan synthesis is inhibited by dynamic 
compression at 0.3 Hz but stimulated at 1 Hz (Lee and Bader, 1997). In addition, 
differences are noted between dynamic compression applied continuously or 
intermittently. Increases in proteoglycan synthesis were greater with intermittent 
dynamic compression regimes when compared with continuous dynamic compression 
(Chowdhury et al., 2003), whilst expression of MMP1 and MMP3 was increased by 
intermittent loading but down-regulated by continuous compression (Nicodemus and 
Bryant, 2010).
With the expanding interest in tissue engineering, chondrocytes have been seeded into 
and studied in numerous constructs and scaffolds other than hydrogels. These studies
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have also demonstrated an enhanced chondrocyte phenotype and synthesis of an 
articular cartilage-like matrix following the application of dynamic mechanical load (Xie 
et al., 2006, Fehrenbacher et al., 2006, Schmidt et al., 2006, Waldman et al., 2006, Wang 
et al., 2009a). In bovine chondrocytes seeded onto calcium polyphosphate substrates, 
MMP3 and MMP13 expression were transiently up-regulated following 30 minutes of 
cyclic compression, increasing at two hours post-loading and returning to baseline levels 
at six hours (De Croos et al., 2006). Catabolic increases in MMP-13 activity and release 
of proteoglycans and collagen at six hours post-compression were also transient and 
were followed by increases in type II collagen and aggrecan mRNA expression and 
synthesis at 12 and 24 hours post-compression.
6.1.2 The Chondrocyte Cytoskeleton and Load
In addition to its effect on the chondrocyte phenotype, mechanical load can alter the 
organisation of the chondrocyte cytoskeleton along with the expression and activity of 
cytoskeletal -associated and -regulatory proteins (see section 1.4.3.2). Furthermore, the 
actin (section 1.4.3.3) and tubulin (section 1.4.2.1.5) cytoskeletal networks have been 
implicated in chondrocyte mechanotransduction pathways.
6.1.3 Mechanotransduction in Osteoarthritic Chondrocytes
Changes in the mechanical integrity of the extracellular matrix, the chondrocyte 
phenotype, the viscoelasticity of chondrocytes and the chondrocyte cytoskeleton in OA 
could result in altered mechanotransduction in OA chondrocytes. In support of this, the 
integrin-, IL-4- and stretch activated ion channel-dependent membrane hyperpolarisation 
induced in normal human chondrocytes by cyclic pressure-induced strain was not 
observed in human OA chondrocytes in monolayer (Millward-Sadler et al., 2000b). OA 
chondrocytes exhibit membrane depolarisation rather than hyperpolarisation, but the 
depolarisation was dependent on a5pl integrins, stretch activated ion channels, tyrosine 
kinases and phospholipase C (Millward-Sadler et al., 2000b) as is the 
electrophysiological response of normal chondrocytes (Wright et al., 1996, Wright et al., 
1997, Lee et al., 2000). In contrast to normal chondrocytes, in which membrane 
hyperpolarisation was prevented by protein kinase C inhibitors or cytochalasin D 
(Wright et al., 1997), the actin cytoskeleton and protein kinase C were not required for 
membrane depolarisation in OA chondrocytes (Millward-Sadler et al., 2000b). Inhibition 
of PI3 kinase blocked mechanically-induced membrane potential changes in OA
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chondrocytes but not normal chondrocytes. In the same model, mechanical stimulation 
did not alter the expression of aggrecan or MMP3 in OA chondrocytes, although this 
regimen up-regulated aggrecan and down-regulated MMP3 expression in normal 
chondrocytes (Millward-Sadler et al., 2000a). Collectively these data suggest different or 
divergent mechanotransduction pathways exist in OA chondrocytes. In support of this, 
strain-induced depolarisation in OA chondrocytes is mediated by secretion of IL-ip in 
addition to IL-4 (Salter et al., 2002), whilst only IL-4 is involved in strain-induced 
hyperpolarisation in normal chondrocytes (Millward-Sadler et al., 1999). Furthermore, 
in the mechanotransduction pathway discussed, IL-4 is suggested to signal through the 
type II IL-4 receptor in normal chondrocytes (Millward-Sadler et al., 2000a) but through 
the type I IL-4 receptor in OA chondrocytes (Salter et al., 2002).
The fact that 1) the chondrocyte cytoskeleton can be altered in response to load and 2) 
the chondrocyte phenotype is influenced by load or disruption of the cytoskeleton, 
provides clear evidence for a significant role of the cytoskeleton in chondrocyte 
mechanotransduction and, hence, modulation of gene expression. Therefore the observed 
differences in the cytoskeletal organisation of OA chondrocytes could alter the response 
of chondrocytes to load.
I therefore sought to:
• Characterise changes in the cytoskeletal organisation of normal and OA human 
chondrocytes in response to cyclic compression.
• Determine changes in the gene expression of cytoskeletal components in 
response to cyclic compression.
• Determine the effect of cyclic compression on expression of chondrocyte 
phenotype markers.
• Determine the role of the chondrocyte cytoskeleton in these responses to 
compression by disrupting the cytoskeleton prior to loading.
• Determine any differences in the response of chondrocytes isolated from normal 
and OA articular cartilage.
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6.2 RESULTS
Normal and osteoarthritic human articular chondrocytes were expanded in monolayer, 
before passage three chondrocytes were encapsulated in 3% agarose and cultured for 48 
hours. Chondrocytes were treated for 24 hours with either 1 pM cytochalasin D to disrupt 
actin microfilaments, 1 pM colchicine to disrupt tubulin microtubules, or 2mM 
acrylamide to disrupt vimentin intermediate filaments. Chondrocyte/agarose constructs 
were then subjected to a cyclic compressive load of 15% strain at 0.5 Hz for 10, 20 or 40 
minutes in the presence of treatments; some samples were loaded for 40 minutes and 
then allowed to recover for 5 hours.
6.2.1 The Effect of Load and Treatments on Cell Viability
The viability of normal and osteoarthritic human chondrocytes in agarose culture was 
determined using the LIVE/DEAD® Viability/Cytotoxicity kit for mammalian cells. In 
viable chondrocytes the fluorogenic esterase substrate calcein AM is hydrolysed and 
fluorescence is visible with a FITC (green) filter, whilst dead chondrocytes are 
visualised with the nucleic acid stain ethidium homodimer-1 and fluorescence is 
detectable with a TRITC (red) filter. The viability of normal and OA chondrocytes was 
not affected by treatment for 24 hours with lpM  cytochalasin D, lpM  colchicine or 
2mM acrylamide (Fig 6.1 A and B, a-d). In normal chondrocytes, there was no increase 
in cell death in all treatment groups loaded for 10 (Fig 6.1 A e-h), 20 (Fig 6.1 A i-1), and 
40 minutes (Fig 6.1 A m-p). There appeared to be a reduction in cell viability in 
constructs left to recover for 5 hours post-load (Fig 6.1 A q-t) when compared with those 
loaded for 40 minutes (Fig 6.1 A m-p), particulary in colchicine- and acrylamide-treated 
samples which showed a 13% decrease in viability over the recovery period. In OA 
chondrocytes there was no clear decrease in cell viability following 10 (Fig 6.IB e-h), 20 
(Fig 6.IB i-1) or 40 minutes load (Fig 6.IB m-p). When compared with unloaded 
controls there was a decrease in cell viability in samples loaded for 40 minutes and 
allowed to recover for 5 hours (Fig 6.IB q-t) and the effect was most evident in 
untreated chondrocytes (15% decrease, Fig 6.IB q).
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Figure 6.1 A :- Viability o f chondrocytes from normal human articular cartilage, 
encapsulated in 3D agarose, cultured without or with the indicated treatment, then either 
unloaded (a-d), loaded (cyclic compression; 15%, 0.5 Hz) for 10 (e-h), 20 (i-1) or 40 (m- 
p) minutes, or loaded for 40 minutes then left to recover for 5 hours (q-t). Viability was 
determined using the LIVE/DEAD® Viability/Cytotoxicity kit for mammalian cells 
(Molecular Probes). Live (green) and dead (red) chondrocytes in slices o f agarose 
constructs were viewed on a fluorescence microscope. Percentages displayed indicate 
the viability, calculated from chondrocytes in focus. Scale bars = 200pm.
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B — Osteoarthritic Chondrocytes
Untreated Cytochalasin D Colchicine Acrylamide
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i> Viability of chondrocytes from osteoarthritic human articular cartilage, 
encapsulated in 3D agarose, cultured without or with the indicated treatment, then either 
unloaded (a-d), loaded (cyclic compression was to 15% strain at 0.5 Hz) for 10 (e-h), 20 
(i-1) or 40 (m-p) minutes, or loaded for 40 minutes then left to recover for 5 hours (q-t). 
Viability was determined using the LIVE/DEAD® Viability/Cytotoxicity kit for 
mammalian cells (Molecular Probes). Live (green) and dead (red) chondrocytes in slices 
of agarose constructs were viewed on a fluorescence microscope. Percentages displayed 
indicate the viability, calculated from chondrocytes in focus. Scale bars = 200pm.
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6.2.2 Changes in Cytoskeletal Organisation with Load
The cytoskeletal architecture of chondrocytes in agarose culture that were either 
subjected to 40 minutes of load or left for a 5 hour recovery post-load was visualised by 
immunofluorescence in conjunction with confocal microscopy.
6.2.2.1 Untreated Chondrocytes
6.2.2.1.1 Normal Untreated Chondrocytes
Actin Microfilaments: As demonstrated in section 5.2.2.1, untreated and unloaded 
normal chondrocytes in 3D agarose culture showed punctate, predominantly cortical 
actin microfilament staining (Fig 6.2A and B a). Following 40 minutes of cyclic 
compressive loading, actin staining appeared less punctate and more diffuse (Fig 6.2A 
d), although the localisation remained predominantly at the cell periphery (Fig 6.2B d). 
At the end of a 5 hour recovery period normal chondrocytes partially regained the 
punctate appearance of actin staining observed in unloaded controls (Fig 6.2A g), 
although fluorescence was more cortical and some diffuse actin microfilament staining 
remained (Fig 6.2A and B g).
Tubulin microtubules: Tubulin staining appeared diffuse throughout untreated and 
unloaded normal chondrocytes, with some evidence of fine filamentous staining that was 
denser around the cell periphery (Fig 6.2A and B b). Loading for 40 minutes caused 
tubulin to become punctate and more dense in the perinuclear region rather than at the 
periphery (Fig 6.2A and B e). Following a 5 hour recovery period, tubulin lost its 
punctate appearance and returned to the diffuse staining of unloaded controls, appearing 
denser at the periphery with some evidence of fine microtubule bundles (Fig 6.2A and B, 
h).
Vimentin Intermediate Filaments: Unloaded and untreated normal chondrocytes 
exhibited clear networks of vimentin intermediate filament bundles that extended 
throughout the cell to a cortical network (Fig 6.2A and B c). Following 40 minutes of 
loading, the clear cortical network was lost, intermediate filament bundles appeared 
clearer and more densely packed (Fig 6.2A and B f). Intermediate filament bundles 
became even more densely packed and appeared thicker after the recovery period (Fig 
6.2B f and i). Vimentin intermediate filament organisation did not return to that of 
unloaded control chondrocytes within the 5 hour recovery period (Fig 6.2A and B i).
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Figure 6.2 A:- 3D reconstruction - The effect of load on the cytoskeletal organisation of 
normal human articular chondrocytes in 3D agarose culture. Chondrocytes were loaded 
(cyclic compression; 15%, 0.5 Hz) for 40 minutes (d-f) and recovery was determined 
five hours after loading (g-i). Unloaded chondrocytes in agarose served as controls (a-c). 
With recovery post-load actin and tubulin, but not vimentin, organisation returned to that 
of controls. Images shown are 3D-reconstructions of a series of scans taken at 0.4pm 
increments across the chondrocyte. Actin was detected with Alexa fluor 488-phalloidin. 
Vimentin and tubulin were detected by indirect immunofluorescence using primary 
antibodies and TRJTC-conjugated anti-mouse IgG.
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Normal Chondrocytes
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Figure 6.2 B:- Single scan - The effect of load on the cytoskeletal organisation of normal 
human articular chondrocytes in 3D agarose culture. Chondrocytes were loaded (cyclic 
compression; 15%, 0.5 Hz) for 40 minutes (d-f) and recovery was determined five hours 
after loading (g-i). Unloaded chondrocytes in agarose served as controls (a-c). With 
recovery post-load actin and tubulin, but not vimentin, organisation returned to that of 
controls. Images shown are scans through the centre of the cell. Actin was detected with 
Alexa fluor 488-phalloidin. Vimentin and tubulin were detected by indirect 
immunofluorescence using primary antibodies and TRJTC-conjugated anti-mouse IgG. 
Nuclei were counterstained with DAPI (blue).
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6.2.2.1.2 Osteoarthritic Untreated Chondrocytes
Actin Micro filaments: In unloaded and untreated OA chondrocytes, actin
microfilaments appeared as elongated punctate spots in a clear cortical ring (Fig 6.3A 
and B a), with actin staining in OA cells more restricted to the cell periphery than in 
normal chondrocytes. Following 40 minutes of cyclic compressive loading, the punctate 
spots of actin became clearer but less closely packed than in unloaded controls, resulting 
in an apparent disruption of the cortical ring (Fig 6.3A and B d). Actin staining became 
more tightly packed following a 5 hour recovery, exhibiting a thick filamentous 
appearance that was not apparent in unloaded controls (Fig 6.3A and B g).
Tubulin Micro tubules: As in normal chondrocytes, tubulin microtubule staining 
appeared diffuse throughout unloaded and untreated OA chondrocytes, with a dense 
staining at the cell periphery (Fig 6.3 A and B b). Tubulin staining became punctate after 
40 minutes of loading and lost the dense peripheral localisation observed in unloaded 
controls (Fig 6.3A and B e). Following recovery for 5 hours, clear microtubule bundle 
networks were apparent throughout OA chondrocytes and the bright cortical staining 
was regained (Fig 6.3A and B h); microtubule bundles appeared more ‘organised’ in 
recovery OA cells than in unloaded controls.
Vimentin Intermediate Filaments: Unloaded and untreated OA chondrocytes 
contained clear vimentin intermediate filament bundle networks that extended 
throughout the cell, appearing more densely packed when compared with unloaded 
normal chondrocytes (Fig 6.3A and B c). Following 40 minutes of loading, intermediate 
filament bundle networks were still evident, but appeared finer (Fig 6.3A and B f). The 
apparent thickness of chondrocyte vimentin intermediate filament bundles after 5 hours 
of recovery resembled that of unloaded controls, although they were more loosely 
packed (Fig 6.3A and B i).
Tubulin microfilament organisation did not differ between unloaded normal and OA 
chondrocytes, nor did the changes in response to 40 minutes of cyclic compressive load. 
However, microtubule organisation following a 5 hour recovery period differed 
significantly between normal and OA chondrocytes, with tubulin staining returning to 
the profile of that of unloaded controls in normal chondrocytes but forming clear 
microtubule bundle networks in OA chondrocytes. Actin microfilament organisation 
also appeared to be enhanced in OA chondrocytes left to recover whilst partially 
returning to that of unloaded controls in normal samples.
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Figure 6.3 A:- 3D reconstruction - The effect of load on the cytoskeletal organisation of 
osteoarthritic human articular chondrocytes in 3D agarose culture. Chondrocytes were 
loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes (d-f) and recovery was determined 
five hours after loading (g-i). Unloaded chondrocytes in agarose served as controls (a-c). 
Bundles of actin and tubulin were more clear following recovery post-load, whilst vimentin 
organisation returned to that of controls. Images shown are 3D-reconstructions of a series of 
scans taken at 0.4pm increments across the chondrocyte. Actin was detected with Alexa 
fluor 488-phalloidin. Vimentin and tubulin were detected by indirect immunofluorescence 
using primary antibodies and TRJTC-conjugaled anti-mouse IgG.
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Osteoarthritic Chondrocytes
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|> Single scan - The effect o f load on the cytoskeletal organisation of 
osteoarthritic human articular chondrocytes in 3D agarose culture. Chondrocytes were 
loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes (d-f) and recovery was 
determined five hours after loading (g-i). Unloaded chondrocytes in agarose served as 
controls (arc). Bundles of actin and tubulin were more clear following recovery post-load, 
whilst vimentin organisation returned to that o f controls. Images shown are scans through 
the centre of the cell. Actin was detected with Alexa fluor 488-phalloidin. Vimentin and 
tubulin were detected by indirect immunofluorescence using primary antibodies and 
TRJTC-conjugated anti-mouse IgG. Nuclei were counterstained with DAPI (blue).
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Interestingly, normal chondrocytes did not recover their vimentin intermediate filament 
organisation, with the organisation of normal recovery samples most closely resembling 
that of unloaded OA chondrocytes.
6.2.2.2 Actin microfilament organisation with cytoskeletal disruption
6.2.2.2.1 Cytochalasin D-treated chondrocytes
As demonstrated in section 5.2.2.2, treatment of normal chondrocytes with lpM 
cytochalasin D resulted in disruption of actin microfilament organisation; in unloaded 
samples, actin localisation in untreated chondrocytes became less evenly distributed and 
the cortical ring was lost with cytochalasin D treatment (Fig 6.4A and B d). Additional 
changes in the actin cytoskeleton with 40 minutes of loading in cytochalasin D-treated 
normal chondrocytes were similar to those in untreated samples, with actin staining 
becoming less punctate (Fig 6.4A and B e). As in untreated samples, punctate staining 
reappeared following 5 hours recovery in cytochalasin D-treated normal chondrocytes, 
although cytochalasin D continued to inhibit the peripheral localisation of actin staining 
(Fig 6.4A and B f).
In OA chondrocytes cytochalasin D treatment also prevented the cortical localisation of 
actin microfilament staining (Fig 6.5B d-f). In unloaded OA chondrocytes punctate actin 
staining became less tightly packed following cytochalasin D treatment (Fig 6.5A d); as 
a result of this, the reduction in density caused by 40 minutes loading of untreated OA 
chondrocytes was less evident in those treated with cytochalasin D (Fig 6.5A and B e). 
The punctate appearance of actin became clearer and there was evidence of 
microfilament networks following 5 hours recovery comparable with that observed in 
untreated OA chondrocytes after recovery (Fig 6.5A and B c,f).
In both normal and OA chondrocytes, cytochalasin D treatment resulted in disruption of 
the actin microfilament organisation, with the most obvious effect on the peripheral 
distribution of actin. However there did not appear to be an additive effect of 
cytochalasin D treatment and load on actin cytoskeletal organisation.
6.2.2.2.2 Colchicine-treated chondrocytes
Disruption of tubulin microtubules with lpM  colchicine treatment had little effect on 
actin microfilaments, although punctate actin spots increased in size in unloaded normal
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Figure 6.4 A:- 3D reconstruction - The effect of load on the actin cytoskeleton of normal 
human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or presence of 
1 pM cytochalasin D (CD, d-f) to disrupt actin microfilaments, 1 pM colchicine (Ch, g-i) to 
disrupt tubulin microtubules, or 2mM acrylamide (Ac, j-1) to disrupt vimentin intermediate 
filaments. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes 
(b,e,h,k) and recovery was determined five hours after loading (c,f,i,l). Unloaded 
chondrocytes in agarose served as controls (a,d,gj). The recovery of actin organisation 
post-load was prevented by colchicine but not cytochalasin D or acrylamide. Images shown 
are 3D-reconstnictions of a series of scans taken at 0.4pm increments across the 
chondrocyte. Actin was detected with Alexa fluor 488-phalloidin.
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Figure 6.4 B:- Single scan - The effect of load on the actin cytoskeleton of normal human 
articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or presence of 1 pM 
cytochalasin D (CD, d-f) to disrupt actin microfilaments, lpM colchicine (Ch, g-i) to 
disrupt tubulin microtubules, or 2mM acrylamide (Ac, j-1) to disrupt vimentin 
intermediate filaments. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) for 
40 minutes (b,e,h,k) and recovery was determined five hours after loading (c£i,l). 
Unloaded chondrocytes in agarose served as controls (a,d,gj). The recovery of actin 
organisation post-load was prevented by colchicine but not cytochalasin D or acrylamide. 
Images shown are scans through the centre of the cell. Actin was detected with Alexa 
fluor 488-phalloidin. Nuclei were counterstained with DAPI (blue).
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Figure 6.5 A:- 3D reconstruction - The effect of load on the actin cytoskeleton of 
osteoarthritic human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c, 
g-i) or presence of 1 pM cytochalasin D (CD, d-f, j-1) to disrupt actin micro filaments, 1 pM 
colchicine (Ch, g-i) to disrupt tubulin microtubules, or 2mM acrylamide (Ac, j-1) to disrupt 
vimentin intermediate filaments. Chondrocytes were loaded (cyclic compression; 15%, 0.5 
Hz) for 40 minutes (b,e,h,k) and recovery was determined five hours after loading (c£U). 
Unloaded chondrocytes in agarose served as controls (a,d,gj). Load-induced changes in 
actin organisation were unaffected by the treatments. Images shown are 3D-reconstructions 
of a series of scans taken at 0.4pm increments across the chondrocyte. Actin was detected 
withAlexa fluor488-phalloidin.
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Figure 6.5 B:- Single scan - The effect of load on the actin cytoskeleton of osteoarthritic 
human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c, g-i) or 
presence of lpM cytochalasin D (CD, d-f, j-1) to disrupt actin microfilaments , lpM 
colchicine (Ch, g-i) to disrupt tubulin microtubules, or 2mM acrylamide (Ac, j-1) to 
disrupt vimentin intermediate filaments. Chondrocytes were loaded (cyclic compression; 
15%, 0.5 Hz) for 40 minutes (b,e,h,k) and recovery was determined five hours after 
loading (c/4,1). Unloaded chondrocytes in agarose served as controls (a,d,gj). Load- 
induced changes in actin organisation were unaffected by the treatments. Images shown 
are scans through the centre of the cell. Actin was detected with Alexa fluor 488- 
phalloidin. Nuclei were counterstained with DAPI (blue).
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chondrocytes (Fig 6.4A and B g). Actin staining was less uniformly distributed in 
colchicine-treated normal chondrocytes following a 5 hour recovery period when 
compared with unloaded and loaded colchicine-treated cells (Fig 6.4A and B g-i). There 
was no clear difference in actin cytoskeletal organisation between untreated and 
colchicine-treated OA chondrocytes whether unloaded, loaded for 40 minutes, or left to 
recover for 5 hours (Fig 6.5A and B g-i), although staining was perhaps less punctate 
than untreated controls in the latter (Fig 6.5A and B i).
6.2.2.2.3 Acrylamide-treated chondrocytes
There was no difference in the actin cytoskeletal organisation of unloaded and untreated 
and acrylamide-treated normal chondrocytes (Fig 6.4A and B j). However, actin 
architecture appeared to be lost following 40 minutes load in acrylamide-treated normal 
chondrocytes (Fig 6.4A and B k). In recovery samples, punctate actin staining appeared 
the same as in untreated controls, although the cortical localisation was lost (Fig 6.4A 
and B 1). In unloaded OA chondrocytes the cortical actin ring was lost with acrylamide 
treatment (Fig 6.5A and B j), but partially restored in chondrocytes loaded for 40 
minutes (Fig 6.5A and B k) and in those allowed to recover (Fig 6.5A and B 1). The 
punctate appearance of actin staining remained unaffected by acrylamide treatment (Fig 
6.4A and 6.5A, j-1).
6.2.2.3 Tubulin microtubule organisation with cytoskeletal disruption
6.2.2.3.1 Colchicine-treated chondrocytes
As demonstrated in section 5.2.2.3, treatment of normal chondrocytes with lpM 
colchicine altered the appearance of tubulin microtubules. In unloaded normal 
chondrocytes, microtubule networks were clearer throughout the cell but there was a 
more speckled appearance to the staining, perhaps indicating shorter microtubule 
bundles (Fig 6.6A and B d). In both untreated and colchicine-treated normal 
chondrocytes tubulin staining was brightest at the cell periphery. The punctate 
appearance of tubulin in untreated loaded chondrocytes was less evident in loaded 
colchicine-treated normal chondrocytes (Fig 6.6A and B e). In addition, tubulin staining 
remained brightest at the cell periphery, rather than in the perinuclear region as in 
untreated controls (Fig 6.6B e). Following 5 hours of recovery in colchicine-treated 
normal chondrocytes, tubulin microtubule bundles became thicker and were densely 
packed throughout the cell (Fig 6.6A and B f).
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Figure 6.6 A:- 3D reconstruction - The effect o f load on the tubulin cytoskeleton of normal 
human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or presence of 
1 pM colchicine (Ch, d-f) to disrupt tubulin microtubules, 1 pM cytochalasin D (CD, g-i) to 
disrupt actin microfilaments, or 2mM acrylamide (Ac, j-1) to disrupt vimentin intermediate 
filaments. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes 
(b,e,h,k) and recovery was determined five hours after loading (c/44)- Unloaded 
chondrocytes in agarose served as controls (a,d,gj). The recovery of tubulin organisation 
post-load was affected by colchicine but not cytochalasin D or acrylamide. Images shown 
are 3D-reconstructions of a series of scans taken al 0.4pm increments across the 
chondrocyte. Tubulin was detected by indirect immunofluorescence using primary 
antibody and TRJTC-conjugated anti-mouse IgG.
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Figure 6.6 B > Single scan - The effect o f load on the tubulin cytoskeleton o f  normal 
human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or presence o f  
1 pM colchicine (Ch, d-f) to disrupt tubulin microtubules, 1 pM cytochalasin D (CD, g-i) to 
disrupt actin microfilaments, or 2mM acrylamide (Ac, j-1) to disrupt vimentin intermediate 
filaments. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes 
(b,e,h,k) and recovery was determined five hours after loading (c/p 4)- Unloaded 
chondrocytes in agarose served as controls (a,d,gj). The recovery o f  tubulin organisation 
post-load was affected by colchicine but not cytochalasin D or acrylamide. Images shown 
are scans through the centre o f the cell. Tubulin was detected by indirect 
immunofluorescence using primary antibodies and TRITC-conjugated anti-mouse IgG. 
Nuclei were counterstained with DAPI (blue).
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In OA chondrocytes colchicine treatment caused tubulin microtubule bundles to appear 
more clearly at the cell periphery (Fig 6.7A d) with the staining remaining brightest in 
this region (Fig 6.7B d). The induction of punctate tubulin staining observed in untreated 
OA chondrocytes following 40 minutes loading was less evident in those treated with 
colchicine, as observed in normal chondrocytes (Fig 6.7A and B e). However, load did 
still have an effect as microtubule bundle networks were no longer as clear as in 
unloaded samples. Following a 5 hour recovery period, tubulin organisation differed 
from that of untreated controls and unloaded colchicine-treated chondrocytes; 
microtubule bundles appeared short, there were no clear networks and staining was no 
longer brightest at the periphery (Fig 6.7A and B f).
In both normal and OA chondrocytes the punctate tubulin staining induced by 40 
minutes of compressive load was lost with colchicine treatment. Treatment with 
colchicine caused microtubule bundles to appear thicker in both normal and OA 
chondrocytes and particularly affected microtubule organisation following recovery after 
loading. Interestingly, microtubule organisation in colchicine treated unloaded OA 
chondrocytes most closely resembled that of untreated OA chondrocytes following 
recovery from load. There was an apparent additive effect of colchicine treatment and 
load on tubulin cytoskeletal organisation.
6.2.2.3.2 Cytochalasin D-treated chondrocytes
There was little difference in the organisation of tubulin in untreated and cytochalasin D- 
treated normal and OA chondrocytes. No difference was observed in unloaded 
chondrocytes (Fig 6.6 and 6.7, A and B, g), whilst cytochalasin D treatment prevented 
the punctate tubulin staining induced by 40 minutes of load (Fig 6.6 and 6.7, A and B, 
h). After recovery, the appearance of microtubule bundles in normal chondrocytes was 
unaffected by cytochalasin D treatment (Fig 6.6A and B i). In OA chondrocytes after 
recovery from loading, the microtubule bundle networks formed in untreated samples 
were less clear, but still present, in cytochalasin D-treated cells (Fig 6.7A and B i).
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Figure 6.7 A:- 3D reconstruction - The effect of load on the tubulin cytoskeleton of 
osteoarthritic human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) 
or presence of 1 pM colchicine (Ch, d-f) to disrupt tubulin microtubules, 1 pM cytochalasin 
D (CD, g-i) to disrupt actin microfilaments , or 2mM acrylamide (Ac, j-1) to disrupt 
vimentin intermediate filaments. Chondrocytes were loaded (cyclic compression; 15%, 0.5 
Hz) for 40 minutes (b,e,h,k) and recovery was determined five hours after loading (c/44)- 
Unloaded chondrocytes in agarose served as controls (a,d,gj). The recovery of tubulin 
organisation post-load was affected by colchicine and acrylamide but not cytochalasin D. 
Images shown are 3D-reconstructions of a series of scans taken al 0.4pm increments across 
the chondrocyte. Tubulin was detected by indirect immunofluorescence using primary 
antibody and TRJTC-conjugated anti-mouse IgG.
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Figure 6.7 B :- Single scan - The effect o f load on the tubulin cytoskeleton o f osteoarthhtic 
human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or presence o f  
1 pM colchicine (Ch, d-f) to disrupt tubulin microtubules, 1 pM cytochalasin D (CD, g-i) to 
disrupt actin micro filam ents, or 2mM acrylamide (Ac, j-1) to disrupt vimentin intermediate 
filaments. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes 
(b,e,h,k) and recovery was determined five hours after loading (c£id )- Unloaded 
chondrocytes in agarose served as controls (a,d,gj). The recovery o f  tubulin organisation 
post-load was affected by colchicine and acrylamide but not cytochalasin D. Images shown 
are scans through the centre o f the cell. Tubulin was detected by indirect 
immunofluorescence using primary antibodies and TRITC-conjugated anti-mouse IgG. 
Nuclei were counterstained with DAPI (blue).
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6.2.2.3.3 Acrylamide-treated chondrocytes
There was no difference in tubulin organisation in untreated and acrylamide-treated 
normal chondrocytes whether unloaded, loaded for 40 minutes, or allowed to recover 
from loading (Fig 6.6A and B j-1). Punctate tubulin staining was evident but less sharp in 
acrylamide-treated cells loaded for 40 minutes when compared with untreated controls 
(Fig 6.6A and B k). In unloaded OA chondrocytes microtubule bundle networks were 
clearer in acrylamide-treated cells than in untreated controls (Fig 6.7A and B j). The 
punctate appearance of tubulin staining in chondrocytes loaded for 40 minutes was 
unaffected by acrylamide treatment (Fig 6.1 A and B k). In OA chondrocytes allowed to 
recover after loading, microtubule bundle networks were apparent but some punctate 
staining remained in the acrylamide-treated cells, which could indicate a slower recovery 
of microtubule organisation with vimentin disruption (Fig 6.1 A and B 1).
6.2.2.4 Vimentin intermediate filament organisation with cytoskeletal disruption
6.2.2.4.1 Acrylamide-treated chondrocytes
As demonstrated in section 5.2.2.4, treatment with 2mM acrylamide resulted in 
disruption of vimentin intermediate filament organisation, with filament bundle 
networks becoming asymmetrically distributed in unloaded normal chondrocytes (Fig 
6.8A and B d); this asymmetry was lost with loading and recovery (Fig 6.8B e and f). 
Following 40 minutes of load, vimentin intermediate filament bundles were still 
apparent but were not as extensive as in untreated controls; vimentin staining appeared 
diffuse towards the periphery of acrylamide-treated chondrocytes (Fig 6.8A and B e). 
This peripheral diffuse staining remained in acrylamide-treated normal chondrocytes 
after 5 hours of recovery post-load, although the intermediate filament bundles that were 
evident appeared thicker, as observed in untreated controls (Fig 6.8A and B f).
In unloaded OA chondrocytes acrylamide treatment also caused an asymmetric 
distribution of vimentin intermediate filament staining, with faint intermediate filament 
bundles evident throughout most of the cell and brighter, denser networks to one side 
(Fig 6.9A and B d). Unlike in normal chondrocytes, this asymmetry persisted following 
40 minutes of load in acrylamide-treated OA chondrocytes (Fig 6.9A and B e). The 
effect of load observed in untreated controls, causing vimentin intermediate filament 
bundles to appear finer, was also observed in loaded acrylamide-treated OA 
chondrocytes (Fig 6.9A and B e),
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Figure 6.8 A :- 3D reconstruction - The effect o f load on the vimentin cytoskeleton o f 
normal human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or 
presence o f 2mM acrylamide (Ac, d-f) to disrupt vimentin intermediate filaments, 1 pM 
cytochalasin D (CD, g-i) to disrupt actin microfilaments, or 1 pM colchicine (Ch, j-1) to 
disrupt tubulin microtubules. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) 
for 40 minutes (b,e,h,k) and recovery was determined five hours after loading (c£ i,l). 
Unloaded chondrocytes in agarose served as controls (a,d,gj). Load-induced changes in 
vimentin organisation were unaffected by the treatments. Images shown are 3D- 
reconstructions o f a series o f scans taken at 0.4pm increments across the chondrocyte. 
Vimentin was detected by indirect immunofluorescence using primary antibody and 
TRITC-conjugated anti-mouse IgG.
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Figure 6.8 B> Single scan - The effect of load on the vimentin cytoskeleton of normal 
human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or presence of 
2mM acrylamide (Ac, d-f) to disrupt vimentin intermediate filaments, 1 pM cytochalasin D 
(CD, g-i) to disrupt actin nucrofilaments, or 1 pM colchicine (Ch, j-1) to disrupt tubulin 
microtubules. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes 
(b,e,h,k) and recovery was determined five hours after loading (c/p,l). Unloaded 
chondrocytes in agarose served as controls (a,d,gj). Load-induced changes in vimentin 
organisation were unaffected by the treatments. Images shown are scans through the centre 
of the cell. Vimentin was detected by indirect immunofluorescence using primary antibodies 
and TRITC-conjugaled anti-mouse IgG Nuclei were counterstained with DAPI (blue).
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Figure 6.9 A :- 3D reconstruction - The effect o f load on the vimentin cytoskeleton o f  
osteoarthntic human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) 
or presence o f 2mM acrylamide (Ac, d-f) to disrupt vimentin intermediate filaments, 1 pM 
cytochalasin D (CD, g-i) to disrupt actin microfilaments, or 1 pM colchicine (Ch, j-1) to 
disrupt tubulin microtubules. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) 
for 40 minutes (b,e,h,k) and recovery was determined five hours after loading (c£ i,l). 
Unloaded chondrocytes in agarose served as controls (a,d,gj). Load-induced changes in 
vimentin organisation were unaffected by the treatments. Images shown are 3D- 
reconstructions o f a series o f scans taken at 0.4pm increments across the chondrocyte, f -  
insert is a 90° rotation o f the reconstruction on the y-axis. Vimentin was detected by indirect 
immunofluorescence using primary antibody and TRTTC-conjugaled anti-mouse IgG.
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Figure 6.9 B:- Single scan - The effect of load on the vimentin cytoskeleton of osteoaithritic 
human articular chondrocytes in 3D agarose culture, in the absence (Un, a-c) or presence of 
2mM acrylamide (Ac, d-f) to disrupt vimentin intermediate filaments, 1 pM cytochalasin D 
(CD, g-i) to disrupt actin microfilaments, or 1 pM colchicine (Ch, j-1) to disrupt tubulin 
microtubules. Chondrocytes were loaded (cyclic compression; 15%, 0.5 Hz) for 40 minutes 
(b,e,h,k) and recovery was determined five hours after loading (c£i»l)- Unloaded 
chondrocytes in agarose served as controls (a,d,gj). Load-induced changes in vimentin 
organisation were unaffected by the treatments. Images shown are scans through the centre 
of the cell. Vimentin was detected by indirect immunofluorescence using primary antibodies 
and TRITC-conjugated anti-mouse IgG. Nuclei were counterstained with DAPI (blue).
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although staining appeared diffuse in places with faint intermediate filament bundles 
(Fig 6.9B e). Vimentin staining remained partially asymmetrical following 5 hours of 
recovery (Fig 6.9A f  -  insert). Intermediate filament bundles appeared thicker with 
recovery in acrylamide-treated cells, comparable to that observed in untreated controls, 
although the filament bundles appeared to be more densely packed in the acrylamide- 
treated chondrocytes (Fig 6.9A and B f).
In both normal and OA unloaded chondrocytes acrylamide treatment resulted in 
disruption of the vimentin intermediate filament organisation and an asymmetric 
distribution. This asymmetry was maintained in OA but not normal chondrocytes, which 
showed more diffuse staining towards the periphery of the cell after loading. There was 
an apparent additive effect of acrylamide treatment and load on vimentin cytoskeletal 
organisation in normal chondrocytes, but not in OA chondrocytes. Vimentin 
organisation in acrylamide-treated OA chondrocytes after recovery is comparable to that 
in unloaded and recovery untreated OA chondrocytes; therefore vimentin organisation 
disrupted by acrylamide treatment is rescued by load and recovery in OA chondrocytes, 
despite the continued presence of acrylamide.
6.2.2.4.2 Cytochalasin D-treated chondrocytes
There was no clear difference in the vimentin organisation of untreated and cytochalasin 
D-treated unloaded normal chondrocytes (Fig 6.8A and B g). Following 40 minutes of 
load, vimentin filament bundles appeared thicker and were less clear in some regions of 
cytochalasin D-treated normal chondrocytes when compared with untreated controls 
(Fig 6.8A and B h). Cytochalasin D treatment showed little clear effect on vimentin 
organisation following 5 hours of recovery, with intermediate filament bundles 
appearing perhaps a little shorter than in untreated controls (Fig 6.8A and B i). 
Cytochalasin D treatment had no effect on vimentin organisation in OA chondrocytes 
whether unloaded, loaded for 40 minutes, or allowed to recover from loading (Fig 6.9A 
and B g-i), although vimentin filament bundles appeared thicker than in untreated 
controls following 40 minutes of compressive load (Fig 6.9A and B h).
6.2.2.4.3 Colchicine-treated chondrocytes
There was no difference in the organisation of the vimentin cytoskeleton in untreated 
and colchicine-treated normal chondrocytes that were unloaded or loaded for 40 minutes 
(Fig 6.8A and B j-k). Following a 5 hour recovery from loading, intermediate filament
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bundle networks were less evident in colchicine-treated samples (Fig 6.8A and B 1). 
Colchicine treatment had no discemable effect on vimentin organisation in unloaded or 
post-load recovery OA chondrocytes (Fig 6.9A and B, j and 1). However, immediately 
after loading for 40 minutes vimentin filament bundles appeared thicker in colchicine- 
treated OA chondrocytes (Fig 6.9A and B k).
Key changes in the organisation of actin (Fig 6.10), tubulin (Fig 6.11) and vimentin (Fig 
6.12) cytoskeletal networks with load and post-load recovery are summarised in figures 
6.10 to 6.12. Additional effects of cytoskeletal disruption on load-induced organisation 
changes are also indicated.
6.2.3 Changes in Gene Expression with Load and Cytoskeletal Element 
Disruption
The effect of cyclic compressive loading on chondrocyte phenotype, along with any 
additional effect of cytoskeletal disruption, was analysed using quantitative PCR to 
determine gene expression changes.
6.2.3.1 Cytoskeletal associated genes
6.2.3.1.1 p-actin
P-actin mRNA expression levels showed a trend towards decreasing with loading for 10 
and 20 minutes, although no changes reached significance. This trend was the same with 
load in both normal and OA chondrocytes and was unaffected by treatment with 
cytochalasin D (Fig 6.13 A), colchicine or acrylamide (data not shown). P-actin mRNA 
levels appeared to return to those of unloaded controls after 40 minutes of loading in 
untreated (Fig 6.13 A) and acrylamide-treated (data not shown) normal chondrocytes. 
Following recovery for 5 hours after loading, p-actin expression remained decreased or 
further decreased and again this trend was the same across all treatment groups and 
pathologies, although statistical significance was not reached (Fig 6.13 B and data not 
shown). As demonstrated in section 5.2.3.1, P-actin expression increased with 
cytochalasin D treatment (at 24 hours; normal p = 0.015, OA p = 0.023). p-actin mRNA 
expression was significantly increased with cytochalasin D treatment in all loading 
groups in both normal and OA chondrocytes (Fig 6.13).
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Figure 6.13:- fLactin gene expression changes with compressive load and actin 
microfilament disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. 
Nucleic acids were isolated from chondrocytes from normal and osteoarthritic 
(OA) cartilage, encapsulated in 3D agarose and cultured without (untreated) or 
with 1 pM cytochalasin D (Cyto D) for 24 hours before loading. Agarose constructs 
were loaded for 10, 20 or 40 minutes (A) or loaded for 40 minutes and left to 
recover for 5 hours (B). Data are presented as mean ± S.E.M. (n=5, n=3 for 
recovery).
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6.2.3.1.2 P-tubulin
In untreated normal chondrocytes p-tubulin mRNA expression increased with loading 
(Fig 6.14 A) and reached significance after 20 (1.7 fold; p = 0.037) and 40 minutes of 
load (1.8 fold; p = 0.020). p-tubulin expression was further increased after 5 hours of 
recovery post-load (Fig 6.14 B) although increased variability meant that the difference 
did not reach statistical significance (2.7 fold increase over unloaded controls; p=0.073). 
OA chondrocytes showed a high variability in p-tubulin mRNA expression levels (Fig 
6.14). As a result of this, no trends for changes with load were evident.
P-tubulin expression also increased with load in normal chondrocytes treated with 
colchicine (Fig 6.14 A), which may have been responsible for, or a result of, the altered 
tubulin microtubule organisation observed (section 6.2.2.3.1). p-tubulin expression was 
increased 1.6 fold (p = 0.046) after 20 minutes of load in colchicine-treated normal 
chondrocytes (Fig 6.14 A). There was an additive effect of colchicine treatment on P~ 
tubulin expression after 40 minutes loading, with expression increasing 2.7 fold over 
unloaded colchicine-treated chondrocytes (p = 0.013); as a result of this, P-tubulin 
expression was increased significantly over untreated controls loaded for 40 minutes (p 
= 0.036; Fig 6.14 A). No further increases in P-tubulin expression were observed in 
colchicine-treated cells allowed to recover for 5 hours post-load (2.9 fold increase over 
unloaded cells; p = 0.069; Fig 6.14 B). Therefore the additive effect of colchicine with 
load on tubulin organisation (section 6.2.2.3.1) was also observed at the mRNA 
expression level. The effect of acrylamide on P-tubulin expression was very similar to 
that of colchicine. Expression was increased in normal chondrocytes after 20 (2.6 fold; p 
= 0.007) and 40 minutes of load (4 fold; p = 0.020), indicating an additive effect with 
load (Fig 6.14 C). There was no further increase in expression with recovery (4 fold 
higher than unloaded samples; p = 0.012). Like colchicine- and untreated chondrocytes, 
the load-induced increase in p-tubulin mRNA expression was only observed in normal, 
not OA chondrocytes. Cytochalasin D treatment had no effect on P-tubulin expression in 
response to load (data not shown), corroborating the tubulin localisation data (section 
6 .2.2 .3.2).
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6.2.3.1.3 Vimentin
Vimentin mRNA expression levels did not change significantly with load in untreated 
normal and OA chondrocytes (Fig 6.15). In normal chondrocytes, vimentin expression 
levels decreased after 5 hours of recovery post-load (1.6 fold below 40 minutes load, not 
significant), dropping below those of unloaded controls (1.3 fold), but not significantly 
(Fig 6.15 B). This effect was also observed in OA chondrocytes, but again differences 
were not significant (recovery vs. unloaded -  1.9 fold, p = 0.399; recovery vs. 40 
minutes load -  2.3 fold, p = 0.286).
Changes in vimentin mRNA expression with loading followed the same trend in 
acrylamide-treated chondrocytes as in untreated controls (Fig 6.15 A and B). Following 
recovery from load, acrylamide treatment resulted in a bigger decrease in vimentin 
expression in normal chondrocytes (Fig 6.15 B), although this decrease did not reach 
significance (2.1 fold below unloaded; p = 0.066. 2.3 fold below 40 minutes loaded; p = 
0.057). The decrease in vimentin expression after 5 hours of recovery post-load was 
enhanced by cytochalasin D treatment of normal (2.1 fold below unloaded; p = 0.048) 
and OA (2.3 fold below unloaded; p = 0.087) chondrocytes (Fig 6.15 C). Colchicine 
treatment had no effect on vimentin mRNA expression under any of the loading 
conditions in normal and OA chondrocytes (data not shown).
6.2.3.1.4 Cofilin
mRNA expression levels of the actin-depolymerising protein cofilin increased 1.8 fold in 
normal chondrocytes subjected to 40 minutes of load (Fig 6.16 A), although this increase 
was not significant (p = 0.108). Cofilin mRNA expression did not alter in loaded OA 
chondrocytes. In both normal and OA chondrocytes cofilin expression levels returned to 
those of unloaded controls following a 5 hour recovery post-load (Fig 6.16 B).
As described in section 5.2.3.1, cofilin mRNA expression was increased in normal 
chondrocytes in response to treatment with cytochalasin D for 24 hours (1.9 fold; p = 
0.013). Cofilin expression also increased with load in cytochalasin D-treated normal 
chondrocytes (Fig 6.16 A), but the increase was smaller than that in untreated samples 
(1.3 fold at 40 minutes load). By contrast, load-induced increases in cofilin expression 
were larger in cytochalasin D-treated OA chondrocytes when compared to untreated 
controls (1.5 fold increase at 40 minutes load); as a result, cofilin expression was
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Figure 6.16:- Cofilin gene expression changes with compressive load and actin 
microfilament disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. Nucleic 
acids were isolated from chondrocytes from normal and osteoarthntic (OA) 
cartilage, encapsulated in 3D agarose and cultured without (untreated) or with 1 pM 
cytochalasin D (Cyto D) for 24 hours before loading. Agarose constructs were 
loaded for 10,20 or 40 minutes (A) or loaded for 40 minutes and left to recover for 
5 hours (B). Data are presented as mean ± S.E.M. (n=5, n=3 for recovery).
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significantly higher in cytochalasin D-treated OA chondrocytes than untreated controls 
after 10 (p = 0.045) and 40 minutes of load (p = 0.040; Fig 6.16 A). There was no 
additional effect of cytochalasin D treatment on cofilin expression following recovery 
after loading (Fig 6.16 B). Disruption of vimentin intermediate filaments with 
acrylamide enhanced the down-regulation of cofilin mRNA with 5 hours recovery post­
load in normal (1.8 fold below 40 minutes loaded; p = 0.206) and OA (1.7 fold below 40 
minutes loaded; p = 0.046) chondrocytes (data not shown). Cofilin expression in the 
presence or absence of load was unaffected by colchicine treatment in normal and OA 
chondrocytes (data not shown).
6.2.3A.5 Destrin
In untreated normal chondrocytes, mRNA expression levels of the actin-depolymerising 
protein destrin was significantly increased after 10 minutes of load (1.6 fold; p = 0.014); 
levels then began to decrease after 20 and 40 minutes of load (Fig 6.17 A). A subtle 
increase (1.3 fold) in destrin mRNA levels was also observed in OA chondrocytes after 
10 minutes of load, although the increase was not significant (Fig 6.17 A). There were 
no further changes in destrin mRNA levels following a 5 hour recovery period in 
untreated normal or OA chondrocytes (Fig 6.17 B).
As demonstrated in section 5.2.3.1, destrin expression was significantly increased 
following treatment of normal chondrocytes with cytochalasin D and was also increased 
over the untreated controls in all loading groups (Fig 6.17). Destrin mRNA levels also 
increased (1.3 fold) in cytochalasin D-treated chondrocytes subjected to 10 minutes of 
load, but due to variability this was not significant (Fig 6.17 A). Destrin mRNA levels 
returned to baseline expression (i.e. unloaded cells) after 40 minutes of load. However, 
unlike untreated controls, destrin expression increased 1.4 fold over the 5 hour recovery 
period (Fig 6.17 B; 40 minutes load vs. recovery; p = 0.098) resulting in a significant 
effect of treatment in recovery cells (p = 0.021). Destrin expression increased with load 
in cytochalasin D-treated OA chondrocytes (1.5 fold increase after 10 minutes; not 
significant) and remained elevated after 20 and 40 minutes of load (Fig 6.17 A). The 
additive effect of cytochalasin D treatment and load resulted in an enhanced effect of 
treatment after 10 (p = 0.071), 20 (p = 0.069) and 40 minutes (p = 0.009) of load. 
Following 5 hours of recovery from loading, destrin expression remained elevated in 
cytochalasin D-treated OA chondrocytes, as did the significant effect of treatment (p =
- 2 6 0 -
Chapter 6: The Effect o f Load and Cytoskeletal Disruption on Chondrocyte Phenotype
0.013; Fig 6.17 B). Acrylamide or colchicine treatment had no effect on destrin 
expression in the presence or absence of load in normal and OA chondrocytes, with the 
exception that colchicine treatment resulted in increased destrin expression in OA 
chondrocytes over the 5 hour recovery period (40 minutes load vs. recovery; p = 0.017; 
data not shown).
6.2.3.1.6 Gelsolin
Expression of another actin-depolymerising factor, gelsolin, was unaffected by loading 
of normal and OA chondrocytes (data not shown). Treatment of chondrocytes with 
cytochalasin D, colchicine or acrylamide did not affect gelsolin mRNA expression with 
loading or recovery; however, a decrease in gelsolin expression following recovery was 
observed after acrylamide treatment, but this down-regulation did not reach statistical 
significance in normal (1.7 fold below 40 minutes loaded; p = 0.060) or OA 
chondrocytes (2.2 fold below 40 minutes loaded; p = 0.072; data not shown).
6.2.3.1.7 Thymosin p4
Thymosin p4 mRNA expression appeared to be increased after 10 minutes loading in 
untreated normal chondrocytes (1.7 fold), remaining elevated at 20 minutes but 
decreasing to unloaded levels after 40 minutes loading; however, expression changes 
were not significant (Fig 6.18 A). Untreated OA chondrocytes showed no change in 
thymosin p4 expression with loading. Following a 5 hour recovery from loading there 
was no further change in thymosin P4 expression in normal or OA chondrocytes (Fig 
6.18 B).
Load-induced changes in thymosin p4 expression were unaffected by cytochalasin D 
treatment in normal chondrocytes (Fig 6.18 A and B). By contrast, the response of OA 
chondrocytes was influenced by cytochalasin D treatment. Thymosin p4 expression 
increased gradually in response to load and was elevated 1.6 fold (p = 0.081) over 
unloaded cytochalasin D-treated OA chondrocytes after 40 minutes of load (Fig 6.18 A). 
The additive effect of cytochalasin D and load resulted in an effect of treatment at 10 (p 
= 0.005), 20 (p = 0.076) and 40 minutes (p = 0.061) of load. Over the 5 hour recovery 
period there was a significant decrease in thymosin P4 expression in cytochalasin D- 
treated OA chondrocytes (2.6 fold below 40 minutes load; p = 0.042, Fig 6.18 B). 
Colchicine treatment also appeared to increase thymosin p4 expression in unloaded 
normal (p = 0.085) and OA chondrocytes (Fig 6.18 C). Colchicine treatment showed no
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Figure 6.17:- Destrin gene expression changes with compressive load and actin 
micro filament disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. Nucleic 
acids were isolated from chondrocytes from normal and osteoarthritic (OA) 
cartilage, encapsulated in 3D agarose and cultured without (untreated) or with 1 pM 
cytochalasin D (Cyto D) for 24 hours before loading. Agarose constructs were 
loaded for 10,20 or 40 minutes (A) or loaded for 40 minutes and left to recover for 
5 hours (B,C). Data are presented as mean ± S.E.M (n=5, n=3 for recovery). * p < 
0.05, loaded compared to unloaded control / loaded with recovery.
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additional effect on thymosin P4 expression changes with loading in normal 
chondrocytes. By contrast, colchicine treatment significantly increased thymosin p4 
expression in OA chondrocytes subjected to 10 (p < 0.001), 20 (p = 0.016), and 40 
minutes of loading (p = 0.039; Fig 6.18 C). Acrylamide had no effect on thymosin P4 
expression changes with load.
6.2.3.1.8 Paxillin
In untreated normal and OA chondrocytes paxillin mRNA expression did not respond 
appreciably to load; however, expression decreased after 40 minutes of load followed by 
a 5 hour recovery period in normal (1.5 fold decreased below unloaded; p = 0.087) and 
OA chondrocytes (1.9 fold decreased from unloaded; p = 0.121; Fig 6.19 A).
Loading for 40 minutes significantly decreased paxillin mRNA expression in colchicine- 
treated normal chondrocytes when compared with unloaded controls (2.4 fold; p = 
0.029; Fig 6.19 A). However paxillin mRNA levels returned to those of untreated 
controls after the 5 hour recovery period. Colchicine treatment did not affect the load- 
induced changes in paxillin expression in OA chondrocytes; as observed in untreated 
controls, paxillin expression decreased after 40 minutes loading and further decreased 
after a 5 hour recovery in colchicine-treated OA chondrocytes (1.8 fold below unloaded; 
p = 0.072; Fig 6.19 A). Acrylamide had no effect on the response of paxillin expression 
to loading and recovery in normal chondrocytes (Fig 6.19 B). By contrast, acrylamide 
prevented the decrease in paxillin expression after 40 minutes of load in OA 
chondrocytes, although a significant reduction in expression following a 5 hour recovery 
period (2.5 fold below 40 minute loaded; p = 0.032) returned paxillin mRNA levels to 
those of untreated controls (Fig 6.19 B). Cytochalasin D treatment had no effect on 
paxillin expression changes with loading and recovery.
6.2.3.2 Matrix metabolism genes
6.2.3.2.1 BMF
As described in section 5.2.3.3, mRNA expression of the pro-apoptotic factor BMF was 
higher in OA chondrocytes cultured in 3D agarose when compared with normal 
chondrocytes, with the difference becoming more pronounced over the culture period 
but not reaching statistical significance at 48 hours (p = 0.092). BMF expression did not 
alter with loading or recovery in normal and OA chondrocytes (Fig 6.20).
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Paxillin gene expression changes with compressive load and 
cytoskeletal disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. Nucleic 
acids were isolated from chondrocytes from normal and osteoarthhtic (OA) 
cartilage, encapsulated in 3D agarose and cultured without (untreated) or with 
treatment Treatments were 1 pM colchicine to disrupt tubulin microtubules (A) or 
2mM acrylamide to disrupt vimentin intermediate filaments (B). Agarose constructs 
were loaded for 40 minutes and left to recover for 5 hours. Data are presented as 
mean ± S.E.M. (n=3). * p < 0.05, loaded compared to unloaded control / loaded and 
recovery.
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Figure 6.20:- BMF gene expression changes with compressive load and tubulin 
microtubule disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. 
Nucleic acids were isolated from chondrocytes from normal and osteoarthritic 
(OA) cartilage, encapsulated in 3D agarose and cultured without (untreated) or 
with 1 gM colchicine. Agarose constructs were loaded for 10,20 or 40 minutes (A) 
or loaded for 40 minutes and left to recover for 5 hours (B). Data are presented as 
mean ± S.E.M. (n=5, n=3 for recovery).
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Colchicine treatment reduced BMF expression in normal chondrocytes (not significant; 
at 40 minutes loading, Un vs. Ch p = 0.081) but had no effect on expression changes in 
response to load or recovery (Fig 6.20). BMF expression was also reduced by colchicine 
treatment in OA chondrocytes (section 5.2.3.3; 24 hours p = 0.162, 48 hours p = 0.045). 
This effect of colchicine treatment was also observed in loaded OA chondrocytes, with 
decreased BMF expression in OA chondrocytes subjected to 20 (p = 0.081) and 40 
minutes (p = 0.037) of load and after a 5 hour recovery period (p = 0.025), when 
compared with untreated controls (Fig 6.20). Acrylamide also significantly reduced 
BMF expression in OA chondrocytes treated for 48 hours (p = 0.008; section 5.2.3.3) but 
unlike colchicine, a significant effect of acrylamide treatment was only observed in OA 
chondrocytes after recovery from loading (p = 0.027 when compared with untreated 
recovery; data not shown). Despite these significant effects of treatment, colchicine or 
acrylamide treatment did not alter BMF expression in response to load or recovery, in 
either normal or OA chondrocytes (Fig 6.20 and data not shown). BMF expression was 
not affected by compression or recovery in cytochalasin D-treated cells (data not 
shown).
6.2J.2.2 SOX9
SOX9 mRNA expression was reduced in OA chondrocytes when compared with normal 
chondrocytes (unloaded p = 0.098) and this was observed at all loading time points with 
the exception of load recovery (Fig 6.21). In normal untreated chondrocytes SOX9 
expression showed a trend to increase with loading and was 1.5 fold higher than in 
unloaded controls after 40 minutes load, although high variability meant no differences 
were significant (Fig 6.21 A). SOX9 expression levels returned to those of unloaded 
controls after 5 hours of recovery (Fig 6.2IB). OA chondrocytes appeared to increase 
SOX9 expression in response to load, peaking after 20 minutes (1.8 fold) and returning 
to the level observed in unloaded controls after 40 minutes of load; however due to 
sample variability these differences were not significant (Fig 6.21 A). In contrast to the 
response of normal chondrocytes, SOX9 expression increased with recovery in OA 
chondrocytes (2.3 fold increase over unloaded; p = 0.016. 2.1 fold increased over 40 
minutes of load; p = 0.052. Fig 6.21 B).
Cytochalasin D treatment altered the response of normal chondrocytes to load-induced 
SOX9 changes, with expression appearing to decrease after 40 minutes of load to levels
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L> SOX9 gene expression changes with compressive load and actm 
microfilament disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. Nucleic 
acids were isolated from chondrocytes from normal and osteoarthritic (OA) 
cartilage, encapsulated in 3D agarose and cultured without (untreated) or with 1 pM 
cytochalasin D. Agarose constructs were loaded for 10, 20 or 40 minutes (A) or 
loaded for 40 minutes and left to recover for 5 hours (B) Data are presented as 
mean ± S.E.M. (n=5, n=3 for recovery). * p < 0.05, loaded with recovery compared 
with loaded or unloaded control.
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below those of unloaded samples (Fig 6.21 A); no differences were observed between 
untreated and cytochalasin D-treated normal chondrocytes after recovery (Fig 6.21 B). 
SOX9 mRNA levels did not increase in response to load in cytochalasin D-treated OA 
chondrocytes (Fig 6.21 A) and cytochalasin D treatment prevented the increase in SOX9 
mRNA levels observed in untreated OA chondrocytes 5 hours post-load (Fig 6.21 B). 
Colchicine and acrylamide treatment had no effect on SOX9 expression changes in 
normal and OA chondrocytes subjected to load and/or recovery (data not shown).
6.2.3.2.3 Aggrecan and type II collagen
Aggrecan expression was lower in OA chondrocytes when compared with normal 
chondrocytes (p = 0.096 for unloaded controls; section 5.2.3.3). In addition, aggrecan 
mRNA levels were reduced in normal and OA chondrocytes subjected to load (Fig 6.22 
A); expression was decreased 2.6 fold after 20 minutes of load in normal untreated 
chondrocytes (p = 0.078) and 1.9 fold after 40 minutes of load in OA chondrocytes (p =
0.155). Following a 5 hour recovery period post-load, there was a small but non­
significant increase in aggrecan expression in normal (1.4 fold increase over 40 minute 
loaded) and OA chondrocytes (1.6 fold increase over 40 minute loaded), although levels 
did not return to basal levels (Fig 6.22 B).
As described in section 5.2.3.3 aggrecan mRNA expression was decreased, but not 
significantly, after treatment of normal chondrocytes with cytochalasin D or acrylamide. 
However, in normal and OA chondrocytes neither treatment had an effect on the load- 
induced changes in aggrecan expression, but both treatments prevented the increase in 
mRNA levels with recovery observed in untreated cells (Fig 6.22 B and data not shown). 
Colchicine had no effect on aggrecan expression in either cell type in response to load or 
recovery (data not shown).
COL2A1 mRNA levels were below the level of detection using real time PCR with 
SYBR® green, therefore differences in expression in response to load and a possible 
combined effect of load and cytoskeletal disruption could not be determined for type II 
collagen.
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Figure 6.22:- Aggrecan gene expression changes with compressive load and 
vimentin intermediate filament disruption. Absolute mRNA levels were determined 
using SYBR Green quantitative PCR and normalised to the housekeeping gene 
GAPDH. Nucleic acids were isolated from chondrocytes from normal and 
osteoarthntic (OA) cartilage, encapsulated in 3D agarose and cultured without 
(untreated) or with 2mM acrylamide. Agarose constructs were loaded for 10, 20 or 
40 minutes (A) or loaded for 40 minutes and left to recover for 5 hours (B). Data 
are presented as mean ± S.E.M. (n=5, n=3 for recovery).
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6.2.3.2.4 Type I  collagen
In untreated normal chondrocytes, COL1A1 expression decreased gradually over the 
loading duration and was 2.3 fold reduced below unloaded controls after 40 minutes of 
load (not significant; Fig 6.23 A). Following a 5 hour recovery from loading, COL1A1 
expression was further decreased in untreated normal chondrocytes (8.3 fold below 
unloaded; p = 0.114; Fig 6.23 A). In contrast to normal chondrocytes, COL1A1 
expression was unaffected by loading for up to 40 minutes in OA chondrocytes; 
however mRNA expression levels were reduced 16.8 fold following recovery (p = 0.023 
for unloaded vs. recovery; Fig 6.23 A). This suggests that physiological load could 
rescue the chondrocyte collagen phenotype.
There was a trend towards decreased expression of COL1A1 in both normal and OA 
chondrocytes following treatment with cytochalasin D. However treatment did not affect 
the trends in COL1A1 expression after loading and/or recovery; COL1A1 mRNA levels 
were reduced 17.8 fold following recovery of cytochalasin D-treated OA chondrocytes 
compared with unloaded cells (p = 0.076; Fig 6.23 A). The decrease in COL1A1 
expression following 40 minutes of load was enhanced in normal chondrocytes treated 
with acrylamide (8.1 fold decrease; not significant; Fig 6.23 B). Acrylamide treatment 
induced a non-significant decrease in COL1A1 mRNA levels in OA chondrocytes, but 
had no effect the cells response to load or recovery (Fig 6.23 B), indicating that 
disruption of vimentin had no effect on the mechanoregulation of COL1A1 mRNA 
expression. Colchicine treatment had no effect on COL1A1 mRNA expression in normal 
and OA chondrocytes and did not affect the cells responses to load and/or recovery (data 
not shown).
6.2.3.2.5 MMP-13
Alterations in MMP13 mRNA expression with loading or recovery mirror COL1A1 
effects in both normal and OA chondrocytes. MMP13 expression decreased gradually in 
normal chondrocytes over the loading duration, culminating in a 2.1 fold reduction after 
40 minutes of load. MMP13 mRNA levels further decreased following a 5 hour recovery 
period (4.2 fold below unloaded levels; p = 0.262; Fig 6.24). In OA chondrocytes 
MMPJ3 expression was not mechanically regulated; however transcript levels decreased
2.2 fold following a 5 hour recovery period post-load (p = 0.090; Fig 6.24).
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Figure 6.23:- COL1A1 gene expression changes with compressive load and 
cytoskeletal disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. 
Nucleic acids were isolated from chondrocytes from normal and osteoarthritic 
(OA) cartilage, encapsulated in 3D agarose and cultured without (untreated) or 
with treatment for 24 hours before loading. Treatments were 1 pM cytochalasin D 
to disrupt actin microfilaments or 2mM acrylamide to disrupt vimentin 
intermediate filaments (B). Agarose constructs were loaded for 40 minutes and left 
to recover for 5 hours. Data are presented as mean ± S.E.M. (n=5, n=3 for 
recovery). * p < 0.05, loaded and recovery compared to loaded or unloaded control.
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Figure 6.24:- MMP13 gene expression changes with compressive load and tubulin 
microtubule disruption. Absolute mRNA levels were determined using SYBR 
Green quantitative PCR and normalised to the housekeeping gene GAPDH. 
Nucleic acids were isolated from chondrocytes from normal and osteoarthritic 
(OA) cartilage, encapsulated in 3D agarose and cultured without (untreated) or 
with lpM colchicine for 24 hours before loading. Agarose constructs were loaded 
for 40 minutes and left to recover for 5 hours. Data are presented as mean ± 
S.E.M. (n=5, n=3 for recovery).
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Colchicine treatment significantly reduced MMP13 mRNA expression in untreated OA 
chondrocytes (p = 0.024; section 5.2.3.3). However, microtubule disruption with 
colchicine did not further affect the cells response to load and/or recovery, as MMP13 
mRNA levels were consistently decreased in colchicine-treated OA chondrocytes even 
after recovery from load (2.4 fold; p = 0.056, Fig 6.24). The effects of acrylamide on 
MMP13 expression were similar to that of colchicine; MMP13 expression was reduced 
by acrylamide in normal and OA chondrocytes (unloaded OA cells, p = 0.014) but 
treatment did not alter the load-induced effects on MMP 13 expression in normal and OA 
chondrocytes (data not shown). Cytochalasin D treatment had no effect on MMP 13 
expression or on the cells response to loading and/or recovery in normal and OA 
chondrocytes.
6.2J.2.6 ADAMTS5
ADAMTS5 mRNA levels were significantly decreased in OA chondrocytes when 
compared with normal chondrocytes (p = 0.048) as described in section 5.2.3.3. 
Mechanical load did not affect ADAMTS5 transcription in the presence or absence of 
cytochalasin D, colchicine or acrylamide in normal or OA chondrocytes (data not 
shown).
6.2.4 Changes in MMP-2 with Load and Cytoskeletal Element 
Disruption
Levels of pro- and active-MMP2 released into the media during loading and recovery of 
normal and OA chondrocytes were determined using gelatin substrate zymography. As 
demonstrated in section 5.2.4, levels of pro-MMP2 released into the media were reduced 
in normal chondrocytes when compared with OA chondrocytes; faint bands of pro- 
MMP2 were observed in untreated normal chondrocytes cultured for 24 hours whilst 
active-MMP2 was barely detectable (Fig 6.25, Normal Un UL). There was little pro- and 
active-MMP2 released into the media by untreated normal chondrocytes over the 10, 20 
or 40 minute loading period and there was no clear accumulation of MMP-2 over a 
further 5 hour recovery period (Fig 6.25, Normal Un). Both pro- and active-MMP2 were 
detected in unloaded OA chondrocytes cultured for 24 hours (Fig 6.25, OA Un UL). 
Over the 10 minute loading period sufficient levels of pro-MMP2 were released by
- 2 7 4 -
Chapter 6: The Effect of Load and Cytoskeletal Disruption on Chondrocyte Phenotype
Normal | | Osteoarthritic
Figure 6.25:- The expression and activation of MMP-2 in chondrocytes isolated 
from normal and osteoarthntic (OA) cartilage, encapsulated in 3D agarose and 
cultured with or without treatment for 24 hours (UL). Media was replaced and 
agarose constructs loaded for 10, 20 or 40 minutes, or loaded for 40 minutes and 
left to recover for 5 hours (Rec). Gelatin substrate zymography was used to detect 
the latent (72kD) and active (62kD) forms of MMP-2 with white bands 
representing zones of gelalinolytic activity. Equivalent volumes of media were 
loaded. ‘Un’- untreated chondrocytes, ‘CD’- 1 pM cytochalasin D, ‘Ch*- lpM 
colchicine, ‘Ac’- 2 mM acrylamide treated chondrocytes. * or ▲ — same sample; 
untreated unloaded control for the normal (*) and OA (a ) donor displayed.
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untreated OA chondrocytes to allow detection by gelatin zymography. No further 
increase in pro-MMP2 levels were evident after 20 and 40 minutes of loading, but there 
was an accumulation over a further 5 hour recovery period, where active-MMP2 was 
also detected (Fig 6.25, OA Un).
Treatment of normal chondrocytes with cytoskeletal disrupting treatments for 24 hours 
did not increase pro-MMP2 levels (Fig 6.25, Normal UL), although cytochalasin D 
increased MMP-2 activation as demonstrated in section 5.2.4. Neither the MMP-2 
release induced by compressive loading, nor the accumulation of MMP-2 with recovery, 
was altered in normal chondrocytes treated with cytochalasin D, colchicine or 
acrylamide (Fig 6.25). Treatment of OA chondrocytes with cytochalasin D increased 
MMP2 activation, as demonstrated in section 5.2.4. Pro- and active-MMP2 were 
detected in the media of cytochalasin D-treated OA chondrocytes loaded for 10 minutes, 
with levels of active-MMP2 increasing after 20 and 40 minutes of load; a further 
accumulation of active-MMP2 was observed after a 5 hour recovery period (Fig 6.25, 
OA CD). Colchicine treatment had no further effect on MMP-2 synthesis and/or 
activation with load and/or recovery (Fig 6.25, OA Ac). MMP-2 activation was 
unaffected by acrylamide treatment in OA chondrocytes, but treatment did appear to 
reduce load-induced pro-MMP2 release and its accumulation over the recovery period 
(Fig 6.25, OA Ac).
MMP-9 was not detected in untreated normal and OA chondrocyte culture media by 
gelatin zymography and neither loading nor treatment increased MMP-9 expression to 
the level of detection (data not shown).
6.2.5 The Effect of Cytoskeletal Element Disruption on Stress under 
Compressive Load
Peak stress was determined for normal and OA chondrocyte/agarose constructs under a 
15% compressive strain; changes in voltage were converted into force using a calibration 
curve (Fig 6.26 A) and force then converted to stress using the equation below.
Stress (Pa) = ______________ Force (N)___________
9.5033 x 10'5 (cross-sectional area m2)
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Figure 6.26:- Stresses experienced in chondrocyte-agarose constructs under a 15% 
strain. Were increased by colchicine and acrylamide treatment A -  Calibration curve 
for the loading machine. B- Calculated stresses in agarose constructs, under a 15% 
strain, containing chondrocytes isolated from normal (green) and osteoarthritic (red) 
cartilage. Constructs were cultured with or without the indicated treatment for 24 
hours before loading. Using a calibration curve (A), voltage changes in constructs 
loaded for 30 seconds, 10 and 40 minutes were converted into force (N) and then 
stress (kPa). ‘Un’- untreated chondrocytes, ‘CD’- I p M  cytochalasin D, ‘Ch’- lp M  
colchicine, ‘Ac’- 2 m M  acrylamide treated chondrocytes. Graph shows mean of all 
time points ± SEM * p<0.05, ** p<0.01, *** p<0.001: * relative to untreated, A 
relative to CD, ■ relative to Ch.
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There was no difference between normal and OA chondrocytes in the stress produced 
under loading of the chondrocyte/agarose constructs (Fig 6.26 B). Treatment of 
chondrocytes with cytochalasin D had no effect on the stress produced under loading of 
normal or OA chondrocytes. A significant increase in the stress in both normal and OA 
chondrocyte/agarose constructs under load was observed with colchicine (normal: 1.8 
fold; p = 0.050. OA: 1.9 fold; p = 0.009) and acrylamide (normal: 2.8 fold; p < 0.0001. 
OA: 2.9 fold; p = 0.0001) treatment (Fig 6.26 B). The stress in colchicine- and 
acrylamide-treated chondrocyte/agarose constructs was significantly increased over that 
of the cytochalasin D-treated constructs (CD vs. Ch; p = 0.002. CD vs. Ac; p < 0.001) 
and the effect of acrylamide was also significant over that of colchicine (p = 0.0004).
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Gene / 
Cytoskeletal 
Element
Affected by 
Cyclic 
Compression?
Difference between 
Normal (N) and OA 
Response to Load?
Additive Effect of Cytoskeletal 
Element Disruption?
c0
c5cn
1  
SP 
o
a
Actin MFs Yes — N & OA Yes, with recovery Tubulin, N recovery only 
Vimentin, N only
Tubulin MTs Yes — N & OA Yes, with recovery Tubulin, N & OA 
Vimentin, OA recovery only
t/io
>»O
Vimentin IFs Yes — N & OA No No
(3-actin No No No
Cofilin ns No Actin, reduced response in N 
Actin, enhanced response in OA 
Vimentin, OA recovery only
Destrin Yes — N only No (trend in OA) Actin, N & OA
U
1/5o
Gelsolin No No Vimentin, N & OA recovery
U
i/jo>
Thymosin p4 ns No Actin, OA only 
Tubulin, OA only
<
ztC
E
Paxillin ns No Tubulin, N & OA 
Vimentin, OA 40min only
p-tubulin Yes -  N only Yes Tubulin, N only 
Vimentin, N only
Vimentin No No Actin, N & OA recovery 
Vimentin, N recovery only
><C
cd
BMF No No No
SOX9 Yes -  OA only Yes Actin, OA only
u
Aggrecan ns No No
>o COL1A1 Yes -  OA only Yes No
OZB
MMP 13 ns No No
ADAMTS5 No No No
Table 6.1:- Summary of results from loading experiments performed with or without 
cytoskeletal disruption, ‘ns’ is used where a trend was clear but changes were not 
statistically significant.
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6.3 DISCUSSION
6.3.1 The Effect of Load on Chondrocyte Phenotype
Physiological load is required for the maintenance of articular cartilage integrity through 
its influence on the chondrocyte phenotype. Numerous studies both in vivo and in vitro 
have shown that load can induce both anabolic and catabolic changes in the chondrocyte 
phenotype, depending on the loading regime used.
The effect o f the loading regime (15%, 0.5 Hz) on the phenotype of human normal and 
osteoarthritic chondrocytes in agarose was determined by assessing the expression of 
typical markers of the chondrocyte phenotype. There was a trend towards increased 
SOX9 mRNA expression with cyclic compression of normal and OA chondrocytes in 
agarose, although no differences reached significance. Furthermore, SOX9 expression 
was further up-regulated in OA chondrocytes after five hours of recovery post-loading. 
Dynamic compression of bovine cartilage explants at 0.1 Hz for one hour has been 
shown to increase SOX9 expression (Fitzgerald et al., 2008). Other studies using 
differentiated chondrocytes have shown that dynamic mechanical load has no effect on 
SOX9 expression. Cyclic compression (20%, 0.3 Hz) of single bovine chondrocytes or 
chondrons for 10 minutes had no effect on SOX9 expression, nor did a recovery period 
of 18 hours after loading (Wang et al., 2009b, Wang et al., 2010). Cyclic hydrostatic 
pressure and cyclic tensile strain had no effect on SOX9 expression in bovine 
chondrocytes in alginate (Wong et al., 2003). SOX9 expression was unaffected by 
dynamically stretching (3%, 0.5 Hz) human chondrocytes in monolayer for three days at 
two hours per day (Das et al., 2008). By contrast, dynamic and static compression 
increased SOX9 expression in rodent chondrocyte precursors encapsulated in hydrogels 
(Takahashi et al., 1998, Li et al., 2009a). In these studies, dynamic and static 
compression enhanced chondrogenesis as indicated by up-regulation of aggrecan and 
COL2A1 expression in addition to SOX9.
The reported effects of mechanical load on aggrecan expression in differentiated 
chondrocytes are varied. Aggrecan mRNA levels were elevated in bovine chondrocytes 
in agarose subjected to static hydrostatic pressure for four hours (Toyoda et al., 2003). 
Cyclic compression (15%) of porcine chondrocytes in agarose at 0.33 Hz or 1 Hz for 12 
hours up-regulated aggrecan expression (Kock et al., 2009) as did intermittent dynamic
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compression (15%, 1 Hz) of bovine chondrocytes in agarose for 24 hours (Mio et al., 
2005). Aggrecan expression is also up-regulated in bovine cartilage explants subjected to 
dynamic compression at 0.1 Hz (Fitzgerald et al., 2008) and in bovine chondrons 
dynamically compressed to 20 or 40% strain at 0.3 Hz for 10 minutes (Wang et al., 
2009b). In normal human chondrocytes cultured as a monolayer, cyclic pressure-induced 
strain at 0.33 Hz for 20 minutes up-regulated aggrecan expression (Millward-Sadler et 
al., 2000a), whilst dynamic stretching (3%) at 0.5 Hz for two hours per day for three 
days down-regulated aggrecan expression (Das et al., 2008). Another study applying 
cyclic tensile strain to bovine chondrocytes in alginate showed no change in aggrecan 
expression with load (Wong et al., 2003). My results showed that, in human normal and 
OA chondrocytes in agarose, cyclic compression (15%, 0.5 Hz) for 10 to 40 minutes 
showed a trend towards reducing aggrecan expression, although no changes reached 
statistical significance and levels began to return to basal levels after a five hour 
recovery post-load. Differences to other published results are likely due to differences in 
culture conditions, which would influence the phenotype of control cells, and also to the 
loading regimes implemented. In addition, the duration of loading used here is relatively 
short when compared with other studies loading for several hours and focused more 
towards the improvement of matrix synthesis for tissue engineering strategies.
With regards to chondrocyte phenotype, the trend towards up-regulation of SOX9 and 
down-regulation of aggrecan transcription with cyclic compression appears 
contradictory. These changes could however be transient, with anabolic changes in gene 
expression occurring at time points later than those studied here. This would be 
supported by the apparent up-regulation of aggrecan with post-load recovery and by 
studies of chondrocytes in agarose, subjected to longer periods of dynamic compression 
or recovery post-load, where increased aggrecan expression and sGAG content have 
been demonstrated (Buschmann et al., 1995, Chowdhury et al., 2003, Mio et al., 2005, 
Mauck et al., 2007, Kock et al., 2009). Further work is required to determine COL2A1 
expression levels; this would help to further determine the effects of load on phenotype.
A reduction in COL1A1 and MMP 13 expression implies that cyclic compression of 
normal and OA human chondrocytes in agarose positively affects the chondrocyte 
phenotype. Both MMP 13 and COL1A1 mRNA expression showed a trend of decreasing 
with cyclic compression of human normal chondrocytes, with expression further
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decreasing after five hours of recovery. In OA chondrocytes, COL1A1 and MMP 13 
expression did not change with cyclic compression but subsequently decreased five 
hours after compression. In conjunction with the increase in SOX9 mRNA with recovery 
post-load, the decrease in COL1AI and MMP 13 mRNA expression supports a positive 
effect of the loading regime on phenotype, particularly in OA chondrocytes. Expression 
of MMP 13 and COL1A1 has been shown to be down-regulated in bovine chondrocytes 
in alginate subjected to cyclic hydrostatic pressure for three hours per day for three days 
(Wong et al., 2003) and in monolayer cultured human normal chondrocytes subjected to 
dynamic stretch at 0.5 Hz for two hours per day for three days (Das et al., 2008). By 
contrast, cyclic tensile strain increased MMP 13 expression in bovine chondrocytes in 
alginate (Wong et al., 2003). MMP13 mRNA expression was also increased in bovine 
cartilage explants subjected to dynamic or static compression (Fitzgerald et al., 2008), 
and in bovine chondrocytes on calcium polyphosphate scaffolds two hours after cyclic 
compression (1.4%, 1 Hz, 30 minutes), with MMP-13 protein levels increased six hours 
post-compression (De Croos et al., 2006). Recent work using the same model separated 
deep zone and surface-mid zone bovine cartilage chondrocytes and showed that cyclic 
compression up-regulated MMP 13 expression in surface-mid zone chondrocytes but 
down-regulated MMP 13 expression in deep zone chondrocytes (Raizman et al., 2009).
Another matrix-degrading protease studied, ADAMTS5, was unaffected by cyclic 
compression in normal and OA human chondrocytes embedded in agarose. In contrast to 
these results, other studies have shown an effect of mechanical compression on 
ADAMTS5 expression in chondrocytes; in bovine cartilage explants, ADAMTS5 
expression is up-regulated in response to dynamic compression (5%, 0.1 Hz) for one 
hour (Fitzgerald et al., 2008), static compression (50%) for two to 48 hours (Wheeler et 
al., 2009) and in response to a single injurious compression (Lee et al., 2005). 
Differences could be due to the use of human as opposed to bovine chondrocytes, 
isolated chondrocytes embedded in agarose rather than cartilage explants, or due to the 
difference in the dynamic compressive loading regime utilised.
Despite being down-regulated by cytoskeletal disruption in OA chondrocytes (chapter 
5), mRNA expression of the pro-apoptotic gene BMF was unaffected by cyclic 
compression in normal and OA human chondrocytes embedded in agarose. There are no 
previous reports of an effect of mechanical stimulation on BMF expression. However,
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anoikis-induced transcriptional up-regulation of BMF expression is inhibited by 
activation of MEK/ERK signalling (Schmelzle et al., 2007). Activation of ERK by 
dynamic compression of chondrocytes in agarose (Bougault et al., 2008) could therefore 
prevent changes in BMF  expression in response to loading. Phosphorylation of BMF by 
JNK causes its release from dynein light chain 2 (DLC2) and therefore from the myosin 
V motor complex which sequesters it to micro filaments (Puthalakath et al., 2001, Lei 
and Davis, 2003). JNK signalling is activated by cyclic compression of chondrocytes 
seeded in calcium polyphosphate scaffolds (De Croos et al., 2006) and therefore effects 
of compression on BMF in human chondrocytes could be mediated post-translationally,
i.e. via increased phosphorylation.
6.3.1.1 Additional Effects of Cytoskeletal Disruption with Load on Chondrocyte 
Phenotype
Disruption of the cytoskeleton in normal and OA chondrocytes embedded in agarose 
altered the transcriptional response of SOX9 and aggrecan to cyclic compression. 
Cytochalasin D treatment, i.e. actin cytoskeletal disruption, appeared to decrease SOX9 
expression in normal chondrocytes subjected to 40 minutes of loading. In OA 
chondrocytes, disruption of the actin cytoskeleton with cytochalasin D inhibits the 
increases in SOX9 expression induced after 20 minutes of cyclic compression and five 
hours recovery. This suggests that load-induced changes in SOX9 expression are 
dependent on the actin cytoskeleton, particularly in OA chondrocytes. Numerous studies 
have demonstrated a link between SOX9 expression and changes in actin cytoskeletal 
organisation, although these are in relation to the role of the actin cytoskeleton in 
regulation of the chondrocyte phenotype (Woods et al., 2005). In human chondrocytes 
disruption of actin stress fibres using cytochalasin D, culturing cells in alginate or 
inhibition of ROCK up-regulates SOX9 expression (Tew and Hardingham, 2006). 
Activation of p38 MAPK was shown to stabilise SOX9 mRNA in human chondrocytes, 
but only in the absence of actin stress fibres. In support of this, a recent study has shown 
that osmotic pressure activates p38 MAPK and only up-regulates SOX9 expression in 
human articular chondrocytes in the absence of actin stress fibres (Tew et al., 2009). 
Culture of passaged chondrocytes in alginate or disruption of actin stress fibres by 
inhibition of ROCK promoted up-regulation of SOX9 expression in response to 
hyperosmotic conditions; however, ROCK inhibition had no effect on hyperosmolarity- 
induced SOX9 up-regulation in freshly isolated chondrocytes that did not contain actin
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stress fibres. p38 MAPK signalling is activated in chondrocytes by dynamic 
compression (Fitzgerald et al., 2008, Bougault et al., 2008) and hyperosmolarity (Tew et 
al., 2009); this could stabilise SOX9 mRNA, providing a mechanism for compression- 
induced up-regulation of SOX9 mRNA that is dependent upon actin cytoskeletal 
organisation. An alternative regulatory mechanism for SOX9 expression and activity 
that is dependent upon actin could be post-translational phosphorylation. Recent work 
has shown that dynamic compression (15%, 0.5 Hz) of human primary chondrocytes 
embedded in agarose for two hours induced a ROCK-dependent increase in the nuclear 
localisation of SOX9 protein (Haudenschild et al., 2010). Dynamic compression for lb - 
18 hours increased SOX9 protein levels and phosphorylation. Work in a human 
chondrosarcoma cell line showed ROCK directly phosphorylates serine-181 in SOX9 
which promotes SOX9 nuclear localisation and increases its transcriptional activity. 
SOX9 can transcriptionally regulate SOX9 expression via a positive feedback loop 
(Kumar and Lassar, 2009). Disruption of actin microfilaments with cytochalasin D could 
alter Rho and therefore ROCK activity, which would subsequently affect the 
transcriptional activity of SOX9 and SOX9 mRNA levels.
Whilst disruption of the actin or vimentin cytoskeleton did not affect the trend towards 
decreased aggrecan expression in response to cyclic compression, disruption of these 
elements did appear to prevent the increase in aggrecan mRNA expression after five 
hours of recovery. It is therefore possible that the recovery of aggrecan expression 
following cyclic compression is mediated by the actin and vimentin cytoskeletal 
networks. In support of this role for the vimentin cytoskeleton, aggrecan expression is 
reduced in response to disruption of intermediate filament organisation in bovine 
chondrocytes (Blain et al., 2006) and in response to siRNA-mediated knockdown of 
vimentin in human multipotent progenitor cells (Bobick et al., 2010). In contrast to the 
suggested role for the actin cytoskeleton in mediating the recovery of aggrecan 
expression post-load, disruption of actin microfilaments with cytochalasin D did not 
prevent up-regulation of aggrecan expression in murine multipotent progenitor cells 
induced by cyclic hydrostatic pressure (1 Hz) applied for two hours per day for three 
days (Shim et al., 2008). Differences to the results presented here could be due to 
differences in chondrocyte maturity (human mature chondrocytes as opposed to murine 
mesenchymal stem cells), type of load applied (compressive load as opposed to 
hydrostatic pressure), load frequency (0.5 Hz rather than 1 Hz), or cellular context
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(embedded in agarose as opposed to pellet culture). As for SOX9, a link between 
aggrecan expression and actin cytoskeletal disruption has been demonstrated in the 
context of chondrocyte differentiation, with cytochalasin D increasing aggrecan 
expression and enhancing chondrogenesis in mouse embryonic stem cells cultured in 
chondrogenic medium (Zhang et al., 2006a). The effect of actin disruption on aggrecan 
expression however is dependent on cellular context; disruption of actin stress fibres in 
chondrocytes up-regulates aggrecan expression in monolayer but down-regulates 
aggrecan expression in 3D micromass culture (Woods et al., 2005); in monolayer, the 
positive effect of actin disruption on phenotype, i.e. cell rounding, could mask the effect 
on transcription observed in 3D. In the present study, disruption of tubulin microtubules 
in human chondrocytes embedded in agarose had no effect on load-induced changes in 
aggrecan expression. This is in contrast to a previous report showing that disruption of 
microtubules in monolayer chondrocytes, by treatment with nocodazole, prevents the up- 
regulation of proteoglycan synthesis in response to cyclic hydrostatic pressure (Jortikka 
et al., 2000); however, the use of monolayer culture and therefore the altered 
differentiation status could explain the difference in results.
Disruption of the chondrocyte cytoskeleton had no effect on the load-induced changes in 
mRNA expression of any other chondrocyte phenotype marker studied, indicating that 
mechanical regulation of their expression likely occurs independently of the 
cytoskeleton. That cytoskeletal disruption affects mechano-regulation of these genes at 
later time points or after longer periods of loading than studied here cannot be excluded.
6.3.2 The Effect of Load on the Chondrocyte Cytoskeleton 
Actin Microfilaments
Remodelling of the actin cytoskeleton in response to cyclic compression was evident in 
both normal and OA human chondrocytes. In normal chondrocytes, cortical F-actin 
appeared less punctate after 40 minutes of cyclic compression, whilst in OA 
chondrocytes punctate spots became clearer and less tightly packed. Load-induced 
changes in actin localisation appeared to be reversible, with staining showing an actin 
organisation similar to that of unloaded controls after five hours of recovery; in OA 
chondrocytes actin microfilaments appeared clearer after recovery than in unloaded 
controls. This is supported by a previous study demonstrating remodelling of the actin 
cytoskeleton in response to two hours of cyclic compressive loading (15%, 1 Hz) of
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bovine chondrocytes in agarose that was reversible within one hour of recovery (Knight 
et al., 2006). This study showed a more punctate appearance of actin staining 
immediately after loading. ROCK-dependent increases in punctate F-actin structures 
have also been observed in normal human chondrocytes embedded in agarose subjected 
to 20 minutes of dynamic compression (Haudenschild et al., 2008a). Interestingly, in the 
present study this increase in punctate actin staining was observed in human OA 
chondrocytes but not in normal chondrocytes, although the loss of punctate staining in 
normal chondrocytes demonstrated actin remodelling was occurring. It should be noted 
however that cytoskeletal organisation after 20 minutes of compressive loading was not 
determined in the present study; therefore reversible increases in punctate actin staining 
could have occurred earlier than the 40 minute time point assayed. A net cortical actin 
depolymerisation in response to cyclic compression at 1 Hz for 10 seconds has been 
shown in bovine chondrocytes in agarose, with cortical actin intensity decreasing after 
10 minutes of recovery (Campbell et al., 2007). Actin remodelling appears to be the 
result of the dynamic changes in chondrocyte shape as there are no changes in actin 
cytoskeletal organisation in response to static compression of rat articular cartilage 
(Durrant et al., 1999) or cyclic physiological hydrostatic pressure in human 
chondrocytes in alginate (Fioravanti et al., 2003).
In addition to altering actin organisation, cyclic compression showed a trend of affecting 
P-actin mRNA expression in human chondrocytes in agarose. In normal chondrocytes, 
P-actin expression was transiently down-regulated by 10 and 20 minutes of cyclic 
compression, increasing to basal levels by 40 minutes of compression but then 
decreasing after five hours of recovery. P-actin expression also appeared to be down- 
regulated in OA chondrocytes by cyclic compression, with levels remaining decreased 
after recovery. This suggests that the recovery of actin organisation is not a result of 
increases in p-actin transcription. However, altered expression of actin-regulatory 
proteins in response to cyclic compression could also result in actin remodelling. 
Consistent with this, mRNA expression of the actin-depolymerising factor destrin was 
up-regulated in normal human chondrocytes after 10 minutes of cyclic compression. 
Expression levels then began to decrease with increasing duration of load. Expression of 
the actin-depolymerising factor cofilin also showed a trend to increase in normal 
chondrocytes with increasing duration of cyclic compression. Expression of both cofilin 
and destrin mRNA is up-regulated in response to 10 minutes of dynamic compression
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(15%, 1 Hz) in bovine chondrocytes embedded in agarose (Campbell et al., 2007). This 
study showed no change in expression of the actin-severing factor gelsolin in response to 
dynamic compression of bovine chondrocytes; this was also observed here in normal and 
OA human chondrocytes seeded in agarose. Campbell et al. 2007 also showed no 
change in expression of the G-actin sequestering protein thymosin |34 in response to 
dynamic compression of bovine chondrocytes in agarose. In contrast to this, thymosin (34 
expression appeared to be up-regulated in the present study in normal human 
chondrocytes subjected to 10 and 20 minutes of cyclic compression; expression levels 
returned to baseline by 40 minutes of load and further decreased following five hours of 
recovery. Expression of thymosin P4 was up-regulated by 10 minutes of dynamic 
compression (0.5 MPa, 1 Hz) in bovine cartilage explants (Blain et al., 2003). Cyclic 
compression had no effect on cofilin, destrin or thymosin p4 expression in OA human 
chondrocytes, suggesting an effect of pathology on the inability of the cell to respond to 
mechanical load via the actin cytoskeleton-regulatory proteins.
Expression of paxillin, which associates with actin microfilaments at cell-matrix 
attachment sites, showed a trend to decrease following five hours of recovery post-load 
in the present study. Phosphorylation of paxillin is enhanced in human chondrocytes in 
response to cyclic pressure-induced strain, although this study was performed on 
chondrocytes in monolayer, an adhesion-dependent culture system promoting the 
formation of paxillin-containing focal adhesions and actin stress fibres (Lee et al., 2000). 
Cytoskeletal dynamics in monolayer are therefore likely to differ from those used in this 
study. However, a decrease in paxillin expression post-load in agarose embedded human 
chondrocytes could indicate an effect on paxillin-mediated mechanotransduction 
pathways.
Tubulin Microtubules
Cyclic compression of normal and OA human chondrocytes in agarose induced changes 
in the organisation of the tubulin cytoskeleton. In both normal and OA chondrocytes, 
tubulin staining became punctate and the intensity at the cell periphery was lost 
following 40 minutes of load; in normal chondrocytes tubulin staining became more 
intense in the perinuclear region. Following five hours of recovery, cortical tubulin 
staining was regained and microtubule bundles appeared clearer. Interestingly, load and 
recovery produced a tubulin organisation resembling that of chondrocytes treated with
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colchicine. The increased clarity of microtubules following load and recovery or 
colchicine treatment could therefore be due to: 1) collapse of microtubules into bundles, 
making them appear thicker and less densely packed, or 2) disruption of a proportion of 
tubulin microtubules, with the remaining intact tubule bundles then more clearly visible. 
Interestingly, a recent study has shown that mechanical compression induces reversible 
widening (i.e. thickening) of mitotic spindles in mammalian cells (Dumont and 
Mitchison, 2009). A previous study showed no change in tubulin network organisation 
in human chondrocytes in alginate subjected to physiological cyclic hydrostatic pressure 
(Fioravanti et al., 2003). However, in the same model, continuous high hydrostatic 
pressure (non-physiological loads) induced changes in tubulin organisation; the uniform 
peripheral localisation of microtubules in normal chondrocytes was lost in normal 
chondrocytes after pressurisation (Fioravanti et al., 2005). In support of the observed 
remodelling of tubulin microtubules, cyclic compression of normal and OA human 
chondrocytes in agarose induced up-regulation of p-tubulin mRNA expression, p-tubulin 
expression was increased in response to loading in normal and OA chondrocytes, 
although the further increase in expression with recovery was only observed in normal 
chondrocytes. Load-induced remodelling of the microtubule network could have reduced 
the pool of p-tubulin monomers in the chondrocytes; reduction below a specific critical 
level would suppress tubulin auto-regulation via mRNA degradation and therefore 
increase p-tubulin mRNA levels (Cleveland and Havercroft, 1983, Cleveland et al., 
1983, Yen et al., 1988).
Vimentin Intermediate Filaments
Changes in the organisation of the vimentin cytoskeleton were also observed in response 
to cyclic loading of human chondrocytes in agarose. In normal chondrocytes, vimentin 
intermediate filament bundles appeared thicker and more densely packed following 
cyclic compression, and regions of the cortical network were lost. Filament bundle 
thickening continued throughout the recovery period. As observed with the tubulin 
network and colchicine, vimentin organisation in recovery cells resembled that of 
normal chondrocytes treated with acrylamide; increased filament thickness could 
therefore indicate the formation of bundles and partial collapse of the intermediate 
filament network. In contrast to normal chondrocytes, vimentin filament bundles in OA 
chondrocytes appeared finer in response to cyclic compression then appeared thicker and 
more loosely packed following the recovery period. Changes in vimentin cytoskeletal
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organisation have been observed in cartilage explants in response to static compression 
(Durrant et al., 1999) and a single impact load (Henson and Vincent, 2008). 
Remodelling of the vimentin cytoskeleton in human chondrocytes in response to cyclic 
compression was not accompanied by changes in vimentin gene expression.
6.3.2.1 Additional Effects of Cytoskeletal Disruption with Load on Chondrocyte 
Cytoskeleton
Actin Microfilaments
Disruption of actin microfilaments with cytochalasin D did not prevent remodelling of 
the actin cytoskeleton in response to cyclic compression, nor did it have any additional 
effect on changes in P-actin mRNA expression in response to load. However, 
cytochalasin D treatment did affect load-induced changes in expression of actin 
associated proteins, although this was not translated into a difference in load-induced F- 
actin reorganisation. In normal chondrocytes, cytochalasin D reduced the load-induced 
increase in cofilin expression but caused an increase in destrin expression following 
recovery that was not observed in untreated chondrocytes. Load-induced up-regulation 
of thymosin p4 expression was unaffected by cytochalasin D in normal chondrocytes. In 
contrast, cytochalasin D enhanced load-induced up-regulation of thymosin P4 and 
destrin expression in OA chondrocytes; thymosin P4 expression decreased following 
recovery whilst destrin expression remained elevated. Cytochalasin D also enhanced the 
load-induced up-regulation of cofilin expression in OA chondrocytes. This indicates that 
the effects of load on cofilin, destrin and thymosin P4 expression are partially mediated 
by the actin cytoskeleton, which could indicate a feedback loop as these proteins 
regulate actin microfilament turnover. The role of the actin cytoskeleton in load-induced 
changes in cofilin and thymosin P4 is altered in OA chondrocytes, with expression in 
these cells appearing to be more sensitive to cyclic compression in the presence of actin 
microfilament disruption.
Disruption of tubulin microtubules with colchicine had no effect on load-induced 
remodelling of the actin cytoskeleton. Changes in p-actin and cofilin expression in 
response to cyclic compression were also unaffected by colchicine treatment. However, 
microtubule disruption did alter load-induced changes in destrin and thymosin P4 
expression; thymosin p4 expression was up-regulated with cyclic compression whilst 
destrin expression increased with recovery in colchicine-treated OA chondrocytes. This
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effect of colchicine treatment was only observed in OA chondrocytes. A previous study 
has demonstrated a link between disruption of microtubule dynamics and increases in 
thymosin p4 expression (Oh et al., 2006). Tubulin disruption enhanced the load-induced 
reduction in paxillin expression in normal and OA chondrocytes. Paxillin has been 
shown to bind to a- and y-tubulin in lymphocytes, co-localising with the microtubule 
organising centre in both adhesive- and suspension-cultured cells (Herreros et al., 2000). 
In endothelial cells decreased microtubule stability, induced by co-culture with vascular 
smooth muscle cells or colchicine treatment, is associated with increased paxillin 
phosphorylation (Hu et al., 2006, Wang et al., 2009c). The results indicate that the 
effects of load on destrin, thymosin p4 and paxillin expression are partially mediated by 
the tubulin cytoskeleton and that, as for actin microfilament-mediated responses, this is 
altered in OA chondrocytes.
Disruption of vimentin intermediate filaments with acrylamide did not affect actin 
organisation in loaded human chondrocytes, although treatment did result in loss of 
cortical actin localisation following recovery in normal chondrocytes. Acrylamide 
treatment did not alter the load-induced changes in expression of P-actin, destrin or 
thymosin p4, indicating that mechanical regulation of these genes occurs independently 
of vimentin intermediate filaments. In the presence of acrylamide, expression of cofilin 
and gelsolin were down-regulated following five hours of recovery post-load in both 
normal and OA chondrocytes, indicating that vimentin intermediate filaments could play 
a role following the removal of compressive load. Acrylamide delayed the load-induced 
down-regulation of paxillin transcription but did not alter the decrease in levels after 
recovery of OA chondrocytes; acrylamide did not alter load-induced paxillin mRNA 
changes observed in normal chondrocytes. As vimentin intermediate filaments play an 
important role in cell signalling, acting as both a phospho-protein and as a regulator of 
ERK activation (Perlson et al., 2006, Kim and Coulombe, 2007), they could mediate 
compression-induced changes in paxillin mRNA expression in OA chondrocytes and 
recovery of cofilin and gelsolin in normal and OA chondrocytes. In addition to the 
ability to alter transcription of paxillin demonstrated here, disruption of vimentin 
intermediate filaments with acrylamide has previously been shown to inhibit tyrosine 
phosphorylation of paxillin in human colon cancer cells adhered to collagen (Haier and 
Nicolson, 1999).
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Tubulin Microtubules
Disruption of tubulin microtubules with colchicine had an additive effect with load, 
enhancing changes in tubulin organisation and expression. Colchicine treatment 
enhanced the up-regulation of p-tubulin expression induced by cyclic compression in 
normal chondrocytes, with expression remaining elevated following five hours of 
recovery; no additive effect was observed in OA chondrocytes. In both normal and OA 
chondrocytes the punctate tubulin staining induced by cyclic compression was lost with 
colchicine treatment, which caused microtubule bundles to appear thicker. Colchicine 
particularly affected microtubule organisation following recovery after loading, causing 
thickening of microtubule bundles in normal chondrocytes but loss of the thick tubule 
bundles in OA chondrocytes. The additive effect of colchicine and load on tubulin 
expression and organisation indicates the presence of a regulatory feedback loop 
between tubulin microtubule dynamics and P-tubulin transcriptional regulation. An auto- 
regulatory loop exists for p-tubulin, with degradation of ribosome-bound p-tubulin 
mRNA if the pool of P-tubulin monomers increases above a specific level (Cleveland 
and Havercroft, 1983, Cleveland et al., 1983, Gay et al., 1987, Pachter et al., 1987). As 
discussed above, load-induced microtubule remodelling observed in normal human 
chondrocytes could reduce the p-tubulin monomer pool and increase p-tubulin mRNA 
levels. The enhanced up-regulation in the presence of colchicine could be due to its 
suppression of microtubule dynamics (Panda et al., 1995), increasing the demand for p- 
tubulin monomers and preventing p-tubulin mRNA degradation. The effect of colchicine 
on load-induced changes in p-tubulin expression in normal chondrocytes was mimicked 
by disruption of vimentin intermediate filaments with acrylamide. Like colchicine, 
acrylamide treatment also resulted in a thicker appearance of microtubule bundles in 
unloaded controls. Whilst acrylamide did not alter load-induced tubulin reorganisation, it 
did appear to slow the recovery of organisation in both normal and OA chondrocytes, 
perhaps indicating a role for vimentin intermediate filaments in regulating microtubule 
dynamics or organisation. There is evidence demonstrating that vimentin intermediate 
filaments co-localise with detyrosinated microtubules in fibroblasts and that 
detyrosinated microtubules recruit vimentin intermediate filaments via kinesin (Gurland 
and Gundersen, 1995, Liao and Gundersen, 1998, Kreitzer et al., 1999). Load-induced 
changes in the tubulin cytoskeleton most likely occurred independently of the actin 
cytoskeleton as cytochalasin D treatment had no clear effect on p-tubulin expression or 
on microtubule organisation.
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Vimentin Intermediate Filaments
An additive effect of acrylamide treatment and cyclic compression was less clear for 
changes in the vimentin cytoskeleton when compared with the microtubule network. In 
normal chondrocytes treated with acrylamide, load and load with a recovery resulted in 
regions of diffuse staining and an apparent loss of vimentin intermediate filament 
bundles towards the cell periphery. However, acrylamide did not affect the thickening of 
intermediate filament bundles in normal and OA chondrocytes following recovery from 
load. By contrast, acrylamide treatment enhanced the down-regulation of vimentin 
expression over the five hour recovery period in normal chondrocytes. Disruption of 
actin microfilaments with cytochalasin D also enhanced down-regulation of vimentin 
transcription following recovery from loading. Vimentin gene transcription could be 
down-regulated in response to load/recovery-induced reorganisation of the actin or 
vimentin cytoskeleton, perhaps due to interruption of shuttling of transcription factors 
along F-actin and ERK regulation by vimentin (Perlson et al., 2006); down-regulation of 
vimentin transcription would therefore be enhanced in the presence of cytochalasin D or 
acrylamide, as observed in the present study. Cytochalasin D also affected the load- 
induced reorganisation of the vimentin network, increasing the thickness of intermediate 
filament bundles in both loaded normal and OA chondrocytes. This could be a structural 
response to compensate for the loss of actin microfilaments, as both the vimentin and 
actin cytoskeleton contribute to the viscoelastic properties of chondrocytes (Trickey et 
al., 2004). Vimentin organisation following recovery was unaffected by cytochalasin D 
in OA chondrocytes, whilst intermediate filament bundles appeared finer and shorter 
with cytochalasin D treatment and recovery in normal chondrocytes. Despite showing no 
effect on load-induced changes in vimentin mRNA expression, disruption of tubulin 
microtubules with colchicine altered vimentin reorganisation in response to cyclic 
compression. In normal chondrocytes, colchicine treatment caused intermediate filament 
bundles to become less clear following recovery from loading, whilst in OA 
chondrocytes, intermediate filament bundles appeared thicker immediately after 
compression in the presence of colchicine. The suppression of microtubule dynamics in 
the presence of colchicine could alter tyrosination of tubulin and therefore the 
recruitment of vimentin intermediate filaments (Gurland and Gundersen, 1995, Kreitzer 
et al., 1999).
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6.3.2.2 Effects of Load and Cytoskeletal Disruption on Mechanical Properties of 
Chondrocytes
Disruption of vimentin intermediate filaments appears to affect the recovery of cofilin, 
gelsolin and vimentin mRNA expression and microtubule organisation following cyclic 
compression of human chondrocytes. A recent study has shown that cytoskeletal 
disruption slows the recovery of chondrocytes following mechanical compression (Ofek 
et al., 2009). Treatment of adult bovine chondrocytes with cytochalasin D, colchicine or 
acrylamide increased the time taken for recovery of cell height following compression of 
single cells for 30 seconds. The same study showed that disruption of actin 
microfilaments decreased bulk cell stiffness, disruption of tubulin microtubules 
increased cell compressibility, and disruption of vimentin intermediate filaments 
decreased cell compressibility (Ofek et al., 2009). Human chondrocyte viscoelasticity 
and cell stiffness is also reduced by actin microfilament disruption (Trickey et al., 2004). 
In contrast to the results presented by Ofek et al. 2009, other studies have shown that 
vimentin intermediate filament disruption reduces cell stiffness and viscoelasticity 
(Wang and Stamenovic, 2000, Trickey et al., 2004) whilst microtubule disruption has no 
effect (Trickey et al., 2004). In the present study, the stress in chondrocyte/agarose 
constructs under compression was increased by colchicine or acrylamide treatment, 
suggesting that disruption of the tubulin or vimentin cytoskeleton reduces cell 
compressibility and therefore increases the force required to produce a 15% strain. The 
observed effect o f vimentin disruption is supported by the results of Ofek et al. 2009; the 
authors suggest that the intermediate filaments function as tensile elements, effectively 
pulling the cell together (Ofek et al., 2009). Intermediate filaments have been shown to 
increase in stiffness with increasing stress and this behaviour in cells is not inhibited by 
acrylamide treatment, nor is it absent from vimentin-deficient fibroblasts (Wang and 
Stamenovic, 2000). In contrast to the studies mentioned above which were performed 
using isolated chondrocytes, the chondrocytes studied here were cultured in agarose for 
three days prior to cyclic compression. Chondrocytes could therefore have begun to 
synthesise and accumulate a pericellular matrix, the mechanical properties of which 
could influence the compressibility of chondrocyte/agarose constructs. A previous study 
showed that bovine chondrocytes exhibit a ‘halo’ of pericellular matrix after 24 hours in 
agarose culture, with sGAG and collagen content increasing from day one to day six of 
culture (Knight et al., 1998). Cell deformation under compressive strain was reduced 
with increasing pericellular matrix accumulation; at day six the pericellular matrix was
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stiffer than the 3% agarose and did not deform during compression. It is also possible 
therefore that altered pericellular matrix synthesis or retention in response to cytoskeletal 
disruption could also influence the mechanical properties of chondrocyte/agarose 
constructs. Cytochalasin D reduces pericellular matrix assembly and retention (Nofal 
and Knudson, 2002) and acrylamide reduces collagen synthesis in bovine chondrocytes 
(Blain et al., 2006). Human chondrocytes in the present study were cultured for two days 
in agarose, then for a further 24 hours with or without cytoskeletal disrupting reagents 
before compression. As cytochalasin D treatment had no effect on stress under 
compression, and acrylamide increases rather than reduces stress, it is likely that the 
effects of cytoskeletal disruption on pericellular matrix synthesis or retention are not 
significant enough after 24 hours to affect the mechanical properties of the constructs. It 
is therefore likely that the effects of cytoskeletal disruption on stress under compression 
are predominantly due to changes in the mechanical properties of the chondrocyte.
6.3.3 The Effect of Pathology on Load-Induced Changes
For a number of the genes studied, load-induced changes in expression differed between 
normal and OA human chondrocytes. These differences could be indicative of different 
or divergent mechanotransduction pathways in OA chondrocytes, which has been 
previously demonstrated in monolayer for the integrin-, stretch-activated ion channel- 
and IL-4-dependent mechano-transduction pathway (Millward-Sadler et al., 2000b, 
Salter et al., 2002); see section 6.1.3.
SOX9 mRNA levels increased after five hours of recovery from 40 minutes of cyclic 
compression in agarose embedded OA human chondrocytes; this response was not 
observed in normal human chondrocytes. Furthermore, disruption of actin 
microfilaments with cytochalasin D inhibited the load/recovery-induced increase in 
SOX9 mRNA levels in OA chondrocytes, suggesting that load-induced changes in SOX9 
expression are mediated by the actin cytoskeleton. As discussed above (section 6.3.1.1), 
in the absence of actin stress fibres SOX9 mRNA is stabilised via p38 MAPK signalling 
(Tew and Hardingham, 2006, Tew et al., 2009), which can be activated by dynamic 
compression (Fitzgerald et al., 2008, Bougault et al., 2008). Dynamic compression can 
also increase SOX9 mRNA expression through activation of Rho and ROCK, which 
increases SOX9 transcriptional activity and SOX9 transcription (Haudenschild et al., 
2010, Kumar and Lassar, 2009). Differences between normal and OA human
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chondrocytes in load-induced changes in SOX9 mRNA levels could be due to inherent 
differences in Rho/ROCK/actin cytoskeleton or in p38 MAPK activation and signalling 
pathways. It cannot be excluded that increases in SOX9 mRNA expression occurred with 
recovery post-load in normal chondrocytes; levels may have increased post-load but 
returned to baseline by the five hour time point assayed, or they might have increased if 
the post-load recovery period was extended.
In OA human chondrocytes, COLJA1 and MMP13 expression were decreased following 
a five hour recovery post-load. No significant decrease was observed in normal 
chondrocytes after the recovery period, although mRNA levels did show a trend of 
decreasing. The difference in response of normal and OA chondrocytes could therefore 
be due to the lower basal expression of COL1A1 and MMP13 in normal chondrocytes 
rather than a difference in the mechano-regulation of these genes. Alternatively, the 
loading regime could have a greater positive effect on the phenotype of OA 
chondrocytes.
Cyclic compression induced actin cytoskeletal remodelling along with apparently 
transient decreases in p-actin mRNA expression in both normal and OA human 
chondrocytes. However, the effect of load on the expression of some of the actin-binding 
proteins differed between normal and OA human chondrocytes; load increased mRNA 
expression of destrin, cofilin and thymosin P4 in normal, but not OA human 
chondrocytes. This could indicate a difference between normal and OA chondrocytes in 
load-induced actin remodelling, which is supported by the observed differences in actin 
cytoskeletal reorganisation following 40 minutes of cyclic compression. The additive 
effect o f cytochalasin D treatment with load on mRNA expression of destrin, cofilin and 
thymosin p4 in both normal and OA human chondrocytes also suggests that mechano- 
regulation of these genes could be mediated by the actin cytoskeleton. Cytochalasin D 
treatment up-regulated destrin mRNA expression with recovery post-load in normal 
chondrocytes and enhanced the load-induced increase in destrin expression in OA 
chondrocytes; this suggests that the load-induced increase in destrin expression is a 
response to a requirement for actin cytoskeletal remodelling, with disruption of 
micro filaments with cytochalasin D enhancing the response. The load-induced increases 
in cofilin mRNA levels were reduced in normal chondrocytes and enhanced in OA 
chondrocytes, suggesting that cofilin expression is mechanically regulated in part by the
-295 -
Chapter 6: The Effect of Load and Cytoskeletal Disruption on Chondrocyte Phenotype
actin cytoskeleton in normal but not OA chondrocytes; this has been observed for 
membrane potential changes induced by mechanical strain in human chondrocytes 
(Wright et al., 1997, Mi 11 ward-Sadler et al., 2000b). The enhanced load-induced up- 
regulation of cofilin expression in OA chondrocytes could be a response to an increased 
requirement for actin remodelling as a result of cytochalasin D treatment. Mechano- 
regulation of thymosin P4 expression was unaffected by actin microfilament disruption 
in normal chondrocytes, whilst in OA chondrocytes cytochalasin D treatment induced a 
thymosin P4 transcriptional response to load. This further suggests differences in actin 
cytoskeletal remodelling and mechanotransduction pathways between normal and OA 
human chondrocytes.
Cyclic compression-induced increases in p-tubulin mRNA levels were observed only in 
normal human chondrocytes and not OA cells. Furthermore, load-induced increases in 
mRNA levels were enhanced by colchicine or acrylamide treatment in normal 
chondrocytes, whilst no effect was observed in OA chondrocytes. As discussed above, 
the increase in P-tubulin mRNA levels could be a result of increased microtubule 
remodelling in response to cyclic compression, reducing the pool of p-tubulin monomers 
and relieving auto-regulation and degradation of p-tubulin mRNA (Cleveland and 
Havercroft, 1983, Cleveland et al., 1983, Yen et al., 1988). The lack of an effect of load 
on p-tubulin mRNA levels in OA chondrocytes could suggest that load-induced 
microtubule remodelling does not reduce the P-tubulin monomer pool below the specific 
level in OA chondrocytes, perhaps due to increased microtubule disassembly in OA, and 
therefore mRNA levels are unchanged (Cleveland and Havercroft, 1983, Cleveland et 
al., 1983). This difference in load-induced microtubule remodelling between normal and 
OA human chondrocytes could be due to the observed differences in basal microtubule 
organisation or to altered mechano-regulation of microtubule dynamics.
In addition to differential gene expression in response to compression, normal and OA 
human chondrocytes exhibit differences in the organisation of actin microfilaments and 
tubulin microtubules after five hours of recovery post-load. Actin and tubulin 
cytoskeletal organisation returned to that of unloaded controls in normal chondrocytes 
whilst both microfilaments and microtubule bundles became more evident in OA 
chondrocytes, suggesting an existing difference in actin and tubulin dynamics.
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In summary:
• Cyclic compression induced cytoskeletal remodelling and changes in the 
expression of p-tubulin, destrin, SOX9 and COL1A1 mRNAs in human 
chondrocytes embedded in agarose.
• Disruption of actin micro filaments affected the load-induced response of cofilin 
and destrin expression in both normal and OA chondrocytes and the response of 
thymosin P4 and SOX9 expression in OA chondrocytes.
• Disruption of vimentin intermediate filaments affected the load-induced response 
of vimentin and p-tubulin expression and reorganisation of actin cytoskeletal 
networks in normal chondrocytes, whilst in OA chondrocytes it affected the 
response of cofilin and paxillin expression and reorganisation of tubulin 
microtubule networks.
• Disruption o f tubulin microtubules affected the load-induced response of paxillin 
expression in both normal and OA chondrocytes and the recovery of actin 
microfilament organisation in normal chondrocytes.
• Differences between the effect of cyclic compression on normal and OA human 
chondrocytes support the existence of different or divergent mechano- 
transduction pathways. An additive effect of cytoskeletal disruption suggests that 
these pathways are mediated in part by elements of the chondrocyte cytoskeleton.
- 2 9 7 -
Chapter 7: General 
Discussion
Chapter 7: General Discussion
7. GENERAL DISCUSSION
The chondrocyte cytoskeleton comprises three distinct elements, actin microfilaments, 
tubulin microtubules and vimentin intermediate filaments. The cytoskeleton plays an 
important role in transducing extracellular signals to the nucleus to modulate 
chondrocyte gene expression and therefore extracellular matrix (ECM) turnover. It is 
also important in maintaining the mechanical properties of the chondrocyte (Trickey et 
al., 2004, Ofek et al., 2009). Changes in chondrocyte phenotype have long been known 
to be associated with reorganisation of the chondrocyte cytoskeleton (Benya and Shaffer, 
1982a, Brown and Benya, 1988). Previous work has shown that disruption of the 
cytoskeleton alters chondrocyte gene expression (Benya et al., 1988) and that both 
chondrocyte cytoskeletal organisation (Durrant et al., 1999, Fioravanti et al., 2005, 
Knight et al., 2006) and matrix molecule gene expression (Blain et al., 2001, Mio et al., 
2005) are altered in response to load. Abnormal loading of joints is a major risk factor 
for the development of osteoarthritis (OA) (Aigner et al., 2006a, Blagojevic et al., 2010) 
and the cytoskeletal architecture in chondrocytes from both human OA (Fioravanti et al., 
2003, Lambrecht et al., 2008) and a rat model of OA (Capin-Gutierrez et al., 2004) has 
been observed to differ to that of normal chondrocytes. This has led us to hypothesise 
that dysregulation of cytoskeletal networks prevents normal ECM-chondrocyte 
signalling and promotes a catabolic phenotype- the hallmark of OA.
7.1 The Implications of Using Human Tissue
Human articular cartilage was used throughout the present study. The use of human 
material is preferred to that from other mammals as protein-protein interactions and 
signalling pathways can vary between species. This is particularly relevant when 
studying pathways and mechanisms relating to human diseases and disorders such as 
OA. One particular example of this in the OA field is the respective role of ADAMTS4 
and ADAMTS5 in disease progression, where the predominant aggrecanase in disease 
differs between mice and humans: studies in mice have demonstrated that ADAMTS5 
knockout alone is sufficient to protect against OA (Glasson et al., 2004, Glasson et al., 
2005, Majumdar et al., 2007) and inflammatory arthritis (Stanton et al., 2005) whilst in 
human articular cartilage explants, siRNA knockdown has demonstrated that both 
ADAMTS4 and ADAMTS5 mediate aggrecan degradation (Song et al., 2007). The 
principal disadvantage of using human samples however is the high variability between
- 2 9 8 -
Chapter 7: General Discussion
donors, resulting in the requirement of a larger number of samples in order for 
experimental changes to reach statistical significance. However, human material is not 
as frequently and easily available as that from other species. In particular, the 
availability o f  normal human cartilage is limited. The use of human material in the 
present study resulted in a high degree of variability in most experimental results. When 
comparing data, this variability results in statistical p values that are not significant at the 
95% confidence level. For this reason, changes with p values significant at the 90% 
confidence level are also discussed based on the assumption that an increased number of 
samples would likely produce statistical significance.
In addition to that associated with human samples in general, another level of variability 
is added to the present study by the heterogeneity of OA as a disease (Mankin et al., 
1971, Rizkalla et al., 1992). Changes in cartilage organisation and extracellular matrix 
integrity have been well characterised in OA and used for grading the disease, allowing 
quantification o f severity (Mankin et al., 1971). However, the aetiology of OA is poorly 
understood and, during the early stages of disease, it is unclear whether changes in the 
cartilage are widespread or localised to particular regions i.e. whether changes in 
chondrocytes occur throughout the cartilage (McDevitt and Muir, 1976, Brew et al., 
2010b) or only in regions exhibiting surface disruption or fibrillation (Yagi et al., 2005). 
If the former is true, this raises a potential problem when attempting to determine causal 
or early disease mechanisms; a visually intact surface does not necessarily mean that the 
sample is not in the early stages of OA (Mankin et al., 1971, Rizkalla et al., 1992), in 
which case the early changes will have been missed. Furthermore, the association of 
cartilage degradation with joint pain has not been determined for OA. In the present 
study, using human cartilage from AstraZeneca, samples are classified as either ‘normal’ 
or ‘OA’ based on clinical parameters rather than histological grading or even visual 
analysis of cartilage on the joint; post-mortem samples are classed as ‘normal’ if the 
donor had never presented to a GP with knee pain. As there is no correlation between 
radiographic OA severity and pain (Link et al., 2003), this does not necessarily mean 
that the cartilage is not in the early or more advanced stages of disease. This problem is 
enhanced by the advancing age of post-mortem donors, which increases the likelihood 
that cartilage has begun to exhibit OA-like changes. This is demonstrated in the present 
study by the varying degrees of degradative changes observed in ‘normal’ samples; this 
added variability in ‘normal’ samples could therefore mask the significance of
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differences observed between normal and OA samples. To begin to address this 
problem, future work would ideally be performed using only post-mortem samples with 
no macroscopic or histological evidence of cartilage degeneration for normal controls 
and isolation of chondrocytes; the practicality of this however is unrealistic.
7.2 The Chondrocyte Cytoskeleton is Altered in Osteoarthritis
The present study is the first to characterise and compare the cytoskeletal organisation of 
normal and OA human chondrocytes in situ. Immunofluorescence in conjunction with 
scanning confocal microscopy showed clear differences between normal and OA human 
cartilage chondrocyte cytoskeletal architecture. Scoring of confocal images revealed a 
significant difference in actin and vimentin organisation in deep zone chondrocytes, 
along with a significant difference in tubulin organisation in superficial and mid zone 
chondrocytes. ECM organisation and composition vary through the depth of cartilage 
tissue, along with mechanical forces experienced by chondrocytes. Changes in the ECM 
alter the strain experienced by chondrocytes in OA cartilage. The fact that significant 
differences between normal and OA cartilage were observed in the superficial and mid 
zone for tubulin microtubules but the deep zone for actin and vimentin cytoskeletal 
networks could be due to their different roles in regulating the biomechanical properties 
of chondrocytes (Trickey et al., 2004, Ofek et al., 2009). No differences in the protein 
levels of the three main cytoskeletal elements was observed, suggesting that the 
differences in architecture are due to reorganisation of existing cytoskeletal elements 
rather than de novo protein synthesis.
The observed differences in cytoskeletal organisation between normal and OA cartilage 
chondrocytes could result in changes to the chondrocyte phenotype and hence ECM 
composition. This was demonstrated in agarose-embedded normal and OA 
chondrocytes, where chemical disruption of each of the cytoskeletal elements altered the 
expression of genes encoding matrix proteins and matrix-degrading enzymes, along with 
those encoding growth factors and inflammatory mediators that could subsequently 
affect chondrocyte phenotype. This supports and expands on previous research 
demonstrating an effect of actin (Benya et al., 1988, Brown and Benya, 1988, Woods 
and Beier, 2006), tubulin (Takigawa et al., 1984) and vimentin (Blain et al., 2006) 
cytoskeletal disruption on the expression of matrix proteins and matrix-degrading 
enzymes in chondrocytes. The present study is the first to demonstrate down-regulation
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of MMP13 mRNA expression with disruption of the tubulin or vimentin chondrocyte 
cytoskeleton and down-regulation of ADAMTS5 transcription with microtubule 
disruption.
Custom-designed Taqman® arrays also indicated a novel effect of cytoskeletal disruption 
on chondrocyte expression of FGFR3\ microtubule disruption down-regulated whilst 
vimentin intermediate filament disruption up-regulated FGFR3 mRNA expression. 
Attempts to validate array data for FGFR3 were unsuccessful due to inefficiency of the 
quantitative PCR. Future experiments are required to optimise different primer sets and 
quantitative PCR conditions to allow validation of the effects of cytoskeletal disruption 
and to determine any effects of cyclic compression on FGFR3 expression in normal and 
OA human chondrocytes. A recent study has implied that increased mechanical load can 
up-regulate FGFR3 expression in rat condylar chondrocytes (Papadopoulou et al., 2007) 
whilst another member of the FGFR subfamily, FGFR1, is suggested to function in 
chondrocyte mechanotransduction (Vincent et al., 2004, Vincent et al., 2007).
In support of previous work in other cell types (Witteck et al., 2003, Kim, 2005), an 
effect of actin and vimentin cytoskeletal disruption on NOS2A (iNOS) expression was 
observed in chondrocytes for the first time. Of particular interest was the differential 
response of NOS2A transcription to vimentin disruption, which was down-regulated in 
normal and up-regulated in OA human chondrocytes. As for FGFR3, attempts to 
validate array data for NOS2A were unsuccessful due to inefficiency of quantitative 
PCRs; optimisation of different primer sets would allow validation of the effects of 
cytoskeletal disruption and determination of any effects of cyclic compression in normal 
and OA human chondrocytes. Dynamic compression has recently been shown to up- 
regulate NOS2A via an actin- and ROCK-dependent mechanism in agarose embedded 
normal human chondrocytes (Haudenschild et al., 2008a, Haudenschild et al., 2008b) but 
no role of the vimentin cytoskeleton has previously been demonstrated. By contrast, 
dynamic compression can reduce IL-ip-induced NOS2A expression mediated by 
integrins and p38 MAPK in bovine chondrocytes (Chowdhury et al., 2008).
Taqman® array data also indicated an effect of actin, tubulin and vimentin cytoskeletal 
disruption on mRNA expression of the pro-apoptotic factor BMF. BMF protein is 
sequestered to actin microfilaments through its interaction with the DLC2 component of
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the myosin V motor complex (Puthalakath et al., 2001) but has not previously been 
linked to microtubules or vimentin intermediate filaments. Furthermore, this is the first 
time that BMF expression has been described in chondrocytes. Results suggest that BMF 
is more highly expressed in OA chondrocytes when compared with normal chondrocytes 
although changes did not reach statistical significance. Future experiments using an 
increased number of donors should produce statistically significant results, whilst 
comparison of BMF  expression in normal and OA human articular cartilage would 
indicate if this up-regulation also occurs in vivo. This would be interesting as mRNA 
expression of anti-apoptotic Bcl2 is reduced in human OA cartilage (Brew et al., 2010b). 
As BMF functions to bind and sequester Bcl2 proteins (Puthalakath et al., 2001), this 
would suggest an increased sensitivity to apoptosis in OA (Hashimoto et al., 1998).
7.3 Are the Observed Differences in Cytoskeletal Organisation due to
the Altered Mechanical Environment in Osteoarthritic Cartilage?
Along with chondrocyte cytoskeletal architecture, cartilage organisation and 
extracellular matrix composition was disrupted in OA cartilage, which would alter the 
mechanical load experienced by chondrocytes within the tissue. As load can induce 
changes in cytoskeletal organisation (Durrant et al., 1999, Fioravanti et al., 2005, Knight 
et al., 2006) it was unclear whether the observed differences in OA cytoskeletal 
organisation were due to the altered mechanical environment in OA cartilage or, as 
hypothesised, the cause of it. Chondrocytes were isolated from normal and OA human 
cartilage for culture in identical mechanical environments. In order to achieve large 
enough numbers for experimentation, chondrocytes were expanded in monolayer to 
passage three. Differences in cytoskeletal organisation between normal and OA 
chondrocytes were retained in culture, indicating that the in situ differences were not 
entirely due to the altered mechanical environment in OA cartilage. However, the 
morphology of normal and OA chondrocytes cultured as a monolayer indicated loss of 
the typical rounded chondrocyte morphology and therefore phenotype (Benya et al., 
1978, Benya and Shaffer, 1982a, Brown and Benya, 1988). In order to ensure that 
expression changes observed with cytoskeletal disruption were not simply due to 
redifferentiation to a chondrocytic phenotype, chondrocytes were embedded in agarose, 
a 3D culture condition that allows maintenance of the typical chondrocyte morphology 
and phenotype. In 3D agarose culture the cytoskeletal architecture of normal and OA 
chondrocytes more closely resembled that observed in situ. The differences in gene
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expression between normal and OA cartilage were also better represented when isolated 
chondrocytes were cultured in 3D agarose, indicating that the culture system was a good 
model for use in further experiments. Furthermore, agarose embedded normal and OA 
chondrocytes exhibited differences in gene expression and cytoskeletal organisation 
demonstrating that these differences are inherent and not simply a result of the altered 
mechanical and extracellular environment that exists in OA cartilage.
The effect of load on the cytoskeletal elements of normal and OA chondrocytes was 
determined by subjecting agarose embedded chondrocytes to cyclic compression at 15% 
strain and 0.5 Hz. Various loading regimes have been used for dynamic compression of 
chondrocytes embedded in hydrogels. Many have used a 15% strain (Lee and Bader, 
1997, Knight et al., 2006, Mio et al., 2005, Kock et al., 2009, Haudenschild et al., 2010) 
as this lies within the physiological range for cells in intact cartilage subjected to 
physiological loads (Guilak et al., 1995, Lee and Bader, 1997). The frequency used is 
more variable, ranging from 0.01 Hz to 3 Hz (Buschmann et al., 1995, Lee and Bader, 
1997). A frequency of 0.5 Hz was selected for use as it lies within the physiological 
range (Lee and Bader, 1997) and allowed maintenance of construct integrity; higher 
frequencies resulted in the agarose cracking. An identical loading regime of 15% at 0.5 
Hz was also used in a recently published study using normal human chondrocytes 
embedded in agarose (Haudenschild et al., 2010). In the present study, analysis of the 
expression of chondrocyte phenotype markers demonstrated that the loading regime up- 
regulated SOX9 and down-regulated COL1A1 and MMP13 mRNA expression in OA 
chondrocytes, indicating that no catabolic changes were being induced. However an 
anabolic response was not observed in AC AN  expression in the loading and recovery 
durations studied. Further experiments to determine COL2A1 and ACAN expression 
changes over longer loading durations and increased recovery periods would allow 
confirmation of the anabolic changes suggested by the up-regulation of SOX9 and 
previous studies subjecting bovine (Mio et al., 2005) and porcine (Kock et al., 2009) 
chondrocytes embedded in agarose to 15% dynamic compression.
Cyclic compression of agarose embedded normal and OA chondrocytes induced 
reorganisation of the actin, tubulin and vimentin cytoskeletal networks. This is the first 
demonstration of cyclic compression-induced reorganisation of the tubulin and vimentin 
cytoskeleton in normal human chondrocytes and confirms that recently demonstrated in
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agarose-embedded normal human chondrocytes for the actin cytoskeleton (Haudenschild 
et al., 2008a). It is also the first to characterise compression-induced cytoskeletal 
reorganisation in OA human chondrocytes, although the effects of physiological cyclic 
(Fioravanti et al., 2003) and continuous high (Fioravanti et al., 2005) hydrostatic 
pressure have been demonstrated for human OA chondrocytes in alginate. Load can 
therefore induce cytoskeletal reorganisation in chondrocytes isolated from normal and 
OA human cartilage. The recovery of actin and tubulin cytoskeletal organisation post­
load differed between normal and OA chondrocytes, with networks returning to the 
organisation of unloaded controls in normal chondrocytes but becoming more evident in 
OA chondrocytes. This suggests that, whilst the differences in cytoskeletal architecture 
observed between normal and OA cartilage chondrocytes in situ could be a result of 
loading and an altered mechanical environment, there are differences in the dynamics of 
the actin and tubulin networks between normal and OA chondrocytes that are 
independent of loading conditions; this supports the hypothesis that changes in the 
chondrocyte cytoskeleton occur before cartilage degradation in OA. This is further 
supported by a study comparing vimentin organisation in alginate embedded 
chondrocytes isolated from normal, macroscopically intact (minimal) OA and fibrillated 
(advanced) OA human cartilage (Lambrecht et al., 2008). Results demonstrated that the 
largest difference in vimentin organisation was between normal human chondrocytes 
and minimal OA chondrocytes rather than between minimal and advanced OA 
chondrocytes.
7.4 What Role does the Human Chondrocyte Cytoskeleton Play in 
Mechanotransduction?
The reorganisation of vimentin intermediate filament networks in chondrocytes in 
response to cyclic compression was not accompanied by changes in vimentin mRNA 
levels. Load-induced changes in levels of vimentin protein, phosphorylation and N- 
terminal cleavage were not determined as protein was not successfully extracted from 
chondrocytes embedded in agarose. Future experiments would replace the agarose 
hydrogel with alginate, allowing depolymerisation of the gel and release of chondrocytes 
for extraction of protein following loading periods. This would help to determine the 
mechanisms leading to vimentin remodelling in response to cyclic compression. 
Increases in vimentin phosphorylation would alter network organisation by increasing 
intermediate filament depolymerisation and slowing the rate of polymerisation (Eriksson
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et al., 2004). N-terminal cleavage of vimentin would reduce intermediate filament 
assembly (Beuttenmuller et al., 1994) and the association of filament networks with the 
plasma membrane (Georgatos et al., 1985), resulting in the ‘looser’ organisation 
observed in normal and OA human chondrocytes following recovery post-load. 
Increased vimentin N-terminal cleavage has been observed in chondrocytes isolated 
from OA human cartilage when compared with those from normal human cartilage 
(Lambrecht et al., 2008) and could contribute to the difference in vimentin intermediate 
filament network organisation observed in situ in human OA in the present study and 
previously in a rat model of OA (Capin-Gutierrez et al., 2004). Whilst load did not 
produce significant changes in vimentin mRNA expression in untreated controls, 
disruption of actin microfilament networks enhanced the down-regulation of vimentin 
expression with recovery post-load in normal and OA chondrocytes. Remodelling of the 
actin cytoskeleton following removal of cyclic compression could interrupt the shuttling 
of transcription factors along microfilaments and reduce vimentin transcription, with 
cytochalasin D further disrupting microfilaments and vimentin transcription to produce a 
significant decrease in mRNA levels with recovery post-load. Actin cytoskeletal 
remodelling in response to the removal of load in vivo could explain the significant 
decrease in vimentin mRNA expression observed in OA cartilage, in which loads 
experienced by chondrocytes are increased due to disruption of cartilage tissue integrity. 
Disruption of vimentin networks also enhanced down-regulation of vimentin mRNA 
expression with recovery post-load, but this was only observed in normal chondrocytes. 
Vimentin intermediate filaments prevent dephosphorylation of phosphorylated ERK 
(Perlson et al., 2006), maintaining it in an activated state, and are also suggested to 
function as substrates for phosphorylation signalling in the cytoplasm (Kim and 
Coulombe, 2007). Through effects on these signalling intermediates and their 
downstream transcription factor targets, vimentin filament reorganisation in response to 
the removal of load could reduce vimentin transcription. Further disruption of 
intermediate filament organisaton by acrylamide would therefore produce a significant 
decrease in vimentin mRNA levels with recovery post-load. As for actin remodelling, 
this could provide a mechanism for the down-regulation of vimentin mRNA expression 
observed in OA cartilage; the lack of effect of acrylamide treatment on loaded OA 
chondrocytes could be a result of the basal differences in intermediate filament 
organisation or signalling pathways between these two cell populations.
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In order to delineate the roles of the actin and vimentin cytoskeleton in the regulation of 
vimentin transcription with recovery post-load, future experiments need to be performed 
altering the conditions under which chondrocytes recover. For instance, 
chondrocyte/agarose constructs would be allowed to recover after treatment and load in 
the absence of cytoskeletal disrupting reagents and the data compared to recovery with 
cytoskeletal disruption. Extraction of protein and analysis of total and phosphorylated 
ERK levels would also help to further characterise the mechanism regulating decreased 
vimentin transcription. Indeed, dynamic compression of murine chondrocytes embedded 
in agarose has recently been shown to activate ERK signalling (Bougault et al., 2008). If 
differences in phosphorylation were observed in loaded chondrocytes then the addition 
of an ERK inhibitor immediately after removal of load could further characterise the role 
of ERK signalling in the regulation of vimentin expression. However, the role of other 
signalling intermediates including p38 MAPK, JNK, PKA and PKC in load-induced 
regulation o f vimentin dynamics cannot be discounted.
Cyclic compression up-regulated p-tubulin mRNA expression in normal but not OA 
chondrocytes embedded in agarose. Furthermore, despite having no effect in the absence 
of load, colchicine and acrylamide enhanced load-induced up-regulation of p-tubulin 
transcription in normal chondrocytes only. As p-tubulin mRNA levels are auto-regulated 
depending on the size of the free tubulin pool (Cleveland and Havercroft, 1983, 
Cleveland et al., 1983, Yen et al., 1988), P-tubulin transcription could be increased as a 
result of a reduction of the free tubulin pool caused by the observed load-induced 
microtubule remodelling. Colchicine treatment suppresses microtubule dynamics (Panda 
et al., 1995) which in the presence of load would increase the demand for remodelling 
and thus further increase P-tubulin mRNA levels. Perhaps as a result of the close 
association of intermediate filaments with microtubules (Gurland and Gundersen, 1995), 
vimentin disruption with acrylamide could also suppress microtubule dynamics. This 
could result in an increased demand for microtubule reorganisation under load, a 
reduction of the p-tubulin pool and hence increased P-tubulin mRNA levels. Extraction 
of protein from chondrocytes post-load would help to determine a difference in the P~ 
tubulin pool between normal and OA chondrocytes and the effect of cyclic compression 
and recovery on the size of the pool. The lack of an effect of load with or without 
cytoskeletal disruption on p-tubulin mRNA levels in OA chondrocytes could indicate 
that the p-tubulin monomer pool is larger in OA chondrocytes and therefore load-
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induced remodelling never decreases it below the critical level to release mRNA from 
degradation. In support of this, in situ observations in rat (Capin-Gutierrez et al., 2004) 
and human (present study) cartilage suggest that the microtubule network is partially 
disassembled in OA, which could result in a larger monomer pool. However, the 
observed increase in p-tubulin mRNA in OA cartilage when compared with normal 
tissue would suggest that the P-tubulin pool is not larger than in normal cells, as this 
would result in reduced mRNA levels in OA. Alternatively, the increased P-tubulin 
mRNA in OA cartilage may never be translated to an increase in protein due to the 
presence of a defective microtubule network. As demonstrated by cyclic compression of 
chondrocytes embedded in agarose, the elevated p-tubulin mRNA levels in OA cartilage 
could be due to increased loading as a result of the altered mechanical environment.
Despite inducing remodelling of the actin microfilament networks, cyclic compression 
has no effect on p-actin mRNA levels. Load did however up-regulate expression of 
destrin and appeared to up-regulate cofilin and thymosin P4 expression in normal 
chondrocytes. Cofilin and destrin are actin depolymerising factors and thymosin P4 
sequesters G-actin, indicating that load increases microfilament depolymerisation and 
the G-actin pool for the observed remodelling of the actin network. This could be the 
cause of the increased thymosin p4 expression detected in OA cartilage. Whilst actin 
reorganisation in response to load was observed in OA chondrocytes, changes in 
expression of the actin binding proteins were only observed in normal chondrocytes. 
Similarly, up-regulation of cofilin, destrin and p-actin mRNA expression in response to 
disruption of the actin or tubulin cytoskeleton was also observed only in normal 
chondrocytes. This indicates that these genes are more sensitive in normal chondrocytes 
to microfilament and microtubule remodelling induced by either cyclic compression 
alone or chemical disruption of cytoskeletal dynamics alone.
Interestingly, whilst neither load nor cytoskeletal disruption alone had a significant 
effect on cofilin, destrin and thymosin p4 mRNA expression, load in combination with 
actin disruption resulted in transcriptional up-regulation of these genes in OA 
chondrocytes. Furthermore, in the presence of colchicine, load induced up-regulation of 
thymosin p4 expression in OA chondrocytes. This suggests that, in contrast to normal 
chondrocytes, these genes are more sensitive in OA chondrocytes to microfilament and 
microtubule remodelling induced by cyclic compression in combination with chemical
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disruption of cytoskeletal dynamics, as opposed to either of these alone. This further 
supports the existence of differences in the dynamics of actin and tubulin networks 
between normal and OA chondrocytes implied by the observed difference in recovery of 
actin and tubulin cytoskeletal organisation post-load. As OA chondrocytes have an 
altered cytoskeletal network they may utilise different or divergent mechanotransduction 
pathways.
mRNA levels of the focal adhesion protein paxillin were decreased in OA cartilage. 
Paxillin interacts with actin microfilaments (Deakin and Turner, 2008) at sites of cell- 
matrix contact; it is phosphorylated in response to mechanical stimulation of integrins in 
human chondrocytes cultured as a monolayer (Lee et al., 2000). Reduced expression of 
paxillin in OA cartilage chondrocytes could alter chondrocyte mechanotransduction 
mediated by integrins. In support of this the integrin-, IL-4- and stretch activated ion 
channel-dependent mechanotransduction pathway characterised in normal human 
chondrocytes cultured as a monolayer (Wright et al., 1996, Wright et al., 1997, Lee et 
al., 2000, Millward-Sadler et al., 2000a) has been shown to differ in OA chondrocytes 
(Millward-Sadler et al., 2000b); see section 6.1.3 for details. Paxillin mRNA levels 
showed a trend to decrease with recovery post-load in normal and OA chondrocytes, 
suggesting that the altered mechanical environment in OA cartilage could decrease 
paxillin expression and result in altered mechanotransduction. In the presence of 
acrylamide or colchicine the decrease in paxillin expression with recovery post-load was 
enhanced in OA chondrocytes, with colchicine also enhancing the down-regulation of 
paxillin transcription in normal chondrocytes loaded for 40 minutes. The effects of load 
on paxillin mRNA levels in chondrocytes and the reduction in OA cartilage could 
therefore be due to vimentin and/or tubulin cytoskeletal changes. The distribution of the 
focal contact proteins paxillin, vinculin and talin is irregular in vimentin-deficient 
fibroblasts, although ECM adhesion is unaffected (Eckes et al., 1998). Vimentin 
maintains ERK in an activated state (Perlson et al., 2006) and paxillin can also interact 
with and regulate ERK signalling (Ishibe et al., 2003); disruption or reduction of ERK 
signalling would have downstream effects on transcription.
Differences exist between the cytoskeleton networks of chondrocytes in normal and 
osteoarthritic articular cartilage and these appear to be due to a reorganisation of existing 
cytoskeletal proteins. As cyclic compression can alter the organisation of all three of the
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main chondrocyte cytoskeletal elements, the observed difference in OA cytoskeleton 
could be a result of the altered mechanical environment in diseased cartilage. However, 
chemically-induced disruption/reorganisation of each of the three main cytoskeletal 
elements altered the chondrocyte phenotype, inducing differential expression of actin 
regulatory proteins, matrix molecules, matrix degrading enzymes, growth factors and 
inflammatory mediators, and therefore could cause the altered mechanical environment 
in OA cartilage. When cultured in vitro in identical mechanical environments, normal 
and OA chondrocytes exhibited differences in cytoskeletal architecture and responded 
differently to cytoskeletal disruption, cyclic compression and the two in combination. 
This demonstrates that cytoskeletal differences observed in situ are not simply a result of 
an altered mechanical environment, but can contribute to disease mechanisms and 
progression.
It should be noted here that, contrary to the expected effect, the presence of a 
cytoskeletal disrupting reagent did not prevent the post-load recovery and reassembly of 
its target cytoskeletal element networks. This would suggest that, contrary to the original 
hypothesis, OA is not due to disruption of cytoskeletal networks, as reassembly can still 
occur post-load in the presence of disrupting reagents. Instead, OA could be caused by a 
lack of the cytoskeletal element monomers, which would result in the observed 
differences in organisation. Studies showing reduced immunofluorescent labelling of 
cytoskeletal elements in human OA (Fioravanti et al., 2005) and a rat model of OA 
(Capin-Gutierrez et al., 2004) suggest that cytoskeletal element protein levels are 
decreased. This hypothesis is also supported by the observed decrease in vimentin 
mRNA in OA cartilage and the increase in thymosin P4 expression which, if translated 
to protein, could indicate an increase in sequestered G-actin and therefore a decrease in 
free G-actin and the ability to form functional actin cytoskeletal networks.
7.5 Future Directions
As discussed above, further experiments with an increased number of donors could 
produce statistical significance where near-significant changes in gene expression were 
observed. Further investigation of cytoskeletal reassembly post-load, where the 
cytoskeletal disrupting reagent is removed for the recovery period only, could clarify the 
role of each cytoskeletal element in the post-load recovery of organisation and gene 
expression changes. Loading experiments could also be repeated in alginate and protein
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extracted from chondrocytes to determine if the transcriptional effects are also observed 
at the protein level. This would allow for the investigation of the effects of load and/or 
cytoskeletal disruption on the phosphorylation status of vimentin, ERK 1/2 and paxillin, 
which could begin to delineate the signalling pathways involved.
Whilst results obtained in the present study showed that the differences between normal 
and OA chondrocytes observed in cartilage are maintained in vitro in agarose culture, 
the use of cartilage explants is preferable as they better represent the conditions 
surrounding chondrocytes in vivo. Degradation and compositional changes in the ECM 
in OA cartilage could result in changes in or loss of cell-matrix interactions, which 
would have additional effects on mechanotransduction and chondrocyte phenotype. A 
recent demonstration of this is that mice lacking the ECM receptor syndecan-4 are 
protected against OA induced by joint instability (Echtermeyer et al., 2009). The use of 
human cartilage explants for cyclic compression does however present a problem, as 
surface fibrillation means it can be difficult to find regions with an even surface to allow 
uniform compression; this would be particularly problematic for OA human cartilage 
and would prevent comparison with results from compression of normal explants.
Outside of the current experimental set-up, future directions could determine how the 
present findings may be utilised to produce a disease-modifying therapy for OA. Could 
the chondrocyte cytoskeleton be manipulated in OA to prevent the loss of organisation 
and its effect on gene expression in the presence and absence of load? The actin 
cytoskeleton is required for many fundamental cell processes so it is not surprising that 
manipulation results in a severe phenotype. Knockout of p-actin in mice is embryonic 
lethal at day 10.5, with embryos displaying severe growth retardation and cardiovascular 
defects, although heterozygous knockouts are viable and fertile (Shawlot et al., 1998, 
Shmerling et al., 2005, Tondeleir et al., 2009). By contrast, transfection of P-actin 
changes the shape of endothelial and epithelial cells and exogenous P-actin accumulates 
as large, unpolymerised deposits at the cell periphery (Mounier et al., 1997). 
Furthermore, disruption of actin microfilament dynamics in cartilage by tissue-specific 
inactivation of the Racl gene results in skeletal deformities, dwarfism and increased 
lethality (Wang et al., 2007). A p-tubulin knockout mouse has not been reported, 
although the requirement of microtubules for mitosis strongly suggests that embryos 
would not develop. Overexpression of P-tubulin in yeast causes cell cycle arrest and cell
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death (Burke et al., 1989). However, in mammalian cells, p-tubulin overexpression has 
little effect on the cell cycle or on microtubule dynamics (Gonzalez-Garay and Cabral,
1995), most likely due to the tubulin auto-regulatory mechanism returning the monomer 
pool to the critical level; p-tubulin overexpression reduces synthesis of endogenous P- 
tubulin and steady state levels of total tubulin are only slightly increased. The exogenous 
p-tubulin is however capable of assembling normally into microtubules (Blade et al., 
1999). Vimentin knockout mice have no obvious phenotype and, whilst no 
compensatory up-regulation of another intermediate filament was detected (Colucci- 
Guyon et al., 1994), this could be due to functional compensation by basal levels of the 
proteins. Studies of vimentin-deficient fibroblasts however have shown decreased 
mechanical stability along with an altered actin cytoskeleton and decreased migration 
(Eckes et al., 1998). Overexpression of vimentin is associated with lens degradation in 
transgenic mice (Capetanaki et al., 1989) and with cancer progression in humans, in 
particular with increased tumour metastasis (Hu et al., 2004, Wei et al., 2008). Direct 
manipulation of the cytoskeleton, particularly actin microfilaments is therefore not likely 
to be a candidate therapy for OA.
Could the changes in the chondrocyte cytoskeleton be used as a biomarker for OA? 
Current serum and urine biomarkers being evaluated for OA are based on providing an 
indication of the extent of cartilage degradation including, for example, peptides 
generated by MMP-mediated cleavage of type II collagen (e.g. CTX-II), COMP and 
cartilage glycoprotein 39 (YKL-40), which increase with increasing tissue damage 
(Abramson and Krasnokutsky, 2006, Li et al., 2007, Huang and Wu, 2009). If changes in 
the cytoskeleton are the cause of, or an early event in, OA disease progression, their use 
as a biomarker could detect OA earlier than cartilage degradation products. Vimentin in 
particular could be used as a biomarker and is being assessed for use in the diagnosis of 
rheumatoid arthritis. Vimentin can be post-translationally modified by peptidylarginine 
deiminases (PAD) during apoptosis and tissue inflammation to produce citrullinated 
vimentin (Vossenaar et al., 2003, Asaga et al., 1998); citrullination of the vimentin N- 
terminal head domain by PAD induced disassembly of vimentin intermediate filaments 
(Inagaki et al., 1989). Auto-antibodies to citrullinated vimentin are a specific and 
sensitive serum marker for rheumatoid arthritis (Vossenaar et al., 2003, Poulsom and 
Charles, 2008). If not citrullinated vimentin, then neoepitope peptides generated by N-
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terminal cleavage of vimentin (Lambrecht et al., 2008) could be used as a biomarker for 
OA.
What is the cause of the observed cytoskeletal differences between normal and OA 
human cartilage? The results of the present study, as discussed above, suggest that the 
altered cytoskeletal organisation observed in human OA cartilage is not simply a result 
of the altered mechanical environment of chondrocytes. However, disruption of the 
articular surface, proteoglycan content and cartilage organisation in OA does result in 
chondrocytes being subjected to higher strains as the tissue is less effective at dissipating 
loads (Saarakkala et al., 2010). If  there is a mechanical threshold, above which the 
cytoskeleton cannot reassemble post-load, then this could more easily be reached in OA 
chondrocytes when compared with normal and could cause the observed differences. 
Recent evidence in chondrocytes supporting this hypothesis has emerged. A single 
impact load induced disassembly of vimentin networks in rat cartilage that did not return 
to that of controls up to 48 hours post-load (Henson and Vincent, 2008). Furthermore, 
compression of single bovine chondrocytes demonstrated a ‘critical strain threshold’ at 
approximately 30% axial strain, after which cells did not fully recover and the 
biomechanical behaviour of cells was irreversibly changed (Ofek et al., 2009); strains 
above this critical level induced catabolic changes in chondrocyte phenotype (Leipzig 
and Athanasiou, 2008) and disruption of actin microfilaments or tubulin microtubules 
lowered the threshold (Ofek et al., 2009). The presence of a ‘critical strain threshold’ 
could be investigated in human chondrocytes and comparison of normal and OA 
chondrocytes would reveal if a change in this threshold occurs in OA or triggers an OA 
phenotype.
Alternatively the cytoskeletal changes observed in OA could be due to proteolytic 
degradation. In addition to the well characterised up-regulation of extracellular 
proteinases in OA, intracellular proteinases are also dysregulated and exhibit increased 
expression in human OA cartilage (Swingler et al., 2009). Expression of a number of 
aspartic proteases, including cathepsin D and p-secretase 1, and cysteine proteases such 
as cathepsin K, caspase-2 and -8, calpain-1, -2, -5 and -6 was up-regulated in OA. 
Furthermore, these proteases or family members have been shown to cleave cytoskeletal 
proteins. For example; calpains have been shown to cleave vimentin, actin, talin, 
paxillin, vinculin and microtubule-associated protein 2 (MAP2) (Fischer et al., 1986,
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Yoshida et al., 1984, Springer et al., 1997, Liu and Schnellmann, 2003); caspases cleave 
actin, gelsolin, a-tubulin and vimentin (Mashima et al., 1997, Silacci et al., 2004, 
Klaiman et al., 2008, Yang et al., 2005, Byun et al., 2001). Vimentin is cleaved by 
cathepsin G (Nakamura et al., 1992) and cathepsin D degrades MAP2 and, to a lesser 
extent, tubulin (Johnson et al., 1991). The role of these proteinases in the changes in the 
cytoskeleton could be assessed in animal models of OA using knockouts or specific 
inhibitors.
In conclusion, this study has shown that changes in the cytoskeleton of OA chondrocytes 
are not simply a result of the altered mechanical environment in OA articular cartilage 
and are maintained following isolation and culture. Changes in the cytoskeleton can 
affect chondrocyte phenotype and the response of chondrocytes to cyclic compression, 
therefore the observed differences in organisation and expression could result in the 
altered phenotype of OA chondrocytes. Differences between the effect of cyclic 
compression on normal and OA chondrocytes support the existence of different or 
divergent mechanotransduction pathways that are mediated in part by elements of the 
chondrocyte cytoskeleton.
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Appendix 1:- Immunohistochemical controls demonstrating the non-specific binding of the TRITC-conjugated secondary antibody 
through the dq)th of normal and osteoarthritic (OA) human articular cartilage sections (20pm). Representative primary-negative controls 
displayed correspond to sections displayed in Fig 3.13.
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Appendix 2:- GAPDH amplification curves from Taqman (A) and SYBR 
Green (B) quantitative PCR The variation of Ct values across samples was 
low and therefore GAPDH was selected for use as the housekeeping gene for 
normalisation of all quantitative PCR data (standards included in the SYBR 
Green quantitative PCR are indicated with black arrowheads).
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Appendix V - Map o f the pGEM*-T Vector (Promega) used for the cloning 
o f PCR prodncts. Ligated vectors with inserts were then transfected into 
JM109 high efficiency competent A1, colt cells, cloned and plasmids purified 
for use as standards in SYBR Green* quantitative PCR. The vectors contain 
T7 and SP6 RNA polymerase promoters flanking a multiple cloning region 
within the a-peptide coding region o f  the enzyme P-galactosidase (lacZ). 
Insertional inactivation o f the a-peptide allows recombinant clones to be 
directly identified by blue/white screening on indicator plates.
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